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  3                                                Abstract 
 
Reperfusion following ischaemia results in endothelial and parenchymal injury 
through a complex cascade of events. This often occurs in human liver transplantation 
as well as with major liver resections and is referred to as Ischaemia Reperfusion 
Injury (IRI). Ischaemic Preconditioning (IPC) is an adaptive response in which 
tolerance to prolonged ischaemia is induced in a target organ by prior brief periods of 
ischaemia.  Benefits of IPC have been demonstrated in experimental models and in 
preliminary human clinical trials. In remote ischaemic preconditioning (RIPC) brief 
ischaemia involves a remote organ. RIPC has been demonstrated to reduce warm liver 
I/R injury in an experimental model by our research group and clinical evaluation is 
ongoing. The effect of RIPC on the late phase of I/R and its mechanism have not been 
investigated. 
This thesis evaluates the effect of  RIPC on both the early and late phases of liver 
warm I/R injury with the hypothesis that beneficial effects are induced by haemoxygenase-
1(HO-1), a free radical scavenger which is involved in degradation of haem and production of 
the vasodilator CO. Male Sprague Dawley rats were subjected to 45 mins of partial hepatic 
(70 %) ischaemia followed by 3 hrs of reperfusion to investigate  the early phase of hepatic IR 
and 24 hrs of reperfusion to study the late phase of hepatic IR. RIPC was performed with four 
cycles of 5 min ischaemia and 5 min reperfusion of the right hind limb before sustained 
ischaemia. Pyrrolidine dithiocarbamate (PDTC) and Zinc Protoporrphyrrin (ZnPP) were 
administered to induce and block haem oxygenase synthesis. Changes to the microcirculation, 
leucocyte adherence and apoptosis were assessed by intra-vital microscopy. Hepatocellular 
injury was assessed by standard liver function tests. HO-1 protein was demonstrated by 
immunohistochemistry (IHC) and measured by Western blot. RIPC improved liver sinusoid 
perfusion, reduced leucocyte adherence and apoptosis in both the early and late phases of IRI. 
  4Hepatocellular injury was reduced. RIPC increased HO-1 production in the liver, particularly 
in hepatic macrophages, as demonstrated by IHC. PDTC treatment (HO-1 inducer) 
reproduced the protective effect of RIPC whereas HO-1 inhibition with ZnPP abolished the 
protective effect.  
The response to HO-1 induction and inhibition indicate that HO-1 has a key role in the 
protective effect of RIPC. Establishing the inducing agent for HO-1 may lead to new 
pharmacological approaches to preconditioning and the protection of the liver from IR injury. 
Studies on RIPC and liver warm I/R using HO-1 knockout mice would clarify the pathways 
involved in RIPC. 
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  6Thesis Description 
 Chapter 1- Remote ischaemic preconditioning a novel 
protective method from ischaemia reperfusion injury- a review. 
an overview of the pathophysiology of ischaemia reperfusion injury,  protective 
strategies are discussed and the evidence and underlying mechanisms of remote 
ischaemic preconditioning have been discussed (review article). 
 
 Chapter 2- materials and methods- 
An description of animals and surgical preparation, experimental   Protocols, tissue 
and     blood collection. The experimental model is described and the methodology 
used within the experiments is elaborately described. 
 
Chapter 3 - Study of microvascular and hepatocellular changes 
in the early phase of hepatic IR (3 hrs) and the effect of RIPC 
on hepatic IR.  
This chapter describes preconditioning of the liver by remote hind limb ischaemia in 
an experimental rat model of warm hepatic IR, microvascular, neutrophil endothelial 
interactions, histological, biochemical changes & hepatocellular death seen in hepatic 
IR and the impact of preconditioning on these changes. 
 
 
 
 
 
 
 
  7Chapter4- The effect of HO-1 inhibition in   modulating the 
protective effect of remote preconditioning in the early phase 
of hepatic IR injury (3 hrs). 
This study demonstrates the role of RIPC induced hepatic haemoxygenase expression 
and its effect on hepatic microcirculatory changes in hepatic IR as demonstrated by 
intravital microscopy in a real time manner. The study demonstrates the effect of 
inhibition of haemoxygenase by Zinc protoporphyrin on remote ischaemic 
preconditioning hepatic microcirculation in hepatic IR. 
 
Chapter5 - New insights into the late phase of hepatic IR and 
the effect of RIPC on hepatocellular and microvascular 
changes after 24 hrs of reperfusion- recovery experimental 
model.  
This chapter describes the hepatic microcirculatory disturbances, biochemical, 
histological, neutrophil endothelial interactions and hepatocyte death in   the late 
phase of hepatic IR and the effect of RIPC on these changes in the late phase of 
hepatic IR.  
 
Chapter6- Study of the spatiotemporal expression of     HO-1 in 
the early and late  phase of hepatic IR and RIPC+IR by 
immunohistochemistry. 
This chapter describes the spatial distribution of haemoxygenase in hepatic IR in the 
early and late phase and effect of RIPC and compared HO expression in different 
groups. 
 
 
 
 
  8Chapter7-   Quantification of   HO-1 expression in the early and 
late phase of hepatic IR and RIPC+IR by Western blot analysis. 
This study quantifies the expression of haemoxygenase by western blots and 
compares the relative density of HO-1 expression in all animal groups. 
 
Chapter 8-   Modulation of Neutrophil activation by RIPC  
Induced inhibition of Cytokine-induced neutrophil 
chemoattractant in the early and late phase of hepatic IR. 
This chapter investigates the modulatory   effects of RIPC on serum CINC levels in 
the early and late phase of hepatic IR and correlates with HO expression.  CINC is a 
neutrophil chemoattractant responsible for activation and recruitment of neutrophils in 
the inflammatory response. Neutrophils are key to IR injury and hence modulation of 
neutrophil activation is of prime importance. 
 
Chapter 9   Mitochondrial function in the early and late phase 
of hepatic IR, modulation by RIPC and correlation with 
biochemical, histological and hepatocellular injury markers. 
This chapter investigates the role of   mitochondria and cytochrome c in early and late 
IR injury and investigates modulatory effects of RIPC on mitochondrial cytochrome c 
release. 
Chapter 10    Summary and discussion of   thesis.  
References appear at the end of the thesis. 
Publications and abstracts from the thesis are enclosed after references of the thesis 
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  19Introduction 
1.1 What is ischaemia reperfusion injury and when does it happen? 
The restoration of blood supply to organs after a certain period of no flow ischaemia 
results in parenchymal damage referred to as reperfusion injury. The critical 
ischaemia period , is  dependent on the organ and is 15-20 minutes (Jaeschke & 
Farhood 2002) in the liver and kidney, 2.5 hours in skeletal muscle(Eckert & 
Schnackerz 1991;Larsson & Hultman 1979;Tountas & Bergman 1977) whilst  in the 
brain ischaemia for more than 5 minutes leads to considerable neuronal death and 
infarction. Reperfusion following periods exceeding the critical ischaemia period 
results in endothelial and parenchymal injury.  The liver is resilient to hypoxic injury. 
Low flow ischaemia found in haemorrhagic shock (MAP-40mmhg for 120 min) 
followed by restoration of normal flow does not lead to activation of Kupffer cells, 
generation of free radicals and associated reperfusion injury  in the initial resuscitation 
period(Jaeschke & Farhood 2002). This is because most kupffer cells are located in 
the periportal region and haemorrhagic shock is characterized by ischaemia in the 
pericentral regions with sinusoidal perfusion failure in the pericentral region as a 
result of which most kupffer cells are not affected by pericentral hypoxia. 
1.2 Pathophysiology of ischaemia reperfusion injury (IRI) (Fig 1.1) 
Following a period of ischaemia tissues adapt to anaerobic metabolism (Carden & 
Granger 2000).  Restoration of blood supply results in oxygen supply in excess of the 
requirements which leads to activation of macrophages in the vasculature and 
consequently generation of super oxide radicals also referred to as reactive oxygen 
species (ROS) causing oxidative stress. The key event in the initial phase of 
reperfusion injury is activation of macrophages which are the primary source of 
extracellular ROS. CD 4 lymphocytes are also activated and serve to recruit 
  20macrophages. Endothelial cells and parenchymal cells are activated leading to release 
of free radicals originating from intracellular mitochondria, xanthine oxidase system, 
NADH oxidase system and iron redox system.  There is an imbalance between 
endothelial nitric oxide and super oxide radicals leading to impairment of protective 
effects of NO on the microvasculature. Free radicals (ROS) are the key initiators of 
reperfusion injury which lead to endothelial injury and further release of pro 
inflammatory cytokines.  Simultaneous activation of complement in the early phase 
serves to prime macrophages and neutrophils for  release of ROS(Jaeschke et al. 
1993). Complement along with cytokines and chemokines leads to recruitment of 
neutrophils, increased expression of adhesion molecules and adhesion of neutrophils 
to the endothelium in venules. Neutrophils damage endothelium, extravasate, adhere 
to parenchymal cells and plug the local microvasculature which along with 
vasoconstriction due to increased endothelin release exacerbates tissue ischaemia. In 
the late phase of IRI neutrophils produce an oxidative burst causing parenchymal 
injury due to release of free radicals and proteases. Thus macrophages and neutrophils 
are the key cells in the initial phase and and   late phase of IRI respectively. 
1.3 The clinical relevance of ischaemia reperfusion injury. 
IRI often happens following transplantation of organs, major organ resections and 
trauma. IRI following transplantation can lead to primary nonfunction of the 
implanted organ (<5%), primary dysfunction (10-30%) and also multiple organ 
dysfunction syndrome. (MODS)  resulting in morbidity and mortality in adult and 
paediatric transplants (Clavien, Harvey, & Strasberg 1992;Margarit et al. 
2000;Pokorny et al. 2000).In  hypovolaemic shock resuscitation leads to IRI in brain, 
gut, pancreas  (Yamakawa et al. 2000) which results in more extensive tissue 
  21infarction. . IRI results in adipocutaneous and musculoskeletal flap necrosis as well as 
non-functioning microvascular flaps. 
Hepatic ischaemia reperfusion injury and its clinical relevance. 
In the liver shock resuscitation reduces its tolerance to subsequent warm ischaemia 
(pedrizet). In major organ resections  inflow occlusion (Liu et al. 1996) and 
subsequent restoration of blood supply causes reperfusion injury. This can lead to 
postoperative organ insufficiency. Ischaemia reperfusion injury is also associated with 
chronic rejection due to arteriosclerosis(Fellstrom et al. 1998) caused by IRI.  In the 
context of liver transplants IR leads to nonfunction or dysfunction of transplanted 
organs in 10% cases. This contributes to the shortage of organs for liver 
transplantation   due to higher susceptibility of   marginal livers to the ischaemic 
insult.  Hence it is highly essential that protective strategies aimed at minimising 
ischaemia reperfusion injury and maximising organ usage are developed.  Hepatic 
ischaemia reperfusion injury may lead to acute renal failure {Lee et al, lab invest 
2009}. Histological assessment of renal tissue showed increased endothelial cell 
apoptosis and renal tubular disruption after hepatic IR. While kupffer cells and 
sinusoidal endothelium are the key cells in the cold phase of hepatic IR, warm IR 
injury    causes hepatocyte parenchymal injury through neutrophil activation and ROS 
release. Protective strategies aimed at reducing kupffer cell activation, sinusoidal 
endothelial damage, neutrophil activation and effects of free radicals released after 
reperfusion need to be developed in order to reduce IR injury and organ dysfunction. 
One of the protective strategies is ischaemic preconditioning which is discussed in the 
next section. 
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(Figure above) 1.1 Diagramatic representation of ischaemia reperfusion injury 
 
 
 
1.4 Ischaemic preconditioning 
 
Protective strategies have been developed for protection of organs from ischaemia 
reperfusion injury which are referred to as organ preconditioning. Preconditioning is 
only a method by which the target organ is conditioned prior to the ischemic insult in 
  23order to reduce the extent of injury. Preconditioning could be mechanical or 
pharmacological. Mechanical preconditioning is either direct or remote (indirect).  
In direct ischemic preconditioning a brief direct ischemic insult to the target organ 
followed by reperfusion results in tolerance to subsequent insults of ischaemia. 
Ischaemic tolerance is induced by regulation of endothelial function, blood flow and 
decreased macrophage as well as neutrophilic activity. This results in decreased 
endothelial injury and eventually decreased parenchymal injury.  Direct ischemic 
preconditioning has been investigated as a surgical tool for many years (Murry, 
Jennings, & Reimer 1986) Although direct IPC does reduce reperfusion injury (Arai 
et al. 1999;Peralta et al. 1996;Yin et al. 1998) as well as its systemic consequences 
(Fernandez et al. 2002;Peralta et al. 2001) its main disadvantage is direct stress to the 
target organ and mechanical trauma to major vascular structures which have limited 
its clinical application. 
Remote preconditioning is a novel method where ischaemia followed by reperfusion 
of one organ is believed to protect remote organs either due to release of biochemical 
messengers in the circulation or activation of nerve pathways resulting in release of 
messengers which have a protective effect. This protects target tissue without direct 
stress. Remote preconditioning was first demonstrated in myocardium (McClanahan 
et al. 1993) by McClanahan in 1993. He found that ischaemia in the kidney followed 
by reperfusion protected myocardium from ischaemia and reduced infarct size. In 
animal models brief ischaemia reperfusion of the limb, gut, mesenteric or kidney 
reduces myocardial infarct size. In humans skeletal preconditioning has been used for 
myocardial protection with the beneficial effect being attributed to regulation of 
endothelial protection(Kharbanda et al. 2002). 
1.5 Remote organ injury and systemic inflammatory response following IRI 
  24In addition to the local effects of IRI several studies have shown evidence of remote 
organ injury following ischaemia reperfusion(Fantini & Conte 1995;Horie & Ishii 
2001;McCarter et al. 2004;McCarter et al. 2004;Schmeling et al. 1989;Weinbroum et 
al. 1997;Weinbroum et al. 1999;Yassin et al. 2002). Due to ischaemia reperfusion 
injury a systemic inflammatory response is created which results in remote organ 
injury as shown in animal models of limb ischaemia reperfusion where prolonged 
limb ischaemia reperfusion leads to lung, liver and kidney dysfunction. Similar 
evidence has been provided in hepatic ischaemia reperfusion and mesenteric 
reperfusion models. Due to systemic cytokine release and neutrophilic activation there 
is multi organ dysfunction following reperfusion injury. However the progress of 
remote organ injury decreases over a period of three hours from the start of 
reperfusion and this time point corresponds to the endogenous expression of 
haemeoxygenase which confers a protective effect on remote organs(Wunder et al. 
2004).In another study ischemic preconditioning of the hind limb by 3 cycles of 
10min ischaemia followed by 10 min reperfusion prior to 4hrs of left lower limb 
ischaemia followed by 2hrs of reperfusion reduced lung injury on histology, 
neutrophilic infiltration, myeolperoxidase activity, plasma TBARS levels indicating 
lower oxidative stress in the preconditioned group(IPC+IR) as compared to IR 
group(Olguner et al. 2006). 
1.6 Evidence of remote preconditioning. 
1.6.1 Intra cardiac regional preconditioning 
The very first evidence of this can be traced to 1993  when Przyklenk   conducted 
regional myocardial preconditioning in an experimental dog models(Przyklenk et al. 
1993). In this model the circumflex coronary artery was occluded 4 times for 5 
minutes followed by 5 minutes reperfusion prior to 1 hour of sustained left anterior 
  25descending coronary artery occlusion and a significant reduction in myocardial infarct 
size was seen as compared to nonpreconditioned groups. Nakano et al questioned the 
existence of remote  preconditioning as in an experimental Langendorff model they 
showed two cycles of 5 min occlusion of a branch of coronary artery followed by 5 
min of reperfusion prior to global cardiac ischaemia protected the  myocardium 
supplied by the artery but  not  the rest of the myocardium against sustained 
ischaemia(Nakano et al. 2002;Przyklenk et al. 1993). However their experiments were 
in a rabbit model and they used a different preconditioning protocol. Moreover their 
argument is not supported by any other studies. Hence evidence for non existence of 
remote preconditioning in other species cannot be concluded from their study.  
Table no 1.1- Studies on intraorgan regional preconditioning. 
Author/refe
rence 
Site of 
preconditi
oning 
stimulus 
Site of index 
ischaemia 
mo
del 
Endpoi
nt 
Organ 
protection 
Proposed 
mechanism 
Intracardiac 
preconditio
ning 
         
Przyklenk et 
al 
1993 
Circumflex 
occlusion 
Lad 
occlusion  Dog  Infarct 
size 
Reduced 
infarct size 
 
Not identified 
Nakano et al 
2002 
Cardiac 
ischaemia 
Total 
LV:global 
ischaemia 
Rab
bit 
Infarct 
size 
Reduced 
infarct size 
 
Not applicable 
Tanaka et al 
1998 
Cardiac 
ischaemia 
Remote 
myocardial 
preconditioni
ng 
Rab
bit 
Infarct 
size 
Reduced 
infarct size 
Heat shock 
proteins 
Gho et al 
1996 
Cardiac 
ischaemia 
Cardiac 
ischaemia  Rat  Infarct 
size 
Reduced 
infarct size 
?Neurogenic 
pathway, ?humoral
1.6.2 Role of stretch in intracardiac preconditioning 
Stretch of myocardial muscle has been shown to reduce infarct size in the heart 
(Domenech & Macho 1998) (Ovize, Kloner, & Przyklenk 1994). Acute volume load 
followed by coronary artery occlusion for 1 hour and reperfusion for 4.5 hours 
  26significantly reduced myocardial infarct size. Injection of Glibaclide (stretch ion 
blocker) into the atrium before volume overload blocked the protective effects. These 
observations supported the argument that stretch acts as a trigger of the remote 
preconditioning stimulus. Contrary to this Weinbrenner et al(Weinbrenner et al. 
2004a) showed that infrarenal aortic occlusion (IOA) was linked to an increase in 
mean arterial pressure(13%) however, myocardial infarct size was only reduced when 
IOA was followed by reperfusion. Their data showed that the increase in MAP was 
inadequate to induce significant myocardial stretch and cardiac preconditioning. 
Dickson et al in a model of isolated perfused hearts which excludes pressure/stretch 
related effects showed transfer of effluent from preconditioned hearts to have a 
protective effect to ischaemia in the virgin recipient hearts. Clearly   experimental 
evidence is in favour of protective substances released into the blood stream which 
confer protection on other organs. Future experiments targeted at clearly 
demonstrating the role of stretch in preconditioning and the underlying mechanism 
are needed.  
In addition to stretch other non ischemic stimuli such as ventricular pacing  have been 
shown to activate  KATP channels, modulate ionic fluxes and protect the myocardium 
from IR injury(Petrishchev et al. 2001;Verdouw et al. 1996). However experimental 
evidence in support of these studies is inadequate and future studies are needed to 
evaluate the underlying mechanisms. 
1.6.3 Interorgan preconditioning 
Remote preconditioning is not confined to within an organ and can be transferred 
from one organ to another. Liauw et al in an experimental model of limb ischaemia   
demonstrated protection of   remote skeletal muscle. 
1.6.4 The effect of cerebral ischaemia on the heart 
  27Spontaneous ischaemic events in the brain have been shown to induce adaptation of 
the heart to ischaemia(Tokuno et al. 2002). Tokuno et al were the first to demonstrate 
in a mouse model decreased myocardial infarction in mice with neurological signs of 
disease. Brain ischaemia induced by bilateral ligation of internal carotid arteries 24 
hours prior to global myocardial ischaemia reduced myocardial infarct size, improved 
myocardial performance and attenuated  increase in left ventricular end diastolic 
pressure  following reperfusion. There was no evidence of brain damage except for 
transient neurological patterns(Tokuno et al. 2002).Importantly this study  
demonstrated that ischaemia rather than reperfusion stimulated signalling pathways 
which led to remote protection. 
Table no 1.2- Studies on RIPC by brief cerebral ischaemia. 
Preconditio
ning by 
cerebral 
ischaemia 
         
Author/refe
rence 
Site of 
preconditi
oning 
stimulus 
Site of index 
ischaemia 
mo
del 
Endpoi
nt 
Organ 
protection 
Proposed 
mechanism 
Tokuno et al 
(2002) 
Cerebral 
ischaemia 
Cardiac 
ischaemia 
Mo
use 
isol
ated 
hear
t 
Infarct 
size 
Reduced 
infarct size  iNOS and NO 
Verdouw et 
al  
2001  
Cerebral 
ischaemia 
Cardiac 
ischaemia  Pig  Infarct 
size 
No change 
in infarct 
size 
Norepinephrine 
 
 
1.6.5 The   effect of renal and infrarenal ischaemia on remote organs  
Five studies showed that brief renal ischaemia reduced the size of infarct resulting 
from myocardial ischaemia(Ates et al. 2002;Gho et al. 1996;Pell et al. 1998;Singh & 
Chopra 2004;Takaoka et al. 1999) 
  28The first  evidence of interorgan remote preconditioning dates back to 1993 when Mc 
Clanahan and his team carried out experiments on a rabbit model and showed that a  
10 min period of renal ischaemia was as effective as a 5 min period of coronary artery 
occlusion in preconditioning the heart(McClanahan, Nao, Wolke, Martin, Metz, & 
Gallagher 1993).Gho et al in 1996 (Gho et al. 1996) showed that brief periods of 
remote organ ischaemia (mesentery and kidney) were as effective in producing 
cardiac protection as direct cardiac preconditioning. On causing MAO (mesenteric 
occlusion) for 15 min and reperfusion prior to 60 min CAO (coronary artery 
occlusion) there was a decrease in myocardial infarct size. 15 min RAO (renal artery 
occlusion) prior to 60 min CAO reduced infarct size under hypothermic conditions 
but not normothermic conditions demonstrating that the brief renal ischaemic 
preconditioning protocol is ineffective by itself. The onset of myocyte injury is 
associated with ATP depletion and breaks in sarcolemmas which are linked to 
intracellular acidosis and raised phosphocreatinine levels. Takoaka et al showed by 
NMR-spectroscopy   that brief renal ischaemia (10 min) followed by reperfusion of 
20 min in rabbits led to decrease in myocardial infarct size on histology, attenuated 
depletion of ATP, preserved myocyte PH and improved recovery of myocardial 
phosphocreatinine as well as ATP levels during the subsequent reperfusion period.. 
Pell et al(Pell et al. 1998) in a rabbit model showed that RAO(10 min) followed by 
reperfusion(10min)prior to CAO for 30 min followed by 2hrs of reperfusion reduced 
infarct size. Singh et al (Singh & Chopra 2004) in a rat model showed that 
preconditioning by  four cycles of 5 min RAO followed by 10 min reperfusion prior 
to CAO for  30 min followed by 2hrs reperfusion reduced myocardial infarct size. The 
study by Gho et al demonstrated that Ganglion blockade abolished the protective 
effects of remote preconditioning but not of direct cardiac preconditioning suggesting 
  29a different pathway of signal transduction in both methods. Takoaka et al showed that 
the protective effects of RIPC from kidney were similar to direct myocardial 
preconditioning.  
These studies collectively demonstrate that brief periods of RAO are necessary for 
preconditioning and brief periods of reperfusion are necessary for preconditioning. 
Preconditioning was not seen in permanent arterial occlusion suggesting that infarct 
size limitation was due to washout of a protective substance during reperfusion. Both 
rat and rabbit models demonstrated the benefit of preconditioning. The extent of 
myocardial protection by RAO was more in Takoaka’s study as compared to 
McClanahan although both used rabbit models possibly due to differences in core 
temperatures of the animal models. This remained unclear as McClanahan did not 
report core body temperature in his study. 
1.6.6 Influence of temp, blood pressure, baroreflex and heart rate on RIPC 
Hypothermia has been shown to contribute to preconditioning in previous studies. 
{Yuan, 2004; Bolling, 2001; Hale, 1999}.  McClanahan demonstrated remote 
preconditioning of the heart from brief RAO  but did not report core body temperature 
and hypothermia could be a factor in preconditioning.Gho et al demonstrated 
preconditioning of myocardium by brief RAO (Gho, schoemaker, sharma)but  they 
observed surgical manipulation to be associated with a fall in core body temperature 
in their experimental model  suggesting  the role of hypothermia in 
preconditioning.Gho et al  demonstrated that  (Gho et al. 1996)  preconditioning by 
RAO for 15 min prior to CAO for 60 min was effective only under hypothermic 
conditions. Hypothermia enhanced   preconditioning by brief CAO prior to CAO for 
60 min but no enhancement of preconditioning by MAO was demonstrated by GHO 
et al. These findings were supported by Pell et al who demonstrated that MAO was 
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preconditioning of the heart. The RAO stimulus was below threshold under 
normothermic conditions and hypothermia enhanced its protective efficacy while 
MAO was near its maximal protective efficacy and hence hypothermia did not 
enhance its effects. These studies demonstrate that the role of temperature critically 
depends upon the experimental protocol and model chosen and the modification of 
protective pharmacological/physiological preconditioning stimuli by temperature. 
Fall in blood pressure may lead to poor flow in the target organ and exacerbate the 
preconditioning ischaemic insult thus enhancing the preconditioning effect. However 
Gho et al observed that Hexamethonium(Gho et al. 1996) (autonomic ganglion 
blocker)was associated with a drop in blood pressure and heart rate .This was seen in 
all groups with no significant difference in infarct size  and hence the contribution of  
drop in blood pressure to the  preconditioning ischaemic stimulus was ruled out. The 
vasopressor response seen on preconditioning by MAO could potentially lead to 
myocardial stretch and preconditioning but the effect of preconditioning was 
abrogated on ganglion blockade despite persistence of the rise in B.P on MAO ruling 
out any preconditioning effects of rise in blood pressure. 
The data from Weinbrenner’s (Weinbrenner et al. 2002)experiments supported the 
argument against any contribution of rise in mean arterial pressure or stretch to the 
protective effect as the rise in MAP alone did not reduce infarct size. The stretch 
stimulus was of inadequate strength (increased MAP by 13%) and duration (only 2 
min) to trigger preconditioning in comparison to the  external stimulus required in an 
experimental setting(Ovize, Kloner, & Przyklenk 1994). They also found a drop in 
heart rate which was attributed to baroreceptive changes following rise in MAP on 
  31IOA. However baroreflex in no way contributed to the protective effect since the drop 
in heart rate was universal in all groups. 
Weinbrenner et al (Weinbrenner et al. 2002)found a rise in lactate following IOA but 
the rise was transient and its decline rapid in comparison to the period(10 min) of 
reperfusion required for remote protection indicating the unlikely role of lactate in 
triggering protection. Moreover additional animal studies have shown no benefit of 
lactate in protection of the heart(Doenst et al. 1996). In IPC studies(Weiss et al. 1996) 
a decrease in lactate levels has been found indicating its  unlikely role in mediation of 
protection . 
1.6.7 Role of mesenteric preconditioning 
The beneficial effect of mesenteric preconditioning on remote organs 
Six studies provide evidence to support remote ischaemia preconditioning from   
mesentery.Shoemaker et al (Schoemaker & van Heijningen 2000b) in an  
experimental rat model showed that  brief mesenteric occlusion (15 min)followed by 
(10 min)reperfusion prior to 60 min CAO and 180 min reperfusion  resulted in 
decreased myocardial infarct size on histology. In a similar rat model GHO et al 
showed 15 min MAO followed by 10 min reperfusion to be as effective as 15 min of 
CAO followed by 10 min reperfusion prior to 60 min CAO and reperfusion. 
Two studies by Wolfrum et al in an experimental rat model showed that 15 minutes of 
mesenteric ischaemia followed by 15 minutes of reperfusion prior to 30 min CAO 
followed by 150 min reperfusion reduced myocardial infarct size on histology. Liem 
et al(Liem et al. 2002a)  showed that brief mesenteric artery occlusion (MAO15min) 
followed by reperfusion preconditioned the intestine and reduced myocardial infarct 
size. Wang et al (Wang et al. 2001) showed that MAO(30 min) followed by 
  32reperfusion and  induction of  myocardial ischaemia 24 hours later (30 min of CAO 
and 180 min of reperfusion) reduced myocardial infarction. They also showed that 
remote preconditioning reduced myocardial MPO (myeloperoxidase activity) which is 
a marker of systemic inflammatory response.  
Patel et al in a rat model showed that a single period of 15 min MAO followed by 10 
min reperfusion was more effective than three cycles of 5 minutes of ischaemia 
followed by 5 min reperfusion prior to 30 min of ischaemia and 2hrs of reperfusion 
although both reduced myocardial infarct size significantly on histology.  
Tang and Xiao worked on protective effects of mesenteric artery occlusion and 
showed that reducing infarct size and myocardial creatinine kinase levels(Tang et al. 
1999;Xiao et al. 2001) .  Experiments by Petrischev (Petrishchev et al. 2001) and 
Vlasov et al supported evidence for remote mesenteric preconditioning however in 
Vlasov’s(Vlasov, Smirnov, & Nutfullina 2001) experiments the effect of remote 
preconditioning was less in comparison to direct preconditioning. 
These studies collectively support the evidence for remote preconditioning by MAO 
and reperfusion. All studies demonstrated an effective preconditioning protocol with 
brief MAO and only one study (Patel) demonstrated that a single cycle of RIPC was 
more effective than multiple cycles. Only one study (Vlasov) showed that direct 
ischaemic preconditioning is more effective than RIPC and one study (Wang et al) 
demonstrated the existence of late phase of mesenteric preconditioning. Histology is a 
common endpoint in all studies but MPO activity or myocardial creatinine kinase 
levels were not evaluated in all studies. Most studies did not find any significant 
haemodynamic alterations except Wolfrum et al   who showed that MAP increased on 
mesenteric occlusion and decreased on reperfusion with a gradual return to baseline in  
This was supported by data from Wang’s study (Wang et al. 2001). None of the 
  33studies measured ventricular function. Future studies aimed at clarifying the 
functional importance of mesenteric RIPC, comparison of preconditioning protocols 
to establish the ideal protocol and clinical application are needed. 
 
 
Preconditioning 
by mesenteric 
ischemia 
 
          
Author/reference 
Site of 
preconditioning 
stimulus 
Site of index 
ischemia  model Endpoint  Organ 
protection  Proposed mechanism 
Gho 
1996 
Mesenteric and 
renal  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size  Neurogenic, humoral 
Schoemaker et al 
(2000) 
Mesenteric 
ischemia  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size 
Bradykinin mediated 
and neuronal pathway 
Liem et al 
 (2002) 
Mesenteric 
ischemia  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size 
Increased interstitial 
adenosine 
levels;  afferent autonomic 
nerve  stimulation, 
activation of myocardial 
adenosine receptors 
Wang Y.P. et al 
(2001)  Mesenteric  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size  Role for iNOS 
Wolfrum 
(2002)  Mesenteric  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size 
 Myocardial PKC 
activation 
through both neuronal and 
bradykinin dep humoral 
pathway. 
Wolfrum  
              2005  Mesenteric   Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size 
Calcitonin gene related 
peptide. 
Patel at al 
2002  Mesenteric  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size  Endogenous opiods 
Tang et al 
 
 
 
Mesenteric  Cardiac ischaemia  Rat  Infarct size  Reduced infarct 
size 
Capsaicin sensitive sensory 
nerves 
Xiao et al 
(2003)  Mesenteric  Cardiac ischaemia  Rat  Infarct size  Reduced infarct 
size 
Capsaicin sensitive sensory 
nerve 
and NOS 
 
 
Petrishcev et al 
 
 
 
 
 
Direct cardiac 
and remote 
mesenteric 
ischaemia 
 
 
  Cardiac   
ischaemia 
 
 
 
Rats 
 
 
 
Infarct size 
 
 
 
Reduced infarct 
size 
 
 
 
NO unlikely mechanism. 
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Verdouw et al 
 
 
Mesenteric 
ischemia, renal 
ischemia and 
ventricular 
pacing 
 
 
 
Cardiac ischemia 
 
 
 
Pig 
 
 
 
  Infarct size 
 
 
 
Reduced infarct 
size 
Ventricular pacing by 
activation of 
katp channels. 
Mesenteric ischemia 
effective at 
low  31 and highcore 36  
degree Celsius 
Renal ischemia only at high 
temp 
.-36 degrees Celsius. 
Vlasov et al 
(2004) 
Intestinal 
ischemia  Heart and intestine  Rat  Infarct size 
No myocardial 
protection. 
Intestinal 
adaptation 
NO in direct 
preconditioning 
but not in remote 
preconditioning. 
 
Liem at al 
(2004) 
Mesenteric 
ischemia 
Cardiac ischemia 
  Rat Infarct  size 
 
reduced infarct 
size 
 
 
      Mesenteric ischemia 
    Adenosine dependent 
pathway 
  Mesenteric 
ischemia  Cardiac ischemia  Rat  Infarct size  Reduced infarct 
size 
Inflammatory gene 
suppression.  
           
 
 
Table no 1.4- Studies on RIPC by brief mesenteric ischaemia. 
 
  351.6.8 The protective effects of prior limb ischaemia on remote organs  
Nine studies have shown the beneficial effects of brief limb ischaemia in 
preconditioning the heart.  
Oxman first showed that hindlimb ischaemia reduced reperfusion cardiac 
tachyarrythmias(Oxman et al. 1997). A brief period of in vivo limb ischaemia (10 
minutes of ischaemia) followed by reperfusion (10min) in a rat model led to 
cardioprotection. From this study it appeared that a systemic stress response was 
associated with catecholamine release due to brief limb ischaemia. Kharbanda 
conducted studies in both a pig model and a clinical setting. Four 5 minute cycles of 
IRI of the hind limb reduced myocardial infarct size and improved ventricular 
function in pigs. Hind limb ischaemia showed a protective effect in reducing 
endothelial injury in humans  (Kharbanda et al. 2002;Oxman et al. 1997). Ischaemia 
reperfusion of the upper limb blunted its vasodilatory response to acetylcholine 
however remote brief ischaemia of the contralateral arm attenuated decrease in 
ipsilateral neutrophil activation following IR. Gunaydin et al showed that 
preconditioning by two cycles of 3min upper limb ischaemia(tourniquet pressure 300 
mm hg) separated by 2min of reperfusion   in patients undergoing coronary bypass 
showed an equal rise in CPK-MB in both preconditioned and control groups, however 
there was a significant   increase in LDH in the preconditioned group with levels of 
myocardial lactate and lactate efflux twice as high compared to the control group 
providing biochemical evidence for maintenance of myocardial anaerobic glycolysis 
in the preconditioned group. From a clinical perspective RIPC as shown by 
Kharbanda et al maybe useful in patients undergoing coronary angioplasty for 
reducing myocyte and endothelial injury while RIPC demonstrated by Gunaydin et al 
maybe useful in patients undergoing cardiopulmonary bypass where preconditioning 
  36by transient upper limb ischaemia can be used to protect the myocardium against 
subsequent ischaemia when the aorta is clamped.  Patients with intermittent 
claudication may have a better tolerance to myocardial ischaemia due to 
preconditioning by brief limb ischaemia and consequently have a longer window 
period for thrombolytic therapy to salvage ischaemic myocardium. Studies by 
Vlasov(Petrishchev et al. 2001) showed that both brief limb ischaemia and cardiac 
ischaemia reduced myocardial infarct size. A significant reduction in NADH 
diaphorase and LDH activity was seen in the ischaemic zone in IR group which was 
attenuated by both RIPC and direct IPC. In addition an increase in NADH diaphorase 
activity was seen in intact cardiomyocytes of the preconditioned groups as compared 
to IR group animals. This provided evidence that both remote and direct 
preconditioning induced some form of metabolic activity and ischaemic adaptation in 
both ischaemic and intact cardiac myocytes. This is supported by evidence from 
Gunaydin who showed attenuated LDH activity due to anaerobic glycolysis in 
preconditioned myocardium. In a mouse model Li et (Li et al. 2004) al used six cycles 
of 5 min hind limb ischaemia followed by 5 min  reperfusion and showed a significant 
reduction in myocardial infarct size. Expression of NF-KB proteins from both limb 
skeletal muscle after preconditioning and myocardium suggested the induction of 
protective signals in the limb being transferred to the heart and leading to ischaemic 
adaptation. 
Kharbanda’s group carried out further studies to characterise the time course of 
protection from RIPC and the existence of two phases of preconditioning.  There was 
evidence of an early period of protection followed by reappearance of a phase of 
protection 24-48 hours later called the second window of preconditioning. 
Observations by Li et al showed that Hind limb preconditioning protected left 
  37ventricular function with the effect being maximal 24 hours after preconditioning, 
which supported the existence of a late phase of preconditioning as seen in studies by 
Kharbanda and Moses. Konstantinov et al showed increased expression of myocardial 
heat shock protein genes after limb preconditioning resulted in myocardial 
cytoprotection. Kristiansen in a rat model of hind limb preconditioning showed that 4 
cycles of 5min hind limb ischaemia followed by 5min of reperfusion in the donor 
significantly reduced coronary IR in donor hearts on implantation in the recipient. 
Konstantinov showed that preconditioning of the recipient by a similar 
preconditioning protocol of 4cycles of 5min hind limb ischaemia reduced myocardial 
infarct size in the donor heart. In contrast weinbrenner showed in a model of single 
cycle of infrarenal aortic occlusion 15 min followed by 10 min reperfusion prior to 30 
min of CAO and 30 min of reperfusion reduced myocardial infarct size(Weinbrenner 
et al. 2004). 
Seven Studies have demonstrated the beneficial effect of skeletal preconditioning on 
adipocutaneous, muscle and  cremasteric muscle flaps as well as remote skeletal 
tissue(Addison et al. 2003;Kuntscher et al. 2002;Kuntscher et al. 2002;Kuntscher et 
al. 2002;Kuntscher et al. 2003;Kuntscher et al. 2003;Moses et al. 2004). 
Remote preconditioning has a protective effect on flaps reducing flap necrosis which 
is of particular benefit in patients with irradiated tissues, smokers and obese patients. 
This protective effect is more pronounced in the late phase of preconditioning .These 
studies showed remote ischemic preconditioning   to be  associated with better 
microcirculation, decreased leukocyte endothelial sticking and endothelial 
dysfunction as well as better capillary blood flow with terminal arteriolar dilatation  
(Wang et al. 2004). Similar evidence of remote skeletal protection following three 
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a pig model was provided by Moses et al(Moses et al. 2004) 
Four studies have shown Hind limb ischaemic preconditioning  to be beneficial in 
protection of the lung and the brain (Harkin et al. 2002; Vlasov, Korzhevskii, & 
Poliakova 2004; Xia et al. 2003). 
 Harkin et al (Harkin et al. 2002)in an experimental porcine model showed that brief 
preconditioning of the lower limb prior to prolonged IRI of the  lower limbs protected 
against lung dysfunction secondary to limb IRI . Limb preconditioning reduced 
plasma cytokine levels, ameliorated impaired gas exchange and oxygen transport, 
reduced the elevation in pulmonary arterial pressure and vascular resistance, reduced 
pulmonary oedema and decreased lung tissue myeloperoxidase activity. In clinical 
settings of surgery of the lower limbs there is release of cytokines after prolonged 
ischaemia leading to ARDS and limb preconditioning could protect against lung 
dysfunction found with ARDS.In a different model of local lung IRI 
Waldow(Waldow et al. 2005) showed that remote limb preconditioning reversed the 
detrimental effects of lung IRI on lung function and attenuated pulmonary 
hypertension and impaired gas exchange. Thus both models of RIPC were effective in 
protecting the lung. Harkins demonstrated that preconditioning of the hind limb prior 
to limb IR injury reduced cytokines (IL-1 and Interleukin-1β) and activated 
neutrophils, SIRS and lung dysfunction. In contrast Waldow et al showed a reduction 
in plasma Interleukin-1β levels and lung tissue macrophage counts in the RIPC group 
to sham levels but IL-6 levels were not reduced to sham levels and release of ROS 
and activation of circulating primed granulocytes was not affected by preconditioning. 
In Waldow’s experimental model systemic preconditioning by repeated hind limb 
  39ischaemia protects again acute IR injury of the lung but not against all indices of 
systemic inflammation.  
Xia et al showed that RIPC by 3 episodes of 5min occlusion and 5 min reperfusion of 
the iliac artery preserved lung function and prevented a rise in pulmonary vascular 
resistance as well as arterial pressure following myocardial reperfusion injury. This 
has important clinical applications in cardiac surgery as coronary IR has deleterious 
effects on the lung which is a major cause of mortality in these patients. In beating 
heart surgery it is not possible to directly clamp the aorta and therefore    direct 
cardiac preconditioning is not possible. Under such circumstances    preconditioning 
from a remote organ such as the limb may be useful as shown by Xia et al.  
 The brain showed ischaemic adaptation to remote preconditioning with decreased 
brain swelling as well as improved blood flow (Vlasov, Korzhevskii, & Poliakova 
2004). 
 Most models of limb preconditioning supported the effectiveness of multiple brief 
cycles of limb ischaemia followed by reperfusion conversely Weinbrenner et al 
showed a single cycle to be more effective than multiple cycles and prolongation of  
length of the single cycle led to more effective preconditioning. 
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RIPC by limb 
ischaemia 
 
         
Author/ 
reference 
Site of 
preconditioni
ng stimulus 
Site of index 
ischaemia 
mod
el  Endpoint  Organ 
protection  Proposed mechanism 
Oxman et al 
(1997)  Hind limb  Cardiac 
ischaemia  Rat 
Reperfusi
on 
arrythmias 
Decreased 
arrythmias  Nor epinephrine 
Birnbaum et al 
(1997) 
Gastroenemiu
s and reduced 
flow 
Cardiac 
ischaemia 
Rabb
it 
Infarct 
size 
Reduced 
infarct size  Not identified 
 
Liauw  
1996 
Gracilis of 
ipsilateral 
limb 
Gracilis of 
contralateral 
limb 
Rat  Muscle 
necrosis 
Reduced by 
60%  Not investigated 
Kharbanda et al 
(2002)  Hind limb  Cardiac 
ischaemia  Pig  Infarct 
size 
Reduced 
infarct size 
Suggested 
involvement of 
adrenergic 
pathway and blockade 
by reserpine. 
Gunaydin et al 
(2002)  Upper limb 
Cardiac 
ischaemia 
(Cardiopulmona
ry bypass) 
Hum
an 
LDH,CK 
release 
Not 
conclusive 
 Enhanced anaerobic 
glycolysis 
Xia et al 
2004  Iliac artery  Cardiac 
ischaemia 
Shee
p 
Pulmonar
y function 
and 
pulmonar
y vascular 
resistance 
Lung 
protection 
And 
decreased 
pulmonary 
vascular 
resistance. 
 
KAtp channel –
pulmonary vascular 
dilatation and 
myocardial protection 
Kharbanda et al 
2002  Upper limb 
Upper 
extremity(contra
lateral arm) 
Hum
an 
Endotheli
al 
dysfunctio
n 
Skeletal 
protection   Not  identified 
Addison et al  Hind limb  Global skeletal 
protection  Pig  Ischemic 
necrosis 
Skeletal 
protection  
Opioid delta 1 
receptors 
 
Kuntscher et al 
2003 
 
Hind limb  Adipocutaneous 
flaps  Rat  Flap 
necrosis 
Protection 
 
NO 
 
 
Kuntscher et al 
  Hind limb  Rat cremasteric 
muscle flaps  Rat  Flap 
necrosis  Protection   NO 
Kuntscher et al  Hind limb  Flap ischaemia  Rat  Flap 
necrosis 
Flap 
Protection 
 
 
 
? 
 
 
 
 
 
Liem et al  Hind limb    Rat   
Skeletal 
muscle 
protection 
 
 
?mechanism 
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Moses et al 
2004 
 
 
Hind limb 
 
Rat 
 
Flap 
necrosis 
 
Skeletal 
muscle  
protection  
 
KATP channels(early 
phase) 
 
Wang  
Hind limb, 
femoral A  Cremaster flap  Rat  Flap 
necrosis 
Reduced flap 
necrosis  ?mechanism 
Liem at al 
2002(check up) 
Check (Hind 
Limb)  Heart Rat  Infarct 
size 
Interorgan 
preconditioni
ng of heart 
Adenosine 
Weinbrenner 
(2002)  Infrarenal  Cardiac 
ischaemia  Rat  Infarct 
size 
Reduced 
infarct size 
Opioid receptors 
and PKC ;  
humoral pathway. 
Harkin et al 
(2002)  Hind limb 
Hind limb 
reperfusion 
injury 
Porci
ne 
Pulmonar
y artery 
pressure. 
PO2(alv)- 
PO2(art) 
Lung 
MPO 
activity 
and 
weight. 
lung 
protection 
 
Decreased circulating 
IL-6, 
circulating primed 
phagocytes and 
pulmonary neutrophil 
infiltration. 
Guohu Li 
(2004) 
 
Hind limb  Cardiac 
ischaemia  Mice  Infarct 
size 
Reduced 
infarct size 
Delayed 
protection 
NFkB and iNOS 
Konstantinov  
June 05  Hind limb 
Cardiac 
ischaemia in 
transplanted 
heart 
Rat  Infarct 
size 
Reduced 
infarct size 
KATP channels 
modulation in 
recipient 
 
   Konstantinov 
Nov 2005 
 
Hind limb 
 
 
   Cardiac       
ischaemia  
 
 
Mou
se 
Infarct    
size 
Reduced 
infarct size 
 
Inflammatory gene 
suppression 
Chen X.G. 
Oct 2005  Hind limb  Cardiac 
ischaemia  Rat  Infarct 
size 
Reduced 
infarct size  NO 
Moses 
Dec  2005  Hind limb  Skeletal muscle  Rat  infarction 
Reduced 
skeletal 
infarction 
K ATP, Late phase 
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Loukogeorgakis 
Aug 2005  Hind limb  Endothelial limb 
injury 
huma
ns 
Flow 
mediated 
dilatation 
Endothelial 
function 
Protected 
Autonomic nervous 
system 
 
Chen YS 
Jun 2005 
 
Hind limb 
 
Cardiac 
ischaemia 
 
Rat 
 
Infarct 
size 
 
Reduced 
infarct size 
 
Free radicals 
Waldouw 
2005  Hind limb  Lung IRI  Pigs   Lung 
functions 
Protection of 
lung functions  Cytokine  IL-6  
Kristiansen 
2005  Hind limb 
Cardiac 
ischaemia in 
explanted heart. 
Rat  Infarct 
size 
Reduced 
infarct size  K ATP channels 
Zhang  
2006  Hind limb  Cardiac 
ischaemia  Rat   Infarct 
size 
Reduced 
infarct size 
Opioid receptors and 
Katp channels 
Dave K.R. 
2006  Hind limb  Brain  ischaemia  Rat  Neuronal 
damage 
Increased 
neuroprotecti
on 
Not investigated 
Kanoria  
2006  Hind limb  Hepatic 
ischaemia  Rat 
Liver 
function 
hepatic 
blood 
flow 
Reduced IRI 
Improved 
liver  
function 
?adenoisne, NO 
Lai  
2006  Hind limb  Hepatic 
ischaemia  Rat 
Liver 
function 
 
Reduced IRI , 
improved 
liver function 
Haemoxygenase(HO-
1) 
Cheung  
2006  Hind limb  Cardiac 
ischaemia 
Hum
an 
Trop I 
 Lung 
function 
Cytokines 
Reduced Trop 
I 
Improved 
lung function 
Reduced cytokine 
levels 
Table no 1.5- Studies on RIPC by brief limb ischaemia 
 
 
 
 
 
 
 
 
 
 
 
 
 
  431.6.9 The protective effect of brief hepatic ischaemia and myocardial ischaemia 
on remote organs.  
Four studies showed the  protective effects of brief myocardial and hepatic ischaemia 
on remote organs (Ates et al. 2002;Brzozowski et al. 2004;Brzozowski et al. 
2004;Peralta et al. 2001). Both brief Hepatic and myocardial ischaemia have 
protective effects on the stomach (Brzozowski et al. 2004;Brzozowski et al. 2004). In 
an experimental rat model Brzozowski et al showed that two  5 min episodes of 
hepatic/myocardial ischaemia followed by 10 minutes of reperfusion each was as 
effective as direct gastric preconditioning in reducing gastric erosions as well as 
increasing gastric blood flow following sustained gastric IR.  Ates et al demonstrated 
in a rat model that brief hepatic ischaemia (10 minutes) prior to 45 min of ischaemia 
in the left kidney in was associated with better creatinine clearance as well as 
improved sodium fractional excretion 24 hours after preconditioning. They showed 
reduced mitochondrial swelling, basement membrane detachment on electron 
microscopy , reduced renal tubular swelling, necrosis , Tnf -α levels, decreased lipid 
peroxidation(TBARSlevels)  (Ates et al. 2002) and a relatively rapid decline in LDH 
levels in the remote preconditioned group as compared to IRI group. This study 
provides evidence of preservation of ultrastructural, histopathological and 
mjmbiochemical renal function in the RIPC group and supports data for beneficial 
effects of brief hepatic ischaemia on remote tissues. 
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Pre 
conditioning 
by hepatic 
ischaemia 
         
Author/referen
ce 
Site of 
preconditioni
ng stimulus 
Site of index 
ischaemia 
mod
el  Endpoint  Organ 
protection  Proposed mechanism 
Ates et al 
(2002) 
Brief  Hepatic 
ischaemia  Renal ischaemia  Rat 
Renal 
blood 
flow and 
creatinine 
clearance 
Decreased 
Renal 
ischaemia 
Adenosine 
,Bradykinin, KATP, 
possible neuronal 
reflex 
 
Peralta et al 
(2003) 
Hepatic 
ischaemia 
Kidneys,lungs 
and other organs  Rat  Organ 
failure 
Protection of 
remote organs 
Inhibition of Tnf –
alpha induced selectin 
up regulation. 
Brzozowski T 
et al 
(2004) 
 
Hepatic 
/cardiac 
Gastric 
ischaemia 
reperfusion 
injury 
Rat 
Gastric 
lesions 
and  blood 
flow 
Protection of 
the stomach 
 
Cyclo-oxygenase 1 
and 
cyclo-oxygenase-2, 
sensory nerve 
activation and release 
of  CGRP, No, 
inhibition ofIl-1 
and TnF alpha. 
Brzozowski T 
et al 
(2004) 
 
Hepatic/cardi
ac 
Gastric  
ischaemia  Rat  Gastric 
lesions 
Protection 
 
Brain gut axis, sensory 
and 
vagal activation,CGRP 
release. 
Table no 1.6- Studies on RIPC by brief hepatic ischaemia 
 
1.7 Does ischaemic preconditioning tolerance induce cross tolerance to RIPC? 
In an experimental rat model Liem et al demonstrated that 2cycles of CAO of 15 min 
ischaemia followed by 15 min reperfusion preconditioned the myocardium prior to 60 
minCAO and reduced infarct size. This effect of IPC was abrogated on use of 8-
sulfophenyl theophylline (adenosine receptor blockade) prior to IPC suggesting the 
role of adenosine in IPC. However 4cycles of 15min CAO followed by 15 min 
reperfusion rendered the myocardium tolerant to IPC and subsequent preconditioning 
was ineffective in reducing myocardial infarct size (Liem et al. 2004). This was 
associated with loss of cardiac interstitial adenosine .However RIPC with two cycles 
of MAO 15min in tolerant myocardium was effective in reducing myocardial infarct 
size suggesting alternate signalling pathways. This data suggests that repetitive brief 
ischaemia of same duration may render tissue tolerant to preconditioning however in 
  45the clinical setting patients with unstable angina are unlikely to develop such 
tolerance to adenosine since angina is of varying severity and duration. However 
exogenous adenosine is effective in ameliorating ischaemia reperfusion even in those 
who develop tolerance as shown by liem et al. Thus remote preconditioning may be 
useful in situations where direct preconditioning is ineffective due to adenosine 
tolerance. 
1.8 Remote preconditioning of Trauma. 
The role of remote trauma  in preconditioning has been addressed in a recent study by 
Ren et al (Ren, Wang, & Jones et al 2004). They demonstrated that carotid artery 
catheterisation (remote nonischemic vascular surgical trauma) aggravates myocardial 
ischaemia however abdominal incision (remote non ischemic nonvascular surgical 
trauma) reduces myocardial infarct size following cardiac IR This effect is more in 
the early phase of remote preconditioning (80% reduction in infarct size) and less in 
the late phase of preconditioning (40% reduction in infarct size). Remote 
preconditioning of trauma (RPCT) unlike ischemic preconditioning or remote 
ischemic preconditioning does not involve ischemic insults in order to initiate 
preconditioning in remote organs. There is both an early and late preconditioning 
phase in RPCT. The underlying mechanism of RPCT is unclear. RPCT further  
reduces myocardial infarct size in TNF-α  knockouts supporting the argument that 
TNF-α  does not mediate remote preconditioning of trauma (Ren, Wang, & Jones et al 
2004). The role of adenosine in RIPC of the heart and noradrenaline in IPC has been 
shown. Therefore adenosine activity, sympathetic neuronal activity and 
catecholamines are potential mediators of RPCT .Since norepinephrine is involved in 
cross signalling with PKC {Minatoguchi et al, 2003}, NO {Costa et al, 2001} 
modulates release of of norepinephrine from skeletal muscle in ischaemia and both 
  46PKC and NO play a role in remote preconditioning one may speculate the role of 
catecholamines, PKC and NO pathways in RPCT. Further studies in animal models   
using sympathetic blockade, knockouts of NO and PKC and ganglion blockade prior 
to RPCT are needed to pinpoint the candidate mechanism and elucidate the pathway 
of signal transmission. 
 
Author/refe
rence 
Site of 
preconditi
oning 
stimulus 
Site of index 
ischaemia 
mo
del 
Endpoi
nt 
Organ 
protection 
Proposed 
mechanism 
Xiaoping Ren 
et al 
(2004) 
1.RPCT 
(Vascular, 
ischaemia 
2.RPCT 
(Nonvascular, 
 
Nonischemic) 
3.Direct IPC 
Cardiac 
ischaemia 
Mou
se 
Infarct 
size 
  1.  Increased 
infarct 
  2.  Reduced 
infarct 
  3.  Reduced  
infarct 
 
          1. TNF-α  
          2 ?Adenosine, 
NO, catechol             
          3. TNF-α 
 
Table no 1.7- Studies on remote preconditioning of trauma. 
 
  47Adenosine  NO 
Norepinephrine 
RPCT 
Sympathetic 
neuronal 
Target organ  Protein 
kinase C 
activity 
Figure 1. 2- Remote preconditioning of trauma. 
 1.9 Transferred preconditioning 
Ischaemic preconditioning of the heart followed by transfer of  coronary effluent from 
the preconditioned heart to the recipient heart proved beneficial in protecting the 
recipient heart from ischaemia reperfusion injury (Dickson et al. 2002;Dickson et al. 
1999;Dickson et al. 1999;Dickson et al. 2001). The mechanism of transferred 
preconditioning was via opioids such as Metencephalins and not due to epinephrine or 
adenosine release into the effluent. Naloxone blocked opioid receptors and abrogated 
the beneficial effect of transfer of coronary effluent from the preconditioned heart. 
Coronary effluent from preconditioned hearts is also effective in preconditioning 
segments of jejunum via opioid receptors and KATPase channels (Dickson et al. 
2002).Mesenteric ischemic tolerance induced by pre-treatment of small bowel 
  48segments with coronary effluent leads to quicker recovery of contractile function of 
small bowel following reoxygenation and reperfusion. 
 
Table no 1. 8- Studies on transferred preconditioning.  
Transferred 
preconditionin
g 
 
         
Author/referen
ce 
Site of 
preconditioni
ng stimulus 
Site of index 
ischaemia 
mod
el  Endpoint  Organ 
protection  Proposed mechanism 
 
Dickson et al 
(1999) 
 
Coronary 
effluent of 
donor 
following 
cardiac 
ischaemia 
Cardiac 
ischaemia 
Rabb
it 
Infarct 
size   Opioid  receptors 
Dickson et al 
(1999) 
Whole blood 
transfusion 
following 
cardiac and 
renal 
ischaemia 
Cardiac 
ischaemia 
Rabb
it 
Infarct 
size 
Reduced 
infarct 
 
 
 
Opioid receptors and 
Katp channel 
Dickson et al 
(2001) 
Coronary 
effluent 
following 
cardiac 
ischaemia 
Cardiac 
ischaemia 
Rabb
it 
Infarct 
size 
Reduced 
infarct  Metenkephalins  
Dickson et al 
(2002) 
Coronary 
effluent 
following 
cardiac 
ischaemia. 
Mesenteric 
ischemic 
tolerance 
Rabb
it 
Jejunal 
peristalsis 
Protection of 
intestine 
Yes 
Metenkephalins 
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Table 1.9 - Studies on remote microvascular preconditioning. 
Remote 
microvascular 
preconditionin
g 
         
Author/referen
ce 
Site of 
preconditioni
ng stimulus 
Site of  
response 
mod
el  Endpoint  Organ 
protection  Proposed mechanism 
Mabanta 
2006 
Proximal 
Microvascular 
network 
Distal 
microvascular 
network 
Micr
ovas
cular 
netw
ork 
Local 
response  Microvascular   Katp channels 
 
 
1.10 Mechanisms and the role of candidate compounds in the process of remote 
ischaemic preconditioning:  
Adenosine, NO, TNF-α, opioids, bradykinins, Protein kinase C, CGRP, cyclo-
oxygenase, KATP channels, capsaicin, heat shock proteins, norepinephrine are all 
involved in the mechanism of remote ischemic preconditioning. These substances are 
released as a response to stress and act via the neuronal or humoral pathway to 
produce organ protection. The pathways involved are different in response to different 
ischemic stimuli and often overlap. The  evidence for role of each of these 
compounds,   the     mechanisms by which they act and the pathways involved are 
reviewed.  
1.11 Direct preconditioning and evidence for different phases of the adaptive 
response. (Fig 1.3) 
 In direct preconditioning there is evidence for different phases of ischemic adaptation 
and protection(Bolli 2000). These phases were first identified in the heart and 
subsequently in other organs. In the heart  the early phase protects against infarction 
  50but not against myocardial dyskinesia(Bolli 2000)  whereas the late phase protects 
against both. The early phase begins soon after  reperfusion and lasts for up to 3 hours 
in ischemic preconditioning whereas the late phase starts 12-24 hours later(Kuzuya et 
al. 1993). The early phase is independent of protein synthesis and is due to release of 
endogenous substances which stimulate post translational modifications in proteins 
whereas the late phase is stimulated by release of endogenous substances which lead  
to synthesis of new proteins and altered gene expression . This is referred to as the 
second window of protection (SWOP)(Yamashita et al. 1998). The effects of the acute 
phase are short lived lasting for a 3-4 hours whereas the effects of the delayed phase 
are longer, lasting  for  48-96 hours or sometimes for weeks(Nandagopal, Dawson, & 
Dawson 2001) (Marber et al. 1993).Both phases   in all organs result in reduced 
cytokine release, neutrophil recruitment and microcirculatory disturbances. This is 
associated with decreased energy requirements; reduced ATP depletion, decreased 
ionic fluxes across the cell membrane, reduction of free radical production and 
preservation of intracellular redox potential. In addition there is decreased reperfusion 
induced apoptosis and preservation of mitochondrial integrity at the cellular level. 
The protective effect of the delayed phase of preconditioning is less compared to the 
early phase and mechanistically different(Bolli 2000). In early PC several endogenous 
substances have been implicated as triggers such as adenosine,  noradrenaline 
,opioids, bradykinin , free oxygen radicals(Cohen, Baines, & Downey 2000) as well 
as angiotensin, endothelin and acetylcholine (Yellon et al. 1998). Receptor mediated 
signalling mechanisms are involved. Protein kinase C(PKC) (Yellon et al. 1998), 
tyrosine kinase , mitogen activated protein kinases  serve as signalling pathways and 
eventually converge on mitochondrial Katp channels as well as calcium channels to 
prevent ATP depletion and reduce calcium influx into cells(Yellon et al. 1998).  
  51In the late phase of PC, synthesis or post translational modifications of Heat shock 
proteins, antioxidant enzymes and iNOS have been postulated(Yellon et al. 
1998).Adenosine is involved in the late phase  in protection against ischaemia and 
acts as a trigger(Downey, Liu, & Thornton 1993) for inducing SWOP. The protection 
is triggered by Adenosine, ROS, NO, Opioids and Catecholamines and subsequent 
pathways involve activation of kinases which lead to transcription of new proteins and 
culminate in formation of mediators such as inducible nitric oxide synthase (iNOS), 
HO-1, HSP which undergo postranslational modifications leading to the protective 
response. 
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Figure-1.3  
 
 
 
Diagram to show the phases of preconditioning. 
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  531.12 Evidence for different phases of adaptation in remote preconditioning. 
 
Eight studies have shown  two phases of protection(ischemic adaptation) in 
RIPC.(Oxman et al. 1997; Pell et al. 1998; Schoemaker & van Heijningen 2000; 
Wang et al. 2001; Wolfrum et al. 2002) These studies showed the existence of 
both phases in all organ systems in animal models and in recent human studies 
1) Two studies(Pell et al. 1998;Singh & Chopra 2004;Takaoka et al. 1999) showed 
brief MAO induced early and delayed preconditioning in the heart  2) Li et al showed 
a pronounced reduction in myocardial infarct size 24 hrs after hind limb RIPC(Li et 
al. 2004b) 3) Four studies  demonstrated late RIPC in remote skeletal muscle 
following skeletal muscle preconditioning(Kuntscher, Kastell, Altmann, Menke, 
Gebhard, & Germann 2002;Kuntscher, Kastell, Sauerbier, Nobiling, Gebhard, & 
Germann 2002;Kuntscher et al. 2002) 4) One study  showed ischemic adaptation of 
the brain to hindlimb ischaemia  after 24 hrs of preconditioning.(Vlasov, Korzhevskii, 
& Poliakova 2004) 5) One study showed late phase of RIPC in the heart and liver due 
to HSP expression 6)The first clinical application of RIPC in children undergoing 
cardiac surgery on bypass showed that RIPC was most effective in myocardial 
protection if applied 24 hours prior to the coronary ischemic insult.(Cheung et al. 
2006) 
1.13 Evidence for the Pathway of transduction of   remote preconditioning 
1.13.1 Evidence for the Pathway of transduction   from brief renal ischaemia 
 Four studies demonstrated the pathway from renal RIPC. Gho showed that remote 
myocardial protection was associated with brief periods of reperfusion of the remote 
organ however persistent ischaemia without reperfusion did not protect the heart.(Gho 
et al. 1996e) This was supported by three studies(Pell et al. 1998;Singh & Chopra 
2004;Takaoka et al. 1999) which showed that reperfusion was essential for 
  54myocardial preconditioning. However, Gho showed the protective effect of RAO was 
abolished by giving hexamethonium (ganglion blocker) suggesting the role of 
neurogenic pathway in conferring protection to distal organs.  
1.13.2 Evidence for pathway of transduction from mesenteric ischaemia 
 Four Studies(Liem et al. 2002;Patel et al. 2002;Wang et al. 2004;Wolfrum et al. 
2002) showed that reperfusionis required for preconditioning supporting the humoral 
pathway for transduction of the protective effect. Prior ganglion blockade abolished 
the protective effect suggesting the simultaneous involvement of the autonomic 
neurogenic pathway. Liem et al showed that brief MAO and reperfusion followed by 
subsequent permanent MAO reduced infarct size significantly more than brief MAO 
alone and this was abolished by ganglion blockade with hexamethonium. These 
results showed that brief periods of MAO are cardioprotective but not optimal as their 
effect was enhanced by further permanent occlusion and reperfusion of virgin 
intestine was necessary for activation of the neurogenic pathway.  
1.13.3. Evidence for pathway of transduction of protective effect from limb 
ischaemia 
 Four studies demonstrated the role of the neurogenic pathway in transduction of 
RIPC from the limb. In an animal model Oxman(Oxman et al. 1997) showed rise in 
plasma catecholamine levels on preconditioning which was abolished by autonomic 
nerve blockade with reserpine. Loukogeorgakis et al showed the role of the autonomic 
nervous system in transduction of the protective signal. However they were unable to 
define the component of the   autonomic system and demonstrate the specific 
pathway. Birnbaum demonstrated RIPC by electrical stimulation of gastroenemius 
muscle in conjunction with brief limb ischaemia in a rabbit model (Birnbaum, Hale, 
  55& Kloner 1997) and Kharbanda showed RIPC from the limb was abolished by 
sympathetic nerve blockade with reserpine. In contrast six studies demonstrated rise 
in plasma levels of nitrates, opioids, free radicals and catecholamines(Addison et al. 
2003;Chen et al. 2005;Chen et al. 2005;Oxman et al. 1997;Weinbrenner et al. 2004) 
(Kanoria et al. 2006) following RIPC providing evidence in support of a humoral 
pathway. In Weinbrenner’s study(Weinbrenner et al. 2004) the protective effect was 
only seen in groups who had a period of reperfusion after ischaemia in comparison to 
those who had no reperfusion or reperfusion at the onset of ischaemia. (Takaoka et al. 
1999; Weinbrenner et al. 2002) Interestingly the protective effects of infrarenal 
aortic occlusion were not abolished by ganglion blockade. They showed that 
simultaneous aortic occlusion along with coronary occlusion did not confer protection 
indicating that  preconditioning had to be prior in order to allow for the substance 
released to reach the heart. These findings demonstrate the release of protective 
substances into the circulation. Autonomic nerve blockade with hexamethonium did 
not abolish RIPC(Chen et al. 2005) and two studies showed  cardioprotection in a rat 
cardiac transplant model(denervated heart) suggesting the role of blood borne factors 
in preconditioning.(Konstantinov et al. 2005; Kristiansen et al. 2004) 
Whether the neurogenic pathway was activated locally in the mesenteric, renal or 
skeletal beds or by release of mediators   into the circulation (humoral pathway) and 
subsequent stimulation of sensory afferent fibres is unclear from these studies. The 
need for reperfusion to confer remote protection and rise in plasma levels of 
catecholamines, adenosine, neuropeptides, cytokines or free radicals suggests that 
these substances may activate neuronal pathways after release into circulation. It 
seems that both the neurogenic pathway and humoral pathway have some element of 
overlap and are not mutually exclusive.  Measurement of interstitial levels of 
  56mediators and sensory afferent nerve activity prior to and after preconditioning and 
specific blockade of synthesis and   release of the mediators would help clarify their 
role in activation of neuronal pathways. Blockade of neuronal pathways and end 
receptors would help define the predominant pathway for transduction of 
preconditioning in different organ systems. 
1.14 Role of Nitric oxide 
Studies in direct IPC have demonstrated the protective effect of Nitric oxide   on 
microcirculation.(Albrecht et al. 2003;Bauer et al. 1997;Gauthier, Davenpeck, & 
Lefer 1994;Kosonen et al. 1998;Kosonen et al. 1999;Kosonen et al. 2000;Kubes & 
McCafferty 2000;Langle et al. 1995;Lefer & Lefer 1996;Peralta et al. 1996;Peralta et 
al. 2001;Wink et al. 1993;Wink & Mitchell 1998)  Nitric oxide is a free radical 
produced from L-arginine  by the enzyme Nitric oxide synthase which has three forms 
eNOS (endogenous NOS), neuronal NOS(neuronal NOS) and iNOS (inducible 
NOS).(Albrecht et al. 2003; Kubes & McCafferty 2000) Of these eNOS and nNOS 
are constitutively expressed while iNOS is produced in response to cytokines and NF-
kb. eNOS has a protective effect on microcirculation and always produces NO in 
small amounts which predominates in the circulation producing a protective effect on 
the microcirculation. 
 Evidence in remote ischaemic preconditioning 
 Six studies have demonstrated the role of  NO(Kuntscher, Kastell, Altmann, Menke, 
Gebhard, & Germann 2002;Kuntscher, Kastell, Sauerbier, Nobiling, Gebhard, & 
Germann 2002;Kuntscher et al. 2002;Kuntscher et al. 2003;Kuntscher et al. 
2003;Vlasov, Korzhevskii, & Poliakova 2004) in remote preconditioning of skeletal 
muscle, intestine, brain and heart. Kuntscher has shown a beneficial effect by hind 
  57Limb preconditioning and protection of   muscle flaps in the late phase of remote 
preconditioning. He showed that the protective effect was due to release of NO in the 
circulation by virtue of inducing hind limb ischaemia 24 hours prior to the ischemic 
insult in the contra lateral limb. Subsequently Kuntscher et al also showed that NO 
has a role in acute ischemic preconditioning after inducing hindlimb 
ischaemia.(Kuntscher, Kastell, Altmann, Menke, Gebhard, & Germann 2002; 
Kuntscher, Kastell, Sauerbier, Nobiling)  
Wang(Wang et al. 2001) et al showed  induction of myocardial iNOS in  the late 
phase of preconditioning following intestinal ischaemia and reduction in myocardial 
infarct size as well as MPO activity(marker of neutrophilic activation). Blockade of 
NO activity abrogated the decrease in myocardial infarct size and MPO activity 
suggesting that NO inhibits neutrophil infiltration.  
Tokuno et al showed that spontaneous brain ischemic events 24-48 hrs prior to 
cardiac IR injury reduced myocardial infarct size.(Addison et al. 2003; Tokuno et al. 
2002) iNOS knock out mice did not show the beneficial effects of remote 
preconditioning. Vlasov demonstrated that NO has a role in direct IPC of the intestine 
and late phase of RIPC of the intestine but its role in the early phase of RIPC of the 
intestine remains unproven (Vlasov, Smirnov, & Nutfullina 2001) Vlasov et al 
(Vlasov, Korzhevskii, & Poliakova 2004)showed recovery of brain blood flow at 120 
minutes after reperfusion and reduced cerebral oedema  in the late phase of remote 
ischemic preconditioning  (hindlimb) due to iNOS induced cerebral ischemic 
adaptation. However the early phase of preconditioning had no effect on brain blood 
flow or oedemas. A recent study has shown expression of NF-kβ  due to brief limb 
ischaemia and  NF-kβ  induced iNOS 24 hours later which  reduced myocardial 
infarct size.(Li et al. 2004) Deletion of iNOS genes in knock out mice abolished the 
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demonstrated that cytokines induce iNOS production. Conversely Petrischev showed 
that NO is not involved in remote preconditioning(Petrishchev et al. 2001) since the 
non-specific NO blocker L-NNA did not abolish increase in NADPH diaphorase 
activity in intact cardiomyocytes  following limb/mesenteric remote 
ischaemia.(Petrishchev et al. 2001) Moreover attenuation of decrease in NADPH 
diaphorase activity in ischaemic tissue by preconditioning was not abrogated by NO 
blockers.  
These studies demonstrate the role of NO in acute RIPC of the heart and muscle but 
its role in acute preconditioning of the intestine and brain remains unproven. IR injury 
impairs endothelial function in the initial phase primarily by impairment of formation 
and bioavailability of NO which may explain lack of effect of the early phase of RIPC 
in the brain and intestine. This may also be explained by different protocols of 
preconditioning used for remote preconditioning in different organs and different 
criteria for assessment of preconditioning in the heart & muscle (cytoprotective 
effects) as against endothelial function in the intestine and brain. Therefore similar 
outcome measures are needed to investigate the role of NO.  
What induces NO? 
In a mouse model increased NF-кß    expression in the limb following RIPC induced 
NF- кß and iNOS in the heart suggesting the role of cytokines in the signalling 
pathway for induction of NO(Li et al. 2004). In a rat model, brief hepatic ischaemia 
increased gastric CGRP, increased (Xiao et al. 2001)  reduced gastric mucosal 
 flow, reduced gastric mucosal erosions and this effect was abolished by L-NAME 
(NO blocker) suggesting that CGRP induces NO release and subsequent vasodilatory 
effects and increased flow. Evidence suggests release of ROS, cytokines and NO into 
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activates nuclear factor-kB and protein kinase C.(Downey & Cohen 1997) These 
signalling pathways induce iNOS(Kelly, Balligand, & Smith 1996) in the target 
organ. Peralta has shown adenosine increases NO formation and this effect is blocked 
by adenosine antagonists.(Peralta et al. 1999) 
Pathway  
The data from the studies discussed shows that brief periods of ischaemia reperfusion 
in RIPC   induce NO pathways. Li et al showed that RIPC by hind limb ischaemia 
increased NF-kβ in skeletal muscle and heart and induced ischemic adaptation in the 
heart by iNOS formation. In view of the short half life of NO (5 seconds) it is unlikely 
for NO to be produced in the remote organ and reach the target organ to confer 
protection by the blood stream. Chen et al(Chen et al. 2005) showed that RIPC of the 
limb reduced myocardial infarct size through NO production. Since hexamethonium 
(autonomic ganglion blocker) did not abrogate reduction in myocardial infarct size it 
seems that NO pathways act through the blood stream. In an animal model of warm 
hepatic IRI Davidson’s group showed increased hepatic venous plasma 
nitrates/nitrites(Kanoria et al. 2006) and amelioration of hepatic IR following  hind 
limb RIPC .  This provides further support for the argument in favour of bloodstream 
being the NO pathway. Clearly further clarification of this is needed by measuring 
systemic venous plasma nitrate/nitrite levels and plasma arginine levels (NO 
precursors) after RIPC. Also knockout models of NOS would be specific for 
investigating the role of NO pathways in preconditioning. 
 Is NO a trigger or mediator? 
Tokuno demonstrated reduced myocardial infarct size following induced brief brain 
ischaemia without an increase in cardiac iNOS however; the protection was abolished 
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RIPC by L-NAME abolished myocardial protection supporting the role of NO as a 
trigger.(Chen et al. 2005) Increased iNOS production 24 hours after RIPC would 
suggest its role as a mediator and future studies by blocking NO after RIPC are 
needed to demonstrate its role as a mediator. 
Effector mechanism 
IPC studies have demonstrated  that NO modulates microvascular perfusion through 
its vasodilatory effect(Jaeschke et al. 1996) and through its anti-inflammatory actions 
including inhibition of stellate cell activation,(Rockey & Chung 1995) neutrophil 
adhesion,(Gauthier, Davenpeck, & Lefer 1994;Harbrecht et al. 1997;Lefer & Lefer 
1996) platelet aggregation. NO plays a key role in initiating and maintaining 
preconditioning. The early phase of preconditioning mediated by eNOS is  through 
generation of cGMP(Lochner et al. 2002) as shown by Lochner et al in the 
myocardium(Gidday et al. 1999) and subsequently inhibition of cAMP levels as well 
as reduction in energy demands. The late phase is protein synthesis dependent and is 
through activation of PKC, NF-kβ and transcription of iNOS.(Nandagopal, Dawson, 
& Dawson 2001a) In the liver NO mediates preconditioning by inhibitory actions on 
endothelin, (Peralta et al. 1996) activation of adenosine A2 receptors and subsequent 
NO formation.(Peralta et al. 1999) NO also has been shown to confer protection 
against cold ischaemia(Yin et al. 1998) of liver. NO inhibits apoptosis of  cells by 
inhibition of caspase activity, TNF alpha and upregulation of Bcl-2.(Kim et al. 
1998;Kim et al. 2000;Kim et al. 1998) NO  has a protective effect on intestinal 
microcirculation such as scavenging of oxygen free radicals, maintenance of normal 
vascular permeability, inhibition of smooth muscle proliferation, reduction of 
leukocyte adherence to the mesenteric endothelium, prevention of mast cell activation 
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Wink et al. 1993) Kubes et al(Kubes & McCafferty 2000) have demonstrated in the 
intestine that eNOS has a protective effect on intestinal mucosa while increased iNOS 
has been shown to increase mucosal apoptosis by generation of free radicals such as 
peroxynitrate.(Suzuki et al. 2000; Wu et al. 2002) However recent studies have shown 
that the production of peroxynitrate may be associated with  loss of eNOS rather than 
increased iNOS production.(Cuzzocrea, Zingarelli, & Caputi 1998) This observation 
suggests a dichotomous role for NO in IR injury with small quantities of NO 
produced by eNOS reducing IRI while excessive NO due to iNOS causing deleterious 
effects. 
1.15 Adenosine 
Evidence 
Adenosine is an extracellular molecule which is both a trigger and mediator of IPC as 
demonstrated from past studies.(Downey, Liu, & Thornton 1993) Adenosine is a 
hormone widely distributed in human tissues. Adenosine production occurs in 
myocytes, endothelial cells and vascular cells. During ischaemia of the heart ,brain 
and the kidney, the imbalance between oxygen supply and demand results in net 
breakdown of adenosine triphosphate (ATP) and  release of  adenosine which can 
increase upto 50 fold {Mullane, 1995 } 
Three studies have shown the role of adenosine in RIPC of the heart by RAO and 
MAO. 1) Pell et al(Pell et al. 1998), rabbit model, RIPC by RAO (10 min), reperfusion 
(10min) prior to CAO 30 min, reperfusion 2hrs reduced myocardial infarct size by 
46% and increased plasma adenosine levels. 2) Takaoka,(Takaoka et al. 1999) rabbit 
model, RIPC by RAO 10 min, 20 min reperfusion before 40 min CAO reduced infarct 
size, increased plasma adenosine levels and 8-SPT  (adenosine blocker) abolished the 
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reperfusion prior to CAO increased   plasma adenosine levels and reduced myocardial 
infarct size.  
Two studies demonstrated the role of adenosine in RIPC of skeletal muscle 
Adenosine release has been shown to be an effector molecule in skeletal muscle 
IPC.(Pang et al. 1997) 1) RIPC increased adenosine plasma levels and the protective 
effect was partially blocked with reserpine. 2) Prior adenosine blockade(Addison et 
al. 2003) did not completely abolish  latissmus dorsi flap protection by RIPC (limb 
ischaemia, 3 × 10 min cycles) however adenosine blockade (8-SPT) and free radical 
scavenger MPG (mercaptopropionyl glycine) completely abolished RIPC effect 
suggesting that adenosine plays a partial role in RIPC.  
Trigger or mediator 
 In a rabbit model adenosine blockade prior to RIPC abolished cardioprotection 
demonstrating its role as a trigger of RIPC(Pell et al. 1998). Adenosine blockade after 
RIPC before reperfusion   abolished cardioprotection suggesting its role as a mediator 
of RIPC also. 
Pathway 
Following ischaemia induced ATP breakdown adenosine crosses the cell membrane 
and enters into the interstitial space by simple diffusion. From the interstitial space it 
escapes into the intravascular space by paracellular washout (slow, 10% under 
physiological conditions). It would seem that in RIPC adenosine produced in the 
remote organ would  reach its target organ by the bloodstream, however it has a half 
life of 0.6-1.5 seconds as it is rapidly taken up by endothelial cells, red blood cells and 
pericytes which contain nucleoside transporters and are responsible for  rapid 
degradation of adenosine(Horie & Ishii 2001) making it unlikely for adenosine to 
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modulation of adenosine degradation or activation of nucleoside transport inhibitors. 
Two studies showed a rise in plasma adenosine levels following preconditioning 
suggesting that reperfusion and release into circulation is required for adenosine 
induced RIPC.(Pell et al. 1998; Takaoka et al. 1999) 
 One study (Liem et al. 2002) supported a neurogenic pathway for adenosine in RIPC. 
They demonstrated abrogation of preconditioning of the heart by brief cycles of MAO 
and reperfusion due to prior ganglion blockade. To further clarify the pathway they 
demonstrated that intramesenteric infusion with adenosine mimicked the effects of 
brief MAO and prior ganglion blockade abolished the protective effects of RIPC. 
Ganglion blockade after reperfusion did not abrogate the protective effects but 
adenosine receptor blockade abolished myocardial protection. These observations 
suggest that adenosine acts locally to stimulate afferent nerves in the mesenteric bed 
which in turn activate adenosine receptors in the heart. This argument is supported by 
data demonstrating lack of preconditioning following intraportal or intracaval infusion 
of adenosine and effectively excludes effects of adenosine spillover during mesenteric 
infusion which could potentially stimulate adenosine receptors in the liver and 
contribute to myocardial protection.   
Effector mechanism 
8-SPT (adenosine receptor blocker) abolished RIPC by MAO. 8-SPT was given after 
reocclusion  of mesenteric artery(Liem et al. 2002) preventing adenosine access to the 
mesenteric bed. This suggested the presence of adenosine receptors on the heart 
whose effect was blocked by 8-SPT.  
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Does adenosine modulate end effectors   KATP channels? 
In RIPC two studies (RAO reduced myocardial infarct size, rabbit model)(Pell et al. 
1998;Singh & Chopra 2004;Takaoka et al. 1999) demonstrated that selective 
mitochondrial KATP channels blockers(5-HD) abolish the protective effect. The 
action potential of sarcolemmal KATP   channels was unaffected. Modulation of KATP 
channels reduced ATP depletion, preserved intracellular PH, and enhanced recovery 
of ATP and phosphocreatinine levels during reperfusion (Takaoka et al. 1999). 
Decreased acidosis reduced intracellular Ca accumulation and myocardial infarct size. 
These observations are supported by IPC studies(Pang et al. 1997) and suggest that 
KATP channels serve as end effectors in adenosine pathways. 
 IPC studies have shown that adenosine mediates both the early and late phases of 
preconditioning via different endorgan receptors. In the heart  adenosine acts via A1 
receptor. Adenosine receptors mediate antiadrenergic effects indirectly by reducing C-
amp levels. The A1 receptor mediated effects involve activation of Protein kinase C, 
Tyrosine kinases,(Dana et al. 2000)  Heat shock protein  and  MAPK. Kinases 
modulate end effector mitochondrial KATP channels. A2 receptors act in the hepatic 
microcirculation as shown by Peralta et al(Peralta et al. 1999) A2 receptors are linked 
to vasodilatation and antiplugging effects of adenosine. Activation of these receptors 
and their effects are due to endothelium dependent and independent mechanisms, 
indirectly through release of NO and through direct relaxation of vascular smooth 
muscles. A3 receptors are found in myocytes. 
 The effects of adenosine include vasodilatation,(Horie & Ishii 2001) inhibition of 
leukocyte adhesion, neutrophil and platelet function {Bouma, 1997 ;Keller, 1991 } 
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have to be clearly demonstrated in Future studies in RIPC. 
1.16 Cytokines 
NF-КB 
Li et al in a mouse model showed RIPC (6 cycles brief hind limb ischaemia) prior to 
myocardial IR reduced infarct size. IRI activated NF-kβ in hearts but prior RIPC  
attenuated activation of NF-kβ in IR.(Li et al. 2004) However RIPC in sham animals 
demonstrated NF-kβ activation in both the limb and hearts. This study demonstrates a 
dual role for NF-kβ. While excessive NF-kβ activation in IR injury has deleterious 
effects and increases infarct size, activation of NF-kβ following limb preconditioning 
led to an adaptive response in the heart, increased ikβ (inhibitory KB) expression 
which attenuated NF-Kβ activation following sustained IR injury and reduced 
myocardial infarct size , attenuated decrease in left ventricular developed pressures 
(LVDF) and increase in left ventricular end diastolic pressures (LVEDP) on 
reperfusion . In NF-kβ and iNOS knockout models the decrease in LVDF was 
attenuated but preconditioning did not confer any additional benefit. NF-kβ and iNOS 
knockouts had less severe increase in LVEDP but no additional attenuation was 
conferred by preconditioning.  
NF-kβ is induced by reactive oxygen species and subsequently acts through activation 
of kinases in the preconditioning response. Preconditioning may downregulate the 
inflammatory response during reperfusion as NF-kβ activation increases its own 
inhibitor Ikβ (Tahepold) or   it may act through a mediator such as iNOS as suggested 
by data from this study. 
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 Increase in TNF–α levels following hepatic IR injury led to remote organ injury (lung 
and kidney) and IPC of the liver reduced both TNF–α levels and remote organ injury 
as demonstrated by Peralta et al. This study suggested that TNF–α may have a role in 
remote preconditioning. In RIPC two studies have investigated the role of TNF–α. 
Ates et al showed raised TNF–α levels following renal IR which were reduced by 
preconditioning with brief hepatic ischaemia and associated with improved renal 
function as compared to IR groups.  RIPC by brief hepatic ischaemia prior to gastric 
IR (30min) attenuated plasma TNF-α levels in a rat model.(Brzozowski et al. 2004) 
Ren et al showed in a rat model of cardiac IR reduced myocardial infarct size 
following IPC and in TNF–α knockout mice. The protective effect of the early phase 
of IPC was not abolished in TNF–α knockouts but that of the late phase of IPC was 
abolished in knockouts suggesting that late IPC is TNF–α dependent. Both the early 
and late phase of RPCT (Abdominal incision prior to cardiac IR) in TNF–α knockouts 
further reduced myocardial infarct size suggesting that  remote preconditioning of 
trauma was mechanistically different from TNF–α ablation.(Ren, Wang, & Jones 
2004). Clinical efficacy of cardioprotective strategies maybe maximised by using a 
combination of RPCT and TNF–α ablation. This study also showed that blockade of 
NF-KB and TNF-α was additive suggesting NF-KB to be involved in the signalling 
pathway of TNF–α. The mechanism of TNF-α induced RIPC and IR is unclear and 
future studies are needed to study the mechanism and signalling pathways involved. 
 IL-6 
In lung IR injury secondary to remote limb ischaemia reperfusion, blockade of 
interorgan inflammatory mediators such as cytokine Il-6 and levels of primed 
neutrophils by prior limb preconditioning confers protection with no significant 
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brief limb ischaemia is mechanistically different and entails incomplete blockade of 
SIRS mediators such as IL-6 and circulating primed neutrophils and complete 
suppression of Il-1β which is an early mediator of reperfusion injury. Therefore 
despite incomplete blockade it is likely that remote preconditioning reduces 
expression of adhesion molecules and neutrophilic infiltration in the lung. 
IL-1β 
RIPC has been shown to confer protection on the remote organ in lung dysfunction 
due to limb IR and local IR by blockade of IL-1β. 
The role of IL-1β was demonstrated by Harkin et al who clearly showed an increase 
in IL-1β in limb IR which led to lung injury and deterioration of lung function.  In 
sustained limb IR, limb IPC protected lung function from remote IR injury by 
blocking the cytokine IL-1β.  Similar rise in IL-1β was shown by Waldow in IRI of 
the lung. RIPC of the limb ameliorated the rise in IL-1β and conferred protection on 
the lung. Thus IL-1β has been shown to have a role as an interorgan mediator of IR 
injury and as a mediator of local IRI.  
1.17 Protein kinase C 
Evidence 
Wolfrum showed that protein kinase C (PKC) was responsible for reduction in 
myocardial infarct size after mesenteric ischaemia reperfusion and blockade of PKC 
by a highly selective inhibitor chelerythrine prevented reduction in infarct size. They 
showed an increase in myocardial Protein kinase C following RIPC and blockade of 
Protein kinase c abolished the protective effect. Weinbrenner showed RIPC by 
infrarenal aortic occlusion for 15 min followed by reperfusion reduced myocardial 
infarct size which was abolished by chelerythrine. 
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There is evidence that myocardial PKC undergoes activation  following ischemic 
stimuli in IPC.(Downey et al. 1994; Downey & Cohen 1997; Liu, Ytrehus, & Downey 
1994) This leads to conversion of the cytosolic PKC to particulate PKC fraction 
thereby increasing the ratio of the particulate to cytosolic fraction. Subsequent 
activation of mitochondrial PKC receptors results in activation of tyrosine kinases and 
Map kinases which lead to opening up of mitochondrial potassium receptor KATP 
channels. Mitochondrial KATP channels serve as end effectors in modulation of 
mitochondrial energy flow and preservation of mitochondrial membrane integrity. 
Both humoral and neuronal pathways have an important role in PKC mediated RIPC. 
Wolfrum et al demonstrated increased plasma bradykinin levels following mesenteric 
ischemic preconditioning which activated myocardial PKC and blockade of 
bradykinin receptors with bradykinin antagonist HOE 140 abolished myocardial 
protection. Ganglion Blockade with hexamethonium did not alter the cytosolic to 
particulate ratio of PKC but prevented activation of PKC. These observations suggest 
that bradykinin induced PKC activation is a prerequisite for cardioprotective effect of 
RIPC, activation of PKC is a decisive step in conferring cardioprotection and both the 
bradykinin dependent humoral pathway as well as neuronal pathway are essential for 
PKC activation. 
1.18 Bradykinin 
Evidence 
 
Shoemaker et al were the first to demonstrate that mesenteric preconditioning induced 
increased endogenous bradykinin levels which had a remote preconditioning effect on 
the heart and reduced infarct size following coronary infarction. Blockade of 
bradykinin receptors was associated with increased myocardial infarct size. However 
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in the absence of preconditioning there was no change in basal bradykinin levels 
(Wolfrum). 
What is the pathway? 
A combined sensory neurogenic and humoral pathway is strongly suggested in the 
bradykinin mediated RIPC (Shoemakers study). Following mesenteric ischaemia 
reperfusion there is local release of bradykinins which stimulates the sensory afferent 
nerves projecting on efferent nerves to the heart which in turn precondition the heart.  
Bradykinin receptors B2 are involved in sensory nerve stimulation and bradykinin 
receptor antagonists HOE-140 (Hoechst-140) abolish the protective effect. This study 
also showed that Bradykinin receptor blockade led to loss of protection in both direct 
and remote IPC but ganglion blockade abolished protection only in remote 
preconditioning. Thus direct preconditioning is associated with blood borne 
kininogens in contrast to the complementary effect of humoral and neurogenic 
pathways in RIPC. Bradykinins activate intracellular transduction of PKC as 
demonstrated by Wolfrum et al   however the pathway downstream of kinases 
remains unclear. Although modulation of   KATP channels   is suggested but this needs 
to be clarified in future studies. 
1.19 Catecholamines 
Toombs et al showed IPC by 5 min of CAO, 10 min reperfusion in rabbits prior to 30 
min CAO and 120 min reperfusion reduced infarct size.{Toombs, 1993}  In 
reserpinised rabbits subsequent IPC failed to reduce infarct size suggesting the role of 
noradrenaline release in IPC. In RIPC two studies provided evidence to support the 
role of catecholamines. Oxman et al(Oxman et al. 1997) showed an increase in 
cardiac norepinephrine release and increased baseline plasma levels after limb 
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reserpine due to depletion of catecholamine stores. In reserpinised animals the 
antiarrhythmic effect of RIPC was blocked. Kharbanda et al showed that sympathetic 
blockade abolished RIPC resulting in increased myocardial infarct size. Verdouw et al 
demonstrated that increase in cardiac interstitial norepinephrine levels following 
ischaemia was cardioprotective but RIPC by cerebral ischaemia was ineffective due to 
inadequate increase in norepinephrine levels. The role of catecholamines in RPCT is 
only speculative and future studies are needed to clarify this.  
Pathway and effector mechanism 
 In direct IPC endogenous catecholamines are known to act upon cardiac 
adenoreceptors stimulating myocardial protein kinase eventually leading to 
preconditioning of the heart.(Hu & Nattel 1995) In RIPC the likely pathway seems to 
be the sympathetic nerve pathway as reserpine abolished protection. It is also possible 
that catecholamines released into the circulation may act on sympathetic nerve 
endings in target organs however this needs to be further clarified by measurement of 
plasma catecholamine levels and use of   adrenergic receptor blockers. The 
postreceptor mechanisms are unclear and the role of catecholamines in activation of 
kinases as well as modulation of KATP channels as end effectors needs to be clearly 
demonstrated in future experiments. 
1.20 Opioids  
Evidence 
 IPC of the intestine (3 cycles of 8 min ischaemia, 10 min reperfusion) prior to 
intestinal IRI (30 min MAO, 2hrs reperfusion) reduced intestinal injury, oedema, 
LDH and malionaldehyde levels(markers of oxidative stress)(Zhang et al. 2001). Pre-
treatment with morphine mimicked the effects of IPC and naloxone abolished the 
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colon are rich in opioid receptors and contain opioid peptides(Zhang et al. 2001). This 
study demonstrated an increase in endogenous opioid peptides in the effluent 
collected after IPC and suggested that opioids are released in response to oxidative 
stress to confer a protective effect against stress. Opioid release from the stress of 
brief IR could result in a remote protective mechanism.  
Five studies have demonstrated the role of opioids in RIPC in intestinal, skeletal 
muscle and heart tissue. 
1) Based on the theory that opioids are released as a natural response to stress, are 
released irrespective of whichever organ is stressed and act widely and ubiquitously 
on remote organs, Patel et al(Patel et al. 2002)  demonstrated in a rat model that RIPC 
by MAO (15min), reperfusion 10 min prior to CAO (30min) and 2hrs reperfusion 
reduced myocardial infarct size which was abolished by naloxone. 2) RIPC (3 cycles 
hind limb ischaemia (10 min), 10 min reperfusion) prior to 4hrs of muscle flap 
ischaemia and 48 hrs reperfusion reduced latissmus dorsi, rectus abdominis and 
gracilis flap infarct size. This study demonstrated the remote protection of all skeletal 
tissue by RIPC. 3) RIPC by 15 infra aortic occlusion (IOA) and 10 min reperfusion 
prior to 30 min IOA and 2hrs of reperfusion reduced myocardial infarct size in a rat 
model(Weinbrenner et al. 2002)  4) RIPC (3cycles of 5min femoral A occlusion, 5min 
reperfusion) prior to 30 min CAO and 120 min reperfusion in a rat model reduced 
myocardial infarct size and plasma LDH levels(Zhang et al. 2006) and naloxone 
abolished these effects. 5) Dickson et al demonstrated a role for opioids in transferred 
preconditioning. Met and leu-enkephalins were liberated from the preconditioned 
donor rabbit heart into the   coronary effluent which subsequently elicited protection 
when given to virgin acceptor hearts. Addition of naloxone to the coronary effluent 
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tolerance in the intestine in direct IPC and the presence of abundant opioid receptors 
in the intestine .Dickson et al treated ischemic gut with coronary effluent from 
preconditioned hearts and showed that the recovery of maximal contractile force of 
gut after ischaemia was enhanced by opioids.     
Pathway  
Opioid receptors are known to be present in neuromuscular regions, especially delta 
receptors(Evans, Hughes, & Smith 1995) and previous studies have described the 
humoral action of opioid receptors in skeletal muscle by demonstrating(Evans, Khan, 
& Smith 1997) that B-endorphins released in the circulation stimulate glucose uptake 
in muscle .In RIPC (hind limb) autonomic ganglion blockade by hexamethonium did 
not abolish the effects of opioids(Addison et al. 2003) suggesting the blood  
circulation to be the likely pathway of transmission of protection in opioids induced 
RIPC. The need for reperfusion following IOA for cardioprotection and lack of 
protection in occlusion without reperfusion(Weinbrenner et al. 2002) and the evidence 
for  transferred preconditioning in virgin acceptor hearts by opioids in coronary 
effluent from preconditioned hearts are observations which support a humoral 
pathway. 
Effector mechanism 
Opioids act on receptors in the target organ .This has been shown in heart, skeletal 
muscle and intestinal tissue.(Addison et al. 2003; Patel et al. 2002; Zhang et al. 2006) 
Skeletal muscle flap protection by RIPC was abolished by selective δ1 opioid receptor 
antagonists and myocardial protection was abolished by selective К1 receptor 
antagonists. δ1 receptors have been shown in all species and human 
cardiomyocytes.(Weinbrenner et al. 2002) Activated δ1 opioid receptors induce 
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opioid receptors to induce ischemic tolerance in myocardium or gut.(Dickson et al. 
2002) 
Opioid induced RIPC prior to skeletal muscle IRI reduced ATP depletion, lactate 
accumulation, neutrophil infiltration and myeloperoxidase activity in preconditioned 
skeletal muscle(Addison et al. 2003) which was abolished by opioid receptor 
antagonists. These observations suggest that the energy sparing effect coupled with 
attenuation of lactate accumulation during early reperfusion is triggered by activation 
of opioid receptors. This is supported by IPC studies. (Cohen et al) 
Opioid receptors modulate   
One  study have shown the role  KATP channels in the end effector energy sparing 
effect.(Dickson et al. 2002; Zhang et al. 2006) Coadministration of Glibenclamide to 
coronary effluent from preconditioned hearts abolished transferred preconditioning in 
ischemic gut.(Dickson et al. 2002) RIPC by к opioid receptors in the heart modulates 
mitochondrial pore mobility in the post receptor mechanism.(Zhang et al. 2006) 
IPC studies have shown opioid  receptors to act via inhibitory G protein , activation of 
multiple kinases  with modulation of mitochondrial and sarcolemmal  KATP channels 
serving as final end effectors.(Zhang et al. 2006) Future studies are needed to clarify 
postreceptor mechanisms in RIPC and resolve receptor subtypes.  
1.21 Free radicals 
IPC studies have shown that Free radicals can directly activate kinases leading to 
transcription of protective proteins {Yue, 2002}, and free radical scavenger 
mercaptopropionyl glycine (MPG) abrogates the protective effects of direct 
preconditioning. Weinbrenner et al were the first to show that free radicals are key 
candidate molecules in RIPC.(Weinbrenner et al. 2004)  A single cycle of 15 min of 
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size significantly MPG blocked the effects of both RIPC and a single cycle of direct 
preconditioning but failed to block multiple cycles of direct preconditioning. This 
suggested that preconditioning is a graded phenomenon with multiple cycles 
producing a more robust preconditioning stimulus with free radicals being   only 
partially involved in the mechanism of protection. This study did not demonstrate the 
source of free radicals. Recently Patwell et demonstrated the appearance of hydroxyl 
free radicals in the circulation following ischaemia reperfusion of the limb and the 
argument that free radicals maybe produced from the ischemic limb in RIPC was 
supported by Chen et al who (Chen et al. 2005)showed that myocardial infarction was 
reduced by 4 cycles of 10 min femoral artery occlusion-reperfusion was associated 
with elevation in whole blood free radical counts upto 2 hours following RIPC  and 
since ROS levels were significantly low compared to IRI group this data suggests the 
role of low dose ROS in inducing preconditioning. In addition a period of reperfusion 
for generation and action of free radicals is needed. These findings collectively 
suggest that free radicals reach the remote organ via the blood stream in order to 
induce a preconditioning effect. Conversely in an animal model occlusion of the 
coronary artery before preconditioning supported a nerve pathway of transmission of 
the preconditioning effect(Chen et al. 2005).   
Effector mechanism 
 Direct IPC studies have shown that reactive oxygen species (ROS) lead to release of   
triggers such as NO, catecholamines, adenosine and bradykinin, ROS activate 
intracellular kinases directly(Baines, Goto, & Downey 1997) and induce synthesis of 
protective proteins . Also ROS activate cytokine NF-Кβ which induces iNOS mRNA 
transcription 24 hours later to confer delayed protection in the target organ. None of 
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induced elevation of heat shock protein and mitochondrial antioxidant enzymatic 
activity which helped maintain mitochondrial function and reduce apoptosis. However 
pre-treatment with MPG abrogated HSP and antioxidant activity. Further clarification 
of the end effector mechanism of ROS in RIPC , the source of ROS , pathway and the 
role of low dose ROS in maintenance of mitochondrial membrane permeability as 
well as prevention of apoptosis is needed. Also quantification of the levels of ROS 
which induce protective mechanisms need to be determined since high levels of ROS 
are the key elements in the initial cascade of IR injury. 
1.22 KATP channels 
Evidence 
 
1) Moses(Moses et al. 2004) et al showed that RIPC (3 cycles hind limb occlusion) 
reduced latissmus dorsi infarct size which was abolished by nonselective  blockers 
(glibenclamide) and   selective mitochondrial channel blockers(5-HD)   
2) Kristiansen et al showed RIPC of the donor heart by 4 cycles ischaemia (5min) of 
hind limb was abolished by blockade of nonselective and mitochondrial   KATP 
channels and increased infarct size in donor heart on implantation. Administration of 
diazoxide (selective mitochondrial k channel activator) prior to explant conferred 
protective effects similar to RIPC suggesting that the effects of RIPC are memorised 
in the explanted hearts and are critically dependent on  modulation of  mitochondrial  
KATP channels.(Kristiansen et al. 2004)  
3) Konstantinov et al showed that blockade of   KATP channels following RIPC in the 
recipient increased myocardial infarct size in the implanted heart in the recipient.  
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preconditioning in virgin hearts conferred by coronary effluent from preconditioned 
hearts  
5) Mabanta et al showed that remote microvascular preconditioning is mediated by   
KATP channels and blockade of   KATP channels abolished preconditioning.  
6) Pell et al showed RIPC by 10 min RAO, 10 min reperfusion reduced myocardial 
infarct size and cardioprotection was abolished by KATP blockers (5-HD). 
7) Addison et al showed remote skeletal protection by RIPC (3×10 min ischaemia)   
was abolished by 5-HD (selective mitochondrial channel blocker). 
Pathway and effector mechanism 
Two studies have demonstrated the modulation of IRI in denervated hearts in a 
transplant model and this suggests that the humoral pathway is involved in conferring 
protection. The role of   opioids in transferred preconditioning supports the humoral 
pathway. 
Are these KATP channels triggers of RIPC, mediators or End effectors?    
Moses showed blockade of KATP channels prior to RIPC abolished protection 
suggesting their role in the trigger mechanism of RIPC. Blockade of KATP channels 
after RIPC abolished protection however blockade 10 minutes prior to ischaemia did 
not influence infarct size indicating a role of KATP channels in the mediation of signal 
transduction. This study demonstrated that the critical time period for KATP channels 
to remain open after triggering was 10 minutes further supporting a role in mediation 
of signal transduction. One study has shown the opening of mitochondrial  KATP 
channels and ionic fluxes across mitochondrial  KATP channels in the opioid pathway 
of RIPC(Zhang et al. 2006) and one study showed ionic fluxes across KATP channels 
in RIPC by the adenosine pathway.(Pell et al. 1998) These observations suggest that 
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be further clarified as endeffectors for other candidate molecules. 
Mitochondrial or Sarcolemmal KATP channels? 
All   studies discussed above clearly demonstrate the role of mitochondrial   KATP 
channels in RIPC as blockade with 5-HD (selective mitochondrial channel blocker) 
abolished RIPC. Pell et al showed that RIPC was abolished by 5-HD without affecting 
the action potential of sarcolemmal fibres or vasodilator effects of sarcolemmal KATP 
channels. The muscle used in Moses model was surgically denervated, not associated 
with changes in action potential and muscle contractility suggesting the unlikely role 
of sarcolemmal KATP channels in the energy sparing effect. Two studies showed K 
flux across mitochondrial   KATP channels after RIPC (Pell and Zhang). 
Pell showed that   KATP channels reduce ATP depletion; maintain intracellular PH and 
phosphocreatinine levels in heart muscle after RIPC. Moses showed decreased 
neutrophilic infiltration, myeloperoxidase activity and ATP sparing effect in 
preconditioned skeletal muscle. These data suggest that KATP channel opening reduces 
the rate of ATP hydrolysis or mitochondrial ATPase activity thereby decreasing the 
rate of ATP depletion. Also opening of mitochondrial KATP channels decreases 
mitochondrial calcium load which preserves mitochondrial integrity.  Mitochondrial 
volume is regulated by   KATP channels and volume changes modify energy flow 
through the electron system thereby influencing energy transfer between mitochondria 
and cellular ATPases. These studies showed that RIPC applied in vivo exerts 
protection upon skeletal muscle and heart after explantation from the body and has 
potential beneficial effects in relation to heart transplantation, cardiopulmonary 
bypass, autologous skeletal muscle transplantation. 
  781.23 CGRP (calcitonin gene related peptide) and brain gut axis 
Evidence 
 
CGRP is a neuropeptide and principal neurotransmitter found in capsaicin sensitive 
sensory nerves. CGRP receptor antagonists abolished reduction in infarct size by 
IPC(Li et al. 1996) in a rat model suggesting the role of CGRP in mediation of IPC of 
the heart. 
Five studies demonstrated the role of CGRP in RIPC by brief MAO. 1) Tang et al 
showed that brief MAO (10 min) and 2) Xiao et al showed that brief MAO (6 cycles, 
4 min ischaemia, 4min reperfusion) increased plasma levels of (CGRP) and reduced 
myocardial infarct size, 3) Wolfrum et al showed that RIPC by MAO (single cycle, 15 
min ischaemia and 15min reperfusion) increased plasma levels of CGRP following 
RIPC, reduced myocardial infarct size and blockade of CGRP receptors and ganglion 
blockade abolished RIPC. Ganglion blockade did not affect CGRP release, 4) 
Brzozowski et al showed decreased mucosal CGRP and blood flow in gastric IR and 
RIPC by hepatic/coronary ischaemia (2 cycles, 5min ischaemia, 10 min reperfusion) 
restored mucosal CGRP levels in gastric IR and gastric flow, 5) Brzozowski et al 
showed that prior treatment with CGRP receptor antagonist and prior treatment with 
Capsaicin induced sensory nerve deactivation abolished RIPC by MAO. 
Administration of exogenous CGRP in denervated animals restored RIPC effects. 
What is the pathway? 
An increase in plasma levels of CGRP as shown in three studies (Tang, Xiao and 
Wolfrum) supports a humoral pathway. However ganglion blockade abolished 
myocardial protection from brief MAO demonstrating a neuronal pathway for CGRP 
in RIPC by MAO (Wolfrum).  
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cause deactivation of sensory afferent neurons. Two studies in RIPC by MAO have 
shown that treatment with capsaicin prior to RIPC by MAO abolished both reduction 
in myocardial infarct size and increase in CGRP levels.(Tang et al. 1999; Xiao et al. 
2001) Two studies in RIPC by brief hepatic artery occlusion and CAO(Brzozowski et 
al. 2004d;Brzozowski et al. 2004f) (brzozowski) also showed that prior treatment with 
capsaicin abolished the increase in gastric mucosal CGRP, increase in gastric blood 
flow and reduction in gastric erosions following RIPC. These observations strongly 
support the role of sensory neurons in RIPC. In addition Brzozowski et al showed that 
vagotomy abolished RIPC from brief hepatic ischaemia or CAO and reduced plasma 
levels of CGRP. This observation suggests that vagal efferents form a part of the 
effector pathway in CGRP mediated RIPC and demonstrates the role of the brain gut 
axis in RIPC. Finally L-name (NO blocker) abolished reduction of myocardial infarct 
size by CGRP mediated RIPC suggesting that CGRP acts via the NO pathway.(Xiao 
et al. 2001) 
End effector mechanism 
One study showed(Wolfrum et al. 2005) that in RIPC by MAO, CGRP activates 
myocardial PKC and reduced infarct size. PKC activation and myocardial protection 
was abolished by both ganglion blockade and CGRP receptor antagonists. These data 
suggest that in RIPC, CGRP acts at the cellular level by activation of kinases. Another 
study showed the NO pathway as discussed above and NO may be the endeffector 
responsible for CGRP effects. This argument is supported by past studies providing 
evidence for CGRP related NO release.(Xiao et al. 2001) One study showed the 
inhibition of cytokines (TNF-α and Il-1β) release in the target organ.(Brzozowski et 
al. 2004) Further clarification of the pathway downstream is needed in future studies. 
  801.24 Prostaglandins 
Evidence 
Brzozowski showed that Indomethacin (nonselective cyclo-oxygenase blockers), SC-
560 (selective cox-1) and rofecoxib (selective cox-2) blockers abolished the gastric 
protective effects of IPC by 2 cycles of 5min celiac artery occlusion, RIPC by 2 
cycles of 5min hepatic ischaemia or CAO(Brzozowski et al. 2004) Concurrent 
treatment with exogenous PGE2 counteracted the effects of Cox blockers and restored 
the hyperaemic mucosal effects of RIPC. Brzozowksi et al also showed increased 
gastric mucosal generation of PGE2 in IPC and RIPC. These observations suggest 
that increased endogenous activity of prostaglandins particularly of the COX-2 variety 
could be involved in preconditioning and it is known from past studies that they have 
a protective effect in gastric ulcers. 
Pathway and effector mechanism 
Brozozowski showed that   functional ablation of sensory nerves by pretreatment with 
capsaicin abolished the protective effects in all preconditioned groups. This 
observation suggests the involvement of sensory   afferent neurons in the pathway. 
Vagotomy abolished RIPC from brief hepatic/CAO suggesting the role of vagal 
efferents and the brain gut axis in mediation of RIPC. RIPC was associated with 
increased CGRP and decreased TNF-α and Il-1β expression and release suggesting 
amelioration of   gastric IRI by   prostaglandins through modulation of cytokine 
release and increased mucosal flow by vasodilatory effects of CGRP through NO 
release. These effects were attenuated by pre-treatment with capsaicin   and ablation 
of sensory nerves known to release NO and CGRP.  
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Heat shock proteins HSP28, 40,60,70,90,104 have an important physiological and 
pathological role. One of the most important heat shock proteins is HSP70 which has 
a cytoprotective role. The constitutive form of heat shock proteins is HSP73 which all 
cells express to some extent. The inducible form is HSP72.   
Heat shock proteins expression is more in myocytes compared to micro vascular cells 
Enhanced heat shock protein expression may serve to protect the heart against 
ischaemia reperfusion, hypoxia and chemicals in addition to hyperthermia. Heat shock 
proteins express themselves as early as 3hours post reperfusion in the myocardium, 
begin to decay from 42 hrs post reperfusion and persist upto 72 hours as detected by 
immunohistochemistry.  
Three studies in RIPC , Tanaka et al showed in a rabbit model  RIPC by 4 cycles of 
5min CAO and 5 min reperfusion(Przyklenk et al. 1993;Tanaka et al. 1998) increased 
cardiac tolerance due to increased HSP expression in the ischaemic and remote 
myocardium, Konstantinov  showed RIPC by 6 cycles of 4min femoral artery 
occlusion and 4 min reperfusion increased expression of HSP73 genes(anti-
inflammatory) in the heart of  preconditioned mice as compared to 
sham(Konstantinov et al. 2005) and Chen et al in a rat model showed increased 
myocardial HSP expression (HSP 70) following hind limb RIPC.(Chen et al. 2005) 
What induces HSP? 
HSP is induced by ischaemia(Tanaka et al. 1998) and ROS.(Chen et al. 2005; Chen et 
al. 2005) Tanaka showed myocytes with immunoreactivity for HSP as early as 3 
hours and persistence of this immunoreactivity upto 72 hrs. This suggests that HSP 
expression may be associated with a delayed phase of protection. Mechanisms by 
which   ischaemia  may induce HSP expression include enhanced   tissue levels of 
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dyskinesia which induces compensatory hyper contraction of nonpreconditioned 
myocardium, increased workload and a modest increase in HSP in the non ischemic 
myocardium and elevated end diastolic pressure which leads to increased workload 
and  HSP expression. However these need to be clearly demonstrated in experimental 
settings.  
What is the pathway and effector mechanism?  
One study showed that (Konstantinov et al. 2005) reperfusion stimulates HSP gene 
expression in myocardium following limb RIPC in a rat model. Chen et al 
demonstrated that reperfusion induced   myocardial HSP expression following limb 
RIPC and this was abrogated by free radical scavengers (MPG)(Chen et al. 2005). 
These studies suggest that circulatory mediators stimulate HSP expression in remote 
tissue and free radicals are one of these mediators. The effector mechanism may 
involve scavenging of ROS and modulation of K channels but this need to be clearly 
demonstrated. 
Haemoxygenase  
Haemoxygenase (HO-1) is a form of inducible heat shock protein. It is an enzyme 
which mediates the rate limiting step of breakdown of haem to biliverdin, CO and 
iron. In this process it scavenges ROS and mitigates IRI. Previous studies have shown 
haemoxygenase   to reduce hepatic IR and lung IR (Amersi et al. 1999;Coito et al. 
2002;Fondevila et al. 2003;Katori et al. 2002). 
One study showed RIPC by Limb ischaemia(Lai et al. 2006) (4cycles of 10 min 
ischaemia) reduced hepatic IRI and improved liver function. Haemoxygenase 
expression at 3hrs of reperfusion suggested its role in amelioration of IR. Zinc 
protoporphyrin (HO-1 inhibitor) 1 hr prior to IR abolished RIPC effects. 
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 So far no studies have demonstrated HO-1 activity in serum following RIPC. It is 
likely that following RIPC peripheral breakdown of haem may lead to increased CO 
levels in the blood and CO has both vasodilatory and antiplugging effects in hepatic 
sinusoids. However no study has measured Post RIPC serum carboxyhaemoglobin 
levels to demonstrate this. Lai et al demonstrated no increase in HO-1 in peripheral 
macrophages following RIPC and therefore   the role of   peripheral macrophages as a 
pathway for HO-1 induction in the liver is unlikely. RIPC induces a low grade 
oxidative stress in the limb which may lead to release of ROS and cytokines into the 
circulation, low grade oxidative stress in the liver and increased hepatic HO-1 
expression. This is hypothetical and needs to be proved by using ROS scavengers. 
HO-1 pathways scavenge ROS following IR, stabilise mitochondrial membrane 
permeability and reduce apoptosis by decreased cytochome C release as shown by 
previous studies. HO-1 also downregulates iNOS and inhibits NF-Kβ expression. 
Future studies are needed to define the pathway and effector mechanism of HO-1. 
1.26 Effect of RIPC on inflammatory gene expression 
The first study to look at effect of remote preconditioning on inflammatory gene   
expression modification in a human model showed that brief forearm ischaemia led to 
suppression of proinflammatory genes(Konstantinov et al. 2004) encoding proteins in 
circulating leukocytes,  reduction in neutrophil chemotaxis, adhesion   and exocytosis. 
Studies by Huda (RIPC MAO model) showed decreased inflammatory gene 
expression following brief MAO.  
1.27 Clinical trials 
Kharbanda et al conducted the first clinical trial in humans(Kharbanda et al. 2002) 
and showed that forearm ischemic preconditioning is associated with diminished 
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endothelial injury. The mechanism was not clearly identified although it was thought 
to be due to a substance released in the circulation. In a recent trial in children 
undergoing cardiac surgery for congenital heart defects on cardiopulmonary bypass 
(CPB) Kharbanda et al demonstrated that four cycles of right hindlimb ischaemia (5 
min) followed by reperfusion(5min) prior to CPB preconditioned the heart and 
reduced infarct size.(Cheung et al. 2006) Thereafter Kristiansen et al studied the effect 
of forearm ischaemia on cardiac ischaemia in cardiopulmonary bypass procedures and 
found it to be protective. This protective effect was attributed to  KATP 
channels.(Kristiansen et al. 2004)  
In  humans  Konstaninov(Konstantinov et al. 2004) showed diminished expression of 
inflammatory genes in neutrophils following limb RIPC. Since neutrophils are one of 
the key mediators of the late phase of IRI responsible for oxidative stress and injury to 
organs modulation of neutrophil activation would be of prime importance in reducing 
IRI. 
The next page shows a tabulated summary of the studies on mechanisms in RIPC. 
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mechanism 
Site of index 
ischaemia 
Site of 
preconditioning 
stimulus 
Author/referenc
e  model Endpoint  Organ 
protection 
1 ?iNOS  expression 
(Humoral 
mechanism) 
Hind 
limb(right)cremast
er flap 
Hind limb(Femoral 
artery) 
Wang W.Z. et al 
2004  Rat  Flap necrosis  Flap protection  
2 
iNOS and NO  Cardiac ischaemia  Cerebral ischaemia  Tokuno et al 
(2002) 
Mouse 
isolated 
heart 
Infarct size  Reduced infarct 
size 
3 
NFkB and iNOS  Cardiac ischaemia  Hind limb 
Guohu Li 
(2004) 
 
Mice Infarct  size 
Reduced infarct 
size 
Delayed 
protection 
4 NO 
 
 
Adipocutaneous 
flaps  Hind limb 
 
Kuntscher et al 
2003 
Rat Flap  necrosis  Protection 
 
5  NO  Adipocutaneous 
flaps  Hind limb  Kuntscher et al 
  Rat Flap  necrosis  Flap Protection 
 
6 
NO  Cardiac ischaemia         Hind limb  Chen X.G. 
Oct 2005  Rat Infarct  size  Reduced infarct 
size 
7  NO  Rat cremasteric 
muscle flaps  Hind limb  Kuntscher et al 
  Rat  Flap necrosis  Protection  
8  NO in direct 
preconditioning 
but not in RIPC. 
 
Heart and intestine  Intestinal 
ischaemia 
Vlasov et al 
(2004)  Rat Infarct  size 
No myocardial 
protection. 
Intestinal 
adaptation 
9  Role for iNOS  Cardiac ischaemia  Mesenteric  Wang Y.P. et al 
(2001)  Rat Infarct  size  Reduced infarct 
size 
10  NO unlikely 
pathway.  Cardiac ischaemia 
Direct cardiac and 
remote mesenteric 
ischaemia 
Petrishcev et al 
  Rats Infarct  size  Reduced infarct 
size 
11 Increased 
interstitial 
adenosine 
levels;  afferent 
autonomic nerve  
stimulation, 
activation of 
myocardial 
adenosine 
receptors 
Cardiac ischaemia  Mesenteric 
ischaemia 
Liem et al 
 (2002)  Rat Infarct  size  Reduced infarct 
size 
12 Adenosine 
receptors 
and sarcolemmal 
Katp channels 
Cardiac ischaemia  Renal  Pell et al 
(1998)  Rabbit Infarct  size  Reduced infarct 
size 
13  Adenosine Cardiac  ischaemia  Renal  Takaoka et al 
(1999)  Rabbit Infarct  size  Reduced infarct 
size 
            
14 
      
       ?Adenosine 
 
Cardiac ischaemia 
         
            RPCT 
      Xiaoping 
Ren et al  (2004) 
Mouse    Infarct size  Reduced infarct 
size 
15 Angiotensin 
receptorss  Cardiac ischaemia  renal  Singh et al 
(2004)  Rat Infarct  size  Reduced infarct 
size 
16  Autonomic 
nervous system 
Endothelial limb 
injury  Hind limb  Loukogeorgakis 
Aug 2005  humans 
Flow 
mediated 
dilatation 
Endothelial 
function 
Protected 
17  Neurogenic, 
humoral  Cardiac ischaemia  Mesenteric and 
renal 
Gho 
1996  Rat Infarct  size  Reduced infarct 
size 
18 Bradykinin 
mediated 
and neuronal 
pathway 
Cardiac ischaemia  Mesenteric 
ischaemia 
Schoemaker et al 
(2000)  Rat Infarct  size  Reduced infarct 
size 
19  Brain gut axis, 
sensory and 
vagal 
activation,CGRP 
release. 
Gastric  ischaemia  Hepatic/cardiac 
Brzozowski T et 
al 
(2004) 
 
Rat  Gastric 
lesions 
Protection 
 
20 
Calcitonin gene 
related peptide.  Cardiac ischaemia  Mesenteric   Wolfrum  
              2005  Rat Infarct  size 
 
 
 
Reduced infarct 
size 
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22 
Capsaicin sensitive  
sensory nerves  Cardiac ischaemia  Mesenteric  Tang et al  Rat  Infarct size 
Reduced infarct 
size 
 
 
 
 
 
 
 
23 
Cyclo-oxygenase 1 
and 
cyclo-oxygenase-
2, 
sensory nerve 
activation and 
release 
of  CGRP, NO, 
inhibition ofIl-1 
and TnF -α. 
Gastric ischaemia 
reperfusion injury  Hepatic /cardiac 
Brzozowski T et 
al 
(2004) 
 
Rat 
Gastric 
lesions and  
blood flow 
Protection of the 
stomach 
 
24  Cytokine  IL-6   Lung IRI  Hind limb  Waldouw 
2005  Pigs   Lung 
functions 
Protection of lung 
functions 
25  Inhibition of TnF –
α induced selectin 
up regulation. 
Kidneys,lungs and 
other organs  Hepatic ischaemia  Peralta et al 
(2003)  Rat Organ  failure  Protection of 
remote organs 
26   Enhanced 
anaerobic 
glycolysis 
Cardiopulmonary 
bypass  Upper limb  Gunaydin et al 
(2002)  Human  LDH,CK 
release  Not conclusive 
27  Free radicals  Cardiac ischaemia  Hind limb  Chen YS 
Jun 2005  Rat Infarct  size  Reduced infarct 
size. 
28  Heat shock 
proteins 
Remote 
myocardial 
preconditioning 
Cardiac ischaemia  Tanaka et al 
1998  Rabbit Infarct  size  Reduced infarct 
size 
29  Inflammatory gene 
suppression  Cardiac ischaemia   Hind limb  Konstantinov 
Nov 2005  Mouse  Infarct size   Reduced infarct 
size 
30 Inflammatory  gene 
suppression.   Cardiac ischaemia  Mesenteric 
ischaemia 
Huda  
2005  Rat Infarct  size  Reduced infarct 
size 
31  K ATP channels  Cardiac ischaemia 
in explanted heart.  Hind limb  Kristiansen 
2005  Rat Infarct  size  Reduced infarct 
size 
32 
K ATP, Late phase  Skeletal muscle  Hind limb  Moses 
Dec  2005  Rat infarction  Reduced 
33 KATP  channel  –
pulmonary 
vascular 
dilatation and 
myocardial 
protection 
Cardiac ischaemia  Iliac artery  Xia et al 
2004  Sheep 
Pulmonary 
function and 
pulmonary 
vascular 
resistance 
Lung protection 
And decreased 
pulmonary 
vascular 
resistance. 
 
34  KATP channels 
modulation in 
recipient 
Cardiac ischaemia 
in transplanted 
heart 
Hind limb  Konstantinov  
June 05  Rat Infarct  size  Reduced infarct 
size 
35 KATP 
channels(early 
phase) 
 Hind  limb  Moses et al 
2004  Rat Flap  necrosis  Skeletal muscle 
protection  
36 Ventricular  pacing 
by activation of 
katp channels. 
. 
Cardiac ischaemia 
Mesenteric 
ischaemia, renal 
ischaemia and 
ventricular pacing 
Verdouw et al 
  Pig Infarct  size  Reduced infarct 
size 
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Table 1.10- Studies on mechanisms in RIPC 
   
  37 
 Myocardial PKC 
activation  Cardiac ischaemia  Mesenteric  Wolfrum 
(2002)  Rat Infarct  size  Reduced infarct 
size 
  
 38 
PKC  and 
mitochondrial 
KATP channels 
Cardiac ischaemia  Mesenteric 
ischaemia 
Wang Y.P. et al 
(2002)  Rat Infarct  size  Reduced infarct 
size 
39  Nor epinephrine  Cardiac ischaemia  Hind limb  Oxman et al 
(1997)  Rat  Reperfusion 
arrythmias 
Decreased 
arrythmias 
40  Norepinephrine  Cardiac ischaemia  Cerebral ischaemia  Verdouw et al  
2001   Pig Infarct  size  No change in 
infarct size 
 
41 
Suggested 
adrenergic 
Pathway and 
blockade by 
reserpine. 
Cardiac ischaemia  Hind limb  Kharbanda et al 
(2002)  Pig Infarct  size  Reduced infarct 
size 
42  Opioid delta 1 
receptors 
Global skeletal 
protection  Hind limb  Addison et al  Pig  Ischemic 
necrosis 
Skeletal 
protection  
43 
Opioid receptors  Cardiac ischaemia 
Coronary effluent 
of donor following 
cardiac ischaemia 
Dickson et al 
(1999) 
 
Rabbit Infarct  size  Reduced infarct 
size 
44 Opioid  receptors 
and PKC ; 
humoral pathway. 
Cardiac ischaemia  Infrarenal  Weinbrenner 
(2002)  Rat Infarct  size  Reduced infarct 
size 
45 
Metenkephalins   Cardiac ischaemia 
Coronary effluent 
following cardiac 
ischaemia 
Dickson et al 
(2001)  Rabbit  Infarct size  Reduced infarct 
46 Endogenous 
opiods  Cardiac ischaemia  Mesenteric  Patel at al 
2002  Rat Infarct  size  Reduced infarct 
size 
47  Haemoxygenase Liver  ischaemia  Hind Limb 
ischaemia  Lai et al (2006)  Rat  Liver function  Improved liver 
function 
1.28 Conclusions and Future work 
Remote preconditioning is a novel method of preconditioning. Limb, mesentery and 
kidney are organs which can effectively be used to induce remote protection and 
reduce IRI. Brief periods of cardiac ischaemia confer protection on the lungs and vice 
versa. This may be of benefit in cardiovascular surgery and coronary bypass 
procedures. 
Similar protection in musculoskeletal flaps and protection of the brain function needs 
to be evaluated in clinical trials. Adenosine, NO, PKC, Bradykinins, Catecholamines, 
Opioids, HO-1(HSP), Free radicals and Cytokines are the candidate mechanisms 
which form part of a complex cascade involved in transduction of the preconditioning 
effect with overlap between neurogenic and humoral pathways. The RIPC stimulus 
requires reperfusion providing unequivocal evidence of a humoral mediator. However 
there are many circulating mediators such as NO, Opioids and Adenosine which have 
undergone selective blockade to abrogate RIPC. The end effect of the remote stimulus 
  88is to reduce the mitochondrial permeability in the target organ conserving cellular 
ATP levels and reducing apoptosis. Microarray analysis has shown transcription of 
anti-inflammatory genes and modulation of oxidative stress to be of prime importance 
in preconditioning. Application of remote preconditioning in clinical settings has so 
far been limited and its use particularly in organ transplantation is of interest. 
 Kanoria et al   demonstrated   improved liver function by RIPC in hepatic IRI and 
increased hepatic blood flow by ICG and laser Doppler flow measurements
13. Lai et al 
demonstrated improved liver functions and the role of haemoxygenase in hepatic 
protection(Lai et al. 2006). Gustaffson demonstrated protection of hepatic function by 
remote preconditioning(Gustafsson et al. 2006). None of these studies addressed the 
in vivo microcirculatory changes seen in hepatic IR and the effect of RIPC on hepatic 
IR. We focused our study on the hepatic microcirculatory changes in hepatic IR and 
the modulation of hepatic microcirculation by RIPC. We hypothesised that RIPC  
modulates hepatic microcirculation in IR injury and applied intravital microscopy to 
investigate effects of RIPC.We also investigated the role of RIPC induced 
haemoxygenase (HO) expression in the liver in modulation of hepatic 
microcirculation in IR and the carried out the first study to investigate the effects of 
remote ischaemic preconditioning in a recovery model of hepatic IR after 24 hours of 
reperfusion. In addition we investigated the effects of HO on neutrophil activation and 
mitochondrial cytochrome c induced activation of caspase apoptotic pathway. 
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Overview of end points and methods of assessment in this study 
In this study we evaluated the microcirculatory changes of IR and its alteration by 
RIPC by applying intravital microscopy. Injection of RBC labelled with 
fluoroisothyocyanate enabled us to assess sinusoidal flow, RBC velocity, sinusoidal 
diameter and perfusion in a real time manner. The endothelial neutrophil interactions 
representative of the inflammatory cascade were assessed by intravital microscopy 
after injecting neutrophils labelled with rhodamine 6 G. Serum was used for assessing 
transaminase levels (markers of hepatocellular injury) and plasma for CINC levels 
(cytokine levels) by ELISA in all animal groups.   
  91 At the end of reperfusion (180 minutes) liver tissues were harvested and stored in 
formalin for histological assessment of liver tissue. Immunohistochemistry was 
carried out to assess expression of haemoxygenase and its spatial distribution. Snap 
frozen liver tissue was used for western blot assessment and quantification of 
haemoxygenase expression and for mitochondrial cytochrome c levels.  
2.1 Experimental protocol 
2.1.1 Animals and surgical procedures. 
The Study was conducted under project license from the Home Office in accordance 
with Animals (Scientific Procedures) Act 1986. Male Sprague –Dawley rats, 
weighing 250-300gms were used. Animals were kept in a temperature controlled 
environment with a 12 hour light-dark cycle and allowed tap water as well as standard 
rat chew pelletes and libitium. Animals were anaesthetized with 0.5-1% isoflurane 
and maintained with 1-1.5l/min of N2O and 0.5-1.0% Isoflurane. They were allowed 
to breathe spontaneously through a concentric mask connected to an oxygen regulator 
and monitored with a pulse oximeter (Ohmeda biox 3740 pulse oximeter, Ohmeda, 
Louisville, USA). 
The technique of remote ischaemic preconditioning involves using a tourniquet, 
which is tied around the thigh in one of the hind limbs. This tourniquet is tightened till 
until the manometric pressure is twice the systolic pressure and there is no audible   
Doppler signal in the leg. The procedure includes 5 minutes of ischaemia followed by 
5 minutes of reperfusion. This will be repeated four times(Kristiansens model) in 
order to obtain a significant beneficial effect based on past experimental evidence in 
animals(Goto et al. 1995) that three or more brief periods of preconditioning are more 
effective than a single period in animals. At the end of the experiment the animals will 
be killed by exsanguination.   
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monitoring of mean arterial blood pressure and right jugular/femoral vein for 
administering normal saline (1ml /100gm body weight to compensate for 
intraoperative fluid loss. 
Laparotomy was carried out through a midline incision. The ligamentous attachments 
of the liver were cut and the liver was mobilised. Partial hepatic ischaemia of the left 
lateral and median lobes of (70% of liver) was induced by clamping the 
corresponding vascular pedicle with an atraumatic microvascular clamp. This model 
facilitates splanchnic decompression. Total hepatic ischaemia can potentially lead to 
splanchnic congestion and cytokine release leading to false results. Ischaemia was for 
a period of 45 minutes followed by 3 hours of reperfusion  to assess the early period 
of hepatic IR(Koti et al 2002) and 24 hrs reperfusion to study the late phase. 
 
 
Fig 2.1 Animal model of Partial hepatic ischaemia (70% 
  93Fig 2.2 Animal model of Remote ischaemic Preconditioning  
2.2   Intravital fluorescent microscopy  
Introduction 
The first intravital fluorescent microscope (IVFM) was made by Ellinger and Hirt in 
Germany, which was a modified version of the fluorescence microscope (developed 
in the early 20
th century) so that it could be used to examine opaque tissues{Kasten et 
al}.  
The IVFM can be divided into two separate measuring systems. The first represents 
the microscope alone, with the light source, lenses, filters and fluorescence acting as 
the functional elements (Fig 2.3). 
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The second system begins with the image seen from the microscope being converted 
via the CCD camera, passing through the frame grabber and onto the computer 
monitor display (Figure 2.4) 
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Figure 1.4 Image recording system in the intravital microscope 
  
The IVFM used for this study was a custom built Nikon Epi-illumination system with 
filter block set suitable for Texas Red, FITC and DAPI dyes as detailed in table 2.1. 
(Fig 2.5) 
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Fluorochrome Excitation 
(nm) 
Emission 
(nm) 
Colour Type of label 
DAPI 360  450 Blue  Nuclear  Stain 
FITC 495 525 Green  Protein 
Conjugation 
Texas Red  596  620  Red  Protein 
Conjugation 
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Figure 2.5 The complete intravital microscopy setup. 
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One of the main characteristics of the intra-vital fluorescence microscope is that it 
requires fluorescence. Fluorescence is the property of some atoms and molecules to 
absorb light of a particular wavelength and after a brief interval – the fluorescent 
lifetime – re-emit light at a longer wavelength.  
The chromophores are excited by an external light source; they absorb the energy and 
pass into an excited energy state. After entering the higher energy state, the molecules 
undergo internal changes.  The electrons in certain molecules instead of returning to 
the ground state enter a metastable state. When the molecules pass down to the 
ground state they emit the excess energy as electromagnetic radiation {Sykes, 1991 2 
/id} – seen as fluorescence. The energy between the metastable and ground states is 
less than the energy absorbed during excitation, so the emission wavelength will be of 
longer wavelength than the absorbed or excitation light{Sykes et al}. 
The light from the epi-illumination light source (which is usually a mercury arc or 
xenon lamp in standard IVFM setups) first passes through an excitation or short-pass 
(SP) filter allowing only the excitation waves through. These are then passed onto a 
chromatic beam splitter (dichromatic mirror) where wavelengths below a certain 
value are reflected onto the specimen while any above the wavelength value are 
passed through and dissipated. The light hitting the specimen then activates the 
fluorescence probe which produces emission light of a particular wavelength.  
A dichromatic mirror allows passage of excitation wavelengths of certain values and 
emission wavelengths of certain values. According to Stokes’ law the wavelength of 
emission is of lower energy and therefore longer wavelength than that of the 
excitation. The dichromatic mirror is designed to allow the transmission of longer 
  97emission wavelengths and reflect the shorter excitation wavelengths. The three filters 
are usually contained within a filter box as illustrated in figure 2.6 
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 Fig 2.6 Schema of Filter Block  
After passing through the dichrom
passes through a barrier filter that removes any light of shorter wavelength that may
have mistakenly passed through the dichromatic beam splitter. This emission 
wavelength then passes into a detector that sends the signals to the eye pieces 
operator observation or into a video camera for image recording.  
2.3 Components 
2.3.1 Light source
The light of the IVF
lamp-house. Since the development of epi-illumination, microscope optics has 
developed with the incorporation of laser light sources increasing the resolution
image and improving the signal-to-noise ratio. A rheostat or ballast alters the current 
applied to the lamp to control the intensity of the light produced. In a gas discharge, 
such as a fluorescent lamp, current causes resistance to decrease. This is because as 
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which frees up electrons, creating more charged particles.  
2.3.2 Objectives 
IVFMs usually use water immersion objectives as these reduce the refractive index in 
living in vivo imaging .The water immersion objective delivers contrast and 
resolution values nearly equivalent to the theoretical limits, and maintains its 
performance when water layers of 80 and 153 micrometers are added between the 
target specimen and cover slip, a simulation of the situation encountered in imaging 
deep within aqueous material such as living cells or tissue.  
There are four types of filters in the intra-vital fluorescence microscope system, 
neutral density (ND) filters, an excitation filter, an emission filter and a multi-band 
pass filter. 
Special neutral density (ND) filters are built in the light path to block 90-95% of the 
incidence light passing into the microscope to prevent damage to the eye as well as 
reduce overexposure of fluorescence in specimens {Nikon et al}. There are three 
neutral density filters which are placed in front of the optical light path to reduce 
illumination without altering the colour balance.  
The excitation filter passes only a selected range of wavelengths of light to cause the 
fluorescently labelled specimen to fluoresce and filters the rest. The bandwidth of a 
filter determines the brightness of the fluorescent image. If the bandwidth is narrow 
then the image appears dark but minimal auto-fluorescence and photo-bleaching 
occur. With a wide bandwidth, although the image appears bright, autofluorescence 
may also be detected with the added disadvantage of photo-bleaching {Nikon et al}. 
The emission or barrier filter allows only light wavelengths that have been emitted 
from the specimen. These are usually longer according to Stoke's law. In older epi-
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one fluorescent dye at a time. However newer developed models have a multi-band 
pass filter or a polychromatic beam splitter that can allow visualisation of three 
different coloured fluorescent dyes. 
2.3.3 CCD Camera  
The image obtained from the IVFM is then recorded by a charged coupled device 
(CCD) camera. For this study a JVC TK-C1360B colour video camera was used. 
CCD sensors are light integrating devices that accumulate photo charges until image 
readout. The CCD chip in the camera contains an array of pixels that transform light 
(wavelength 400nm to 1000nm) into a charge, which during readout is transformed 
into a voltage. 
Once photo charges are shifted to the storage area, images are erased from the CCD 
light sensing area {Cinelli, 1998}. New photo charges can not pile up on top of the 
previous images. In video rate CCD cameras, this process occurs at regular video-rate 
of 60 Hz in RS 170 format. However the JVC camera used in this study produces an 
image acquisition rate of 50 Hz). 
The photo charges are shifted in block from the sensing area to the storage area, then 
each line is individually read to the serial registers and finally photo charges are 
transferred to the output buffers. Each readout cycle is initiated by a vertical sync 
pulse (vertical blanking sync) which activates the parallel driver and triggers the shift 
block of photo charges accumulated in the sensing area to the CCD storage area. 
Exposure time is the main factor that determines the sensitivity of CCD cameras. 
Long exposure times improve camera sensitivity and reduce the noise levels of the 
images, since the accumulation of the photo charge in the CCD sensor is proportional 
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varying resolutions typically around 8 bits resolution by a frame grabber board. 
2.3.4 Frame Grabber 
The Matrix Meteor II/Standard frame grabber used in this study allows image 
acquisition at 25 frames per second. The main parts of the frame grabber are the low-
pass filter, the decoder, the trigger and the image coding components. The low pass 
filter reduces the high frequency noise and aliasing effects from the analogue CCD 
signals and passes the refined signals to the video decoder. This is the component of 
the frame grabber that performs the actual analogue to digital conversion of the 
component (Y/C) analogue video signals. 
2.3.5 Image Analysis Software 
Adjusting the output image can enhance the resolution and contrast of the image. 
Light intensity and colour are represented in numbers between 0 (black) and 255 
(white). Converting the image into binary form means it is converted into a black and 
white image. This is done by assigning threshold values which determine the 
distribution of the pixels into two populations either of value 0 or 255.  
An image can be transformed into binary form using many different types of software 
packages. 
Laboratory Universal Computer Image Analysis (LUCIA) is a multi-spectral image 
analysis software developed specifically for image processing independently on red, 
green and blue components and then combining them together into the RGB image at 
the same time. Most Nikon microscopes are supplied with Lucia software and there 
are many versions available denoted by the letter following Lucia. Lucia G is the top 
of the range package that allows 24-bit colour image analysis with the function to 
allow user to create specialized macros.  
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and Propidium iodide. 
Protocol for Fluorescence Labelling Of RBC 
 
Stock Solution 1 (adjust to pH 7.4) 
Barbital Sodium   2.55 g 
1M HCl     10 ml 
NaCl      6.8  g 
Bring to     0.5 L 
 
Stock Solution 2:- 
MgSO4.7H2O 24.6 g 
100ml distilled water makes 1M solution 
 
Stock Solution 3(0.03M CaCl2): 
CaCl2.2H2O    4.41  g 
100ml distilled water makes solution. 
 
Note: Stock solutions can be kept for around a month in a fridge at 4
0C. 
 
Working Solution (glucose saline buffers) 
Stock 1  50 ml   
Stock 2  0.1 ml 
Stock 3  0.1 ml 
Glucose  4.2 g  
Make up to 200ml with distilled water 
 
FITC for red blood cells:- 
40mg of FITC 
2ml of glucose saline buffer 
 
Labelling cells: 
1. Collect approx 8ml blood in heparinised tube or as much as you need.  
2. Centrifuge blood at 400g or 2000r.p.m for 10mins.  
3. Remove plasma + buffy coat.  
4. Wash cells with glucose saline buffer 5 times.  
5. 1ml of washed red cells are added to 1ml of buffer and 0.4ml of FITC. 
6. Leave for 1.5 to 2hrs at room temp.  
7. Labelled cells are washed 3 times until no colouring is left in supernatant. 
8. Suspend in glucose saline buffer in 1:2 dilution. 
  
Preparation of Rhodamine 6G (Sigma Aldrich) 
Rhodamine 6G was prepared by dissolving in normal saline and the dose given was 
0.3mg /kg i.v.  Dose used was based on previous experiments by Wunder et( Wunder 
et al) 
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Preparation of Propidium iodide (Sigma Aldrich) 
 
Propidium iodide was dissolved in normal saline and administered at the end of the 
experiment intrarterially before termination of the animal to assess the number of 
dead hepatocytes. The dose used was 0.5 kg/ml based on previous experiments by 
Potter et al. 
2.3.7 Intravital videofluorescence microscopy 
The animals were maintained under anaesthesia with isoflurane and oxygen .Their 
temperature was maintained by a warm mat which was regulated by thermostat. 
The liver was exposed and placed upon a glass mount and covered with a cover slip. 
The liver was continuously irrigated with normal saline. A drop of saline was placed 
on the cover slip and the tip of the lens of the microscope was immersed in the saline 
drop. 
A Nikon microscope attached to a video camera was used. The power of 
magnification was 10x and 40x.The microscopy images were transferred by the 
camera to the video monitor and recorded for offline analysis. Quantitative 
assessment of microcirculatory parameters was performed offline by frame by frame 
analysis of the videotaped images. Microcirculation was assessed by evaluating acinar 
perfusion in ten randomly chosen acini and leukocyte endothelial interaction in ten 
postsinusoidal   venules. 
RBC velocity (V) 
•  0.5 ml of FITC labelled red cells suspended in glucose saline buffer solution 
(20mgFITC /ml of RBC) were given intravenously to assess the velocity of 
RBC flow. Ten randomly chosen nonoverlapping rappaport acini were 
assessed.  
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movement (microns) in each sinusoid in subsequent frames. 25 frames were 
captured per second. Hence the velocity was calculated using the formula= 
L×25/number of frames moved. 
Sinusoidal Perfusion and perfusion index (PI) 
 The sinusoidal perfusion index was evaluated as ratio of perfused sinusoids 
(Continuous (CP) + intermittent (IP)) to the amount of total visible sinusoids which 
includes non perfused sinusoids as well. (Scp +Sip/ Scp+Sip+Snp). 
Sinusoidal diameter (D) 
This was measured by assessing the length across the sinusoids and expressed in 
microns. {Potter et al} 
Sinusoidal blood flow    
The sinusoidal blood flow was calculated using the formula- Velocity (V) ×22/7× 
(D/2)2. {Potter et al} 
2.3.8 Neutrophil adhesion 
Rhodamine 6G (0.3mg/kg) was given intravenously for staining of neutrophils. 
Rhodamine has an affinity for binding to neutrophils and its use for visualising 
adherent neutrophils is well established (Wunder et al).The numbers of sticking 
leukocytes were counted as those stationary for a period of 30 seconds under green 
filter light and expressed   as leukocytes/mm2.The area of the vessels was calculated 
using the product of diameter and length assuming cylindrical geometry (3.14×D×L). 
2.3.9 Hepatocellular death 
Hepatocellular death was assessed by intravenous injection of Propidium iodide 
(0.15mg/kg i.v) prior to termination of the animal and the number of nuclei stained 
with the dye were counted under the camera and expressed as number of apoptotic 
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(oncolytic necrosis/ apoptosis) as it penetrates the cell membrane to stain dead nuclei. 
(Brock&Potter et al) 
2.4 Data collection and statistical analysis 
Data from the pulse oximeter, pressure monitor were collected through the time 
period of observation on a laptop. All values are expressed as mean ±standard error of 
the mean (SEM). Analysis of variance (ANOVA) and Bonferroni adjustment for 
multiple comparisons were used unless otherwise stated, where unpaired Student’s t-
test was used for statistical analysis between groups. P< 0.05 was considered 
statistically significant.  
2.5 Biochemical assays 
The serum was thawed and analysed on a Hitachi 747 auto-analyzer (Hitachi Ltd, 
Tokyo, Japan) by using commercially available enzymatic kits (Boehringer 
Mannheim Ltd., East Sussex,UK) for lactate dehydrogenase (LDH), aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT). 
2.6 Histological investigations 
At the end of the experiment the liver was removed, fixed in 10 per cent neutral 
buffered formalin and embedded in paraffin; paraffin section 4μm thick were cut 
using a microtome and mounted on slides for haematoxylin and eosin staining. The 
paraffin sections were dewaxed by immersing them in xylene three times for duration 
of 2 minutes each followed by a gap of 2 minutes.  Subsequently the sections were 
immersed in 100% OP twice followed by 74%OP once and thrice in water for 2 
minutes each. Sections were stained in haematoxylin 5 mins and then differentiated in 
1% acid alcohol. Blue in tap water .Stained with 1% Eosin 5mins and de-Hydrated in 
alcohol and cleared in Xylene & mounted in DPX. 
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Numerical 
assessment 
0 1 2 3 4 
Sinusoidal 
congestion 
None Minimal  Mild  Moderate  Severe 
Vacuolation None  Minimal  Mild  Moderate  Severe 
Necrosis   None  Single cell  30%  60%  >60% 
 
2.7 Evaluation of spatiotemporal   expression of haemoxygenase by 
immunohistochemistry.   
2.7.1 Controls 
 Positive control section for each antibody was used and included in every run. The 
positive control used was recombinant HSP 32 obtained from abcam laboratories .The 
negative control used was normal rabbit serum instead of the primary antibody 
(recommended dilution, 1/4000). 
2.7.2 Antigen retrieval – in order to retrieve the antigen the following steps are 
essential-  
Blocking endogenous peroxidase. 
Slides were immersed in 0.3% hydrogen peroxide in methanol (for a full rack of 
slides this is 4ml H2O2 in 400ml of methanol) for 30 minutes.  
Blocking non specific background. 
Non-specific protein binding sites were blocked with serum from goats because   goat 
serum contains antibodies which bind with the non specific antigenic binding sites 
thus preventing them from binding secondary antibody.One drop of blocking solution 
(50-100μl) was placed on each section and left for 1 hour.  
Blocking endogenous avidin-biotin 
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immunostaining sections. Avidin biotin activity was blocked. 
2.7.3 Primary antibodies. 
Primary antibodies used were anti rabbit polyclonal IgG for HO. All primary antibodies were 
diluted with PBS (1:200) 50-100μl for each section. This antibody chosen was a polyclonal 
antibody which detected HO-1. The incubation period was overnight. 
2.7.4 Secondary antibodies. 
Goat serum (anti rabbit monoclonal IgG) was used as secondary antibody because this 
would specifically bind to the polyclonal rabbit antobody The dilution used was 1:50 , 
duration of incubation was 45 minutes and the positive reaction was identified by 
ABC kit (Santa Cruz biotechnology, Santa Cruz, Ca with peroxidase as substrate and 
3.3’ diaminobenzidine tetrachloride as  chromogen was used.  
2.7.5 PBS and antibody diluents 
PBS (0.01M) containing 0.1% bovine serum albumin and 0.1% sodium azide is used 
as a diluent for all immunoreagents except those containing peroxidase (since azide 
inhibits peroxidase and would prevent the immunoreaction becoming visibly 
labelled). Dilute peroxidase conjugates in plain PBS. The purpose of adding azide is 
to prevent contamination with fungi etc. The purpose of the BSA is to provide a high 
concentration of “inert” protein to compete with the diluted antibody for non-specific 
binding sites on the walls of the storage vessel. It may also absorb any anti-albumin 
that may be present and might produce unwanted staining.  
2.7.6 Method of   HO-1 immunohistochemistry and controls. 
The method used for   HO-1 immunohistochemistry has previously been used (polka 
and Van Noorden et al).Positive control section for each antibody was used and 
included in every run. The positive control used was recombinant HSP 32 (abcam 
  107lab). The negative control used was normal rabbit serum instead of the primary 
antibody (recommended dilution, 1/4000). 
Reliability of technique  
The technique used is the indirect immunoperoxidase technique well described in the 
literature (Nakane and Pierce 1967). Although it is a sensitive technique to identify 
HO protein and its distribution antibodies used are not highly specific and may cross 
react with other antigens. The technique does not help quantify HO expression. 
2.7.7 Immunostaining procedure 
The paraffin fixed slides were dewaxed in several changes of xylene and then 
rehydated through absolute alcohol, 90%alcohol, 70%alcohol to distilled water or 
deionised water (1-2 minutes in each solvent). Mercury pigment was removed with 
iodine. In order to retrieve antigen the slides were immersed for 30 min in a solution 
of 0.3% H2O2 (4ml of H2O2 per 100 ml) in methanol to inactivate endogenous 
peroxide. The slides were rinsed in phosphate buffer solution (PBS).  This was 
followed by blocking of non-specific background with 100 ml of normal rabbit serum 
(diluted 1:30 with PBS) for 30 minutes. The serum was drained off onto paper tissue. 
The primary rabbit polyclonal antibody was diluted in PBS containing 0.05% bovine 
serum albumin and 0.01% sodium azide at room temperature for 2hrs. The slides were 
rinsed with PBS three times for 5 minutes each and then incubated for 30minutes with 
50-100 µl of 1:200 diluted biotinylated antibody solution(anti rabbit IgG). This was 
followed by three rinses with PBS for 5 minutes each. The slides were then incubated 
with secondary antibody (1:50 for 45 minutes)) 50-100µl on each slide for 45 minutes 
Finally the sections were incubated with vectastain ABC reagent. As per kit 
instructions 1 drop A + 1 drop B into 5ml PBS. 50 - 100υl were put on each and left 
for 30 min and then rinsed with PBS. Slides were placed in rack – 3 x 5min DAB 
  108(Diaminobenzidine) for approx. 5-10 minutes 10min and counterstained with 
haematoxylin (approximately 40 sec). Dehydrated and mounted. 
Immunostaining Steps 
•  The sections were dewaxed  & re-hydrated  
  Xylene   → Xylene    →  Xylene   → 
  (2  min)   (2  min)   (2  min) 
 
   
          →  70% 74 OP    →    100% 74 OP    →    100% 74 OP   → 
  (2  min)   (2  min)   (2  min)     
 
          
  → Water    → Water    → Water 
  (2  min.)   (2  min.)   (2  min. 
•  Antigen Retrieval  
•  Endogenous peroxidase (0.3% H2 O2): For 30 minutes. 
    400ml MeOH + 4ml 30% H2O2 
•  Washed with PBS×3. 
•  100µl of 1:30 normal rabbit serum on each. Leave for 20 min to 2 hr (30 min). 
•  Primary antibody (rabbit polyclonal IgG) in optimum dilution – 50 - 100µl was 
applied on each section. 
Sections left for 2 hr at room temperature / overnight at 4
oC 
•  Rinsed with PBS:  sldes were placed in rack – 3 x 5min 
•  Secondary antibody ( goat serum anti rabbit IgG ) 
  50 - 100µl of 1:200 on each slide   for 45 minutes. 
•  Rinsed with PBS: Place slides in rack – 3 x 5min 
•  ABC: Important: Prepare at least 30 min in advance  
As per kit instructions 1 drop A + 1 drop B into 5ml PBS 
50 - 100µl on each and leave for 30 min.    
•  Rinsed with PBS: Place slides in rack – 3 x 5min  
  109•  DAB (Diaminobenzidine) for approx. 5-10 minutes (10min.). 
  PBS 400ml + DAB (50mg/ml) 4ml=1:100+30%H2O2 200υl=0.015% 
  (Denature DAB with household bleach before disposal). 
  Check development regularly (some antibodies need only a short incubation) 
•  Counterstained with haematoxylin (approximately 40 sec) 
•  Dehydrated and mounted 
 70%  74OP   100%  74OP   100%  74OP 
    (2 min.)       (2 min.)        (2 min.) 
 
 
 Xylene    Xylene    Xylene 
 (2  min.)   (2  min,)   (2  min.) 
•  Mounted with coverslip using pertex (line of pertex and drop of xylene).  
The immunohistochemistry slides were studied by light microscopy. One section from 
each animal (6 animals in one group) was used for immunohistochemistry assessment. 
2.7.8 Assessment and quantification 
Paraffin embedded tissue was stained with haematoxylin.An objective scoring method 
was devised which assessed the intensity of sinusoidal macrophage staining graded 
from 0 (no positive stain) to 4 (intense and crisp brown stain).  A percentage positive 
score was obtained by multiplying the grade with the percentage of stained 
macrophages. The maximum score possible was 400 (4X100%) while the minimum 
was 0 (0X0%). 
2.8 Western blot analysis for haemoxygenase (HO-1) 
Haemoxygenase protein was identified using Western blotting. Frozen samples of 
Liver tissue (100- 200 mg) were homogenised in TOXEX buffer (20 mM HEPES [pH 
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mmol/L ethylenediaminetetraacetic acid [EDTA], 0.1 mmol/L ethylene glycolbis( b-
aminoethyl ether)-N,N-tetraacetic acid [EGTA], 100 mmol/L dithiothreitol [DTT], 
0.1% phenylmethylsulfonyl fluoride [PMSF], 10 mg/mL aprotinin) on ice, incubated 
for 30 minutes, and centrifuged at 13,000 rpm for 5 minutes. For each lane, 100 mg of 
protein was dissolved in 10 mL of 13 sodium dodecyl sulfate loading dye and boiled 
for 5 minutes. A biotinylated protein marker (New England Biolabs, Schwalbach, 
Germany) was added. The samples were separated on a 12% sodium dodecyl sulfate–
polyacrylamide gel and transferred to a polyvinylidene fluoride membrane 
(Immobilon-P, Millipore, Bedford, MA) by electroblotting for 2.5 hours (Semidry 
Trans-Blot, BioRad, Hercules, CA). The membrane was blocked in a buffer 
containing 20 mmol/L Tris-base (pH 7.6), 137 mmol/L NaCl, 3.8 mL 1 mol/L HCl/L, 
0.1% Tween (13 TBST), and 5% low-fat dry milk powder for 1 hour and incubated 
with a rabbit polyclonal anti–HO-1 antibody (1:1,000 dilution; SPA 895, StressGen, 
Biotechnologies, Victoria, British Columbia, Canada)  in 13 TBST and 5% low-fat 
dry milk for 2 hours at room temperature. After 3 washing steps with 1 X TBST, a 
secondary anti-rabbit (1:10,000 dilution; ECL-detection kit, Amersham Pharmacia, 
Freiburg, Germany) and horseradish peroxidase– conjugated anti-biotin antibody 
(1:1,000, New England Biolabs) was added and incubated for 1 hour in 1 X TBST 
and 5% low-fat dry milk. Following 2 washing steps with 1 X TBST and 2 washing 
steps with 1 X TBS, detection was performed by the ECL detection kit (Amersham 
Pharmacia) according to the manufacturer’s instructions. After this the membrane was 
exposed to a digital camera as part of an electronic imaging system to visualise the 
proteins bound to the antibody. 
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Positive control used was recombinant HSp 32 manufactured by Stressgen 
laboratories.  
Quantification and measurement 
Densitometry  
This was done by using Adobe Photoshop. The JPEG picture of the western blot was 
analysed using this software. The maximum density of the film is 255. The density of 
the background on the film was measured and the density of the HO band obtained for 
each sample was measured. The density of the background was subtracted from the 
density of the HO band. The value obtained was subtracted from 255 to obtain the 
final density of the sample. 
2.9 Elisa for CINC-1  
2.9.1 The assay 
The Quantikine Rat CINC-1 Immunoassay is a 4.5 hour solid-phase ELISA designed 
to measure rat CINC-1 in cell culture supernates, serum and plasma. It contains 
E. coli-expressed recombinant rat CINC-1 and antibodies raised against the 
recombinant factor. This immunoassay has been shown to accurately quantitate the 
recombinant factor.Results obtained using natural rat CINC-1 showed linear curves 
that were parallel to the standard curves obtained using the Quantikine kit standards. 
These results indicate that the Quantikine rat CINC-1 kit can be used to determine 
relative mass values for naturally occurring rat CINC-1. 
2.9.2 Principle of assay 
This assay employs the quantitative sandwich enzyme immunoassay technique. A 
polyclonal antibody specific for rat CINC-1 has been precoated onto a 
microplate.Standards, controls and samples are pipetted into the wells and any rat 
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substances, an enzyme linked polyclonal antibody specific for rat CINC-1 is added to 
the wells. Following a wash to remove any unbound antibody-enzyme reagent, a 
substrate solution is added to the wells. The enzyme reaction yields a blue product 
that turns yellow when the stop solution is added. The intensity of the colour 
measured is in proportion to the amount of rat CINC-1 bound in the initial step. The 
sample values are read off the standard curve. 
Standards used in the assay 
The undiluted rat CINC-1 standard served as the high standard 500 pg/ml. Calibrator 
diluent served as the zero standard (0 pg/ml). 
Control used in assay 
Rat recombinant CINC in a buffered protein base was used as positive control. 
Reagents 
Rat CINC-1 microplate- one 96 well polystyrene microplate coated with polyclonal 
antibody specific for rat CINC-1. 
Rat CINC-1 conjugate- 12.5ml of a polyclonal antibody against rat CINC-1 
conjugated to horseshoeradish peroxidise with preservatives. 
Rat CINC-1 Standard- 2.5 ng of recombinant rat CINC-1 in a buffered protein base 
with preservatives, lyophilized. 
Rat CINC-1 control- 1 vial of recombinant rat CINC-1 in a buffered protein base 
with preservatives, lyophilized.  
Assay diluent RD1W- 12.5ml of a buffered protein solution with preservatives. 
Calibrator diluent RD5-4- 21ml of a buffered protein solution with preservatives. 
Wash buffer concentrate- 50ml of a 25 fold concentrated solution of buffered 
surfactant with preservatives. 
  113Colour reagent A-12.5 ml of stabilized hydrogen peroxide. 
Colour reagent B- 12.5 ml of stabilized chromogen. (tetramethyl benzidine) 
Stop solution-23ml of a diluted HCL 
Plate covers- 4 adhesive strips. 
Sample collection 
 Blood samples were allowed to clot for 2 hours at room temperature before 
centrifuging for 20 minutes at approximately 1000 x g. Serum samples were aliquoted 
and stored  at -20° C.  
Sample preparation 
Rat serum samples were diluted 2-fold into calibrator diluent RD5-4 prior to assay. 2-
fold dilution is 70 µl + 70µl calibrator diluent RD5-4. 
REAGENT PREPARATION 
 All reagents were brought to room temperature before use. 
Rat CINC-1 Kit Control - The Kit Control was reconstituted with 1.0 mL deionized 
or distilled water. Assay the Control undiluted. 
Wash Buffer - If crystals were formed in the concentrate, the buffer was warmed to 
room temperature and mixed gently until the crystals were completely dissolved. To 
prepare enough wash buffer for one plate, 25 mL of Wash Buffer Concentrate was 
added into deionized or distilled water to prepare 625 mL of Wash Buffer. 
Substrate Solution - Color Reagents A and B were mixed together in equal volumes 
within 15 minutes of use and protected from light. 100 µL of the resultant mixture 
was required per well. 
Rat CINC-1 Standard - The Rat CINC-1 Standard was reconstituted with 5.0 mL of 
Calibrator Diluent RD5-4 (care was taken not to substitute other diluents). This 
  114reconstitution produced a stock solution of 500 pg/mL. The standard was allowed to 
sit for a minimum of 5 minutes with gentle mixing prior to making dilutions. 
Use polypropylene tubes. 200 µL of Calibrator Diluent RD5-4 was pipetted into 
each tube. The stock solution was used to produce a 2-fold dilution series (below). 
Each tube was gently mixed but thoroughly before the next transfer. The undiluted rat 
CINC-1 Standard served as the high standard (500 pg/mL). Calibrator Diluent RD5-4 
serves as the zero standard (0 pg/mL). 
CALIBRATION 
This immunoassay is calibrated against a highly purified E. coli-expressed 
recombinant rat CINC-1 produced at R&D Systems. The mature protein contains 72 
amino acid residues and has a predicted molecular mass of approximately 7.8 kDa. 
Based on total amino acid analysis, the absorbance of a 1 mg/mL solution of the 
E. coli-expressed recombinant rat CINC-1 at 280 nm was determined to be 0.08 A.U. 
Assay procedure 
50 µl of assay diluent RD1W added to each well. 50 µl of standard, control or sample 
per well added. The plate was gently tapped for 1 minute to mix the contents and 
covered with adhesive strip. This was followed by incubation for 2hrs at room 
temperature. Each well was aspirated and washed for a total of five times with wash 
buffer (400µl). 100 µl of rat CINC-1 conjugate was added to each well. The plate was 
covered with adhesive strip and incubated for 2hrs at room temperature. The wells 
were aspirated and washed five times. 100 µl of substrate solution was added to each 
well and incubated at room temp for 30 min under protection from light. 100 µl of 
stop solution was added to each well. Plate was gently tapped to ensure mixing. 
Optical density was measured within 30 minutes using a microplate reader set to 450 
nm.(correction wavelength set at 540nm or 570nm).  
  1152. 10 Western blots for cytochrome C. 
Method for Western blots for cytochrome C. 
Sampling of tissues- liver tissues from six animals in each group of the early phase of hepatic 
IR were taken. Total of 36 samples were taken. 
Tissue homogenisation and mitochondrial extraction. 
Cytosol and mitochondrial enriched fractions obtained from the liver were rinsed in 0.15 
mol/L KCL, scissor minced and homogenized in 3 volumes of 0.25 mol/L sucrose. Low speed 
centrifugation was performed to remove cellular debris and obtain whole cell lysates.The 
whole cell lysates were centrifuged at 500g for 10 minutes. The supernate was spun at 2600g 
for 10 minutes. The resulting pellet was resuspended in a buffer consisting of 20mmol/L Tris 
–Hcl (PH 7.4), 0.25 mol/L sucrose and 5.4 mmol/L ethylenediaminetetraacetic acid.  
Western blot for cytochrome c.  
Equal amounts of protein loads were added onto 15% polyacrylamide gels were transferred to 
nitrocellulose membranes. Thereafter the membranes were treated with anticytochrome C 
(BD biosciences pharmingen, Franklin, Lakes, NJ, USA), anti Bax (BD biosciences 
pharmingen ) . Positive control used was rat pc 12 cell lysate. Mean density of the band area 
was measured using the Scion image beta  4.02 (Scion Frederick, Md, USA) after obtaining 
black and white inages as Tiff files by an image scanner 
2.11 Drugs used for HO induction and inhibition 
PDTC (HO inducer) 
Group five animals (PDTC+IR) were given Pyrrolidine dithiocarbamate (PDTC, 
Sigma Chemical Co, St Loius, Mo, USA) 100 mg /kg dissolved in 0.9% sodium chloride 
given subcutaneously   30 minutes prior to IR 30 min before ischaemia. 
PDTC and sham and toxicity of   PDTC 
Tsuchihashi et al (2003) demonstrated in an animal model that doses in excess of 600 
mg /kg killed animals   but animals did not die by injection of   any dose upto 
600mg/kg. Doses more than 200 mg/ kg offset the beneficial effects of   PDTC as 
  116demonstrated by Liu et al (1999). Hence we chose a dose of 100 mg/ kg as used in 
experiments by Tsuchihashi. PDTC shows a dose dependent relation ship with regard 
to its beneficial effects. At doses of 100 mg/ kg PDTC induces HO in kupffer cells but 
does not influence sinusoidal dilatation. Hata et al showed that at doses of 150 mg/ kg 
PDTC induced sinusoidal dilatation in sham animals , increased HO-1 with peak 
mRNA levels detectable at 3 hrs after PDTC injection and then declined. HO Protein 
expression peaked at 24-48 hrs after injection and was dose dependent. 
Immunohistochemistry revealed that   PDTC at higher doses induced HO-1 in both 
periportal kupffer cells and heatocytes in pericentral areas. Since previous 
experiments have shown  effects of PDTC in sham we did not investigate PDTC in 
sham  
ZnPP (HO inhibition) 
Group six   animals (ZnPP+RIPC+IRI) were given Zinc protoporphyrin (ZnPP Sigma 
Chemical Co, St Loius, Mo, USA) 1.5 mg/kg (HO-1 blocker) by  intraperitoneal route 
1 hour prior to RIPC and subsequent IRI. 
ZnPP and sham and hepatotoxicity of ZnPP. 
Previous experiments in sham animals have shown that ZnPP   inhibits 
haemoxygenase if used in the darkness. If ZnPP is exposed to light its effect of HO 
inhibition is lost however, ZnPP inhibits hepatic artery dilatation when exposed to 
light and this potentially   leads to hepatotoxicity (Greenbaum et al; 1991, zygmunt et 
al; 1994). Hepatoxicity can confound the experimental data and hence in order to 
avoid this confounding effect ZnPP was prepared in the dark and administered 
through a syringe covered with silver foil with minimal laboratory light. The dose 
used was 1.5 mg /kg (2.5µmol/kg) and this is much lower than the hepatotoxic toxic 
dose of ZnPP (5- 10µmol/kg) as shown by Greenbaum et al.  Amersi et al (1999) 
  117showed that ZnPP treatment in shams led to undetectable baseline HO and reduced 
portal flow and bile flow. Since previous experiments on shams have been detected 
we did not undertake experiments to investigate effect of ZnPP on sham group in our 
study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1182.12 Hypothesis and Aim 
Our hypothesis was that remote ischaemic preconditioning from limb ischaemia 
may have a beneficial effect in reducing ischaemia reperfusion injury of the liver 
by modulation of hepatic microcirculation through haemoxygenase pathways.  
Aim- To study the effect of remote ischaemic preconditioning   in an animal rat 
model of Ischaemia reperfusion injury and the role of haemoxygenase in the 
mechanism of RIPC. 
The next chapter focuses on investigating dynamic microcirculatory changes and 
hepatocellular injury in the early phase of hepatic ischaemia reperfusion injury and 
the effects of remote ischaemic preconditioning on hepatic IR in the early phase (3 hrs 
of reperfusion). Subsequent chapters describe the effect of   haemoxygenase   
inhibition on the effects of RIPC in the early phase of hepatic IR and the effect of HO 
induction in modulating the early phase of hepatic IR. The next chapter describes the 
effects of hepatic IR after 24 hrs of reperfusion and the role of remote ischaemic 
preconditioning on hepatic IR in a recovery model. The final chapters describe the 
effect of RIPC on CINC (cytokine) in hepatic IR and the effect of RIPC on 
mitochondrial cytochrome c release. 
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                                                       Chapter 3 
 
Study of microvascular and hepatocellular injury in 
the early phase of hepatic IR (3 hrs) and the effect of 
RIPC on hepatic IR. 
 
 
 
 
 
  1203.1 Introduction 
The effect of hepatic IR on hepatic microcirculation: Findings & mechanism of 
IR induced hepatic injury. 
Menger et al (1999) have demonstrated that the nature of microvascular injury which 
precedes manifestation of hepatic parenchymal tissue damage includes both hypoxia 
due to lack of microvascular perfusion (i.e. no-reflow) and a reperfusion-associated 
inflammatory response, which includes the activation and dysfunction of leukocytes 
and Kupffer cells (the reflow paradox). No-reflow in sinusoids is thought to be caused 
by endothelial cell swelling and intravascular hemoconcentration, and involves also a 
deterioration of the balance between ET and NO. The reflow paradox is associated 
with: (i) the release and action of proinflammatory cytokines (TNF-alpha, IL-1) and 
oxygen radicals; (ii) the up-regulation of endothelial and leukocytic adhesion 
molecules (selectins, beta-integrins, ICAM-1); and (iii) the interaction of leukocytes 
with the endothelial lining of the hepatic microvasculature. Menger et al demonstrated 
the in vivo relevance of leukocyte-endothelial cell interactions in the manifestation of 
hepatic ischaemia-reperfusion (I/R) injury. Reperfusion following either 20 min or 60 
min of left hepatic lobar ischaemia resulted in a significant increase in the number of 
stagnant leukocytes in sinusoids and adherent cells in postsinusoidal venules 
compared with sham-operated controls. In parallel, hepatic I/R was associated with 
increased serum transaminases and reduced bile flow  with significant correlation to 
the number of adherent leukocytes in postsinusoidal venules but not with sinusoidal 
stasis. These findings suggested that the adherence of leukocytes to the endothelial 
lining of venules, rather than of sinusoids, may determine the manifestation of 
hepatocellular damage and liver dysfunction. Menger et al also demonstrated that 60 
min of lobar ischaemia followed by reperfusion injury caused a significant decrease in 
  121serum AST and ALT activities and reduction of bile flow which directly correlated 
with the extent of microcirculatory failure, ie, impairment of sinusoidal perfusion and 
decrease of erythrocyte flux, indicating the decisive role of microvascular  
The effect of RIPC on hepatic haemodynamics. 
Lai et al demonstrated improved liver functions and the role of haemoxygenase in 
hepatic protection(Lai et al. 2006). Gustaffson demonstrated protection of hepatic 
function by remote preconditioning(Gustafsson et al. 2006). Kanoria et al   carried out 
the only study on effect of RIPC on   hepatic macrodynamics demonstrating   
improved liver function, increased hepatic blood flow by ICG and laser Doppler flow 
measurements
 (Kanoria et al 2006). Kanoria et al showed an increase in nitrate levels 
in hepatic venous plasma but did not specifically investigate the role of NO in the 
mechanism of RIPC.  None of these studies demonstrated the in vivo microcirculatory 
changes seen in hepatic IR and the effect of RIPC on hepatic IR. We focused our 
study on the hepatic microcirculatory changes in hepatic IR and the modulation of 
hepatic microcirculation by RIPC. We hypothesised that RIPC   modulates hepatic 
microcirculation in IR injury and applied intravital microscopy to investigate effects 
of RIPC. 
 
 
 
 
 
 
 
 
  1223.2 Material and methods 
3.2.1 Animals and surgical procedures- refer material and methods, chapter 2, 
pg 92.  
3.2.2 Animal model – refer material and methods, chapter 2, pg 92. 
3.2.3 Limb preconditioning- refer material and methods, chapter 2, pg 92. 
3.2.4 Experimental groups (n=6 in each group) 
Four groups of animals were studied. Group one (Sham) in which animals were 
subjected to laparotomy only and underwent an identical experimental protocol 
without clamping. In group two (IRI) the animals were subjected to 45 minutes of 
ischaemia followed by three hours of reperfusion. Ischaemia was induced by a 
microvascular clamp applied across the vascular pedicle supplying the left and 
median lobes of the liver (70 % ischaemia). Group three were preconditioned 
immediately prior to IRI (RIPC+IRI) group. In group four (RIPC+Sham) 
preconditioning was done in Sham. Standard protocols for preconditioning and 
inducing ischaemia as described above were used. 
Experimental design – 
RIPC (limb)                                          Liver          Liver                  
                                                               Ischaemia    Reperfusion 
5m 5m 5m 5m 5m 5m 45  min  180  min 
Isch   rep   Isch     rep    Isch    rep   
                                                   Laparotomy     Flow   Neutrophil adhesion 
                                                                                         Apoptosis 
 
Figure 3.1 
 
  123Intravital videofluorescence microscopy.  
Refer material and methods- chapter 2, page 92-102. 
 
Figure 3.2 - Red blood cells labelled with FITC are seen in the hepatic sinusoids. 
                   Velocity= Length moved/ no of frames ×25 µm/sec. 
                   Perfusion Index= Perfusion index = (Scp +Sip/ Scp+Sip+Snp). 
[Continuous perfusion (Scp) + intermittent perfusion (Sip) to the total visible 
sinusoids which includes non perfused sinusoids (Snp)] 
 
RBC velocity (V) 
•  0.5 ml of FITC labelled red cells prepared from rat blood suspended in glucose 
saline buffer solution (20mgFITC /ml of RBC) were administered 
intravenously to assess the velocity of RBC flow. Ten randomly chosen 
nonoverlapping rappaport acini were assessed at each time point and the mean 
value was calculated.  
•  The RBC velocity was calculated by assessing the distance of RBC movement 
(microns) in each sinusoid in subsequent frames. 25 frames were captured per 
second. Hence the velocity was calculated using the formula= D×25/number 
of frames moved. 
Sinusoidal Perfusion and perfusion index (PI). 
 The sinusoidal perfusion index was evaluated as ratio of   perfused hepatic sinusoids 
Continuous perfusion (Scp) + intermittent perfusion (Sip) to the total visible sinusoids 
  124which includes non perfused sinusoids (Snp). Perfusion index = (Scp +Sip/ 
Scp+Sip+Snp). 
Sinusoidal diameter (D)  
Sinusoidal diameter was assessed by measuring the distance across ten randomly 
chosen hepatic sinusoids at each time point and the mean value was expressed in 
microns. Ischaemia reperfusion injury is known to cause endothelial injury and 
endothelial   constriction. Measuring sinusoidal diameter using intravital 
microscopy helped clarify the effects of IR &   RIPC on sinusoidal diameter and 
the mechanism of increased blood flow in hepatic IR injury. 
Sinusoidal blood flow    
The sinusoidal blood flow was calculated using the formula- (V) ×22/7× (D/2)2. 
V= Velocity, D= diameter. 
Neutrophil adhesion 
Rhodamine 6G (0.3mg/kg)(Wunder et al. 2002) was given intravenously for staining 
of neutrophils.  The numbers of   leukocytes adherent to the sinusoidal endothelium 
and venular endothelium were counted as those stationary for a period of 30 seconds 
under green filter light and expressed   as leukocytes/mm2.The area of the vessels was 
calculated using the product of   circumference and length assuming cylindrical 
geometry (3.14×D×L).  
Hepatocellular cell death 
Hepatocyte apoptosis was assessed by intravenous injection of Propidium iodide 
(0.15mg/kg i.v) (Brock et al. 1999) and the number of nuclei stained with the dye 
were counted under the camera and expressed as number of apoptotic cells/high 
power field seen on the video monitor.  
Histology 
  125Liver tissue was fixed in 10% formalin and   embedded in paraffin in preparation for 
light microscopy analysis. Sections were cut at 5µ and stained with haematoxylin and 
eosin for histological analysis. Modified Suzuki criteria were used to describe the 
histological changes. The scoring used is detailed in chapter 2, pg 103-104. 
Statistical analysis 
All data are presented as mean and standard error of the mean (SEM).Differences 
were considered significant for P<0.05 .Comparisons between groups were performed 
by one way analysis (ANOVA). Bonferroni correction was applied for ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1263.3 Results 
Haemodynamic   parameters. 
Blood pressure (MAP) (Figure 3.5) 
Sham 
The sham group was haemodynamically   stable through all time points of 
observation.  
IRI 
In the IR injury group the baseline MAP showed an insignificant fall immediately 
after reperfusion from 102.00 mm hg to 81.66 mm hg.  
RIPC+IRI 
Preconditioning in the IR group (RIPC+IR) showed an insignificant fall in blood 
pressure immediately after reperfusion but the blood pressure recovered rapidly to 
baseline levels   ( 30-60 min) as compared to IR ( 60-120 min)  group.  
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Blood pressure changes in Hepatic IR
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                 Figure-3.5 
                  Changes in blood pressure seen in hepatic IR and effect of preconditioning.  
                  Both IR and RIPC+IR show a similar fall in blood pressure immediately  
                  after  reperfusion, however RIPC  prior to IR restores B.P. to baseline rapidly  
                  compared to IR only. Values expressed as mean
 + sem. P<0.05. 
 
Pulse rate 
 No significant difference   between IR and preconditioned groups was seen as shown 
graphically. 
Oxygen saturations 
No significant fall in saturations in both IR group and RIPC+IR group 
Hepatocellular injury (liver transaminase levels)  
The hepatic transaminase levels were lower in the preconditioned group but were not 
significantly different between IR injury and preconditioned group. (Figure 3.6) 
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Figure 3.6 (above) graphically depicting liver transaminases in RIPC+IR/ IR. 
IR was associated with significantly higher ALT values in contrast to sham (p<0.05).  
Preconditioning prior to IR injury reduced serum transaminase levels although  
the difference was not statistically significant. Preconditioning in Sham animals  
did not show any significant elevation in transaminases. 
            IR     RIPC+IR    Sham  RIPC+Sham 
ALT (IU/ml)  2079+ 322.3 1398+ 460.8  118+ 22.37  132+ 25.49 
 
Table (above) showing liver transaminases in different animal groups. 
Histological investigation 
 IR  RIPC+IR  Sham  RIPC+Sham 
Suzuki score  8.83+ 0.7 6.2+ 0.58 4+ 0.31 1.5+ 0.34 
The modified Suzuki score was significantly reduced in the preconditioned group 
compared to IR group (P<0.001).Histological changes of   IR injury were significant 
periportal congestion in association with severe necrosis in zones 2 and 3 and also sub 
capsular necrosis. The changes were diffuse. The Suzuki score was significantly 
reduced in RIPC+IR which showed less necrosis and damage compared to the IR 
  129group. Sham animals revealed minimal changes. Congestion was present in both 
portal vein and central veins. Hepatocytes show vacuolation. RIPC+Sham animals 
show minimal changes, some vacuolation, but no necrosis, similar to the sham group.  
 
   
  IR Injury                                                  RIPC+IR 
 
 
   
 
Sham                                                        RIPC+Sham 
 
Figure (3.7) Histology a).IR- The HE section shows large areas of necrosis and  
                                        sinusoidal congestion, normal residual hepatocytes noted at   
                                        bottom of the frame 
                                     b).RIPC+IR-The HE section shows sinusoidal congestion,     
                                         some hepatocyte vacuolation but no significant necrosis 
                                     c).Sham- The HE section reveals no significant damage but some   
                                         central vein congestion. 
                                     d).RIPC+Sham- The HE section reveals congested central vein 
                                         but no other significant change . Cells are viable around portal area. 
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Intravital microscopy results 
Velocity of RBC flow 
The mean RBC velocity in the sham group was constant throughout the time of 
observation. IRI led to decreased RBC velocity and preconditioning led to an 
increased RBC velocity, which was significantly higher than the IR group at all time 
points. (Figure 3.8) 
Sinusoidal flow 
Sinusoidal flow was also was significantly increased in the preconditioned (RIPC+IR) 
group as compared to IR group. (Figure 3.9) 
Sinusoidal diameter 
No significant difference between sinusoidal diameter in IR injury and RIPC+IR was 
seen suggesting that preconditioning does not modulate sinusoidal tone in the early 
phase of hepatic IR. (Figure 3.10) 
Sinusodial perfusion 
The perfusion index is the ratio of   perfused sinusoids (continuous+ intermittent) to 
non perfused sinusoids. RIPC+IR group shows significantly increased perfusion in the 
sinusoids as compared to IR group. (Figure 3.11)  
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Changes in RBC velocity following RIPC
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Figure 3.8 (above) Velocity of RBC flow in sham remained unchanged through 180 
minutes of observation. Significant increase in velocity in preconditioned animals 
(RIPC+IRI) as compared to IRI at all time points of observation.  Values expressed as 
mean + sem. * = P<0.05 (RIPC+IR/IR).**= P<0.05 (RIPC+IR/Sham).  
 
Sinusoidal flow 
 
Effect of RIPC on sinusoidal flow 
0
5
10
15
20
25
30
30 60 120 180
Observation (min)
S
i
n
u
s
o
i
d
a
l
 
f
l
o
w
 
(
U
/
s
e
c
)
IRI
RIPC+IRI
Sham
RIPC+Sham
 
 
Figure 3.9 (above) Sinusoidal flow - V× (D/2)2×л = V is velocity of RBC, D is 
sinusoidal diameter. Significantly better flow in preconditioned animals (RIPC+IRI) 
as compared to non preconditioned (IR). Values expressed as mean + sem. * = 
P<0.05(RIPC+IR/IR). ** = P<0.05(RIPC+IR/ Sham). ●= P<0.05 (Sham/IR). 
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Diameter of sinusoids 
Effect of RIPC on sinusoidal diameter
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Figure 3.10 (above) - The mean diameter showed no significant difference between the 
RIPC+IR group and IR group. The difference between Sham and RIPC+IR and between 
Sham and IRI was not statistically significant. 
Perfusion of sinusoids.   
Modulation of sinusoidal perfusion by RIPC 
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Figure 3.11 (above) Sinusoidal perfusion index -The PI remains unchanged in sham 
throughout 180 minutes of observation. The PI in remote preconditioned animals (RIPC+IRI) 
is significantly higher than non preconditioned animals (IRI). The PI in RIPC+IR is not 
different from Sham. Values expressed as mean + sem. * =P<0.05. 
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Venular neutrophil adhesion 
The image (figure 3.12) shows adherent neutrophils to the venular endothelial wall. 
The number of adherent neutrophils /mm
2 was assessed by the formula described in 
chapter 2. Significantly reduced venular neutrophil adhesion in the RIPC+IR group 
compared to IR group was observed (figure 3.13).   
Sinusoidal neutrophil adhesion 
 
Significantly reduced neutrophil adhesion was observed in the sinusoids in 
preconditioned animals in comparison to hepatic IR only (figure 3.14). 
 
Neutrophil adhesion 
 
     
Figure 3.12 Neutrophils stained by rhodamine is seen adherent to post sinusoidal venular 
endothelium.  The number of adherent neutrophils divided by the area of endothelial surface 
(л×D×L) gives the number of neutrophils/ mm2. D= sinusoidal diameter, L= length of 
segment along adherent neutrophils.  
    
 
  134Effect of RIPC on  venular neutrophil  adhesion
0
100
200
300
400
500
600
700
800
900
Animal groups
N
e
u
t
r
o
p
h
i
l
s
/
m
m
2
IRI
RIPC+IR
Sham
RIPC+Sham
 
 
Fig 3.13- Significantly reduced venular neutrophil adhesion in preconditioned  
 
(RIPC+IRI) group compared to non preconditioned group (IRI). Values expressed as  
 
mean + sem.  
  
* = P<0.05 (IR/RIPC+IR), ** = P<0.05(IR/Sham), 
 ●= P<0.05(IR/RIPC+Sham). 
 
 
  Sinusoidal neutrophil adhesion in IR and effect of 
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Figure 3.14 - Significantly reduced sinusoidal neutrophil adhesion in preconditioned group 
(RIPC+IRI) compared to non preconditioned group (IRI). Values expressed as mean + sem. * 
= P<0.05 (IR/RIPC+IR), **= P<0.05(IR/Sham), 
 ●= P<0.05(IR/RIPC+Sham). 
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    IRI   (12a)                                                      RIPC+IRI (12b) 
Hepatocellular cellular death as seen by 
propidium iodide staining. 
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Figure 3.15 
Figure a - Hepatocellular cell death in IRI by propidium iodide staining (IVM). The dead cells 
appear pink stained by propidium iodide. The number of cells divided by the surface area of 
the field above gives the number of cells/mm2.  
Fig  b - Hepatocellular cell death seen in RIPC+IR by propidium iodide staining (IVM). 
Figure  c- Hepatocellular cell death in preconditioned group (RIPC+IRI) is significantly less 
compared to non preconditioned (IRI) group. Values expressed as mean 
+ sem. * = P<0.05 (IR/RIPC+IR), **= P<0.05(IR/Sham), 
 ●= P<0.05(IR/RIPC+Sham). 
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3.4 Discussion      
New findings 
This   study demonstrates that RIPC modulates the hepatic microcirculatory changes 
in IR injury to produce increased RBC velocity, sinusoidal perfusion and decreased 
neutrophil adhesion in the sinusoids resulting in improved hepatic microcirculation 
and decreased hepatocyte cell death. This   suggests that RIPC results in   improved    
hepatic microcirculation   . This is the first in vivo study to demonstrate 
microcirculatory effects of RIPC in hepatic IR by intravital microscopy. Recently 
remote ischaemic preconditioning has been shown to modulate pancreatic 
microcirculation and reduce pancreatic IRI (Oehmann et al. 2007).  
Adequacy of model 
The experimental model used is a previously well described hepatic lobar 
ischaemiamodel  of warm IR .In the model 45 minutes of partial ischaemia(70% of 
the liver) was induced followed by three hours of reperfusion (Koti et al. 2002). 
Intravital microscopy has shown that IRI significantly reduced velocity of flow and 
perfusion as compared to sham animals (Menger et al). Therefore the model was 
considered suitable to study the effects of RIPC.  
Transplant vs warm hepatic IR 
Since this study was limited to investigating the effects of warm IR and the effects of 
RIPC in warm IR a partial hepatic IR model was chosen as against a transplant model.  
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Global hepatic ischaemia  is an ideal model which truly reflects liver transplantation 
but global ischaemia can potentially lead to congestion of the intestine and cytokine 
release which can confound the results.To avoid this a portosystemic shunt is 
necessary. Global hepatic ischaemia without portosystemic shunt   in a rabbit model 
has been described by Kanoria et al however the limitation of this model was that 
ischaemia could only be induced for about 25 minutes. Moreover to study the effects 
of hepatic IR, 70% partial hepatic IR models are well described in the literature 
(Menger et al 1994; Menger et al 1996).  
Animal specificity 
Partial hepatic IR models have been described in mice and pigs   in addition to rats. In 
all these animal models hepatic IR is reproducible and has been used to investigate the 
effects of preconditioning. 
Adequacy of preconditioning 
 RIPC was produced using a tourniquet around the Hind limb for four cycles of five 
minute ischaemia followed by reperfusion. Preliminary experiments showed a 
significant   protective effect of   four cycles of RIPC in hepatic IR.  This technique of 
RIPC has previously been used in the modulation of cardiac IR injury following 
transplantation (Kristiansen et al 2004). Three or more cycles of limb  preconditioning 
have been shown to be more effective than a single cycle in previous experimental 
studies (Addison et al. 2003; Kristiansen et al. 2004; Moses et al. 2004) and this 
formed the basis for four cycles of RIPC used in the current study.  
Systemic haemodynamics 
Shams were haemodynamically stable   throughout the course of the experiments. 
Limb preconditioning in sham animals caused a transient insignificant fall in blood 
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major effects of sham laparotomy, anaesthesia or RIPC alone. A transient fall in blood 
pressure and oxygen saturations associated with onset of   reperfusion was seen in 
both the IR group and RIPC+IR group. However recovery of blood pressure to 
normal levels was rapid in the RIPC+IR group   (30-60 minutes) as compared to IR 
only (60-120 minutes). These observations  have been made in preconditioning 
models of lung IRI (Harkin et al. 2002;Waldow et al. 2005). Kanoria et al have 
demonstrated fall in blood pressure following hepatic IR in a rabbit model and rapid 
recovery of blood pressure in the group which was preconditioned (60 minutes) 
(Kanoria et al 2006).  
 Histological findings and limitations of the scoring system. 
The RIPC+IR group showed less necrosis, vacuolation and congestion compared to 
IR group and objective scoring showed a significantly less score in the preconditioned 
group. However it was difficult to arrive at an objective score if the changes noted 
were focal/patchy. There were several sections with only sub capsular 
infarction/necrosis.  Hence despite an objective system of scoring it was difficult to 
score these sections using the criteria. This is one of the limitations of an objective 
scoring system. 
Hepatic microcirculatory changes. 
Sham  
The sham group showed constant velocity, flow and perfusion in the sinusoids over 
the 180 minutes of   observation. This suggests a stable model for the study. 
Effects of IR injury on hepatic microcirculation and neutrophil adhesion.  
 Our study shows a significant fall in sinusoidal perfusion and velocity of RBC flow 
in IRI group which was observed at all time points in our study. Increased venular 
  139neutrophil adhesion  was seen in the IR group as compared to sham group. There was 
an increase in sinusoidal neutrophil stasis in the IR group with the the perfusion index 
being significantly lower compared to sham animals.  
Significance of sinusoidal perfusion 
Past studies have demonstrated that the mechanisms which contribute to failure of 
perfusion include endothelial swelling and injury, leukocyte endothelial interaction, 
leukostasis, alteration in RBC flow and increased viscosity of blood (Vollmar et al. 
1995;Vollmar et al. 1996;Vollmar et al. 1994;Vollmar et al. 1994;Vollmar, Richter, & 
Menger 1996). Reduced RBC velocity maybe secondary to free radical release 
producing erythrocyte damage, and deformity. This contributes to increased viscosity 
of blood and decreased RBC velocity (Vollmar et al. 1994). Leukocyte adhesion 
causes endothelial injury, red blood cell stasis, modulation of sinusoidal tone and 
perfusion (Vollmar et al. 1995;Vollmar et al. 1994). Perfusion failure has been shown 
to correlate with hepatic dysfunction, reduced bile flow and increased 
transaminases(Vollmar et al. 1994). .Venular adhesion of neutrophils  correlates 
directly with hepatic dysfunction, raised serum transaminases and decreased bile 
flow(Vollmar et al. 1994) .  
The above discussed studies have shown that reduction in RBC velocity occurs due to 
leukocyte adhesion, endothelial injury and perfusion impairment (No reflow 
phenomenon) and increased RBC damage due to free radical release during IR  
Effect of IR on serum transaminases 
Serum transaminases are  higher in the IR group suggesting hepatocellular injury.  
Effect of IR on hepatocellular death 
In our study significantly increased hepatocyte cell death was seen in the IR group 
after 180 minutes of reperfusion as compared to sham group and RIPC+IR group. 
  140Correlation of   microcirculatory flow, neutrophil adhesion, hepatocellular death 
and serum transaminases in hepatic IR 
This study demonstrates that decreased sinusoidal perfusion, RBC velocity and 
increased neutrophil adhesion are associated with increased hepatocellular injury and 
hepatocellular death. These findings are supported by studies from Vollmar and 
Menger as discussed above.  
Effects of RIPC on hepatic microcirculation in IR injury (early phase of IR). 
This study demonstrates that RIPC increases RBC velocity and erythrocyte flux 
across sinusoids,   significantly reduced hepatocyte cell death, increased sinusoidal 
perfusion and  sinusoidal flow as compared to the IR group. Interestingly there is a 
significant initial rise in RBC velocity and flow in the RIPC+IR group as compared to 
sham and IR although the initial velocities in sham and IR are not significantly 
different. However at 120 minutes a significant drop in velocity is seen in the IR 
group   in comparison to RIPC+IR and sham. Hence the initial rise in velocity in the 
RIPC+IR group serves to maintain RBC flow in comparison to IR group. The initial 
molecular pathway responsible for the increased baseline velocity is unclear but it is 
likely to be induced by RIPC in the hepatic ischaemia period itself since the velocity 
of flow is seen to be   high as early as 30 minutes following reperfusion in the local 
microvasculature.  
 In the RIPC+IR group perfusion is significantly better than the IR group and 
comparable to sham values suggesting that preconditioning prevents a fall in 
perfusion in hepatic IR. The significantly improved perfusion is associated with 
decreased serum transaminases and significantly reduced hepatocellular death. 
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Effect of RIPC on neutrophil adhesion in early phase of IR. 
A significant reduction in both venular neutrophil adhesion and sinusoidal adhesion 
implies modulation of neutrophil activation by RIPC. The decrease in neutrophil 
activation accounts for decreased oxidative stress, IR injury and perfusion failure.  
Previous studies(Glanemann et al. 2003)  have shown ischemic preconditioning to 
reduce hepatic IR induced  perfusion failure and preservation of mitochondrial redox 
state but none have demonstrated the role of RIPC in hepatic IR  
 The observations in our study suggest that RIPC modulates RBC flow, neutrophil 
adhesion and sinusoidal perfusion. RIPC may induce protective mechanisms which 
protect RBC against free radical induced damage, however this needs to be further 
investigated.  
Effect of RIPC on hepatocellular injury 
The serum transaminase levels in the RIPC+IR group were lower than IRI  suggesting 
decreased liver injury in the RIPC+IR group as compared to IR group. 
Correlation of microcirculatory flow, hepatocellular injury, neutrophil adhesion 
serum transaminases  and hepatocellular death in RIPC+IR 
The findings in our study show that  significantly increased  RBC velocity, sinusoidal 
perfusion are  associated with decreased neutrophil adhesion, decreased hepatocellular 
injury and cell death in comparison to IR.  
Effects of RIPC on Sham. (RIPC+Sham group) 
Remote ischemic preconditioning in the normal sham group showed  reduced RBC 
velocity, sinusoidal flow and perfusion  at 120 minutes  as compared to 30 minutes 
after laparotomy and recovery to baseline at 180 minutes.   This maybe due to initial 
preconditioning induced oxidative stress  .  Chen et al (Chen et al 2005) who 
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which may explain the oxidative stress.  
Potential pathway and mechanisms in remote ischaemic preconditioning of the 
liver. 
Chen at al demonstrated RIPC induced NO in the heart to reduce myocardial IRI 
which was not abolished by neurogenic blockade (Chen Y.S et al). In another study 
increase in plasma free radicals following brief limb RIPC  induced heat shock 
proteins in remote skeletal muscle (Chen X.G et al). Lai et showed  increased 
haemoxygenase (HO-1) in hepatic macrophages following limb preconditioning the 
which was associated with protection of liver function (Lai et al, 2006). These data 
suggest that brief limb ischaemia leads to release of biochemical messengers such as   
free radicals in the blood   which may induce oxidative stress in the remote organ and 
HO-1 expression. HO-1 is known to promote degradation of haem, increase CO 
production and scavenge free radicals and protect the liver from hepatic IR. It has 
been observed in animal models of ischaemia reperfusion injury of the liver and 
kidney that there is an increase in microsomal haem content accompanied by a 
decrease in cytochrome-p450 content.  Haem is a source of reactive oxygen species 
i.e. free oxygen radicals which cause disruption of mitochondrial membranes 
associated with oxidative stress. Moreover it has also been seen that following 
reperfusion the oxygen flow to the organ is more than its requirement and hence 
excessive oxygen results in free radical generation under the influence of the xanthine 
oxidase system.The activation of the haemoxygenase system would scavenge these 
free radicals and prevent reperfusion injury. 
Based on this hypothesis experiments were conducted by Katori et al (Katori et al 
2002) and they found that overexpression of hepatic HO  was beneficial in reducing 
  143IRI. Mc Carter (Mc Carter et al 2004)   showed that prolonged limb ischaemia 
reperfusion resulted in remote organ injury however, the release of endogenous 
haemoxygenase is involved in protection of the liver from limb ischaemia reperfusion 
injury. They showed that following bilateral limb ischaemia there was remote liver 
injury which did not progress beyond six hours from the onset of limb reperfusion 
.This correlated with increased hepatic haemoxygenase activity. Blockade of HO 
activity with chromium mesoporphyrin resulted in progression of liver injury with 
increased apoptosis. They also showed that adenovirus mediated gene transfer of 
haemoxygenase mitigated remote liver injury following limb ischaemia reperfusion. 
Similar experimental evidence was produced by Wunder et al who showed the role of 
endogenous hemoxygenase by showing decreased leukocyte endothelial interactions 
in the liver under intravital microscopy in animal groups who were pretreated with 
haemin before limb ischaemia limb reperfusion   as compared to groups in whom 
hemoxygenase activity was blocked with chromium mesoporphyrin.  Haemoxygenase 
(HO-1) is an inducible form of haemoxygenase which is expressed under oxidative 
stress such as hypoxia, ischaemia and inflammation. In vivo studies of liver have 
shown Ito cells, which are hepatic sinusoid associated pericytes primarily responsible 
for CO (derived from HO-1) mediated blood flow regulation in hepatic 
sinusoids(Hayashi et al. 1999;Suematsu, Wakabayashi, & Ishimura 1996).  These 
studies formed the basis of our hypothesis that RIPC may induce HO-1   to modulate 
hepatic microcirculation. 
Conclusion 
This study demonstrates the microcirculatory effects of hepatic IR and the modulatory 
effects of RIPC   on hepatic microcirculation   as demonstrated by intravital 
microscopy. Improved hepatic blood flow is associated with decreased neutrophil 
  144adhesion and cell death. The modulatory effects of RIPC could potentially be due to 
HO-1. The effect of   HO-1 inhibition on protective microcirculatory changes induced  
by   RIPC has not been demonstrated so far and hence we investigated by intravital 
microscopy the effects of HO inhibition on RIPC in hepatic IR. The next chapter 
focuses on the role of HO inhibition in RIPC in an animal model of hepatic IR. 
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                                             Chapter 4 
  The effect of HO-1 inhibition in modulating the 
protective effect of remote preconditioning in the 
early phase of hepatic IR injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1464.1 Why haemoxygenase? 
Evidence for HO-1 in IR 
As discussed in the last chapter it has been observed in animal models of ischaemia 
reperfusion injury of the liver and kidney that there is an increase in microsomal haem 
content accompanied by a decrease in cytochrome-p450 content.  Haem is a source of 
reactive oxygen species i.e. free oxygen radicals which cause disruption of 
mitochondrial membranes associated with oxidative stress. Following reperfusion 
excessive oxygen results in free radical generation under the influence of the xanthine 
oxidase system in addition to haem. 
  HO   the rate limiting enzyme in the degradation of haem    catalyzes the oxidative 
degradation of haem into carbon monoxide (CO), biliverdin (which is rapidly 
converted to bilirubin)   and free iron (Fe2+). There are three isoforms of 
haemoxygenase HO-1 (inducible HO) also known as heat shock protein,   HO-2 
(constitutive HO found mainly in brain and testis), HO-3 which is related to HO-2 but 
not well characterised. HO-1   is responsible for degradation of haem in senescent 
RBCs. Degradation of haem and formation of CO results in consumption of free 
radicals.Thus haemoxygenase (HO-1) enhances scavenging of  free radicals and could 
potentially reduce hepatic IR injury by promoting haem degradation (Katori et al. 
2002). Based on this hypothesis experiments were conducted by Busuttil et al and 
they found that the HO system was beneficial in reducing hepatic IR in animal liver 
transplant models. Kato ( Kato et al, 2001)  showed  that pre-treatment of  donor rat 
livers with cobalt protoporphyrin (COPP) reduced hepatic IR    after cold preservation 
and reperfusion in ex vivo models with significantly increased  bile flow and portal 
flow as compared to non treated livers. In liver transplant models pre-treatment with 
COPP enhanced rat survival and decreased   histological severity of IR injury   in the 
  147liver as compared to nontreated rats. The beneficial effects of haemoxygenase have 
been demonstrated in genetically fat zucker rats (Amersi et al, 1999) with 
significantly decreased hepatic IR injury in steatotic livers.  
Stimuli   inducing HO. 
Haemoxygenase (HO-1) is an inducible form of haemoxygenase which is expressed 
under oxidative stress such as hypoxia, ischaemia and inflammation . 
Mechanism of action  
The mechanism of   HO system is not fully established. It plays   a pivotal role in in 
the maintenance of antioxidant and oxidant homeostasis during cellular injury. It 
exerts four major beneficial effects: a) antioxidant function b) antiapoptosis c) Anti-
inflammatory function d) maintenance of microcirculation. The antioxidant function 
relies on haem degradation, production of biliverdin, bilirubin and the formation of 
ferritin via FE2+. The production of CO with its vasodilatory and antiplatelet 
properties maintains microcirculation and may be involved in antiapoptotic 
mechanisms. The functions of HO-1 and CO seem to be related to their ability to 
modulate immune functions. (Haga et al, 1996). CO has been shown to exert i) anti-
inflammatory actions ii). Regulate cGMP activity through activation of guanylate 
cyclise which is known to regulate endothelial-dependent vasodilatation iii). Inhibit 
platelet aggregation (Brune et al, 1987) i.v). CO inhibits apoptosis by activating 
MAPK (Otterbein et al, 2000). Endogenously generated CO rather than NO generated 
from iNOS (Pannen et al, 1998) has been shown to preserve sinusoidal perfusion and 
to limit hepatic dysfunction in a model of haemorrhagic shock in rats. HO activity 
maybe linked to iNOS (haem protein) (Maines et al 1997). INOS requires two haem 
molecules, and CO generated by HO-1 can bind to   NO (Wang J et al, 1994) thus 
producing an inhibitory effect on iNOS. 
  148RIPC and HO-1 
Recently Lai et al  (Lai et al. 2006) in a rat model of partial hepatic IR injury showed 
that remote ischaemic limb preconditioning confers cytoprotection and protection of 
liver function against IRI due to haemoxygenase expression. In a rat model of partial 
hepatic IR  Lai preconditioned the liver by four brief cycles of  prior hind limb 
ischaemia (10 min) followed by 10 min of  reperfusion followed by hepatic ischaemia 
and 240 min of reperfusion. Lai et al demonstrated that RIPC reduced hepatic IR by 
decreased histological evidence of injury, decreased serum transaminase levels and 
showed   increased haemoxygenase expression in the liver. They showed that 
haemoxygenase inhibition by zinc protoporphyrrin abolished the protective effects of 
RIPC. They also demonstrated that increased hepatic haemoxygenase persisted for 24 
hrs in the liver and then showed a gradual decline.They did not demonstrate the 
microcirculatory changes in hepatic IR, the modulatory effect of remote ischaemic 
preconditioning on hepatic microcirculation and the effect of HO inhibition on the 
modulatory effects of RIPC in hepatic IR. We applied intravital microscopy to study 
the effect of haemoxygenase induction on the hepatic microcirculation in hepatic IR 
and the effect of inhibition of HO on the modulatory effecs of RIPC in hepatic IR. 
Effects of PDTC  
Therapeutic strategies aimed at reducing IR injury have focused both on preventing 
the effects of reactive oxygen species and on downregulating the signal transduction 
cascades related to the expression of proinflammatory genes. Pharmacologic 
preconditioning based on modulating endogenous protective molecules has   been 
proposed as an alternative therapeutic intervention. 
Among such agents, pyrrolidine dithiocarbamate (PDTC) has a range of biochemical 
activities including redox state alternation, chelation of heavy metals and enzyme 
  149inhibition(Tsuchihashi et al., 2003). PDTC was initially regarded as a potent inhibitor 
of nuclear factor- kappa B (NF-κB) and used as an antioxidant compound to 
counteract the toxic effects of free radicals(Liu et al., 1999). PDTC is one of the most 
effective inducers of haeme oxygenase-1(HO-1), which also confers cytoprotection 
against oxidative stress(Hartsfield et al., 1998).  Hartsfield demonstrated that 
the antioxidant PDTC enhances HO-1 gene transcription (Hartsfield et al, 1998). HO 
is the rate-limiting enzyme in the conversion of haeme into carbon monoxide (CO), 
biliverdin (which is rapidly converted to bilirubin) and free iron (Fe
2+)(Katori et al., 
2002). HO cleaves the haem ring into CO and biliverdin which is rapidly reduced to 
bilirubin. 
Zinc protoporphyrrin (ZnPP) 
Zinc protoporphyrrin   is a competitive inhibitor of the enzyme HO-1 and also inhibits 
guanylate cyclase   and depletes endogenous cGMP (Verma et al, 2003). Thus it 
inhibits the effect of CO (end product of haem degradation by HO-1) on endothelium 
through guanylate cyclase. ZnPP is a non-specific blocker of both HO-1 and HO-2. It 
has got toxic side effects on the CNS, liver at high doses (Greenbaum et al). ZnPP is a 
metalloporphyrrin which on exposure to light disintegrates and does not inhibit 
haemoxygenase. On exposure to light it exerts toxic effects and inhibits hepatic 
vasodilation.  
 
 
 
 
 
 
  1504.2 Material and methods 
4.2.1Animals and surgical procedures 
Refer chapter 2, pg 92 
4.2.2 Limb preconditioning 
Refer chapter 2, pg 92 
4.2.3Tissue and blood collection 
Refer chapter 2, pg 105 
4.2.4 Experimental groups (n=6 in each group)  
Six groups of animals were studied. (Observations for first four groups are based 
on experiments in  chapter 1). 
•  Group one (Sham) in which animals were subjected to laparotomy only and 
underwent an identical experimental protocol without clamping.  
•  Group two (IRI) the animals were subjected to 45 minutes of ischaemia 
followed by three hours of reperfusion. Ischaemia was induced by a 
microvascular clamp.  
•  Group three were preconditioned prior to IRI (RIPC+IRI) group.  Protocols 
described above for preconditioning and inducing ischaemia were used. 
•  Group four  sham animals were preconditioned.(RIPC+Sham) 
•  Group five animals (PDTC+IR) were given Pyrrolidine dithiocarbamate 
(PDTC, Sigma Chemical Co, St Loius, Mo, USA) 100 mg /kg dissolved in 0.9% 
sodium chloride given subcutaneously   30 minutes prior to IR. 
•  Group six   animals (ZnPP+RIPC+IRI) were given Zinc protoporphyrin (ZnPP 
Sigma Chemical Co, St Loius, Mo, USA) 1.5 mg/kg (HO-1 blocker) by 
intraperitoneal route 1 hour prior to RIPC and subsequent IRI. 
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The  dose of ZnPP was selected according to the experiment described by 
Tsuchihashi.(Tsuchihashi et al., 2003) (Kato et al.,2003). The route of administration was 
selected according to the study by Lai et al i.e intraperitoneal (Lai et al., 2006). Animals 
received a single dose of 1.5mg/Kg (2.5µmol/kg) of Zinc Protoporphyrin (HO inhibitor) 
given intraperitoneally 1 hr prior to RIPC   . Our preliminary experiements revealed that 
higher doses caused animal death after 1-2 hrs of reperfusion and intravenous infusion caused 
the animals to be haemodynamically unstable soon after reperfusion with animal death. In 
order to obtain a haemodynamically stable model with gradual absorption of the drug through 
the intraperitoneal route we used the drug dosage and intraperitoneal route described above. 
Lai et al have described administration of ZnPP by intraperitoneal route 1 hr prior to RIPC. 
ZnPP was dissolved in 0.2 mol/L sodium hydroxide and diluted in 0.85% sodium chloride 
according to manufacturer guidelines. Ph was adjusted to 7.4. Stock solution concentration 
was 1mg/ml. ZnPP was prepared in a dark room to prevent disintegration and toxicity of the 
drug. It was administrered through a syringe covered with silver foil to avoid exposure to 
light.The dose for PDTC and route of administration was   selected based on experiments by 
Tsuchihashi (Tsuchihashi et al., 2003). The time course and dose of PDTC used were based 
on previous studies by Liu et al(Liu et al., 1999).  
Experimental design 
RIPC (limb)                                          Liver          Liver                  
                                                               Ischaemia    Reperfusion 
5m 5m 5m 5m 5m 5m 45  min  180  min 
Isch   rep   Isch     rep    Isch    rep   
                                                  Laparotomy    
Figure (above) showing time points used in the study. 
 
 
  1524.2.5 Intravital videofluorescence microscopy 
Refer chapter 2 – material and methods, pg- 100-102 
End points observed were- RBC velocity (V), sinusoidal Perfusion and perfusion 
index (PI), sinusoidal diameter (D), sinusoidal blood flow, neutrophil adhesion 
and hepatocellular death. 
4.2.6 Histology 
Liver tissue was fixed in 10% formalin and   embedded in paraffin in preparation for 
light microscopy analysis. Sections were cut at 5µ and stained with haematoxylin and 
eosin for histological analysis. Modified Suzuki criteria (chapter 2, pg 103-104) were 
used to describe the histological changes.  
4.2.7 Immunohistochemistry for HO-1 and western blots for HO-1 
Immunohistochemistry and western blots for HO-1 were done as described in chapter 
2, material and methods, pg 104-108. 
4.2.8 Biochemical analysis for ALT / AST (Hepatocellular injury). 
As described in chapter 2, material and methods, pg 103. 
4.2.9 Statistical analysis 
All data are presented as mean plus minus standard error of the mean 
(SEM).Differences were considered significant for P<0.05 .Comparisons between 
groups were performed by one way analysis (ANOVA). Bonferroni correction was 
applied for ANOVA. 
 
 
 
 
 
  1534.3 Results 
Haemodynamic measurements. (Fig 4.1) 
RIPC+IR group showed a drop in MAP similar to IR only group however MAP 
recovered to baseline in RIPC+IR   rapidly (30- 60 min) compared to IR (60-120min).  
HO inhibition caused a further drop in B.P. and delayed recovery of B.P. 
There was no significant   difference in pulse rate. 
Hepatocellular injury (Fig 4.2) 
The significant derangement of transaminases seen in on administering ZnPP to the 
RIPC group suggests that inhibition of HO-1 abolishes the protective effect of RIPC 
on the liver   leading to increased hepatocellular in IR injury.  
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Figure 4.1 Changes in blood pressure - effect of HO inhibition on RIPC.  
                 RIPC prior to IR restores B.P. to baseline rapidly compared to IR only. Inhibition  
                 of HO showed a greater fall in B.P but there was no difference in recovery to   
                 Baseline.Values expressed as mean
 + sem. P<0.05. 
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Effect of HO inhibition on hepatic transaminase 
levels  in RIPC+IR
0
2000
4000
6000
8000
10000
Animal groups
A
L
T
 
I
U
/
L
IRI
RIPC+IR
PDTC+IR
ZNPP+RIPC+IR
Sham
RIPC+SHAM
 
Figure 4.2   (IR/RIPC+IR, P>0.05.  RIPC+IR/ZNPP+RIPC+IR, P<0.05) 
 
 
  155Intravital microscopy results (Early phase of IR) 
Velocity of RBC flow (Figure 4.3)  
The velocity of flow   was significantly reduced in hepatic IR (160.83 + 12.24 
μm/sec) after 180 min of reperfusion. RIPC significantly increased velocity of flow 
(328.04 + 19.13 μm/sec). PDTC (HO induction) reproduced the effects of RIPC in 
hepatic IR (300.88+ 22.109 μm/sec). ZnPP (HO inhibition) significantly reduced   
velocity of flow of RBC in the RIPC group   (170.74+ 13.43 μm/sec). 
Sinusoidal flow (Figure 4.4) 
The sinusoidal flow was significantly reduced in hepatic IR (8.42 + 1.19). RIPC   
significantly enhanced sinusoidal flow (17.75+ 2.59)   and the effects of   RIPC were 
reproduced by PDTC (17.66+ 3.71). ZnPP significantly reduced sinusoidal flow in the 
RIPC group (9.46+ 1.34).  
Sinusoidal diameter (Figure 4.5) 
There was no significant   difference in the sinusoidal diameter between different 
groups. 
Sinusoidal perfusion (Figure 4.6) 
The sinusoidal perfusion index was significantly higher in RIPC group (67.28 + 1.82)      
as compared to IR group at all time points (42.12 +   7.28). PDTC reproduced the 
effects of RIPC in hepatic IR (82.33+ 3.5). However inhibition of HO by ZnPP in 
RIPC (60.29+ 1.82) showed a   fall in perfusion only at 180 min of reperfusion. 
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Figure 4.3 – Velocity of blood flow. 
Significant increase in velocity in preconditioned animals prior to ischaemia reperfusion 
injury (RIPC+IRI) as compared to IRI at 30, 60 and 120 minutes of reperfusion.HO inhibition 
causes a significant fall in velocity of  flow in preconditioned animals. Values expressed as 
mean + sem. * = P<0.05 (RIPC+IR/IR). **= P<0.05 (RIPC+IR/ ZNPP+RIPC+IR).  
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Figure 4.4- sinusoidal flow 
Sinusoidal flow - V× (D/2)2×л = V is velocity of RBC, D is sinusoidal diameter. 
Significantly better flow in preconditioned animals (RIPC+IRI) as compared to non 
preconditioned (IR). HO inhibition significantly inhibits flow in preconditioned 
animals.Values expressed as mean + sem. * = P<0.05(RIPC+IR/IR).  
** = P<0.05(RIPC+IR/ ZNPP+RIPC+IR).  
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Effect of HO inhibition and induction on 
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Figure 4.5 (No significant change in sinusoidal diameter seen in preconditioned animals and 
on inhibition of HO) 
 Perfusion of sinusoids 
Effects of HO inhibition and induction on 
sinusoidal perfusion.
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Figure 4.6 
Sinusoidal perfusion index - The PI in remote preconditioned animals (RIPC+IRI) is 
significantly higher than non preconditioned animals (IRI). HO inhibition does not affect 
sinusoidal perfusion in the early stage of IR however sinusoidal perfusion declines at 180 
minutes of reperfusion. Values expressed as mean +   sem. P<0.05. 
 
  158Neutrophil    adhesion   in venules and  sinusoids as seen by    IVM. 
Effect of IR   
Significantly increased   neutrophil adhesion in IR injury is seen in both 
postsinusoidal venules   (769.05 + 87.48) and   sinusoids (97.4+ 7.49). 
Effect of RIPC+IR  
Preconditioning    significantly reduced neutrophil adhesion in   IR injury in both 
postsinusoidal   venules (219.66+ 93.79) and sinusoids (25.69+   9.08). 
Effect of PDTC+IR 
PDTC   significantly reduced neutrophil adhesion in both postsinusoidal venules 
(89.58+ 58.32) and sinusoids (17.98 + 11.01) reproducing the effects of RIPC.  
Effect of HO inhibition  on RIPC+IR. 
HO inhibition with ZnPP significantly increased venular (589.04 + 144.36) and 
sinusoidal neutrophil adhesion in preconditioned animals (121.39 + 30.65). 
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Figure 4.7 (Venular neutrophil adhesion in early phase of hepatic IR) 
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Figure 4.8 (Sinusoidal neutrophil adhesion in early phase of hepatic IR) 
Significantly reduced venular neutrophil adhesion in preconditioned (RIPC+IRI) group 
compared to non preconditioned group (IRI). HO inhibition in RIPC+IR   showed 
significantly increased venular neutrophil adhesion .Values expressed as mean + sem.  
 * = P<0.05 (IR/RIPC+IR), ** = P<0.05(RIPC+IR/ ZNPP+RIPC+IR), 
Significantly reduced sinusoidal neutrophil adhesion in preconditioned group (RIPC+IRI) 
compared to non preconditioned group (IRI). Values expressed as mean + sem. * = P<0.05 
(IR/RIPC+IR), **= P<0.05(RIPC+IR/ ZNPP+RIPC+IR). 
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Significantly increased cell death was observed in IR injury of the liver (80.83 + 
13.03) Fig 4.9 a & 4.9 b. 
Hepatocellular death in RIPC+IR 
Preconditioning significantly reduced hepatocellular death in hepatic IR (17.35 + 
2.47)  Fig 4.9a& 4.9c. 
Hepatocellular cell death in PDTC+IR (HO induction) 
PDTC significantly reduced hepatocellular death in hepatic IR   reproducing the 
effects of RIPC (11.66 +   1.17) Fig 4.9 a & 4.9d. 
Hepatocellular death in ZnPP +RIPC+IR (HO inhibition) 
ZnPP significantly increased hepatocellular death in preconditioned animals (41.33 +   
3.07) Fig 4.9 a & 4.9e. 
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 b)    c).               
  d ) e) 
Figure 4.9 
Figure a). Hepatocellular cell death in preconditioned group (RIPC+IRI) is significantly less 
compared to non preconditioned (IRI) group. HO inhibition significantly enhances 
hepatocellular death in preconditioned animals. Values expressed as mean +   sem. * = 
P<0.05 (IR/RIPC+IR), **= P< 0.05 (RIPC+IR/ ZNPP+RIPC+IR). 
Fig b).Hepatocellular cell death in IRI by propidium iodide staining (IVM). The dead cells 
appear pink stained by propidium iodide. The number of cells divided by the surface area of 
the field above gives the number of cells/mm2.  
Fig c).Hepatocellular cell death seen in RIPC+IR by propidium iodide staining (IVM). 
Fig d). Hepatocellular cell death is also significantly less in PDTC+IR group. 
Fig e).HO inhibition by Zinc protoporphyrin significantly increases cell death in RIPC group. 
  162Histology   
Group  IR         RIPC+IR  ZnPP+RIPC+IR PDTC+IR Sham  RIPC+Sham
Suzuki 
score 
8.83+0.7 6.2+  0.58  8.83 +  0.6  4.5 + 0.5  4+0.31  1.5 + 0.34 
 
Table   5.1 (Suzuki criteria) 
IR group showed significant periportal congestion in association with severe necrosis 
in zones 2 and 3 and also sub capsular necrosis. The changes are diffuse. RIPC+IR 
showed a significantly lower Suzuki score compared to the IR group. On inhibition of 
HO in RIPC+IR (ZNPP +RIPC +IR group) most of the sections showed diffuse and 
severe congestion and vacuolation. The necrosis is diffuse and focally associated with 
acute inflammatory cells.  Changes are similar to IR group and significantly more 
compared to RIPC+IR. Only one animal showed exception to the necrosis with 
extensive congestion and vacuolation but minimal necrosis. On HO induction 
(PTDC+IR) most animals showed diffuse congestion and necrosis except for one 
which shows mild congestion with significant vacuolation and no well established 
infarction or necrosis. Sham animals revealed minimal changes. Congestion is present 
in both portal vein and central vein. Hepatocytes show vacuolation. RIPC+Sham 
animals show minimal changes, some vacuolation, but no necrosis, similar to sham. 
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a) Hepatic IR                                      b) Hepatic IR+RIPC 
    
c) Sham                                                d) RIPC+Sham 
    
     
 
e) PDTC+Hepatic IR                            f) ZNPP+RIPC+IR   
Figure 4.10 
a).IR- The HE section shows large areas of necrosis and sinusoidal congestion, 
normal residual hepatocytes noted at bottom of the frame.b).RIPC+IR-The HE section 
shows sinusoidal congestion, some hepatocyte vacuolation but no significant necrosis 
c).Sham- The HE section reveals no significant damage.d).RIPC+Sham- The HE 
  164section reveals congested central vein but no other significant change.e) PDTC+IR-
diffuse congestion and patchy necrosis. f) ZNPP+RIPC+IR- extensive necrosis seen 
Immunohistochemistry and western blots for HO-1 
Immunohistochemistry   revealed increased HO-1 expression in kupffer cells in RIPC 
+IR animals in comparison to IR group. PDTC reproduced the effects of RIPC. ZnPP 
decreased HO expression in RIPC (results, chapter 6). Western blot analysis showed 
by densitometry significantly more HO expression in RIPC groups as compared to 
hepatic IR and PDTC reproduced the effects of RIPC. ZnPP inhibited HO expression 
in the RIPC group (results, chapter 7). 
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4.4 Discussion and conclusion. 
 
New findings 
 
This is the first study to demonstrate   RIPC induced modulation of hepatic 
microcirculation through   haemoxygenase    by intravital microscopy.  
Microcirculatory changes 
Effect of IR. (Early phase) 
In hepatic IR there was a significant decrease in   RBC flow, sinusoidal flow and 
sinusoidal perfusion. There was no significant change in sinusoidal diameter as 
compared to sham group in the early phase of hepatic IR. 
Effect of RIPC on hepatic IR (RIPC+IR) (Early phase) 
In this experimental model RIPC+IR showed an increased velocity of RBC flow, 
sinusoidal perfusion compared to IR group at all time points of observation. No 
difference in sinusoidal diameter in the RIPC group as compared to IR injury group 
was seen. This observation was made in previous studies in ischaemic preconditioning 
which have demonstrated no significant variation in sinusoidal diameter between HO 
induction and controls (Hata et al).Moreover the HO produced in the initial phase is in 
response to stress (inducible HO-1) and is responsible for anti-inflammatory 
functions. The HO which modulates sinusoidal tone and diameter is constitutive HO 
(HO-2) and   is not produced in kupffer cells in the early phase of hepatic IR (3hrs of 
reperfusion). Constitutive HO (HO-2) is produced in parenchmal cells after 6hrs of 
reperfusion as shown by Goda et and CO derived from an increase in HO-2 
(Constitutive HO) in the parenchyma is responsible for modulation of sinusoidal tone 
and diameter (Goda N et al 1998). 
 
  166 
Effect of HO induction on hepatic IR (PDTC+ IR) 
This study shows increased RBC velocity and sinusoidal flow in the PDTC+IR group 
as compared to IR only. The perfusion index in the PDTC group is significantly 
higher than IRI at all time points suggesting that PDTC modulates sinusoidal 
perfusion. PDTC is known to induce HO-1, inhibit NF-KB and modulate IRI and 
increased HO-1 may be responsible for modulation of sinusoidal perfusion. This 
finding is supported by evidence from studies in animal models which have shown 
that HO-1 expression is associated with better sinusoidal perfusion {McCarter et al, 
2004; Nie et al, 2002}. However there was no significant difference in sinusoidal 
perfusion between HO induction and HO inhibition (ZnPP group) upto 120 minutes of   
reperfusion. This observation suggests that HO pathways maybe responsible for 
modulation of perfusion after 120 min of reperfusion. This observation is supported 
by previous studies which have shown PDTC induced HO to increase sinusoidal 
perfusion at 120 minutes of reperfusion {Nie et al, 2002} in hepatic IR secondary to 
prolonged limb ischaemia. The initial modulation of sinusoidal perfusion in hepatic 
IR by PDTC   maybe due to its   anti-inflammatory action    and inhibitory effect on 
NF-kβ. 
A previous study by Hata demonstrated no significant difference between PDTC and 
ZnPP with regard to sinusoidal diameter however; recently Hata et al have 
demonstrated an increase in sinusoidal diameter due to increase in parenchymal HO-1 
on  administration of  higher doses of PDTC (150 mg/kg) intramuscularly in a rat 
model of hepatic IRI. Hata has shown that CO derived from PDTC induced increase 
in parenchymal HO & modulated sinusoidal diameter in the early phase of hepatic IR. 
{Hata et al, 2003}.  
  167Effect of HO inhibition on RIPC+IR (ZnPP+RIPC+IR) 
 Inhibition of HO in preconditioned groups showed a significant fall in RBC velocity 
and sinusoidal flow in the RIPC+IR+ZnPP group   suggesting that RIPC induced HO 
modulates RBC flow and sinusoidal flow in hepatic IR. HO inhibition did not affect 
sinusoidal perfusion initially in preconditioned groups but a late fall in perfusion 
index was observed suggesting the role of RIPC induced HO in modulation of 
sinusoidal perfusion at 120 minutes of reperfusion. This finding is consistent with 
PDTC (HO inducer) induced modulation of sinusoidal perfusion which showed 
significantly increased sinusoidal perfusion as compared to ZnPP group at 120 
minutes of reperfusion. The lack of any change in sinusoidal diameter on HO 
inhibition suggests that RIPC   modulates IR injury by   anti-inflammatory properties 
of HO rather than sinusoidal dilatation in the early phase of hepatic IR.  
Correlation of histological changes in IR with microcirculatory flow, 
hepatocellular death, neutrophil adhesion, serum transaminases& HO 
expression.  
The modified Suzuki score in IR injury was   significantly higher (8.83 +   0.7) than 
preconditioned group or PDTC group. This correlated with decreased flow and 
sinusoidal perfusion, increased hepatocellular death observed by propidium iodide 
staining under IVM in hepatic IR, increased sinusoidal and venular neutrophil 
adhesion and increased serum transminase levels suggestive of increased 
hepatocellular death. Increased HO expression was seen in kupffer cells in hepatic IR 
as compared to sham group. This is due to oxidative stress of IR and has been 
observed in hepatic IR in previous experiments by Katori et al and Hata et al. 
  168Correlation of histological changes in   RIPC+IR   with microcirculatory flow, 
hepatocellular death, neutrophil adhesion, serum transaminases & HO 
expression. 
The modified Suzuki score in preconditioned animals was significantly lower (6.2 + 
0.58) in preconditioned animals which correlated with  improved blood flow, 
sinusoidal perfusion, decreased hepatocellular death observed by IVM , decreased 
sinusoidal and venular neutrophil adhesion and decreased serum transaminase levels 
suggestive of decreased hepatocellular death. Lai et al showed in an animal model 
decreased histological evidence of injury and serum transaminases supporting our 
findings in this study although they did not investigate microcirculatory flow. 
Increased HO expression was seen in RIPC as compared to IR only. This finding was 
observed by Lai et al (2006) and supports our finding. 
Correlation of histological changes in PDTC+IR   with microcirculatory flow, 
hepatocellular death, neutrophil adhesion, HO expression& serum 
transaminases. 
PDTC+IR group showed a significantly lower Suzuki score (4.5+ 0.5) suggestive of 
less congestion and necrosis. This correlated well with improved flow, sinusoidal 
perfusion, decreased neutrophil adhesion, hepatocellular death and serum 
transaminase levels   suggestive of decreased hepatocellular injury. PDTC reproduced 
the effecs of RIPC. Increased HO expression was seen on both western blot analysis 
(Chapter 7) and Immunohistochemistry (chapter 6) as compared to IR. 
Previous studies have shown by intravital microscopy improved flow and sinusoidal 
perfusion and decreased hepatocellular death following PDTC induced   HO 
expression in the liver {McCarter et al, 2004} {Wunder et al, 2002}.   
  169Correlation of histological changes seen on HO inhibition   in RIPC   with 
microcirculatory flow, hepatocellular death, neutrophil adhesion, serum 
transaminases and HO expression. 
Inhibition of HO by   ZnPP in the preconditioned group showed a significantly high 
Suzuki score (8.83 +  0.6)  suggestive of increased cell necrosis and congestion which 
correlated with decreased sinusoidal flow and perfusion, increased hepatocellular 
death on IVM , increased neutrophil adhesion and  serum transaminase levels 
suggestive of significantly increased hepatocellular injury. Decreased HO expression 
was seen on immunohistochemistry and Western blot analysis in comparison to RIPC 
group. Previous studies by Busuttil et al have shown that HO inhibition of the donor 
with chromium mesoporphyrrin prior to harvest of the liver was associated with 
decreased recipient animal survival following subsequent implantation in recipient 
liver transplant models. Lai et al showed that inhibition of HO by ZnPP in RIPC was 
associated with significantly increased histological evidence of cell necrosis and 
congestion   and increased serum transmanases. 
ZnPP and sham and hepatotoxicity of ZnPP. 
Previous experiments in sham animals have shown that ZnPP   inhibits 
haemoxygenase if used in the darkness. If ZnPP is exposed to light its effect of HO 
inhibition is lost however, ZnPP inhibits hepatic artery dilatation when exposed to 
light and this potentially   leads to hepatotoxicity (Greenbaum et al; 1991, zygmunt et 
al; 1994). Hepatoxicity can confound the experimental data and hence in order to 
avoid this confounding effect ZnPP was prepared in the dark and administered 
through a syringe covered with silver foil with minimal laboratory light. The dose 
used was 1.5 mg /kg (2.5µmol/kg) and this is much lower than the hepatotoxic toxic 
dose of ZnPP (5- 10µmol/kg) as shown by Greenbaum et al.  Amersi et al (1999) 
  170showed that ZnPP treatment in shams led to undetectable baseline HO and reduced 
portal flow and bile flow. Since previous experiments on shams have been undertaken 
we did not undertake experiments to investigate effect of ZnPP on sham group in our 
study.  However   toxic effects of ZnPP   cannot be completely ruled out and future 
work to investigate the effects of ZnPP on Shams should be undertaken. 
PDTC and sham and toxicity of   PDTC. 
Tsuchihashi et al (2003) demonstrated in an animal model that doses in excess of 600 
mg /kg killed animals   but animals did not die by injection of   any dose upto 
600mg/kg. Doses more than 200 mg/ kg offset the beneficial effects of   PDTC as 
demonstrated by Liu et al (1999). Hence we chose a dose of 100 mg/ kg as used in 
experiments by Tsuchihashi. PDTC shows a dose dependent relation ship with regard 
to its beneficial effects. At doses of 100 mg/ kg PDTC induces HO in kupffer cells but 
does not influence sinusoidal dilatation. Hata et al showed that at doses of 150 mg/ kg  
{Hata et al, 2003} PDTC induced sinusoidal dilatation in sham animals increased 
HO-1 with peak mRNA levels detectable at 3 hrs after PDTC injection and then 
declined. HO Protein expression peaked at 24-48 hrs after injection and was dose 
dependent. Immunohistochemistry revealed that PDTC at higher doses induced HO-1 
in both periportal kupffer cells and hepatocytes in pericentral areas. 
Haemodynamics 
Blood pressure  
The model used was haemodynamically stable. However a fall in blood pressure on 
reperfusion was seen in hepatic IR, preconditioned animals, PDTC+IR and ZnPP 
group with recovery to baseline in 30-60 minutes. The blood pressure thereafter was 
stable throughout the time course of observation. Hence the potential effect of 
  171hypotension leading to decreased   parenchymal perfusion   and confounding results 
was avoided.  
Conclusion 
This study has again demonstrated the hepatic haemodynamic changes which are 
associated with the early phase of liver warm IR injury. Sinusoidal perfusion and flow 
during this early period are improved with remote preconditioning. The effect of 
RIPC could be reproduced by HO-1 induction prior to the IR injury and inhibited by a 
HO-1 blocker. This data would suggest that HO-1 is key to these early haemodynamic 
changes. In this early period inducible HO-1 rather than constitutive HO-1 is likely to 
be responsible.  
The next chapter focuses on investigation of microcirculatory changes in the late 
phase of hepatic IR and the effect of RIPC on the late phase of hepatic IR. 
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                                 Chapter 5 
New insights into the late phase of hepatic IR and the 
effect of RIPC on hepatocellular and microvascular 
changes after 24 hrs of reperfusion 
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5.1 Introduction 
Why study the late phase of hepatic IR and the effect of RIPC on the late phase 
of hepatic IR? 
The previous chapters have analysed the early phase of liver warm ischaemia 
reperfusion injury and demonstrated that HO-1 inhibition can abolish the protective 
hepatocellular and microvascular changes associated with RIPC in hepatic IR injury. 
In this chapter we have studied the late phase of hepatic IR and the effect of RIPC on 
the late phase of IR. In the clinical setting ischaemia reperfusion injury in the late 
phase has a major bearing on patient survival, graft function and morbidity. Therefore 
it is imperative that experimental studies investigate the pathophysiology of the late 
phase, the mechanism of hepatocellular injury caused in the late phase of hepatic IR 
and the effect of   preconditioning on protection of the liver in hepatic IR 
Previous studies investigating the effect of RIPC in the late phase of IR (recovery 
models). 
Eight studies have shown  protection of the target organ  24-48hrs following 
RIPC.(Oxman et al. 1997; Pell et al. 1998; Schoemaker & van Heijningen 2000; 
Wang et al. 2001; Wolfrum et al. 2002) These studies showed delayed protection in 
all organ systems in animal models and in recent human studies (refer chapter one, 
page 47, 48).  One study showed reduced myocardial infarct size following RIPC   
( Chen et al , 2005) induced HSP expression  in the myocardium.The first clinical 
application of RIPC in children undergoing cardiac surgery on bypass showed that 
RIPC was most effective in myocardial protection if applied 24 hours prior to the 
coronary ischaemic insult.(Cheung et al. 2006).  
  174There have been no studies which have investigated the effect   of RIPC on the 
microvascular changes in late phase of hepatic IR and haemoxygenase expression in 
the late phase of hepatic IR following RIPC. This study has investigated the impact of 
RIPC on microvascular and hepatocellular injury in the late phase of hepatic IR. The 
study also investigates hepatic HO expression in the late phase of preconditioning. 
Pathophysiological changes in IR (early and late phase) 
 The key event in the initial phase of reperfusion injury is activation of macrophages 
which are the primary source of extracellular ROS (free radicals). Endothelial cells 
and parenchymal cells are activated leading to release of ROS originating from 
intracellular mitochondria, xanthine oxidase system, NADH oxidase system and iron 
redox system.  There is an imbalance between endothelial NO and ROS leading to 
impairment of protective effects of NO on the microvasculature. Free radicals (ROS) 
are the key initiators of reperfusion injury which lead to endothelial injury and further 
release of pro inflammatory cytokines.  Simultaneous activation of complement in the 
early phase serves to prime macrophages and neutrophils for  release of 
ROS(Jaeschke et al. 1993). Complement along with cytokines and chemokines leads 
to recruitment of neutrophils, increased expression of adhesion molecules and 
adhesion of neutrophils to the endothelium in venules. Neutrophils damage 
endothelium, extravasate, adhere to parenchymal cells and plug the local 
microvasculature which along with vasoconstriction due to increased endothelin 
release exacerbates tissue ischaemia. In the late phase of IRI neutrophils produce an 
oxidative burst causing parenchymal injury due to release of free radicals and 
proteases. 
Microvascular, biochemical and histological changes (comparison of early and 
late phase of hepatic IR) 
  175In the early phase of hepatic IR there is significant impairment of RBC velocity, 
sinusoidal flow, sinusoidal perfusion and significant increase in sinusoidal and 
postsinusoidal venular neutrophil adhesion and hepatocellular death by intravital 
microscopy as demonstrated by the findings in this study and previously by Menger 
and Vollmar. In the late phase of hepatic IR there is significant impairment of 
sinusoidal perfusion and significantly increased neutrophil adhesion in sinusoids and 
postsinusoidal venules. Neutrophil adhesion is markedly increased as compared to the 
early phase. In both phases there is increased parenchymal cell death and evidence of 
raised hepatic transaminases suggestive of hepatocellular injury. In both phases there 
is histological evidence of apoptosis, necrosis and neutrophilic infiltratrion with these 
changes being significantly more in the late phase of hepatic IR.   
Potential inducible mechanisms in the late phase of hepatic IR which may not be 
evident in the early phase of IR.  
In the late phase of RIPC, synthesis or post translational modifications of Heat shock 
proteins, antioxidant enzymes and iNOS have been demonstrated. These mechanisms 
are triggered by adenosine, ROS, NO, Opioids and Catecholamines and subsequent 
pathways involve activation of kinases which lead to transcription of new proteins and 
culminate in formation of mediators such as inducible nitric oxide synthase (iNOS), 
HO-1, HSP which undergo postranslational modifications leading to the protective 
response (chapter 1 , page 52-80) . HO –mRNA protein is detectable as early as 2hrs 
after reperfusion and increased levels in the liver have been demonstrated at 18hrs of 
reperfusion following preconditioning (Terajima et al, 2000) and proteins such as 
iNOS are usually detectable after 24 hrs of reperfusion.  
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5.2Materials and methods 
Animals and surgical procedures-refer chapter 2 (material and methods). 
5.3 Animal model 
5.3a Hepatic I/R (24 hrs) 
Refer chapter 2, material and methods, page 92. 
5.3 b Limb preconditioning 
Refer chapter 2, material and methods, page 92. 
5.4 Experimental groups (n=6 in each group) 
1.  Group one- Hepatic IR-24- in which animals were subjected to ischaemia for 
45 minutes and reperfusion for 24 hours. Ischaemia was induced by an 
atraumatic microvascular clamp.  
2.  Group two- RIPC+IR-24 - were preconditioned immediately prior to 
ischaemia for 45 min and reperfusion for 24 hrs.Both groups were terminated 
at 24 hours after intravital microscopy. Standard protocols for preconditioning 
and inducing ischaemia were used. 
Experimental design –RIPC (limb)    Liver          Liver                  
                                                               Ischaemia    Reperfusion 
5m 5m 5m 5m 5m 5m 45  min  24hrs  IVM 
Isch   rep   Isch     rep    Isch  
                                              Laparotomy          Re-laparotomy    Flow,  
                                                                                                      Neutrophil adhesion   
                                                                                                      Hepatocellular death 
Figure- 5.1 
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5.5 Recovery after surgery and survival 
Rat recovery was closely monitored. Animal behaviour was assessed every hour for 4 hours 
and then at 22 and 24 hours. Signs of poor clinical condition were lethargy , ruffled fur and 
guarding upon abdominal palpation, lack of grooming and decreased food intake. Animals 
which appeared to do poorly were killed before the 24 hour reperfusion end point. One 
animal died after 24 hours of reperfusion in the IR group only. After 24 hours of 
reperfusion the animals were relaparotomised and cannulated in the carotid and jugular 
vessels of the opposite side of the neck. The liver was then subjected to intravital microscopy 
assessment. 
5.6 Intravital videofluorescence microscopy 
Refer chapter 2 - material and methods, pg 103. 
5.7 Biochemical analysis 
 Liver transaminases were assessed by method described in material and methods 
chapter 2, page 105 
5.8 Histology- refer chapter 2 material and methods, pg 105 
5.9 Immunohistochemistry and western blots for HO – refer chapter 2 material and 
methods, pg 106- 110. 
5.10 Statistical analysis 
All data are presented as mean plus minus standard error of the mean 
(SEM).Differences were considered significant for P<0.05 .Comparisons between 
groups were performed by one way analysis (ANOVA). Bonferroni correction was 
applied for ANOVA. 
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5.11 Results 
Velocity of flow 
The velocity of blood flow is not significantly different in preconditioned animals in 
comparison to IR injury only at 24 hours of reperfusion. The mean velocity in 
RIPC+IR-24 was 415.75 + 48.12 in comparison to 399.86+ 48.09 in the IR-24 
(Figure 5.2). 
Sinusoidal flow 
The sinusoidal flow is more in the RIPC+IR-24 group but not significantly different 
in comparison to IR injury at 24 hours of reperfusion. The mean sinusoidal flow in 
RIPC+IR-24 was 28.43+ 2.99 in comparison to 21.88 + 2.58 in IR-24 (Figure 5.3). 
Sinusoidal diameter 
The sinusoidal diameter is significantly more in the RIPC+IR group (9.33+ 0.17) as 
compared to the IR group (8.37 + 0.22) 24 hours of reperfusion injury. (P<0.05) 
(Figure 5.4) 
Sinusoidal perfusion 
 The sinusoidal perfusion index which is the ratio of perfused (continuous and 
intermittent) to non perfused sinusoids is significantly higher in the RIPC+IR-24 
group (0.83+ 0 .016) in comparison to IR-24 (0.64 + 0.05)(Figure 5.5) 
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Figure 5.2 
Figure - Velocity of RBC flow in RIPC+IR-24 as compared to IR-24.  Values expressed as 
mean + sem. P>0.05.  (No significant difference seen between IR-24 and RIPC+IR-24) 
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 Figure 5.3  
 Sinusoidal flow - V× (D/2)2×л = V is velocity of RBC, D is sinusoidal diameter.  Better flow 
in preconditioned animals (RIPC+IRI-24) as compared to non preconditioned (IR-24). Values 
expressed as mean + sem. (P>0.05) 
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Figure 5.4 
Figure - Sinusoidal diameter- Significantly increased diameter in the preconditioned group 
(RIPC+IR-24). Values expressed as mean + sem. P<0.05. (Significantly increased sinusoidal 
diameter in the preconditioned group.) 
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Figure 5.5 
Sinusoidal perfusion index - The PI in remote preconditioned animals (RIPC+IR-24) is 
significantly higher than non preconditioned animals (IR-24).  Values expressed as mean +  
sem. * =P<0.05 
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Effect of RIPC on venular neutrophil adhesion
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Effect of RIPC on sinusoidal neutrophil adhesion
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Figures 5.6 a - Neutrophils stained by rhodamine are seen adherent to post sinusoidal 
venular endothelium and to hepatic sinusoids.  The number of adherent neutrophils divided by 
the area of endothelial surface (л×D×L) gives the number of neutrophils/ mm2. D= sinusoidal 
diameter, L= length of segment along adherent neutrophils.  
 Fig 5.6 b - Significantly reduced venular neutrophil adhesion in preconditioned (RIPC+IR-
24) group compared to non preconditioned group (IR-24). Values expressed as mean + sem. * 
= P<0.05 (IR-24/RIPC+IR-24) 
Figure 5.6 c- Significantly reduced sinusoidal neutrophil adhesion in preconditioned group 
(RIPC+IRI) compared to non preconditioned group (IRI). Values expressed as mean + sem. * 
= P<0.05 (IR-24/RIPC+IR-24 
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The liver transaminases were higher in the IR-24 group in comparison to RIPC+IR-24 
group. (Figure 5.7) 
Hepatocellular death 
The number of dead cells in the IR-24 group was significantly higher as compared to 
the RIPC+IR-24 group. The mean number of dead hepatocytes in IR group was  
36+ 2.9. The mean number of dead hepatocytes in RIPC+IR was 10+ 1.92. (Figure 
5.8) 
Histology 
Very severe injury with abundant ballooning degeneration and necrosis is seen in the 
IR-24 injury group.  Very diffuse and significant neutrophil adhesion is seen in the IR 
group. Apoptosis is evident in the IR group. 
RIPC +IR-24 group shows less injury with some ballooning and degeneration as well 
as neutrophilic infiltration. (Figure 5.9) 
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Figure 5.7 
Transaminases show a lower rise in preconditioned animals. 
Values expressed as mean + sem. P > 0.05. 
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Figure 5.8a Hepatocellular cell death in IRI by propidium iodide staining (IVM). The of dead 
cells appear pink stained by propidium iodide. The number of cells divided by the surface 
area of the field above gives the number of cells/mm2.  
Fig 5.8 b - Hepatocellular cell death seen in RIPC+IR-24 by propidium iodide staining 
(IVM). 
Figure 5.8c- Hepatocellular cell death in preconditioned group (RIPC+IR-24) is significantly 
less compared to non preconditioned (IR-24) group. Values expressed as mean+ sem. * = 
P<0.05 (IR-24/RIPC+IR-24 
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Histology 
 
 
 
 
a).IR-24 
 
 
b). RIPC-24 
Figure 5.9  
Figure – a) IR-24                               
              b) RIPC+ IR-24  
 
Very severe injury with abundant ballooning degeneration and necrosis is seen in the 
IR injury group.  Very diffuse and significant neutrophil adhesion is seen in the IR 
group. Apoptosis is evident in the IR group. 
RIPC group shows less injury with some ballooning and degeneration as well as 
neutrophilic infiltration. 
 
 
  1865.12 Discussion  
Model stability, deaths and complications 
The animal model was haemodynamically stable during the period of ischaemia and 
recovery. The animals were resuscitated with intravenous fluids prior to closure of 
laparotomy wound and recovery from anaesthesia. Only one animal in the IR-24 
group died after 24 hours of reperfusion. Post mortem examination revealed a 
completely necrotic liver in this animal. All RIPC+IR-24 animals were successfully 
recovered and all of them survived. 
Microcirculatory changes in hepatic IR injury at 24 hours and comparison with 
early phase (3hrs)  
The velocity of flow and sinusoidal flow in hepatic IR after 24 hours of reperfusion 
are not significantly less in comparison to RIPC+IR in the late phase of hepatic IR 
which is in contrast to the early phase where we found the velocity of flow and 
sinusoidal flow to be significantly lower in the IR group . The sinusoidal perfusion  in 
both the early (Chapter 3) and late phase of hepatic IR were found to significantly low 
in  the IR group.However the sinusoidal diameter is significantly less in the IR-24 
group in comparison to preconditioned animals whereas in the early phase no 
difference was found in the sinusoidal diameter.  
Neutrophil adhesion in the early and late phase of hepatic IR 
The sinusoidal neutrophil adhesion and postsinusoidal venular neutrophil adhesion in 
both the early and late phase of hepatic IR was significantly more in comparison to 
the preconditioned animals. However the number of adherent neutrophils was 
significantly more in the late phase of hepatic IR in comparison to the early phase of 
hepatic IR suggesting that there is increased neutrophil activation and adhesion as IR 
injury progresses over a period of time. Previous intravital studies by Menger et al 
  187have shown that increased neutrophil adhesion to endothelium is responsible for 
increased endothelial injury and poor sinusoidal perfusion.  
Effect of RIPC on microcirculatory changes in IR at 24 hours and comparison 
with early phase (3hrs) 
As discussed above RIPC significantly enhanced sinusoidal perfusion and increased 
sinusoidal diameter in the late phase of hepatic IR. In the early phase RIPC improves 
sinusoidal perfusion but does not modulate sinusoidal diameter. The velocity of flow 
and sinusoidal flow were not significantly better in the late phase of hepatic IR in 
contrast to observations in preconditioned animals in the early phase of IR. These data 
suggest that RIPC modulates hepatic microcirculation and reduces hepatocellular 
injury primarily by improved RBC velocity and sinusoidal flow in the early phase   
whereas in the late phase RIPC primarily modulates sinusoidal diameter and perfusion 
to improve hepatic flow. The absence of any significant difference in velocity of flow 
between the two groups is partly explained by RBC velocity data from our study on 
the effect of RIPC in the early phase of hepatic IR (Chapter 3) which demonstrate that 
the velocity of RBC in the preconditioned group is significantly high at all time points 
of observation but the  value of RBC velocity shows a downward trend from 30 min 
to 180 min of reperfusion and   the difference  between  the IR injury and RIPC+IR 
group  is less at 180 minutes of reperfusion  in comparison to 30 minutes of 
reperfusion.  
Neutrophil adhesion in RIPC+IR (3 hrs and 24 hrs)  
 The data here clearly demonstrate that RIPC markedly attenuates neutrophil adhesion 
to endothelium in the IR injury group in both sinusoids and venules and the reduced 
neutrophil adhesion may account for the improved sinusoidal perfusion seen in the 
preconditioned group. In the early phase of hepatic IR RIPC significantly reduces 
  188neutrophil adhesion in both sinusoids and venules. Previous studies on direct 
ischaemic preconditioning have demonstrated   modulation of sinusoidal perfusion by 
reduced neutrophil activation and adhesion at 24 hours. The data in our study clearly 
demonstrate that modulation of neutrophil activation is a key mechanism responsible 
for preservation of sinusoidal perfusion in the RIPC+IR group in both phases.  
Hepatocellular death in IR and RIPC+IR (comparison of early and late phases) 
Hepatocellular death is significantly reduced in both the early and late phase of 
hepatic IR by RIPC as shown by intravital propidium iodide staining. 
Since neutrophil activation is responsible for free radical release and parenchymal 
injury the reduced cell death seen maybe attributed to the preconditioning effect and 
modulation of both neutrophil activation and preservation of perfusion in the 
sinusoids as demonstrated by data in our study 
Liver injury in IR and the effect of RIPC. (3hrs and 24 hrs) 
Hepatic transaminases are significantly higher in the IR injury group at 24 hours as 
compared to the preconditioning group suggesting reduced hepatocellular injury in the 
RIPC group. Hepatocellular injury is also reduced by preconditioning in the early 
phase of hepatic IR although the difference was not statistically significant (chapter 3  
Histological changes in IR -24 and the effect of RIPC. (Early and late phase) 
 Histological findings in this study clearly demonstrate increased parenchymal 
necrosis and neutrophilic infiltration in the IR injury group at 24 hours as compared to 
the RIPC group. In the early phase the modified Suzuki score was significantly more 
in IR injury in comparison to RIPC+IR. However the Suzuki score is an objective 
score described only for assessing the early phase of hepatic IR and cannot be used 
for describing the late phase changes.  
 
  189Conclusions 
This is the first study to demonstrate the protective effects of RIPC on hepatic 
microcirculation in a recovery model of hepatic IR in rats. The study clearly 
demonstrates reduced hepatic injury in preconditioned animals.  
 In the next chapter HO expression and its spatial distribution in liver tissues in both 
the early and late phase of hepatic IR and RIPC shall be investigated by 
immunohistochemistry. 
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   Study of the spatiotemporal expression of 
   HO-1 in the early and late phase of hepatic 
   IR and RIPC by immunohistochemistry. 
 
                                 
 
 
 
 
 
 
 
 
 
  1916.1 Introduction 
Distribution and timing of HO-1 expression with hepatic IR and the 
experimental evidence for effect of RIPC on the degree and site of HO-1 
expression.  
HO-1 expression in hepatic IR 
 Upregulation of HO-1 is a critical cytoprotective mechanism against cellular stress 
induced by ischaemia, hypoxia or inflammation.  HO-1 is produced in the hepatic 
macrophages (kupffer cells).HO-1 protein is expressed after 3hrs of reperfusion in 
kupffer cells. HO-1 expression peaks at 3hrs after reperfusion and then hepatic HO-1 
expression decreases in 48 hrs. Increased expression in parenchymal cells has been 
shown and is usually constitutive HO i.e HO-2. Huawel et al have shown by 
bioluminescent activity detection of HO-1 signals at 3hrs of reperfusion. 
Effect of RIPC on hepatic IR 
 Lai et al.(Lai et al. 2006) in an animal model of hepatic IR demonstrated that RIPC 
from the limb by four cycles of brief limb ischaemia prior to hepatic ischaemia 
increased HO-1 expression in the liver which was observed in kupffer cells in the 
early phase of hepatic IR.  
Effect of haemin and HO-1 inducers in hepatic IR 
Previous studies have shown the increased expression of HO-1 in kupffer cells 
suggesting that kupffer cells are the key source of HO-1.(Hirano et al. 2001)  
HO-1 has been shown to enhance graft survival in experimental models.(Redaelli et 
al. 2002) Pretreatment with HO-1 inducer (Amersi et al. 1999) has shown increased 
survival in liver transplants in rat models and examination of liver specimens has 
demonstrated increased expression in macrophages(Amersi et al. 1999). 
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The previous chapters in this study have shown the loss of protective effect of RIPC 
in hepatic IR after HO inhibition by zinc protoporphrin. The data demonstrate that 
HO-1 inducer (PDTC) protected hepatic microcirculation in hepatic IR. The aim of 
this study is to investigate the expression of HO-1 in hepatic IR and RIPC+IR in both 
the early and late phase of hepatic IR and the effect of RIPC on hepatic IR. The study 
also investigates the site and timing of HO expression by PDTC in hepatic IR. 
Immunohistochemistry technique used in this study 
The enzyme labelled antibody technique is a fast cheap and convenient method for 
light microscopy. It is a useful preliminary to ultrastructural methods.The enzyme 
labelled antibody technique is nearly as specific and sensitive as fluorescent 
techniques. It has a permanent staining unlike fluorescent techniques and does not 
require fluorescence or fluorescence microscopes. In addition auto fluorescence does 
not interfere with the visualisation of antigen (Nakane and Pierce, 1967). It has got 
good penetration into tissues. 
6.2 Material and methods 
a) Animals and surgical procedures 
Refer chapter 2 – material and methods  , pg 92 
Six animals in each group as described previously in chapter 2 were studied. There 
were eight groups and hence the total no of samples evaluated were 48. 
 Sections from liver tissue from each animal were assessed.  
b) Method of tissue processing for immunohistochemistry. 
Refer to chapter 2 - material and methods, pg 106 
 
 
  193c) Immunohistochemistry criteria and assessment methodology. 
 Paraffin embedded tissue was stained with haematoxylin.An objective scoring 
method was devised which assessed the intensity of sinusoidal macrophage staining 
graded from 0 (no positive stain) to 4 (intense and crisp brown stain).  A percentage 
positive score was obtained by multiplying the grade with the percentage of stained 
macrophages. The maximum score possible was 400 (4X100%) while the minimum 
was 0 (0X0%)  {Harvey et al, 1999}.  
 
 
 
                                                                                                                                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1946.3 Results 
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Immunohistochemistry scoring - table 6.1 
 
 
 
 
 
  195Immunohistochemistry for HO-1 
         
6.1 IR                                       6.2 RIPC+IR (Increased HO-1 expression in kupffer cells) 
        
Fig 6.3 PDTC+IR (HO inducer) Fig 6.4 ZnPP+RIPC+IR (HO inhibition)                                   
          
Fig 6.5 Sham                        Fig 6.6 RIPC+Shams 
         
Fig 6.7 IR-24                            Fig 6.8 RIPC+IR-24 
Fig 6.1- There is some HO expression seen in macrophages (kupffer cells) in IR 
injury in response to oxidative stress.  Fig 6.2- The expression of   HO-1 was 
significantly more in kupffer cells in the RIPC+IR group. Fig 6.3-PDTC (HO-1 
  196inducer) showed   increased HO-1 expression in macrophages and reproduced effects 
of RIPC+IR group. Fig 6.4- Prior administration of ZnPP significantly reduced the 
expression of HO-1 in preconditioned animals ZNPP+RIPC+IR. Fig 6.5- Sham 
animals showed baseline HO-1 expression in sinusoidal kupffer cells. Fig 6.6- RIPC 
in sham induced HO-1 above   baseline levels in response to oxidative stress. 
6.4 Discussion 
Site of HO-1 expression 
Immunohistochemistry showed HO-1 expression in macrophages at the end of three 
hours of reperfusion.  Lai et al.(Lai et al. 2006)  demonstrated that RIPC from the 
limb increased HO-1 expression in the liver and increased HO-1 was seen in kupffer 
cells. Previous studies have shown the increased expression of HO-1 in kupffer cells 
suggesting that kupffer cells are the key source of HO-1.(Hirano et al. 2001)  
HO-1 has been shown to enhance graft survival in experimental models.(Redaelli et 
al. 2002) Pretreatment with HO-1 inducer (Amersi et al. 1999) has shown increased 
survival in liver transplants in rat models and examination of liver specimens has 
demonstrated increased expression in macrophages .(Amersi et al. 1999) 
Reproducibility of scoring system, validity & references for new scoring system 
The scoring on immunohistochemistry for HO-1   macrophage marker is based on the system 
routinely used in the laboratories to assess Oestrogen receptor status of Invasive ductal 
carcinoma cells of the breast in paraffin embedded sections (Harvey et al 1999, leake R et al 
2000, Rhodes et al 2001). The cells which are positive on immunohistochemical staining for 
the HO-1 macrophage marker (name of the stain) is graded into 4 grades depending on the 
intensity of staining. 
0= No staining 
1= Weak staining 
2= Moderate staining 
  1973= Strong staining 
This is subsequently multiplied with the percentage of cells which are positive. The 
percentage is arrived at by counting the positive cells in a total of 100 cells with in the 
particular high power field.Hence the minimum score possible is 0 and the maximum is 300 
This system is valid and has been used for oestrogen receptor status and   is reproducible.,, 
Variability in methodogy and assessment of immunohistochemistry  
Interobserver   variability is due to differences in methodology of dilution and 
pipetting of samples.  
HO expression in shams  
Baseline   HO expression is seen in kupffer cells in sinusoids of sham group. 
HO distribution in hepatic IR (3hrs of reperfusion and 24 hrs of reperfusion). 
Haemoxygenase expression in IR (3hrs of reperfusion) was more compared to 
sham.This is due to increased oxidative stress from which acts a direct stimulus to 
HO-1 expression. The increased HO expression was observed in kupffer cells which 
are the primary source of HO production and degradation of haem to biliverdin and 
CO. At 24 hrs of reperfusion more HO was observed in Kupffer cells due to a longer 
period of oxidative stress in comparison to 3 hrs of reperfusion. 
HO expression in RIPC+IR (early and late phase) 
Haemoxygenase expression is seen to be significantly more in RIPC group as 
compared to IR group at 3hrs of reperfusion suggesting that the remote 
preconditioning stimulus induced increased HO-1 expression in the liver. RIPC 
induces a low grade oxidative stress which maybe responsible for increased HO in the 
liver. The increased HO expression was observed in kupffer cells at 3hrs of 
reperfusion. HO-1 pathways are initiated after oxidative stress and previous studies 
(Potter, Bussutil) have shown expression of mRNA as early as 2 hours after the initial 
oxidative stress. The increase in velocity  and flow seen after 30 minutes of 
  198reperfusion  corresponds to 2 hours after the first cycle of preconditioning and  the 
time point of earliest HO-mRNA expression suggesting that HO-1 pathways maybe 
responsible for modulation of  hepatic microcirculation in this study. 
 Lai et al {Lai et al, 2006} demonstrated increased hepatic HO-1 expression in both 
kupffer cells and parenchymal cells. Hirano et al demonstrated increased HO-1 in 
kupffer cells in response to injected senescent RBCs and increased bilirubin in the 
bile suggesting that kupffer cells are the principal source of HO-1 in the liver.{Hirano 
et al, 2001 }  Previous studies have demonstrated increased  free radicals in the blood 
following RIPC.{Chen et al , 2005}  Increased ROS may induce a low grade 
oxidative stress in the liver and since kupffer cells are the key cells in the initial 
inflammatory response this may explain the increased HO-1 in the kupffer cells.  
In the late phase of hepatic IR (24 hours)  there was increased HO expression in both 
kupffer cells and hepatocytes (parenchymal cells) in preconditioned animals in 
comparison to IR only. This may explain the increased sinusoidal diameter observed 
in RIPC group at 24 hrs on intravital microscopy.Increased HO in parenchymal cells 
modulates sinusoidal tone and diameter as shown by Goda et al. Goda et al have 
shown that CO derived from an increase in HO-2 (Constitutive HO) in the 
parenchyma is responsible for modulation of sinusoidal tone and diameter in the late 
phase of hepatic IR (Goda N et al 1998).  Increased HO-1 in kupffer cells in the early 
phase of hepatic IR was seen in preconditioned animals but there was no evidence of 
parenchymal expression of HO explaining the absence of sinusoidal dilatation in the 
early phase of hepatic IR.  
HO expression with inducible (PDTC) and inhibitory agents (ZNPP) 
.PDTC induced HO-1 in macrophages in the early phase of hepatic IR. Inhibition of 
haemoxygenase by ZnPP (ZnPP inhibits both HO-1 and HO-2) showed decreased HO 
  199expression in macrophages in the early phase of hepatic IR. This explains the 
intravital findings of increased neutrophil adhesion and hepatocellular death in 
comparison to preconditioned animals. 
PDTC (100mg/kg) did not cause any significant change in sinusoidal diameter. This 
observation is supported by previous studies in ischaemic preconditioning which have 
demonstrated no significant variation in sinusoidal diameter after HO induction with 
PDTC at doses of 100mg/kg s. c. Recently Hata has shown that CO derived from 
PDTC induced increase in parenchymal HO-1 modulated sinusoidal diameter in the 
early phase of hepatic IR {Hata et al, 2003}. Hata used higher doses of PDTC i.e 
150mg/kg s.c.  and the effects were dose related. 
Animal model and in vivo assessment (chapter 4 and 5) 
Early phase of hepatic IR (3 hrs of reperfusion) and effects of RIPC (Refer 
Chapter 4) 
Intravital microscopy demonstrated in real time manner significantly better RBC 
flow, sinusoidal flow, sinusoidal perfusion and decreased endothelial   neutrophil 
interaction as well as hepatocellular cell death in RIPC+IR as compared to IR only. 
The improved flow was observed as early as 30 minutes after reperfusion. 
There was no difference in sinusoidal diameter between RIPC+IR and IR only. Zinc 
protorporhyrin abolished all protective effects in preconditioned animals suggesting 
the role of haemoxygenase in modulation of hepatic microcirculation. 
Late phase of hepatic IR (24hrs) and effect of RIPC. (Refer Chapter 5) 
Intravital microscopy showed significantly better sinusoidal perfusion, increased 
sinusoidal diameter and decreased neutrophil adhesion as well as hepatocellular cell 
death in  RIPC+IR-24 in comparison to IR-24 only. There was no difference in 
velocity of flow and sinusoidal flow.    
  200Lack of change in sinusoidal diameter on HO inhibition suggests that RIPC   
modulates IR injury by   anti-inflammatory properties of HO rather than sinusoidal 
dilatation in the early phase of hepatic IR.  
Conclusions and future assessment. 
 Immunohistochemistry strongly suggests increased haemoxygenase expression in the 
liver of preconditioned animals in hepatic IR following preconditioning. Increased 
HO is seen in kupffer cells in the early phase of hepatic IR and in both kupffer cells as 
well as parenchymal cells in the late phase of hepatic IR following preconditioning. 
Although the cellular distribution of haemoxygenase has been identified it is 
necessary to quantify haemoxygenase expression. 
The next chapter focuses on quantification of HO expression by western blot analysis 
in all animal groups. 
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Quantification of HO-1 protein expression in the early 
and late phase of hepatic IR and RIPC by Western   
Blot analysis 
                            
                                  
 
 
 
 
 
 
 
 
 
 
 
 
  2027.1 Why western blotting for HO-1? 
Immunohistochemistry has shown increased HO expression primarily in macrophages 
in the early phase of hepatic IR following RIPC and in both macrophages and 
hepatocytes in the late phase of hepatic IR following RIPC. Immunohistochemistry is 
useful for showing distribution of HO expression. However it is not specific for HO-1 
as the antibody cross reacts with HO-2 and also the antibody may cross react with 
other proteins. Moreover immunohistochemistry could not be used to quantify HO 
expression.  
Western blotting is a technique which involves extraction of HO protein using 
specific antibodies and is a semiquantitative method which helps quantify HO 
expression. In order to quantify HO-1 expression in RIPC, western blots for HO-1 
expression were carried on snap frozen liver tissues. 
7. 2 Material and methods 
Animals and surgical procedures 
As described in chapter 2 (Pg 92). Liver tissues were snap frozen in – 80 degrees  
celsius for HO western blot analysis. 
Experimental groups (n=6 in each group) 
Eight groups of animals were studied as described in material and methods pg 92. 
Method of western blots and densitometry for HO-1 expression. 
Refer material and methods, chapter 2, pg 110. 
Number of samples 
Liver tissues from six animals in each group (eight groups) were processed. The total 
number of samples analysed for HO expression were 48.  
 
 
  203Controls  
The positive control used was recombinant HSP-32 (protein lysate) from Stressgen 
laboratories.   
Quantitation 
This was done using densitometry analysis and software for measurement of band 
densities as described in chapter 2 material and methods. 
Statistical analysis 
All data are presented as mean plus minus standard error of the mean 
(SEM).Differences were considered significant for P<0.05.Comparisons between 
groups were performed by one way analysis (ANOVA). Bonferroni correction was 
applied for ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  2047.3 Results (early and late phase of IR) 
The results show a significantly increased HO-1 expression in RIPC groups as 
compared to IR groups and administration of HO-1 blocker ZnPP significantly 
reduced the   haemoxygenase expression in the preconditioned groups. Also PDTC is 
a known HO-1 inducer and the expression of HO-1 in PDTC reproduced the effects of 
RIPC in the early phase (Fig 7.1, 7.2). Sham showed baseline HO expression and 
preconditioning in sham induced HO expression over baseline levels. In the late phase 
of IR signififcantly more HO-1 expression is seen in RIPC-24 as compared to IR-24 
only (Fig 7.1, 7.3). 
 
 
 
 
 
 
  205HO-1 
Fig 7.1 Representative   example of     western blots done for all groups. 
  IR 
                         
+VE  ZnPP  RIPC
+IR   
PDTC  RIP- 
24  RS 
Sham 
IR-24    MW 
Lane 1- Sham 
Lane 2- MW- 32 Kda for HO   protein. 
Lane 3- IR-24 (HO expression in late phase of hepatic IR) 
Lane 4-RS 
Lane 5- RIPC+ IR-24 (effect of RIPC on HO expression in late phase of IR) 
Lane 6- PDTC- HO inducer 
Lane 7- Positive control 
Lane 8- ZnPP- HO inhibitor 
Lane 9- Ischaemia reperfusion inury (early phase) 
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Fig 7.2 - Early phase of hepatic IR (above). Densitometry for western blots showing increased 
HO-1 expression in RIPC+IR and PDTC+IR which was abolished by ZnPP +RIPC+IR. 
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Fig7.3 – Densitometry for late phase of hepatic IR and RIPC western blot showing 
increased HO-1 expression in the RIPC group at 24 hours. 
 
 
 
 
  2077.4 Discussion and conclusion 
Method of assessing HO-1  
Reliability, reproducibility of technique and assay variability  
The technique used is a well described semiquantitative technique used for detecting 
HO protein. It has been used in rats, rabbits and mice. Interobserver variability is 
possible due to differences in pipetting and dilution. This was minimised by the same 
person doing all the samples. All the samples from different groups were compared to 
a standard control. The technique is reproducible and has been validated for use in 
other species i.e rabbits, humans, mouse etc (stressgen).  
Positive Control used was recombinant HSP-32 (protein lysate).   
Validation and antibodies 
The primary and secondary antibodies chosen were commercially standardised 
anitobodies from Stressgen laboratories. These antibodies have been validated for 
detection of HO-1 by Stressgen. The method used and dilution of antibodies was 
according to manufacturer’s guidelines. 
Extraction of protein and incubation with antibody makes the technique more 
sensitive and specific than immunohistochemistry and helps quantification. 
We chose polyclonal rabbit IgG (StressGen, Canada) as it was easily available 
commercially as against monoclonal antibodies and it was diluted 1; 1000. The rat 
HO-1 antibody does not cross react with rabbit HO-1 because it is raised in rabbits. 
Biotinylated secondary antibody helps develop a peroxidase based reaction. HRP 
conjugated secondary antibody (1:2000) was used and HRP conjugated antibiotin 
antibody (1:1000). 
 
 
  208HO-1 in sham (Early phase) 
Studies by Tsuchihashi (2003), Hata et al (2003) have shown that baseline HO is 
essential for RIPC or other stressful stimuli to   induce HO expression as HO is 
not inducible in HO knockout mice   as shown by Tsuchihashi et al. These 
observations suggest that genes expressing HO are required for protection of the liver 
from oxidative stress. 
HO-1 in IR (Early and late phase of hepatic IR) 
Increased HO expression in IR group was seen as compared to shams in the early 
phase of hepatic IR. This is due to oxidative stress in hepatic IR and has been shown 
in previous studies by Lai et al   in the early phase and Katori et al in   liver transplant 
models respectively.  
HO-1 in RIPC+IR (Early and late phase of hepatic IR) 
Significantly   more hepatic HO protein expression was observed in our study in both 
the early and the late phase of RIPC in hepatic IR.  This is the first study to 
demonstrate increased HO expression findings in a recovery model of hepatic IR and 
RIPC. Lai et al (2006) have demonstrated increased hepatic HO expression in the 
early phase of RIPC+IR by western blot analysis.  
Effects of HO induction and inhibition (Early phase of hepatic IR) 
RIPC+IR and PDTC+IR induced increased HO protein in the liver which was 
significantly more compared to IR and shams. HO inhibition with ZnPP led to 
significantly reduced HO protein expression in RIPC group.  Our findings in 
RIPC+IR   are supported by Lai et al (2006) who observed increased HO after 4 hrs of 
reperfusion in the liver following brief   limb RIPC. Hata et al have demonstrated 
PDTC induced increased hepatic HO expression supporting our observation. ZnPP 
  209inhibits hepatic HO protein expression as seen in our study and this observation is 
supported by Lai et al (2006). 
Correlation with Immunohistochemistry (for HO-1) in the early and late phase 
of hepatic IR. 
Immunohistochemistry supports our findings from western blots for HO-1.  
Baseline HO-1 expression was observed in sinusoids in sham animals on 
immunohistochemistry and western blot analysis demonstrates baseline levels of HO 
in sham animals.  Increased HO expression was seen in IR (early phase) in kupffer 
cells as compared to sham in the early phase of IR and this is confirmed by western 
blot analysis. In RIPC +IR significantly more HO expression is seen in kupffer cells 
in the early phase  on immunohistochemistry and this finding is supported by 
significantly increased HO protein expression found on western blot analysis. PDTC 
induced HO expression is seen both by immunohistochemistry and western blot 
analysis. Immunohistochemistry in our study showed primarily increased HO in 
sinusoidal kupffer cells. PDTC induced HO expression on both   western blots and 
immunohistochemistry   has   previously been demonstrated by Hata et al (2003). 
Hata showed a dose dependent relationship between PDTC and HO expression with 
HO expression in Kupffer cells at doses of 100 mg/ kg as observed in our study and in 
both parenchymal cells and kupffer cells at doses of 150 mg/kg. Hata et al showed 
that ZnPP abolished the effects of PDTC.   ZnPP significantly reduced HO expression 
in RIPC+IR in our study as observed by both immunhistochemistry and western blots. 
This finding is supported by Lai et al (2006).  
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late phase of hepatic IR and RIPC. 
In the early phase of RIPC+ hepatic IR   increased   HO protein is associated with 
significantly better RBC flow, sinusoidal flow and sinusoidal perfusion. There was no 
change in sinusoidal diameter on HO induction or inhibition. Sinusoidal dilatation on 
HO induction by PDTC was not   observed in our   study since the dose we used was 
100mg/kg as against 150 mg/kg which has been shown to induce sinusoidal dilatation 
recently by Hata et al. Moreover the HO-1   induced by RIPC or PDTC in the early 
phase of IR was observed   in   kupffer cells and HO-1 induced in kupffer cells is in 
response to oxidative stress as shown by previous studies. Inducible HO-1 in kupffer 
cells is responsible for anti-inflammatory functions (Katori et al).  HO-1 induced in 
parenchymal cells is responsible for generating CO and modulation of sinusoidal   
tone as shown by Hata et al using   higher doses of PDTC (150mg/kg) { Hata et al 
2003}.  
In the late phase there was a significant increase in HO seen on western blot analysis  
 in RIPC +IR -24 as compared to IR-24 only . Immunohistochemistry demonstrated 
increased HO both in sinusoids and parenchymal cells in RIPC+IR-24. Increased HO 
in the sinusoids has anti-inflammatory functions as shown previously by Katori et al. 
Goda et al have shown parenchymal  HO-2 (constitutive) expression in the late phase 
of ischaemic preconditioning  to be responsible for CO generation and sinusoidal 
dilatation. This suggests that the sinusoidal dilatation seen in our study in the late 
phase of RIPC   maybe due to HO produced in the hepatic parenchymal cells.  
Relation of HO protein to leukocyte adhesion and   hepatocellular death in the 
early and late phase of hepatic IR and RIPC. 
  211Increased HO protein correlated with   decreased sinusoidal and venular neutrophil 
adhesion in RIPC in both the early and late phases, correlated with decreased 
histological necrosis and congestion in both the early and late phases of RIPC, 
decreased hepatocellular death as observed by propidium iodide staining in both the 
phases of RIPC+IR and in PDTC induced HO expression and decreased serum 
transaminase levels in both phases of   RIPC+IR. This suggests that HO protein is 
responsible for protection of liver parenchyma, hepatic microcirculation and reduced 
hepatocellular injury. 
Conclusions and future assessment 
 Western blots have demonstrated that RIPC induced hepatic haemoxygenase 
expression in both the early and late phase of hepatic IR has a significant role in 
modulation of hepatic microcirculation and reduction of   hepatocellular injury. 
Further investigation in HO knockout models would be necessary to specifically 
investigate the effects of haemoxygenase.   
Since intravital microscopy has shown decreased neutrophil adhesion suggesting 
reduced neutrophil activation the focus of the next chapter was to investigate if 
hepatic HO expression in this study modulated CINC-1 levels in order to reduce 
neutrophil activation. 
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     Modulation of Neutrophil activation by RIPC  
 induced   inhibition of Cytokine-induced neutrophil 
chemoattractant in the early and late phase of 
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8.1 Introduction 
Relationship   between IR, HO-1 and   neutrophil   adhesion. 
IR injury   is associated with increased venular and sinusoidal neutrophil adhesion 
seen by intravital microscopy and histologically in both the phases of hepatic IR. 
RIPC reduced   neutrophil adhesion in both phases of hepatic IR and this was 
associated with increased HO-1 protein as observed by immunhistochemistry and 
western blot analysis   in our study. These data suggest that HO-1 is associated with 
modulation of neutrophil activation and adhesion. Previous studies have shown HO to 
reduce neutrophil activation. This study was carried out to study the effect of RIPC on 
serum CINC-1 levels   and its correlation with hepatic HO expression. 
What is CINC-1? 
Functionally, CINC-1 is described as a major neutrophil chemoattractant and 
activator. CINC-1, induced by IL-1, TNF- and bacterial products, promotes both 
neutrophil rolling and adhesion, likely through the upregulation of surface integrins. 
Thus, it directs neutrophils to sites of bacterially-induced inflammation. It is also 
reported to stimulate neutrophil activity by promoting cathepsin G release from 
azurophilic granules. It does not, however, seem to impact nitrite production. Thus it 
makes a partial contribution to bacterial killing. Relative to CINC-2 and CINC-3, 
CINC-1 seems to be equal in chemotactic activity but less efficient in inducing 
calcium mobilization. It is also induced earlier in macrophages than CINC-2 and -3 
and declines more quickly in expression (16). The significance of this is unclear. 
. CINC (Cytokine-induced neutrophil chemoattractant), a peptide in the IL-8 
superfamily has been reported to be a potent neutrophil chemoattractant in rats 
  214{Watanabe, 1989; Watanabe, 1989}. Kupffer cells, which comprise the largest fixed 
macrophage population in the liver, produce cytokines when activated and represent 
an important source of chemoattractants. 
What is the role of CINC-1 in hepatic IR? 
Neutrophils play an important role in hepatic IR. The infiltration of neutrophils 
intoinflammatory lesions is brought about chemotactic substances. CINC, a peptide in 
the IL-8 superfamily has been reported to be a potent neutrophil chemoattractant in 
rats {Watanabe, 1989; Watanabe, 1989}. Kupffer cells, which comprise the largest 
fixed macrophage population in the liver, produce cytokines when activated and 
represent an important source of chemoattractants. Hisama et al {Hisama et al, 1996} 
demonstrated that serum   CINC levels peaked 6 hours after reperfusion and then 
gradually decreased. The expression of CINC mRNA transcripts in the liver peaked at 
3 hrs in untreated animals   as shown by northern blot analysis. Treatment of animals 
wih heparin or gadolinium chloride inhibited   serum CINC levels and CINC 
transcript expression in liver and both together had an additive inhibitory effect on 
CINC m RNA expression, serum CINC levels. The number of neutrophils which 
infiltrated the liver 24 hours following reperfusion significantly decreased following 
CINC inhibition.  
Studies showing effect of RIPC on CINC-1. 
 There have been no studies demonstrating the effect of RIPC on CINC-1. 
Pharmacological preconditioning by Glycine and heat shock preconditioning have 
been shown to reduce serum CINC-1 levels in hepatic reperfusion injury. Since data 
from previous chapters have shown a significant effect of RIPC on neutrophil 
adhesion in both the early and late phase of hepatic IR we investigated the effects of 
RIPC on CINC levels in hepatic IR (early and late phase).  
  215 
Aim of this study 
The aim of this study was   to   investigate the effects of RIPC on CINC levels in 
hepatic IR and correlate with microcirculatory data and HO data from the previous 
chapters. 
8.2 Material and methods 
 Animals and surgical procedures 
As detailed in the chapter on methodology,  pg 92. 
Experimental groups (n=6 in each group) 
Eight (8) groups of animals were studied as described in chapter 2. 
CINC Elisa 
Elisa for quantification of CINC was done as described in chapter 2, pg 112. 
Intravital microscopy 
As described in chapter 2, pg 9103. 
Western blot analysis for HO 
As described in chapter 2, pg 110. 
Statistical analysis 
All data are presented as mean plus minus standard error of the mean 
(SEM).Differences were considered significant for P<0.05.Comparisons between 
groups were performed by one way analysis (ANOVA). Bonferroni correction was 
applied for ANOVA. 
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8.3 Results 
The CINC data shows significant difference between IR injury, RIPC+IR and 
ZnPP+RIPC+IR in the early phase of hepatic IR. In the late phase of IR there is a 
significant difference seen between IRI and RIPC+IRI suggesting that 
preconditioning modulates release of CINC-1 from kupffer cells. 
CINC -1 levels in Sham and RIPC+Sham 
The CINC cytokine levels in sham were significantly low (101.32+ 6.42).   RIPC in 
sham led to relatively high CINC levels (412.18 + 65.24) as compared to sham. (Fig 
8.1) 
Effect of IR on CINC-1   in the early and late phase of hepatic IR 
Hepatic IR injury produced a significantly high serum CINC level in comparison to 
sham animals in the early phase of hepatic IR (644.08 + 181.24). The serum CINC 
levels were significantly high in the late phase of hepatic IR (15306+ 1222.04). (Fig 
8.1, 8.2) 
Effect of RIPC on CINC-1 in the early and late phase of hepatic IR 
RIPC significantly reduced CINC -1 levels in both the early (401.62 + 78.56) and late 
phase (467.46 + 26.06) of hepatic IR in comparison to IR only. 
Effect of HO induction (PDTC) and inhibition (ZNPP) on CINC-1 levels (early 
phase).   
PDTC (HO inducer) significantly reduced CINC-1 levels in serum in hepatic IR  
(413.36 + 63.06)  
HO inhibition in preconditioned animals with Zinc protoporphyrin increased serum 
CINC levels (  521.81+ 74.9).     
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Correlation of CINC-1 with intravital findings on neutrophil adhesion 
Intravital microscopy has shown increased neutrophil adhesion in IR in the early and 
late phase and after HO inhibition in preconditioned animals. PDTC+IR (HO 
induction) significantly reduces Serum CINC levels. Neutrophil adhesion is 
significantly less in RIPC+IR in both the early phase of IR and late phase of IR.  
Correlation of   Hepatocellular death with CINC-1 
Increased hepatocellular death on propidium iodide staining was observed in IR injury 
in both phases of hepatic IR in comparison to preconditioned animals. Also increased 
hepatocellular death was observed after HO inhibition in RIPC+IR (early phase) 
Correlation of CINC-1 with HO western blots.  
Increased HO expression is seen in RIPC+IR animals in both the early and late phase 
of hepatic IR and after HO induction with PDTC prior to hepatic IR.  In these groups 
reduced serum CINC levels are observed. Reduced HO in IR injury in both phases 
and after HO inhibition with ZNPP prior to RIPC are observed (Chapter 7). In these 
groups increased CINC levels are observed. 
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Modulation of CINC by HO induction , RIPC and HO inhibition
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Figure 8.1 Modulation of CINC in early phase of hepatic IR 
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Figure 8.2   Modulation of CINC in late phase of hepatic IR 
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8.4 Discussion 
Assay, controls and variability 
If samples generate values higher than the highest standard, further dilute the samples 
with the Calibrator Diluent and repeat the assay.Any variation in operator, pipetting 
technique, washing technique, incubation time or temperature, and kit age can cause  
variation in binding.This assay is designed to eliminate interference by soluble 
receptors, binding proteins and other factors present in biological samples. Until all 
factors have been tested, however, the possibility of interference cannot be excluded. 
Reliability of technique and validity cross reactions, sensitivity and specificity. 
Twelve assays were evaluated and the minimum detectable dose (MDD) of rat CINC-
1 ranged from 0.7 - 1.3 pg/mL. The mean MDD was 1.1 pg/mL. 
The MDD was determined by adding two standard deviations to the mean optical 
density value of twenty zero standard replicates and calculating the corresponding 
concentration. This assay recognizes both recombinant and natural rat CINC-1. 
Several factors were prepared at 50 ng/mL in  Calibrator Diluent RD5-4 and assayed 
for cross-reactivity. No significant cross-reactivity or interference was observed 
Findings in this study 
Serum CINC levels in sham in comparison with RIPC+Sham and correlation 
with intravital findings of neutrophil adhesion and hepatocellular death and HO 
western blots. 
The serum levels of CINC are   more in RIPC+Sham. These may be due to low grade 
oxidative stress induced by RIPC in sham animals. This correlates with more 
neutrophil adhesion & hepatocellular death in RIPC+sham as compared to sham 
animals. Due to oxidative stress HO expression is more in RIPC+Sham.   
  220Serum CINC levels in hepatic IRI and correlation with intravital findings of 
neutrophil adhesion and hepatocellular death and HO western blots. 
The serum CINC levels in the early phase of hepatic IR were significantly higher 
compared to sham animals. Liang et al, 2000 have shown that CINC transcript 
expression in the liver peaks at 3 hours following hepatic IR and serum CINC levels 
peak at about 6 hours. Oxidative stress due to ROS results in increased NF-кB   
production and NF-кB    stimulates CINC production by kupffer cells. Increased 
CINC levels correlate with increased neutrophil adhesion and hepatocellular death in 
the early and late phase of hepatic IR. HO expression is less in IR compared to 
RIPC+IR. 
Effect of RIPC on CINC levels in hepatic IR and correlation with intravital 
findings of neutrophil adhesion, hepatocellular death (early and late phase).  
RIPC   reduced CINC in the early phase of hepatic IR and in the late phase of hepatic 
IR (24hrs) CINC levels are significantly inhibited following preconditioning. The 
serum CINC levels correlate with reduced neutrophil adhesion and hepatocellular 
death as well  suggesting modulation of CINC and neutrophil activation by RIPC in 
hepatic IR. This needs to be clarified in future studies. 
Effect of HO induction in IR and HO inhibition in RIPC+IR on CINC-1 levels    
and correlation with intravital findings of neutrophil adhesion and 
hepatocellular death and   HO western blots. 
RIPC   reduced CINC levels and PDTC (HO inducer) reproduced   the effects of 
RIPC in hepatic IR.  PDTC induced   HO correlated with   decreased neutrophil 
adhesion and   hepatocellular death and increased HO expression in liver tissue. 
Inhibition of HO by ZnPP in RIPC reduced hepatic HO expression, increased serum 
  221CINC levels, increased neutrophil adhesion and hepatocellular death suggesting the 
role of HO in modulation of CINC. 
 Does HO inhibit CINC? 
Our study demonstrates that HO induction  is associated with decreased neutrophil 
adhesion and serum CINC levels.Kubulus et al have shown that hemin arginate 
caused a profound increase in HO expression in the liver after 24 hours, decreased 
TNF-α, improved hepatic sinusoidal perfusion and protected hepatic microcirculation. 
H.P. Yu et al have shown that HO upregulation in proestrus rats significantly 
attenuates shock lung following trauma haemorrhage and reduces ICAM, CINC and 
MPO activity in lungs{Yu et al , 2006 } {Uchinami et al 2002}.   
Conclusion 
These data suggest that RIPC reduces serum CINC levels and decreases neutrophil 
activation in hepatic IR   and also the potential role of RIPC induced HO in 
modulating CINC & neutrophil activation.  
The next chapter focuses on investigating the role of HO in modulation of 
mitochondrial cytochrome c and apoptosis and whether or not HO inhibits release of 
mitochondrial cytochrome c. 
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phase of hepatic IR, modulation by RIPC and 
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  2239.1 Introduction  
 
What is the role of mitochondria in hepatic IRI? 
Recent studies have provided evidence for the role of mitochondria in both apoptosis 
and cellular necrosis (A elimadi, J. pharmacol.exp.ther. 286(1998). Mitochondria are 
the main source of intracellular ROS production which are produced excessively 
following reperfusion and damage mitochondrial membranes and proteins through 
lipid peroxidation. This peroxidation damages and increases the permeability of 
mitochondrial membrane leading to loss of mitochondrial integrity resulting in release 
of cytochrome c into cytoplasm and subsequent activation of caspase activity which 
initiates apoptotic cell death.  
Ischaemia leads to ATP depletion, loss of mitochondrial transmembrane potential 
which is associated with Ca
2+ overload and opening of mitochondrial membrane 
pores. The mitochondria then undergo rapid swelling and rupture due to osmotic 
effects eventually leading to cytochrome c release and caspase activation causing 
DNA fragmentation and apoptosis. 
Thus mitochondria are involved in both apoptotic and oncolytic necrosis pathways of 
IR injury. Neutrophils are the main source of extracellular ROS which are also 
responsible for cellular necrosis. 
Does RIPC induced HO -1 reduce mitochondrial membrane disruption and 
release of cytochrome C? 
Wang et al have demonstrated blood borne transferred preconditioning in an animal 
model of  explanted hearts from rabbits which were perfused  prior to non infarct 
cardioplegic arrest   with blood from rabbits whose hearts were preconditioned by 
RIPC. They showed rapid recovery of perfused hearts following non infarct   
cardioplegic arrest and reperfusion. Mitochondrial cytochrome c assessment showed   
  224decreased release of cytochrome c into cytosol in preconditioned animals suggesting 
the role of RIPC induced blood borne factors which induce preconditioning and 
modulate cytochrome c release. 
Does reperfusion cause   hepatocellular death through apoptosis or necrosis? 
Reperfusion causes release of reactive oxygen species which directly attack cellular 
molecules and indirectly promoting synthesis of pro-inflammatory mediators.  These 
effects lead to hepatocellular cell death which typically follows one of the two 
patterns: oncolytic necrosis and apoptosis. Oncolytic necrosis is caused by the direct  
effect of ROS and is characterised by loss of membrane integrity leading to swelling 
and rupture of cells which release their denatured cytoplasmic contents into plasma. 
These lead to a secondary inflammatory response and apoptotic cell death of 
surrounding cells. In addition to necrosis it is possible that cells sublethally damaged 
undergo programmed cell death i.e apoptosis. Eum et al demonstrated that hepatic IR 
caused periportal cell death by necrosis and pericentral cell death by apoptosis {Eum 
et al, 2007}.   
Aim 
The aim of this study was to investigate whether RIPC induced HO-1 inhibits 
mitochondrial cytochrome c release following ischaemia reperfusion injury (early 
phase). 
9.2 Material and methods 
 
Animals and surgical procedures 
As described in chapter 2, material and methods, pg 92. 
Tissue and Blood collection. 
As described in chapter two, material and methods, pg 105. 
Number of animals sampled 
  225Liver tissues were taken from all animals in the early phase of hepatic IR and late phase of IR.  
48 samples were processed for mitochondrial cytochrome c western blot. 
Experimental groups (n=6 in each group) 
Sham 
RIPC+SHAM 
Hepatic IR 
RIPC+IR 
PDTC+IR 
ZnPP+RIPC+IR 
IR-24 
RIPC+IR-24 
Western blot analysis for cytochrome C (early and late phase) 
This was carried out as described in chapter 2, material and methods, pg 114. 
Western blot for HO (early and late phase)as described in chapter 2, pg 108 
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9.3 Results 
Effect of RIPC in Sham on cytochrome c levels in comparison to Sham only animals  
There is no significant difference in mitochondrial   cytochrome c levels in sham animals and 
preconditioned shams. (Fig 9.1 ) 
Effect of hepatic IR (early phase) on mitochondrial cytochrome c release in comparison 
to sham. 
In the early phase of hepatic IR   the mitochondrial cytochrome c levels are lower compared 
to sham however the difference is not significant.(Fig 9.1 )  
Effect of RIPC+IR (early phase) on mitochondrial cytochrome c release. 
RIPC did not significantly   inhibit   release of mitochondrial cytochrome c in IR injury. (Fig 
9.1) 
Effect of HO induction in hepatic IR (early phase) on mitochondrial cytochrome c 
release 
PDTC induced HO did not significantly inhibit release of   mitochondrial cytochrome c   in 
hepatic IR.  (Fig 9.1) 
Effect of HO inhibition in RIPC+IR on mitochondrial cytochrome c release. 
Inhibition of HO did not significantly decrease in mitochondrial cytochrome c. (Fig 9.1) 
Sinusoidal perfusion in the early phase of hepatic IR, RIPC+IR, PDTC+IR, 
ZNPP+RIPC+IR, Sham and RIPC+Sham (Chapter 4). 
Sinusoidal perfusion was observed to be significantly low in hepatic IR and after HO 
inhibition in comparison to sham. After preconditioning and HO induction there was 
significant increase in sinusoidal perfusion.  
Haemoxygenase western blots in the early phase of hepatic IR, RIPC+IR, PDTC+IR, 
ZNPP+RIPC+IR, Sham and RIPC+Sham (Chapter 4). 
 (Chapter 4). 
  227HO expression in the liver was significantly more in RIPC+IR compared to IR. After HO 
inhibition there was a significant   decrease in HO liver expression.  
Effect of IR and RIPC on mitochondrial cytochrome c in the late phase of IR 
In the late phase   RIPC mean cytochrome c levels were higher in the mitochondria in IR 
injury compared to RIPC. This suggests that RIPC doe not modulate cytochrome c levels in 
the late phase of IR as well. 
Sinusoidal perfusion in the late phase of IR and RIPC+IR 
The sinusoidal perfusion is more in RIPC+IR as compared to IR only at 24 hrs of reperfusion 
(chapter 5). Hepatocellular death and neutrophil adhesion are significantly less in RIPC+IR. 
Haemoxygenase western blots in the late phase of IR and RIPC+IR 
HO-1 expression is significantly more in RIPC+IR-24 as compared to IR-24 only (chapter 
7). 
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Figure 9.2 - No significant difference in the mitochondrial cytochrome c levels between 
hepatic IR/RIPC+IR/ ZnPP+RIPC+IR.  
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Fig 9.4 Densitometry for cytochrome c late phase. 
Fig 9.4-   Mitochondrial cytochrome c   in IR injury at 24 hours was more than 
the RIPC- 24 samples except for one animal as shown above. This suggests that 
RIPC does not prevent release of mitochondrial cytochrome c   following hepatic 
reperfusion for 24 hrs. 
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The assay and variability. 
Variability in the assay can arise due to different methods of pipetting, dilution.These 
were minimised by using standard techniques of dilution, assays being done by the 
same person. 
Controls 
Rat lysate   was used as positive control. 
Cytochrome c release in Sham, comparison with RIPC+Sham and correlation 
with hepatocellular death, Sinusoidal, neutrophil adhesion on IVM 
There was no significant difference between mitochondrial cytochrome c levels 
between sham and RIPC+Sham. This correlates well with no significant difference 
seen in hepatocellular death and neutrophil adhesion observed by IVM between Sham 
and RIPC+Sham.  . 
Effect of IR on cytochrome c release, correlation with hepatocellular death by 
IVM, sinusoidal perfusion, neutrophil adhesion (early phase) 
This study has shown decreased mitochondrial cytochrome c in comparison to shams 
suggesting the release of cytochrome c into cytosol after IR. Reperfusion injury 
causes mitochondrial ROS generation, disruption of mitochondrial permeability and 
efflux of cytochrome c.  IVM showed increased hepatocellular death by propidium 
iodide staining. This cell death maybe secondary to apoptosis induced by cytochrome 
c release or due to oncolytic necrosis induced by ROS from neutrophils. Increased 
neutrophil adhesion and decreased sinusoidal perfusion on intravital microcopy 
suggest a prominent role for neutrophil induced endothelial injury. Decreased hepatic 
HO by western blot analysis in IR   in correlation with increased neutrophil adhesion 
and increased cell death would suggest a role for HO in protecting liver parenchyma 
  231by modulation of neutrophil function rather than modulation of cytochrome c release 
in the early phase of IR. 
Effect of RIPC on cytochrome c release in the early phase of IR and correlation 
with haemodynamics, neutrophil adhesion, apoptosis. 
RIPC does not significantly decrease   cytochrome c release from mitochondria in the 
early phase of IR. This does not correlate with decreased hepatocellular death seen on 
propidium iodide staining by intravital microscopy. There is a significant decrease in 
neutrophil adhesion in RIPC and   RIPC significantly improved sinusoidal flow and 
perfusion. In the early phase of hepatic IR oxidative stress leads to free radical release 
and cell injury.  Since RIPC reduces CINC hence it acts to reduce neutrophil 
activation and decrease release of ROS. Thus the main mechanism of cytotoxicity in 
the early phase is ROS generation and cell damage rather than mitochondrial release 
of   cytochrome c and activation of apoptosis.  
Hai et al showed that IR injury led to a significant increase in cytosol mitochondrial 
cytochrome c and activation of caspase 3 and increased translocation of Bax 
(proapoptotic proten) into the mitochondrial membrane promotes efflux of 
cytochrome c into the cytosol.  Hirakawa (JSR, 2003)   demonstrated the role of 
mitochondrial permeability pore resulting in increased cytosolic caspase 3 following 
reperfusion injury (Hirakawa, JSR). Hirakawa showed that cytosol cytochrome c 
appeared as early as 30 min after ischaemia and caspase 3 activity began to increase 
after 90 min. Soeda et al demonstrated the role of ROS after reperfusion in disruption 
of mitochondrial integrity and   cytochrome c release early into the cytosol {Soeda et 
al, 2001}.   
 
 
  232Effect of HO inhibition and HO induction on cytochrome c release and 
correlation with HO expression on western blots (early phase of IR).  
HO induction or inhibition did not significantly influence cytochrome c release from 
mitochondria. Increased HO was observed after HO induction  with PDTC   and RIPC 
induced HO in the liver by western blot analysis. This does not correlate with 
decreased cytochrome c release in our study suggesting that HO may not modulate 
Cytochrome c release from mitochondria in the early phase of hepatic IR. HO 
expression in the early phase of hepatic IR modulates CINC and neutrophil adhesion 
and hence influences release of ROS.  
Effect of IR on cytochrome c release, correlation with hepatocellular death by 
IVM, sinusoidal perfusion, neutrophil adhesion. 
IR injury the mitochondrial c levels were high. This did not correlate with the 
increased hepatocellular death, increased neutrophil adhesion and decreased perfusion 
observed by IVM. This suggests that cytochrome c pathway is unlikely to be of 
significance in late phase of hepatic IR and that free radicals   released from 
neutrophils are the key factors responsible for hepatocellular death.  
Effect of RIPC on cytochrome c release in the late phase of IR and correlation 
with haemodynamics, neutrophil adhesion, apoptosis, HO expression 
RIPC did not significantly modulate   mitochondrial cytochrome c levels although 
there was a significant decrease in  neutrophil adhesion, hepatocellular death and 
significant increase in hepatic HO expression suggesting that RIPC and HO modulate 
IR injury by modulation of neutrophil activation rather than the cytochrome c 
pathway. 
 
 
  233Conclusion 
RIPC in the early and late phase of hepatic IR reduces cell death due to oncolytic 
necrosis secondary to free radicals. RIPC does not modulate apoptosis (programmed 
cell death) in the early phase and the late phase of IR. 
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  23510.1   Chapter 1- Background literature 
This chapter has discussed the pathophysiology of hepatic IR, evidence for remote 
ischaemic preconditioning and potential mechanisms of preconditioning.  Review of 
experimental studies has clearly demonstrated that brief ischaemia of the heart, 
mesentery, kidney and limb conferred protection on remote organs. RIPC prior to IR   
of limbs, heart, liver and kidney conferred protection on these organs as demonstrated 
by these studies. Only one study by Kanoria et al demonstrated improved hepatic 
haemodynamics following brief RIPC of the hind limb and   Lai et al showed 
improved liver function. The studies reviewed have shown release of biochemical 
messengers such as cytokines, free radicals, opioids, NO which act either through the 
neurogenic or humoral pathway on the target organ. 
In RIPC of the liver Kanoria et al suggested the role of NO however there was no 
clear evidence of the mechanism in RIPC. Lai et al showed haemoxygenase 
expression in the liver following RIPC and reduced hepatic IR. This formed the basis 
of further investigation in this study. 
10.2 Chapter 2- Methodological considerations 
 Adequacy of model 
The experimental model used is a previously well described hepatic lobar ischaemia 
model of warm IR. In the model 45 minutes of partial ischaemia (70% of the liver) 
was induced followed by three hours of reperfusion (Koti et al). Intravital microscopy 
has shown that IRI significantly reduced velocity of flow and perfusion as compared 
to sham animals (Menger et al). Therefore the model was considered suitable to study 
the effects of RIPC.  
 
  236Transplant vs partial hepatic IR model, global IR vs lobar IR. 
Since this study was limited to investigating the effects of warm IR and the effects of 
RIPC in warm IR a partial hepatic IR model was chosen as against a transplant model.  
Global hepatic IR would result in congestion of   intestine and   release of cytokines 
resulting in confounding results. To avoid this  a portosystemic shunt is needed in a 
global IR model however this was not done in our study. 
Technique of preconditioning and its adequacy. 
RIPC was produced using a tourniquet around the Hind limb for four cycles of five 
minute ischaemia followed by reperfusion.  This technique of RIPC has previously 
been used in the modulation of cardiac IR injury following transplantation 
(Kristiansen et al). Three or more cycles of preconditioning have been shown to be 
more effective than a single cycle in previous experimental studies (Addison et al, 
Kristiansen et al ) and this formed the basis for four cycles of RIPC used in the 
current study. Preliminary experiments demonstrated a significant effect of four 
cycles of RIPC on hepatic IR and hence the number of   preconditioning cycles was 
considered optimal. 
Correlation of the model with other animal models and human IR 
The rat was selected as the experimental animal due to its resistance to surgical 
trauma and infection, the advantage of size and the liver microvascular anatomy 
which makes the technical procedure possible, compared with other laboratory 
animals; the availability and the relative economy of maintenance. Sprague Dawley is 
a very docile outbred albino rat (Rattus norvergicus), originated in Madison, 
Wisconsin in 1925, by R. Dawley. The original colony was closed shortly after its 
development and no new stock has been introduced since then, producing stable 
colonies which are descended directly from the original stock.  
  237The rat model of hepatic ischaemia and reperfusion is a useful procedure for the study 
of the local and systemic effects of ischaemia and reperfusion injury. This model 
offers a well defined volume of tissue that can be easily rendered ischaemic with 
insignificant alteration of systemic haemodynamics. 
 In vivo fluorescent microscopy 
 In vivo microscopy of the liver allows assessment of the hepatic microvascular 
perfusion, the analysis of dynamic processes such as changes in diameters of blood 
vessels, interactions between leukocytes and endothelium. 
For the purposes of in vivo microscopic assessments, a plane organ surface is 
necessary to provide clear and sharp images without inducing trauma to the tissue 
under the objective. The anaesthetized animals were placed on the stage of a Nikon 
custom built microscope (Nikon, Japan) with an integrated heating system where the 
temperature was maintained at 37˚C. The whole set up was placed on a pneumatic 
vibration isolation workstation (Newport, USA) to minimise vibration. The liver was 
exteriorised by adequate mobilisation and division of the hepatic ligaments and 
mounted on a plane glass surface. The liver was continuously irrigated with saline to 
wet the surface of the liver and prevent drying as dryness of the liver would aggravate 
hepatic ischaemia. This procedure was easily tolerated by the animals and allowed the 
tissue to be exteriorized with a minimum of trauma. This method of exteriorisation of 
the liver also eliminated the respiratory movements in the tissue. During the 
experiments, the animal’s abdomen was covered with a plastic wrap (Saran wrap®, 
Dow Chemical, Michigan, USA) to prevent fluid evaporation. The liver was carefully 
handled, as mechanical trauma induces disturbances in microcirculation.  In order to 
obtain clear images, it was necessary to match the concentration of fluorescent dyes 
with the filter systems, the light intensity and the magnification. 
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 Blood levels of intracellular enzymes are a way of estimating tissue damage: tissue or 
organ specific enzyme levels provide valuable information about related tissues. 
Transaminases released from the damaged liver during ischaemia enter the circulation 
during reperfusion and their blood levels increase. ALT and AST are indicators of 
major alterations of liver integrity, and were utilized in this study as a marker of 
hepatocellular injury. 
10.3 Effect of RIPC on hepatic IR in a rat model of warm hepatic IR.(Chapter 3) 
Remote ischaemic preconditioning modulated hepatic microcirculation leading to 
increased red blood cell velocity (i.e. blood flow), sinusoidal flow, sinusoidal 
perfusion and decreased leukocyte- endothelial interaction as well cell death. There 
have been no previous studies which have demonstrated these findings.  
Histology 
Light microscopy examination allows excellent appraisal of degree of tissue injury. In 
the liver the end points of necrosis, vacuolation, sinusoidal congestion and neutrophil 
infiltration were chosen as histologic markers, realising that more detailed 
ultrastructural studies may be useful either to confirm or to explain histological 
findings in some cases. In this study, clear differences were found between groups, 
and histology was of great help to understand the nature of ischaemic injury. An 
objective scoring system using modified Suzuki’s criteria was used to assess 
histological changes in the early phase of hepatic IR. 
10.4 Effect of HO-1 inhibition on RIPC in hepatic IR and HO-1 induction in 
hepatic IR. (Chapter 4) 
RIPC was associated with an increase in hepatic haemoxygenase production and 
protection of liver function.The administration of HO-1 inducer Pyrrolidine 
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perfusion, flow, improved red blood cell velocity and attenuated leukocyte-
endothelial interactions. Pyrrolidine dithiocarbamate administration was associated 
with increased expression of HO-1.The administration of Zinc Protoporphyrin (HO-1 
inhibitor) abolished the protective effect of remote ischaemic preconditioning strongly 
suggesting the role of  haemoxygenase in modulation of hepatic microcirculation. 
10.5 New insights into the late phase of hepatic IR (Chapter 5) 
Intravital microscopy in a real time manner has provided new insights into the  
modulation of the late phase of  hepatic IR  by remote ischaemic preconditioning. The 
data clearly demonstrates that RIPC modulates sinusoidal perfusion,   neutrophil 
adhesion and hepatocyte death in hepatic IR after 24 hours of reperfusion. There is 
evidence of sinusoidal dilatation seen in the late phase of RIPC in contrast to the early 
phase. These effects are associated with better liver function and significantly 
increased haemoxygenase expression in the liver in preconditioned animals.  
10.6 Haem Oxygenase studies (Chapter 6&7) Immunohistochemistry and W 
blots. 
In this study HO estimations were used as marker of HO production and to affirm the 
response to pharmacological manipulation with Pyrrolidine dithiocarbamate and Zinc 
Protoporphyrin. The expression of haemoxygenase and its cellular distribution was 
assessed by immunohistochemistry using polyclonal primary and monoclonal 
seconday antibodies. Immunohistochemistry demonstrated HO-1 expression in 
Kupffer cells in the early phase of IR following RIPC and in parenchymal cells as 
well as kupffer cells in the the late phase of hepatic IR. The limitation of 
immunohistochemistry is lack of quantification. 
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expression in this study and western blotting showed increased expression of HO-1 in 
preconditioned animals and PDTC induced HO-1 groups in the early phase and in the 
late phase of hepatic IR. Inhibition of HO showed decreased  HO expression in the 
ZnPP group. 
Polyclonal antibodies against the specific HO isoforms are commercially available   
and can identify the isoforms on tissues sections and these were used for western 
blotting in this study. A limitation of molecular biology techniques is that they only 
indicate the presence of protein and as such may indicate synthesis of new protein but 
these techniques do not give an indication of protein phosphorylation and therefore 
activity. The other option is to use enzyme phosphorylation assays, but these are 
indirect measurements and again do not help in establishing a direct link between 
protein and enzymatic HO. In theory, a combination of specific HO isoform genetic 
knockout model and molecular biology techniques would give a better understanding 
of HO-1 activity in a given setting.    
10.7 Cytokine studies (Chapter 8)  
Cytokine induced neutrophil chemoattractant (CINC-1) which is secreted by kupffer cells 
induces activation of neutrophils in IR injury. CINC belongs to the IL-8 cytokine family 
which mediates the recruitment of neutrophils into sites of inflammation. Quantification of 
CINC-1 by elisa is a well described technique (Nakagawa et al). A sensitive enzyme–linked 
immunosorbent assay for rat CINC using biotin-conjugated anti-CINC rabbit immunoglobulin 
has been established. The biotin-streptavidin sandwich enxyme-linked immunosorbent assay 
detects CINC at concentrations of 3 pg/ml to 30ng/ml.The significantly decreased CINC 
following RIPC and decreased neutrophil endothelial interaction observed in intravital 
microscopy suggests modulation of neutrophil activation by RIPC.  RIPC modulated  
neutrophil activation and neutrophil endothelial interaction through inhibition of CINC and 
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in this study. 
10.8. Cytochrome c mitochondrial apoptosis (chapter 9) 
Western blot analysis for mitochondrial cytochrome c in hepatic IR and RIPC+IR  
 did not show any significant difference between the two groups following reperfusion 
injury. Haemoxygenase inhibition or induction did not demonstrate any effect on 
mitochondrial cytochrome c levels in the early phase of hepatic IR. These data 
suggest that RIPC does not modulate release of mitochondrial cytochrome c and 
activation of the mitochondrial apoptotic pathway in the early and late phase of 
hepatic IR. Haemoxygenase induction or inhibition does not appear to have an effect 
on mitochondrial cytochrome c activation in early IR. This can be explained by the 
fact that in the early phase necrosis is predominantly responsible for cell death as 
against apoptosis.  
Observations on Sinusoidal dilatation 
Ischaemia reperfusion injury is known to cause sinusoidal constriction due to 
endothelial injury and effects of endothelin.  Our observations did not show any 
change in sinusoidal diameter compared to shams which was an unexpected finding. 
The extent of   endothelial neutrophil adhesion and hepatocellular death was 
significantly more in IR injury in the early and late phase suggesting that the model 
was appropriate for the study. RIPC did not induce any change in sinusoidal diameter 
since HO-1 expression was mainly seen in the Kupffer cells in response to oxidative 
stress.  PDTC did not cause any sinusoidal dilatation. The dose chosen for PDTC in 
our study was 100mg/kg. Hata et al have shown that PDTC at doses of 150mg/kg or 
higher induces sinusoidal dilatation and the dilatation is proportional to PDTC dosage. 
They explained that PDTC at higher doses induced parenchymal HO-1 expression 
which led to release of CO into the space of disse and CO induced sinusoidal 
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animals suggesting that RIPC induced HO in the early phase of hepatic IR  primarily 
has anti-inflammatory effects.  In our study there was increased   parenchymal   HO 
expression in the late phase of RIPC and there was significant sinusoidal dilatation in 
comparison to IR injury. Goda et al have also shown that expression of constitutive 
HO (HO-2) in parenchymal cells   is responsible for inducing sinusoidal dilatation. 
Future studies would need to investigate parenchymal HO expression and the 
subtypes of HO expressed in parenchymal cells in the early and late phase of hepatic 
IR following RIPC. 
Overall conclusions arising from the thesis . 
The results of the study have been discussed in detail in each chapter detailing the 
experiments (Chapters 3 to 9).The above conclusions support the hypothesis 
presented in this study and strongly suggest a role for HO-1 in the protection 
conferred by RIPC in early and late phase of ischaemia reperfusion induced hepatic 
injury. Although the technique of   RIPC is simple and easily applicable there are 
concerns about increased operative time (due to period of time involving brief 
ischaemia and reperfusion) which may not be tolerated well in many operating 
theatres. However this limitation can be overcome by commencing preconditioning 
from the time the patient is anaesthetized to the time a laparotomy incision is made. 
Finally, although current research on the mechanisms of preconditioning seems to 
diverge more and more, it is possible that all these mechanisms converge into an 
unidentified final common pathway. This conclusion is based on the belief that a  
powerful adaptive phenomenon that is induced so easily and reproducibly in different 
models, laboratories, and species is almost certain to be mediated by a  universal 
mechanism. The data from this study suggests that haeme oxygenase is the candidate 
  243molecule in remote ischaemic preconditioning of the liver and is   likely to be central 
to the universal mechanism. 
Clinical application of RIPC/ IPC and the wider implications of this work. 
IPC trials in liver IR.  
Rela et al ( transplantation 2006) showed that 10 min of clamping of the hepatic 
pedicle prior to retrieval led to significantly lower hepatic injury in donor livers , 
decreased serum lactate, neutrophilic infiltration in preconditioned livers and also 
decreased ITU stay. This trial showed a beneficial effect for ischaemic 
preconditioning. Recent Cochrane review by Kurinchi et al showed no evidence to 
support or refute the use of ischaemic preconditioning in hepatic transplantation. This 
review showed no difference in mortality, primary graft function or delayed graft 
function {Kurinchi et al, Cochrane 2007). Pharmacological preconditioning 
particularly with agents inducing NO has shown some promise recently. During liver 
transplantation patients were exposed to inhale a high but non toxic dose of nitric 
oxide (80 ppm). Inhaled NO improved serum transaminase and coagulation times and 
reduced hepatocyte apoptosis and hospital stay {Lang et al, J Clin Inv 2007}.  
Potential clinical applications of RIPC . 
There have been no published clinical trials investigating modulation of ischaemia 
reperfusion injury of the liver by remote ischaemic preconditioning. The first clinical 
trial evaluating effects of RIPC has been in children undergoing cardiac surgery  and 
this study demonstrated that RIPC significantly reduced trop I levels, peak airway 
resistance and inotrope requirements in patiens compared to those who were not 
preconditioned. The patients were preconditioned by four cycles of 5 min ischaemia 
and 5 min of reperfusion {Cheung et al, 2007}.  In another recent study RIPC reduced  
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et al,  Heart 2009}. 
This study has demonstrated that preconditioning of livers prior to hepatic IR  
conferred protection of hepatic microvasculature and flow. However preconditioning 
shams induced a low grade oxidative stress and reduced flow transiently in normal 
livers. These data suggest that preconditioning recipients may   lead to free radicals 
damaging normal  organs in the recipient and causing  organ failure and eventually 
death. In contrast preconditioning donors would protect the donor organ from IR 
without causing   injury to normal organs in the recipient.   
Amersi et al showed that   inducing HO-1 through adenovirus HO-1 gene transfer in 
genetically fat zucker rats significantly reduced hepatic IR after explantation and 
reimplantation. Also Koito et al have shown that cold preservation injury due to 
sinusoidal endothelial ell injury is reduced after pre-treatment with HO-1 inducers. 
These data suggest that preconditioning prior to  retrieval may reduce hepatic 
ischaemia reperfusion injury significantly and enhance organ usage. 
Future plans 
Knock out models 
Further studies need to be taken up in HO-1 knockout mice models to pinpoint the 
definitive role of HO-1 in RIPC in hepatic IR. The   use of small interfering RNA 
sRNA which specifically inhibit HO-1 pathways would also be useful in investigating 
the role of HO-1 in hepatic IR. ZnPP is both toxic and a non-specific inhibitior of HO 
as it inhibits both HO-1 and HO-2. This limits its role in investigating HO-1 pathways 
in preconditioning.  
Effect of HO on endothelial function 
  245 The effect of HO on endothelial function would need to be demonstrated in 
experimental models. This study has shown RIPC induced   increased parenchymal 
expression of HO in the late phase of hepatic IR   which led to increased sinusoidal 
dilatation.  It has been suggested by Goda et al that this is due to increased CO 
production by HO-1 or HO-2 expression in parenchmal cells. In the early phase HO-1 
was primarily expressed in kupffer cells in response to oxidative stress. Hence it did 
not cause sinusoidal dilatation . Hata et al have shown increased doses of PDTC to 
induce HO-1 and  sinusoidal dilatation in the early phase of hepatic IR. The effect of 
HO-1 on endothelial adhesion molecules and endothelin which is a sinusoidal 
constrictor and has been shown to cause sinusoidal constriction   in hepatic IR  will 
need to be investigated in future experimental studies. 
Future therapeutic regimes. 
PDTC and its limitations in humans. 
There have been no   satisfactory drugs which have been developed to induce HO-1 in 
the human liver and modulate ischaemia reperfusion injury. PDTC is extremely toxic 
and cant be used in humans.  
Clinical trials 
RIPC would need to be taken up in clinical trials in patients undergoing liver resection 
and liver transplant. Preconditioning of heart beating donors would lead to an 
increased donor pool of organs and also reduce  ischaemia reperfusion injury in the 
grafts thus reducing patient morbidity , mortality and costs in patient care.  
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Appendix – abstracts and publications arising from the thesis 
 
Abstracts 
 
1. Title-Remote ischemic preconditioning modulates hepatic microcirculation to 
ameliorate hepatic ischaemia reperfusion injury in a rat model. 
 
N.Tapuria, S.P.Junnarkar, Wenxuan Yang, A. Seifalian, B.R.Davidson. 
 
Introduction- Liver resection and transplantation surgery involve a period of 
ischaemia reperfusion injury (IRI) which initiates an inflammatory cascade resulting 
in hepatic and remote organ injury. It has been established that remote ischemic   
preconditioning (RIPC) protects the liver.RIPC entails brief periods of limb ischaemia 
followed by reperfusion. The effect of RIPC on the hepatic microcirculation has not 
been studied previously. 
 
Hypothesis-RIPC would protect the liver from ischaemia reperfusion injury by 
modulation of hepatic microcirculation. 
 
Aim-To use a well described model of ischaemia reperfusion injury to study the effect 
of RIPC on hepatic microcirculation under intravital microscopy. 
 
Material and methods-The effect of RIPC was studied in a rat model of ischaemia 
reperfusion injury with 45 minutes of partial liver ischaemia(70%) followed by 3 
hours of reperfusion. Three groups of animals namely Sham, IRI and RIPC +IRI were 
studied with six animals in each group .Hepatic microcirculation was assessed by 
studying velocity of blood flow and sinusoidal perfusion and apoptosis was assessed 
by propidium iodide staining under intravital microscopy. 
 
Results-. The velocity of blood flow was significantly better in the RIPC group at the 
end of three hours of reperfusion compared to IRI group (P<0.05) but no difference 
was found between RIPC and Sham. Sinusoidal perfusion was better in the RIPC 
group. The number of apoptotic cells in the RIPC group was significantly less as 
compared to IRI only (P<0.05). 
 
Conclusions-RIPC protects the liver from IRI by modulation of hepatic 
microcirculation. 
 
 
Abstract published in the HPB sep 2006 supplement. 
 
 
  2622. Title- Remote ischemic preconditioning modulates hepatic microcirculation 
through the hemeoxygenase pathway in a rat model of warm ischaemia 
reperfusion injury of the liver. 
 
N.Tapuria, S.P.Junnarkar, Neelanjana Dutt, Barry Fuller, A. Seifalian, B.R.Davidson. 
 
Introduction- Liver resection and transplantation surgery involve a period of ischaemia 
reperfusion injury (IRI) which initiates an inflammatory cascade resulting in hepatic and 
remote organ injury.  IRI leads to nonfunction or dysfunction of liver grafts in clinical 
transplant settings. Davidson’s group at the Royal Free have shown that remote ischemic   
preconditioning (RIPC) protects liver function. However the mechanism of protection has not 
been studied. This is the first study under intravital microscopy to investigate the effect of 
remote ischemic preconditioning upon hepatic microcirculation and the role of 
hemeoxygenase pathways as a candidate mechanism. 
Aim-To   study the role of hemeoxygenase pathways in RIPC as the candidate mechanism in 
the modulation of hepatic microcirculation in a rat model of hepatic IRI. 
Material and methods-The effect of RIPC was studied in a rat model of ischaemia 
reperfusion injury with 45 minutes of partial liver ischaemia(70%) followed by 3 hours of 
reperfusion. Five groups of animals namely Sham, IRI and RIPC +IRI , RIPC+Sham, PDTC 
(HO donor)+IRI, ZNPP(HO blocker)+RIPC+IRI were studied with six animals in each group 
.Hepatic microcirculation was assessed by studying velocity of blood flow , sinusoidal 
perfusion , sinusoidal flow, sinusoidal diameter  and neutrophil adhesion . Apoptosis was 
assessed by propidium iodide staining under intravital microscopy. Liver functions were 
assessed in all groups. 
Results- The velocity of blood flow was significantly better in the RIPC group at the end of 
three hours of reperfusion compared to IRI group (P<0.05) but no difference was found 
between RIPC and Sham. Sinusoidal perfusion and flow was better in the RIPC group. The 
number of apoptotic cells in the RIPC group was significantly less as compared to IRI only 
(P<0.05). The PDTC group (HO Donor) showed significantly improved liver functions 
compared of IRI and ZNPP groups. ZNPP significantly blocked the effects of RIPC on the 
microcirculation at about two hours of reperfusion strongly suggesting the role of HO-1 
pathways in RIPC mediated amelioration of hepatic IR injury. 
Conclusions- This is the first study to demonstrate that RIPC modulates hepatic 
microcirculation in order to ameliorate IRI and hemeoxygenase pathways are one of the key 
pathways in the mechanism of RIPC. 
Abstract published in the IHPBA supplement of the American chapter of HPB  April 
2007. 
  2633. NEW INSIGHTS INTO PROTECTION OF HEPATIC FUNCTION BY 
REMOTE ISCHEMIC LIMB PRECONDITIONING IN THE LATE PHASE 
OF HEPATIC ISCHEMIA REPERFUSION INJURY. 
Tapuria, Niteen; Junnarkar, Sameer; Fuller, Barry; Seifalian, Alexander M; 
Davidson,Brian 
Royal Free Hospital, HPB & Liver transplant surgery, London, United Kingdom 
 
BACKGROUND: Ischemia reperfusion injury (IRI) may lead to nonfunction or dysfunction 
of transplanted liver grafts. At the Royal Free (UK) experimental studies by intravital 
microscopy have demonstrated that remote ischemic limb preconditioning (RIPC)modulates 
hepatic microcirculation by increasing RBC velocity, sinusoidal flow, sinusoidal perfusion 
and decreasing neutrophil adhesion as well as apoptosis to protect liver function in the early 
phase of hepatic reperfusion injury. This is the first study to focus on the role of RIPC in 
protection of hepatic function in the late phase of reperfusion injury. AIM: To investigate the 
effect of RIPC on late phase of reperfusion injury in an animal model of 24 hour hepatic 
ischemia reperfusion injury. MATERIAL AND METHODS:A rat model of IRI with 45 
minutes of partial liver ischemia (70%) followed by 24 hours of reperfusion was used for this 
study. Twoanimal groups studied included IRI-24 and RIPC+IR-24. The animals were 
preconditioned by 4 cycles of right hind limb ischemia(5minutes), reperfusion (5 minutes) 
prior to ischemia. Hepatic microcirculation was assessed by studying velocity of RBC 
flow,sinusoidal perfusion, sinusoidal flow and sinusoidal diameter under intravital 
microscopy. The number of neutrophils adherent toendothelium/mm2 and the numbers of 
stained apoptotic cells/HPF were assessed by intravital microscopy. Liver functions 
wereassessed. RESULTS: There was no significant difference in the RBC velocity, 
sinusoidal flow or sinusoidal diameter between the IR-24 and RIPC+IR-24 groups. Sinusoidal 
perfusion was significantly better in the RIPC+IR-24 group. Neutrophil adhesion and 
apoptosis were significantly reduced and liver functions were significantly better in the RIPC 
group. CONCLUSION: Modulation of hepatic microcirculation and neutrophil activation by 
RIPC in the late phase of hepatic IR is a key mechanism in protection of liverfunction. The 
role of modulation of neutrophil activation to prolong graft survival needs further 
investigation 
Abstract published in IHPBA   supplement 2008. 
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Ischemia Reperfusion Injury—A Review
Niteen Tapuria, M.S., F.R.C.S., Yogesh Kumar, M.S., M.R.C.S., Meer Mohammad Habib, M.Sc., F.R.C.S.,
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Background. Restoration of blood supply to an organ
after a critical period of ischemia results in parenchy-
mal injury and dysfunction of the organ referred to as
reperfusion injury. Ischemia reperfusion injury is often
seen in organ transplants, major organ resections and in
shock. Ischemic preconditioning (IPC) is an adapta-
tional response of brieﬂy ischemic tissues which serves
to protect against subsequent prolonged ischemic in-
sults and reperfusion injury. Ischemic preconditioning
can be mechanical or pharmacological. Direct mechani-
cal preconditioning in which the target organ is exposed
to brief ischemia prior to prolonged ischemia has the
beneﬁt of reducing ischemia-reperfusion injury (IRI)
but its main disadvantage is trauma to major vessels and
stress to the target organ. Remote (inter organ) precon-
ditioning is a recent observation in which brief ischemia
of one organ has been shown to confer protection on
distant organs without direct stress to the organ. Aim:
To discuss the evidence for remote IPC (RIPC), under-
lying mechanisms and possible clinical applications of
RIPC.
Methods of search. A Pubmed search with the key-
words “ischemic preconditioning,” “remote precondi-
tioning,” “remote ischemic preconditioning,” and
“ischemia reperfusion” was done. All articles on re-
mote preconditioning up to September 2006 have been
reviewed. Relevant reference articles from within
these have been selected for further discussion.
Results. Experimental studies have demonstrated
that the heart, liver, lung, intestine, brain, kidney and
limbs are capable of producing remote preconditioning
when subjected to brief IR. Remote intra-organ precon-
ditioning was ﬁrst described in the heart where brief
ischemia in one territory led to protection in other ar-
eas. Translation of RIPC to clinical application has been
demonstrated by the use of brief forearm ischemia in
preconditioning the heart prior to coronary bypass and
in reducing endothelial dysfunction of the contra lateral
limb. Recently protection of the heart has been demon-
strated by remote hind limb preconditioning in children
who underwent surgery on cardiopulmonary bypass for
congenital heart disease. The RIPC stimulus presum-
ably induces release of biochemical messengers which
act either by the bloodstream or by the neurogenic path-
way resulting in reduced oxidative stress and preserva-
tion of mitochondrial function. Studies have demon-
strated endothelial NO, Free radicals, Kinases, Opioids,
Catecholamines and KATP channels as the candidate
mechanism in remote preconditioning. Experiments
have shown suppression of proinﬂammatory genes, ex-
pression of antioxidant genes and modulation of gene
expression by RIPC as a novel method of IRI injury
prevention.
Conclusion. There is strong evidence to support
RIPC. The underlying mechanisms and pathways
need further clariﬁcation. The effective use of RIPC
needs to be investigated in clinical settings. © 2008
Elsevier Inc. All rights reserved.
Key words: Ischemic preconditioning; remote pre-
conditioning; remote ischemic preconditioning; ische-
mia reperfusion.
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The restoration of blood supply to organs after a
certain period of no ﬂow ischemia results in parenchy-
mal damage referred to as ischemia-reperfusion injury
(IRI). The critical ischemia period is dependent on the
organ and is 15–20 min [1] in the liver and kidney,
2.5 h in skeletal muscle [2–4], whereas in the brain
ischemia for more than 5 min, leads to considerable
neuronal death and infarction. Reperfusion following
periods exceeding the critical ischemia period results
in endothelial and parenchymal injury. The liver is
resilient to hypoxic injury. Low-ﬂow ischemia found in
hemorrhagic shock (mean arterial pressure [MAP]-40
mmHg for 120 min) followed by restoration of normal
ﬂow does not lead to activation of Kupffer cells, gener-
ation of free radicals and associated IRI in the initial
resuscitation period [1]. This is because most Kupffer
cells are located in the periportal region and hemor-
rhagic shock is characterized by ischemia in the peri-
central regions with sinusoidal perfusion failure in the
periportal region as a result of which Kupffer cells are
not affected by pericentral hypoxia.
Pathophysiology of IRI (Fig. 1)
Following a period of ischemia, tissues adapt to an-
aerobic metabolism [5]. Restoration of blood supply
results in oxygen supply in excess of the requirements
that lead to activation of macrophages in the vascula-
ture and consequently generation of super oxide radi-
cals, also referred to as reactive oxygen species (ROS),
causing oxidative stress. The key event in the initial
phase of reperfusion injury is activation of macro-
phages that are the primary source of extracellular
ROS. ROS are the key initiators of reperfusion injury,
which leads to endothelial injury and further release of
pro-inﬂammatory cytokines. Thus neutrophils are the
key cells in the late phase of IRI.
The Clinical Relevance of IRI
IRI often happens following transplantation of or-
gans, major organ resections, and trauma. IRI follow-
ing transplantation can lead to primary nonfunction of
the implanted organ (5%), primary dysfunction (10–
30%), and also multiple organ dysfunction syndrome,
resulting in morbidity and mortality in adult and pe-
diatric transplants [6–8]. In hypervolemic shock resus-
citation leads to IRI in brain, gut, and pancreas [9],
which results in more extensive tissue infarction. In
the liver shock resuscitation reduces its tolerance to
subsequent warm ischemia [10]. In major organ resec-
tions inﬂow occlusion [11] and subsequent restoration
of blood supply causes reperfusion injury. This can lead
to postoperative organ insufﬁciency. Ischemia reperfu-
sion injury is also associated with chronic rejection due
to arteriosclerosis [12] caused by IRI. IRI results in
adipocutaneous and musculoskeletal ﬂap necrosis as
well as nonfunctioning microvascular ﬂaps.
IPC
Protective strategies have been developed for protec-
tion of organs from ischemia reperfusion injury, which
are referred to as organ preconditioning. IPC is only a
method by which the target organ is conditioned prior
to the ischemic insult to reduce the extent of injury.
IPC could be mechanical or pharmacological. Mechan-
ical preconditioning is either direct or remote (indi-
rect). In IPC a brief direct ischemic insult to the target
organ followed by reperfusion results in tolerance to
subsequent insults of ischemia. Ischemic tolerance is
induced by regulation of endothelial function, blood
ﬂow, and decreased macrophage as well as neutrophilic
activity. This results in decreased endothelial injury
and eventually decreased parenchymal injury. Direct
IPC has been investigated as a surgical tool for many
years [13]. Although direct IPC does reduce reperfu-
sion injury [14–16] as well as its systemic conse-
quences [17, 18], its main disadvantage is direct stress
to the target organ and mechanical trauma to major
vascular structures, which have limited its clinical ap-
plication.
Remote ischemic preconditioning (RIPC) is a novel
method where ischemia followed by reperfusion of one
organ is believed to protect remote organs either due to
release of biochemical messengers in the circulation or
activation of nerve pathways, resulting in release of
messengers that have a protective effect. This protects
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FIG. 1. Diagramatic representation of ischemia reperfusion
injury. (Color version of ﬁgure is available online.)
305 TAPURIA ET AL: REMOTE ISCHEMIC PRECONDITIONINGtarget tissue without direct stress. RIPC was ﬁrst dem-
onstrated in myocardium [19] by McClanahan in 1993.
He found that ischemia in the kidney followed by
reperfusion protected myocardium from ischemia and
reduced infarct size. In animal models brief ischemia
reperfusion of the limb, gut, mesenteric, or kidney re-
duces myocardial infarct size. In humans skeletal pre-
conditioning has been used for myocardial protection
with the beneﬁcial effect being attributed to regulation
of endothelial protection [20].
Aim
The aim of this article was to discuss the evidence for
existence of remote preconditioning, the underlying
mechanisms and pathways in different methods of re-
mote preconditioning, the mediators of precondition-
ing, and the possible clinical applications of remote
preconditioning.
Methods of Search
A PubMed search with the keywords “ischemic pre-
conditioning,” “remote preconditioning,” and “remote
ischemic preconditioning” and “ischemia reperfusion”
was done. All articles on remote preconditioning up to
September 2006 have been reviewed. Relevant refer-
ence articles from within these have been selected for
further discussion.
Evidence for RIPC
Intracardiac Regional Preconditioning (Table 1)
The very ﬁrst evidence of RIPC can be traced to 1993
when Przyklenk conducted regional myocardial pre-
conditioning in an experimental dog model [21]. In this
model the circumﬂex coronary artery was occluded four
times for 5 min followed by 5 min reperfusion prior to 1 h
of sustained left anterior descending coronary artery oc-
clusion. A signiﬁcant reduction in myocardial infarct size
was seen as compared to non-preconditioned groups. Na-
kano et al. questioned the existence of RIPC as in an
experimental Langendorff model they showed two cycles
of 5 min occlusion of a branch of coronary artery fol-
lowed by reperfusion (5 min) prior to global cardiac
ischemia protected the myocardium supplied by the
arterial branch but not the rest of the myocardium
against sustained ischemia [21, 22]. However, their
experiments were in a rabbit model and they used a
different preconditioning protocol. Moreover, their ar-
gument is not supported by any other studies. Hence
evidence for nonexistence of RIPC in other species can-
not be concluded from their study.
TABLE 1
Studies on Intraorgan Regional Preconditioning
Author/reference
Site of
preconditioning
stimulus
Site of index
ischemia Model Endpoint Organ protection Proposed mechanism
Intracardiac
preconditioning
Przyklenk et al. [21] Circumﬂex occlusion Lad occlusion Dog Infarct size Reduced infarct size Not identiﬁed
Nakano et al. [22] Cardiac ischemia Total LV:global
ischemia
Rabbit Infarct size Reduced infarct size Not applicable
Tanaka et al. [131] Cardiac ischemia Remote myocardial
preconditioning
Rabbit Infarct size Reduced infarct size Heat shock proteins
Gho et al. [26] Cardiac ischemia Cardiac ischemia Rat Infarct size Reduced infarct size ?Neurogenic pathway,
?humoral
TABLE 2
Studies on RIPC by Brief Cerebral Ischemia
Author/reference
Site of
preconditioning
stimulus
Site of index
ischemia Model Endpoint
Organ
protection Proposed mechanism
Preconditioning by
cerebral ischemia
Tokuno et al. [23] Cerebral ischemia Cardiac ischemia Mouse isolated
heart
Infarct size Reduced infarct
size
iNOS and NO
de Zeeuw et al. [119] Cerebral ischemia Cardiac ischemia Pig Infarct size No change in
infarct size
Norepinephrine
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RIPC is not conﬁned to within an organ and can be
transferred from one organ to another.
The Effect of Cerebral Ischemia on the Heart (Table 2)
Spontaneous ischemic events in the brain have been
shown to induce adaptation of the heart to ischemia [23]
and Tokuno et al. were the ﬁrst to demonstrate in a
mouse model decreased myocardial infarction and im-
proved myocardial function in mice by prior brain ische-
mia (bilateral internal carotid ligation) with no evidence
of brain damage except for transient neurological pat-
terns [23]. Importantly, this study demonstrated that
ischemia rather than reperfusion stimulated signaling
pathways, which led to remote protection.
The Effect of Renal Ischemia on Remote Organs (Table 3)
Five studies showed that brief renal ischemia re-
duced the size of infarct resulting from myocardial
ischemia [24–28]. The ﬁrst evidence of RIPC dates
back to 1993 when McClanahan carried out experi-
ments on a rabbit model and showed that a 10 min
period of renal ischemia was as effective asa5m i n
period of coronary artery occlusion in preconditioning
the heart [19]. In 1996, Gho et al. [26] showed that brief
periods of mesenteric artery occlusion (MAO) (15 min)
and reperfusion prior to 60 min coronary artery occlu-
sion (CAO) was as effective as direct CAO and 15 min
renal artery occlusion (RAO) prior to 60 min CAO
reduced infarct size under hypothermic conditions but
not normothermic conditions, demonstrating the un-
masking of effects of RAO by hypothermia. The onset of
myocyte injury is associated with adenosine triphos-
phate (ATP) depletion and breaks in sarcolemmas,
which are linked to intracellular acidosis and raised
phosphocreatinine levels. Takoaka et al. showed by
nuclear magnetic resonance spectroscopy that RAO
(10 min) followed by reperfusion (20 min) in rabbits led
to a decrease in myocardial infarct size on histology,
attenuated depletion of ATP, preserved myocyte pH,
and improved recovery of myocardial phosphocreati-
nine as well as ATP levels during subsequent ischemia-
reperfusion (IR) [25]. Two studies, one in a rabbit
model [27] and the other in a rat model [28], showed
RIPC by RAO reduced myocardial infarct size prior to
CAO (30 min) followed by 2 h reperfusion. One study
showed that RIPC from kidney was as effective as
direct myocardial IPC in reducing infarct size [25].
These studies collectively demonstrate that brief peri-
ods of RAO and reperfusion are necessary for RIPC.
RIPC was not seen in permanent arterial occlusion,
suggesting that infarct size limitation was due to
washout of a protective substance during reperfusion.
Both rat and rabbit models demonstrated the beneﬁt of
RIPC. The extent of myocardial protection by RAO was
more in Takoaka’s study as compared to McClanah-
an’s, although both used rabbit models, possibly due to
differences in core temperatures of the animal models.
This remained unclear as McClanahan did not report
core body temperature in his study. Further studies in
different animal models and in clinical settings are
needed to test the efﬁcacy of RIPC by RAO and to
deﬁne the indications for its application.
Role of Mesenteric IPC (Table 4)
Ten studies demonstrated that RIPC from mesen-
tery reduced myocardial infarct size on histology in a
rat model. Seven studies [26, 29–33] showed that RIPC
by single cycle of MAO (15 min) and subsequent reper-
fusion preconditioned the intestine and reduced myo-
cardial infarct size. In contrast, two studies showed
that RIPC, by multiple cycles of MAO [34, 35], reper-
fusion preconditioned the intestine and reduced myo-
cardial infarct size, while one study demonstrated
myocardial protection even after induction of myocar-
dial ischemia 24 h later [36]. These studies collectively
TABLE 3
Studies on RIPC by Brief Renal Ischemia
Author/reference
Site of
preconditioning
stimulus
Site of index
ischemia Model Endpoint Organ protection Proposed mechanism
Preconditioning by renal
ischemia
McClanahan et al. [19] Renal Cardiac ischemia Rabbit Infarct size Reduced infarct size Not identiﬁed
Pell et al. [27] Renal Cardiac ischemia Rabbit Infarct size Reduced infarct size Adenosine receptors
and sarcolemmal
KATP channels
Takaoka et al. [25] Renal Cardiac ischemia Rabbit Infarct size Reduced infarct size Adenosine
Singh et al. [28] Renal Cardiac ischemia Rat Infarct size Reduced infarct size Angiotensin receptors
Lang et al. [138] Renal Cardiac ischemia Rat Infarct size Reduced infarct size Humoral factor (MW
8 kDa), ?Neurogenic
pathway
307 TAPURIA ET AL: REMOTE ISCHEMIC PRECONDITIONINGsupport the evidence for RIPC by MAO and reperfu-
sion. All studies demonstrated an effective precondi-
tioning protocol with brief MAO and only one study
[33] demonstrated that a single cycle of RIPC was more
effective than multiple cycles. Only one study (Vlasov
[37]) showed that direct IPC is more effective than
RIPC and one study (Wang et al. [36]) demonstrated
the existence of late phase mesenteric RIPC. Histology
is a common endpoint in all studies but myeloperoxi-
dase activity (MPO) activity or myocardial creatinine
kinase levels were not evaluated in all studies. One
study showed that RIPC reduced myocardial MPO,
which is a marker of systemic inﬂammatory response
[36]. Two studies found signiﬁcant hemodynamic alter-
ations [30, 36] and showed that MAP increased on
mesenteric occlusion and decreased on reperfusion
with a gradual return to baseline. None of the studies
measured ventricular function. Future studies aimed
at clarifying the functional importance of mesenteric
RIPC, comparisons of preconditioning protocols to es-
tablish the ideal protocol, and clinical applications are
needed.
TABLE 4
Studies on RIPC by Brief Mesenteric Ischemia
Author/reference
Site of
preconditioning
stimulus
Site of index
ischemia Model Endpoint Organ protection Proposed mechanism
Preconditioning by
mesenteric
ischemia
Gho et al. [26] Mesenteric and renal Cardiac ischemia Rat Infarct size Reduced infarct size Neurogenic, humoral
Schoemaker et al.
[29]
Mesenteric ischemia Cardiac ischemia Rat Infarct size Reduced infarct size Bradykinin mediated and
neuronal pathway
Liem et al. [32] Mesenteric ischemia Cardiac ischemia Rat Infarct size Reduced infarct size Increased interstitial
adenosine levels;
afferent autonomic
nerve stimulation,
activation of
myocardial adenosine
receptors
Wang et al. [36] Mesenteric Cardiac ischemia Rat Infarct size Reduced infarct size Role for iNOS
Wolfrum et al.
[30]
Mesenteric Cardiac ischemia Rat Infarct size Reduced infarct size Myocardial PKC
activation through both
neuronal and
bradykinin DEP
humoral pathway
Wolfrum et al.
[31]
Mesenteric Cardiac ischemia Rat Infarct size Reduced infarct size Calcitonin gene related
peptide
Patel et al. [33] Mesenteric Cardiac ischemia Rat Infarct size Reduced infarct size Endogenous opioids
Tang et al. [35] Mesenteric Cardiac ischemia Rat Infarct size Reduced infarct size Capsaicin-sensitive
sensory nerves
Xiao et al. [34] Mesenteric Cardiac ischemia Rat Infarct size Reduced infarct size Capsaicin-sensitive
sensory nerve and NOS
Petrishcev et al.
[43]
Direct cardiac and
remote mesenteric
ischemia
Cardiac ischemia Rats Infarct size Reduced infarct size NO unlikely mechanism
Verdouw et al.
[139]
Mesenteric ischemia,
renal ischemia and
ventricular pacing
Cardiac ischemia Pig Infarct size Reduced infarct size Ventricular pacing by
activation of KATP
channels Mesenteric
ischemia effective at
low and high core
temp. 31 and 36°C
Renal ischemia only at
high temp.36°C
Vlasov et al. [37] Intestinal ischemia Heart and
intestine
Rat Infarct size No myocardial
protection.
Intestinal
adaptation
NO in direct
preconditioning but not
in remote
preconditioning
Liem et al. [62] Mesenteric ischemia Cardiac ischemia Rat Infarct size Reduced infarct size Mesenteric ischemia
Adenosine dependent
pathway
Huda et al. [140] Mesenteric ischemia Cardiac ischemia Rat Infarct size Reduced infarct size Inﬂammatory gene
suppression
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Organs (Table 5)
Twelve studies have shown the beneﬁcial effects of
brief limb ischemia in preconditioning the heart. Oxman
et al. showed reduced cardiac tachyarrythmias following
brief limb ischemia [38], while Birnbaum et al. demon-
strated that gastrocnemius electrical stimulation coupled
with brief limb ischemia reduced myocardial infarct size
[39]. Konstantinov et al. [40] and Kharbanda et al. [20] by
multiple cycles of limb preconditioning and Weinbrenner
et al. by a single cycle of preconditioning [41] demon-
strated that RIPC reduced myocardial infarct size in
animal models. Kharbanda showed that limb precon-
ditioning reduced endothelial injury in humans [20].I R
of the upper limb (ischemia 20 min, 200 mm Hg cuff)
blunted its vasodilatory response to acetylcholine;
however, RIPC of the contralateral arm (3  5 min
ischemia) attenuated neutrophil activation following
ipsilateral limb IR. Gunaydin et al. showed that RIPC
by two cycles of 3 min upper limb ischemia (tourniquet
pressure 300 mm Hg) separated by 2 min of reperfu-
sion in patients undergoing coronary bypass showed an
equal rise in creatinine phosphokinase-MB in both pre-
conditioned and control groups; however, there was a
signiﬁcant increase in lactate dehydrogenase (LDH) in
the preconditioned group with levels of myocardial lac-
tate and lactate efﬂux twice as high compared to the
control group, providing biochemical evidence for
maintenance of myocardial anaerobic glycolysis in the
preconditioned group [42]. From a clinical perspective
RIPC (Kharbanda model, [20]) may be useful in pa-
tients undergoing coronary angioplasty for reducing
myocyte and endothelial injury and in patients under-
going cardiopulmonary bypass (Gunaydin model, [42])
where RIPC by transient upper limb ischemia can be
used to protect the myocardium against subsequent IR
when the aorta is clamped. Patients with intermittent
claudication may have a better tolerance to myocardial
ischemia due to preconditioning by brief limb ischemia
and consequently have a longer window period for
thrombolytic therapy to salvage ischemic myocardium.
Vlasov [43] showed that both brief limb ischemia and
cardiac ischemia reduced myocardial infarct size. A
signiﬁcant reduction in nicotine amide dehydrogenase
(NADH) diaphorase and LDH activity was seen in the
ischemic zone in the IR group, which was attenuated
by both RIPC and direct IPC. In addition an increase in
NADH diaphorase activity was seen in intact cardio-
myocytes of the preconditioned groups as compared to
IR group animals. This provided evidence that both
RIPC and direct IPC induced some form of metabolic
activity and ischemic adaptation in both ischemic and
intact cardiac myocytes. This is supported by Gunay-
din et al. [42], who showed attenuated LDH activity
due to anaerobic glycolysis in preconditioned myocar-
dium. Li et al. [44] in a mouse model demonstrated that
RIPC signiﬁcantly reduced myocardial infarct size. Ex-
pression of nuclear factor-kappa B (NF-B) proteins
from both limb skeletal muscle after RIPC and myo-
cardium suggested the induction of protective signals
in the limb being transferred to the heart and leading
to ischemic adaptation. Two studies demonstrated the
role of RIPC in a rat cardiac transplant model. Kris-
tiansen et al. preconditioned the donor (rat model, 4 
5 min IR cycles, hindlimb ischemia), which signiﬁ-
cantly reduced coronary IR in donor hearts on implan-
tation in the recipient [45]. In contrast, Konstantinov
et al. preconditioned the recipient (rat model, 4  5 min
IR cycles, hindlimb), which reduced myocardial infarct
size in the donor heart on implantation [46].
Eight studies have demonstrated the beneﬁcial ef-
fect of skeletal preconditioning on adipocutaneous,
muscle, and cremasteric muscle ﬂaps as well as remote
skeletal tissue [47–54]. Moses et al. [47] demonstrated
reduced LD muscle ﬂap infarct size in a pig model
following RIPC (3  10 min). Contralateral hindlimb
RIPC [48, 50–53] prior to ipsilateral cremasteric ﬂap
ischemia (2 h) and reperfusion in a rat model improved
RBC ﬂow and reduced neutrophil adhesion. Similarly
Liauw et al. in a rat model showed that RIPC (ipsilat-
eral Gracilis) reduced muscle necrosis of contralateral
muscle by 60% as compared to non-preconditioned [54].
RIPC reduced ﬂap necrosis, which is of particular
beneﬁt in patients with irradiated tissues, smokers,
and obese patients. This protective effect is more pro-
nounced in the late phase of preconditioning. These
studies showed remote ischemic preconditioning to be
associated with better microcirculation, decreased leu-
kocyte endothelial sticking, and endothelial dysfunc-
tion as well as better capillary blood ﬂow with terminal
arteriolar dilation [55].
The following four studies have shown hindlimb
ischemic preconditioning to be beneﬁcial in protection
of the lung and the brain [56–58]. (1) RIPC by hindlimb
ischemia (3  5 min), 5 min reperfusion prior to 2 h
bilateral hindlimb ischemia, and 2.5 h reperfusion in a
porcine model [58] protected against lung dysfunction
secondary to limb IRI. RIPC reduced plasma cytokine
levels, ameliorated impaired gas exchange and oxygen
transport, reduced the elevation in pulmonary arterial
pressure and vascular resistance, reduced pulmonary
edema, and decreased lung tissue myeloperoxidase ac-
tivity. During surgery of the lower limbs, there is re-
lease of cytokines after prolonged limb ischemia lead-
ing to acute respiratory distress syndrome and limb
preconditioning could protect against lung dysfunction
found with acute respiratory distress syndrome. (2) RIPC
by left femoral artery occlusion (3  5 min) prior to lung
IRI (90 min ischemia, 5 h reperfusion) [59] in a porcine
model reversed the detrimental effects of lung IRI on
lung function and attenuated pulmonary hypertension
and impaired gas exchange. Thus, both models of RIPC
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Studies on RIPC by Brief Limb Ischemia
Author/reference
Site of
preconditioning
stimulus
Site of index
ischemia Model Endpoint Organ protection Proposed mechanism
RIPC by limb
ischemia
Oxman et al.
[38]
Hindlimb Cardiac ischemia Rat Reperfusion
arrhythmias
Decreased
arrythmias
Norepinephrine
Birnbaum et al.
[39]
Gastroenemius
and reduced
ﬂow
Cardiac ischemia Rabbit Infarct size Reduced infarct size Not identiﬁed
Liauw et al. [54] Gracilis of
ipsilateral limb
Gracilis of
contralateral limb
Rat Muscle necrosis Reduced by 60% Not investigated
Kharbanda et al.
[20]
Hindlimb Cardiac ischemia Pig Infarct size Reduced infarct size Suggested
involvement of
adrenergic pathway
and blockade by
reserpine.
Gunaydin et al.
[42]
Upper limb Cardiac ischemia
(Cardiopulmonary
bypass)
Human LDH, CK release Not conclusive Enhanced anaerobic
glycolysis
Xia et al. [57] Iliac artery Cardiac ischemia Sheep Pulmonary
function
and pulmonary
vascular
resistance
Lung protection and
decreased
pulmonary
vascular
resistance
KATP channel–
pulmonary vascular
dilatation and
myocardial
protection
Kharbanda et
al.[20]
Upper limb Upper extremity
(contralateral
arm)
Human Endothelial
dysfunction
Skeletal protection Not identiﬁed
Addison et al.
[49]
Hindlimb Global skeletal
protection
Pig Ischemic
necrosis
Skeletal protection Opioid delta-1
receptors
Kuntscher et al.
[48]
Hindlimb Adipocutaneous
ﬂaps
Rat Flap necrosis Protection NO
Kuntscher et al.
[52]
Hindlimb Rat cremasteric
muscle ﬂaps
Rat Flap necrosis Protection NO
Kuntscher et al.
[50]
Hindlimb Adipocutaneous
ﬂaps
Rat Flap necrosis Flap protection NO
Kuntscher et al.
[53]
Hindlimb Flap ischemia Rat Flap necrosis Flap protection ?
Liem et al. [141] Hindlimb Rat Skeletal muscle
protection
?Mechanism
Moses et al. [47] Hindlimb Rat Flap necrosis Skeletal muscle
protection
KATP channels (early
phase)
Wang et al. [55] Hindlimb,
femoral A
Cremaster ﬂap Rat Flap necrosis Reduced ﬂap
necrosis
?Mechanism
Weinbrenner et
al. [78]
Infrarenal Cardiac ischemia Rat Infarct size Reduced infarct size Opioid receptors and
PKC; humoral
pathway.
Harkin et al.
[58]
Hindlimb Hindlimb
reperfusion injury
Porcine Pulmonary
artery
pressure.
PO2(alv)-
PO2(art) Lung
MPO activity
and weight
Lung protection Decreased circulating
IL-6, circulating
primed phagocytes,
and pulmonary
neutrophil
inﬁltration
Li et al. [44] Hindlimb Cardiac ischemia Mice Infarct size Reduced infarct size
Delayed
protection
NFkB and iNOS
Konstantinov
et al. [46]
Hindlimb Cardiac ischemia in
transplanted
heart
Rat Infarct size Reduced infarct size KATP channels
modulation in
recipient
Konstantinov et
al. [40]
Hindlimb Cardiac ischemia Mouse Infarct size Reduced infarct size Inﬂammatory gene
suppression
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onstrated that IPC of the hindlimb prior to limb IR injury
reduced cytokines (IL-1 and IL-1), and activated neu-
trophils, systemic inﬂammatory response syndrome, and
lung dysfunction [58]. In contrast, Waldow’s experimen-
tal model demonstrated that RIPC (hindlimb ischemia)
protects the lung from acute IR injury but does not mod-
ulate all indices of systemic inﬂammation (IL-6, ROS,
and activated granulocytes were not modulated by RIPC)
[59]. (3) Xia et al. [57] showed that RIPC by three epi-
sodes of 5 min occlusion and 5 min reperfusion of the iliac
artery preserved lung function and prevented a rise in
pulmonary vascular resistance as well as arterial pres-
sure following myocardial reperfusion injury. This has
important clinical applications in cardiac surgery as cor-
onary IR has deleterious effects on the lung, which is a
major cause of mortality in these patients. In beating
heart surgery it is not possible to directly clamp the aorta
and therefore direct cardiac preconditioning is not possi-
ble. Under such circumstances preconditioning from a
remote organ such as the limb may be useful as shown by
Xia et al. [57]. (4) RIPC by femoral artery occlusion (30
min), reperfusion (15 min) and (30 min) occlusion, 48 h
(reperfusion) [56] prior to IR (30 min brain ischemia by
carotid artery occlusion and 48 h reperfusion) reduced
brain edema and circulating endotheliocytes and im-
proved blood ﬂow, demonstrating ischemic adaptation in
the early and late phase of IRI.
Most models of limb preconditioning supported the
effectiveness of multiple brief cycles of limb ischemia
followed by reperfusion; conversely, Weinbrenner et al.
showed a single cycle to be more effective than multiple
cycles and prolongation of length of the single cycle led
to more effective preconditioning [41].
The Protective Effect of Brief Hepatic Ischemia and
Myocardial Ischemia on Remote Organs (Table 6)
Four studies showed the protective effects of brief
myocardial and hepatic ischemia on remote organs
[17, 24, 60, 61]. Both brief hepatic and myocardial
ischemia have protective effects on the stomach [60,
61]. In an experimental rat model, Brzozowski et al.
showed that two 5 min episodes of hepatic/myocardial
ischemia followed by 10 min of reperfusion each was as
effective as direct gastric preconditioning in reducing
gastric erosions as well as increasing gastric blood ﬂow
following sustained gastric IR. Ates et al. demon-
strated in a rat model that brief hepatic ischemia (10
min) prior to 45 min of ischemia in the left kidney was
associated with better creatinine clearance as well as
improved sodium fractional excretion 24 h after precon-
ditioning. They showed reduced mitochondrial swelling,
basement membrane detachment on electron micros-
copy, reduced renal tubular swelling, necrosis, tumor
necrosis factor-alpha (TNF-) levels, decreased lipid
peroxidation (TBARS levels) [24], and a relatively
rapid decline in LDH levels in the remote precondi-
tioned group as compared to IRI group. This study
provides evidence of preservation of ultrastructural,
TABLE 5
Continued
Author/reference
Site of
preconditioning
stimulus
Site of index
ischemia Model Endpoint Organ protection Proposed mechanism
Chen et al. [75] Hindlimb Cardiac ischemia Rat Infarct size Reduced infarct size NO
Moses et al. [142] Hindlimb Skeletal muscle Rat Infarction Reduced skeletal
infarction
KATP, late phase
Loukogeorgakis et al.
[74]
Hindlimb Endothelial limb
injury
Humans Flow mediated
dilatation
Endothelial function
Protected
Autonomic nervous
system
Chen et al. [76] Hindlimb Cardiac ischemia Rat Infarct size Reduced infarct size Free radicals
Waldow et al. [59] Hindlimb Lung IRI Pigs Lung
functions
Protection of lung
functions
Cytokine IL-6
Kristiansen et al. [45] Hindlimb Cardiac ischemia in
explanted heart
Rat Infarct size Reduced infarct size KATP channels
Zhang et al. [122] Hindlimb Cardiac ischemia Rat Infarct size Reduced infarct size Opioid receptors and
KATP channels
Dave (2006) Hindlimb Brain ischemia Rat Neuronal
damage
Increased
neuroprotection
Not investigated
Kanoria et al. [77] Hindlimb Hepatic ischemia Rat Liver function
hepatic
blood ﬂow
Reduced IRI
Improved liver
function
?Adenoisne, NO
Lai et al. [136] Hindlimb Hepatic ischemia Rat Liver function Reduced IRI,
improved liver
function
Hemoxygenase
(HO-1)
Cheung et al. [73] Hindlimb Cardiac ischemia Human Trop I Lung
function
Cytokines
Reduced Trop I
Improved lung
function
Reduced cytokine
levels
311 TAPURIA ET AL: REMOTE ISCHEMIC PRECONDITIONINGhistopathological, and biochemical renal function in
the RIPC group and supports data for beneﬁcial effects
of brief hepatic ischemia on remote tissues.
Does Ischemic Preconditioning Tolerance Induce Cross
Tolerance to RIPC?
In an experimental rat model Liem et al. demon-
strated that two cycles of CAO of 15 min ischemia
followed by 15 min reperfusion preconditioned the
myocardium prior to 60 min CAO and reduced infarct
size, which was abrogated by 8-sulfophenyl theophyl-
line (adenosine receptor blockade) prior to IPC, sug-
gesting the role of adenosine in IPC. However, four
cycles of 15 min CAO followed by 15 min reperfusion
rendered the myocardium tolerant to IPC and subse-
quent preconditioning was ineffective in reducing myo-
cardial infarct size [62] due to depletion of cardiac
interstitial adenosine. However, RIPC with two cycles
of MAO 15 min in tolerant myocardium was effective in
reducing myocardial infarct size, suggesting alternate
signaling pathways. This data suggests that repetitive
brief ischemia of same duration may render tissue
tolerant to preconditioning; however, in the clinical
setting patients with unstable angina are unlikely to
develop tolerance to adenosine since angina is of vary-
ing severity and duration. However, exogenous adeno-
sine is effective in ameliorating IRI even in those who
develop tolerance, as shown by Liem et al., and RIPC
may be useful in situations where direct precondition-
ing is ineffective due to adenosine tolerance.
Remote Ischemic Preconditioning of Trauma
(Fig. 2 and Table 7)
The role of remote trauma in preconditioning has been
addressed in a recent study by Ren et al. [63]. They
demonstrated that carotid artery catheterization (remote
nonischemic vascular surgical trauma) aggravates myo-
cardial ischemia; however, abdominal incision (remote
nonischemic nonvascular surgical trauma) reduces myo-
cardial infarct size following cardiac IR. This effect is
more in the early phase of remote preconditioning (80%
reduction in infarct size) and less in the late phase of
preconditioning (40% reduction in infarct size). Remote
preconditioning of trauma (RPCT), unlike ischemic pre-
conditioning or remote ischemic preconditioning, does not
involve ischemic insults to initiate preconditioning in re-
mote organs. There is both an early and a late precondi-
tioning phase in RPCT. The underlying mechanism of
RPCT is unclear. RPCT further reduces myocardial in-
farct size in TNF- knockouts, supporting the argument
FIG. 2. Remote preconditioning of trauma.
TABLE 6
Studies on RIPC by Brief Hepatic Ischemia
Preconditioning by
hepatic ischemia
Ates et al. [24] Brief hepatic
ischemia
Renal ischemia Rat Renal blood ﬂow and
creatinine
clearance
Decreased renal
ischemia
Adenosine, Bradykinin,
KATP, possible
neuronal reﬂex
Peralta et al.
(2003)
Hepatic
ischemia
Kidneys, lungs,
and other
organs
Rat Organ failure Protection of remote
organs
Inhibition of TNF-
alpha-induced
selectin up-regulation
Brzozowski et al.
[53]
Hepatic/
cardiac
Gastric ischemia
reperfusion
injury
Rat Gastric lesions and
blood ﬂow
Protection of the
stomach
Cyclo-oxygenase 1 and
cyclo-oxygenase-2,
sensory nerve
activation and
release of CGRP, No,
inhibition of IL-1 and
TnF alpha
Brzozowski et al.
[54]
Hepatic/
cardiac
Gastric ischemia Rat Gastric lesions Protection Brain gut axis, sensory
and vagal activation,
CGRP release.
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trauma [63]. The role of adenosine in RIPC of the heart
and noradrenaline in IPC has been shown. Therefore
adenosine activity, sympathetic neuronal activity, and
catecholamines are potential mediators of RPCT. Since
norepinephrine is involved in cross-signaling with pro-
tein kinase C (PKC) [64], nitric oxide (NO) [65] modulates
release of norepinephrine from skeletal muscle in isch-
emia and both PKC and NO play a role in remote pre-
conditioning. One may speculate the role of catechol-
amines, PKC, and NO pathways in RPCT. Further stud-
ies in animal models using sympathetic blockade, knock-
outs of NO and PKC, and ganglion blockade prior to
RPCT are needed to pinpoint the candidate mechanism
and elucidate the pathway of signal transmission.
Transferred Preconditioning (Table 8)
Ischemic preconditioning of the heart followed by
transfer of coronary efﬂuent from the preconditioned
heart to the recipient heart proved beneﬁcial in pro-
tecting the recipient heart from ischemia reperfusion
injury [66–69]. The mechanism of transferred precon-
ditioning was via opioids such as metencephalins and
not due to epinephrine or adenosine release into the
efﬂuent. Naloxone blocked opioid receptors and abro-
gated the beneﬁcial effect of transfer of coronary efﬂu-
ent from the preconditioned heart.
Coronary efﬂuent from preconditioned hearts is also
effective in preconditioning segments of jejunum via
opioid receptors and KATP channels [66]. Mesenteric
ischemic tolerance induced by pretreatment of small
bowel segments with coronary efﬂuent leads to quicker
recovery of contractile function of small bowel follow-
ing reoxygenation and reperfusion.
Remote Microvascular Preconditioning (Table 9)
Mechanisms and the Role of Candidate Compounds
in the Process of Remote Ischemic Preconditioning
Adenosine, NO, TNF-, opioids, bradykinins, PKC, cal-
citonin gene related peptide (CGRP), cyclo-oxygenase,
KATP channels, capsaicin, heat shock proteins, and nor-
epinephrine are all involved in the mechanism of remote
ischemic preconditioning. These substances are released
as a response to stress and act via the neuronal or hu-
moral pathway to produce organ protection. The path-
TABLE 7
Studies on Remote Preconditioning of Trauma
Author/reference
Site of preconditioning
stimulus
Site of index
ischemia Model Endpoint Organ protection Proposed mechanism
Remote
preconditioning
of trauma
Ren et al. [63] 1. RPCT (Vascular, ischemia)
2. RPCT (Nonvascular, non-
ischemic)
3. Direct IPC
Cardiac ischemia Mouse Infarct size 1. Increased
infarct
2. Reduced infarct
3. Reduced infarct
1. TNF-
2. ?Adenosine, NO,
catechol
3. TNF-
TABLE 8
Studies on Transferred Preconditioning
Author/reference
Site of preconditioning
stimulus
Site of index
ischemia Model Endpoint
Organ
protection
Proposed
mechanism
Transferred
preconditioning
Dickson et al. [67] Coronary efﬂuent of
donor following
cardiac ischemia
Cardiac ischemia Rabbit Infarct size Opioid receptors
Dickson et al. [69] Whole blood transfusion
following cardiac and
renal ischemia
Cardiac ischemia Rabbit Infarct size Reduced infarct Opioid receptors and
KATP channel
Dickson et al. [68] Coronary efﬂuent
following cardiac
ischemia
Cardiac ischemia Rabbit Infarct size Reduced infarct Metenkephalins
Dickson et al. [66] Coronary efﬂuent
following cardiac
ischemia
Mesenteric ischemic
tolerance
Rabbit Jejunal
peristalsis
Protection of
intestine Yes
Metenkephalins
313 TAPURIA ET AL: REMOTE ISCHEMIC PRECONDITIONINGways involved are different in response to different isch-
emic stimuli and often overlap. The evidence for the role
of each of these compounds and the mechanisms by
which they act and the pathways involved are reviewed.
Direct Preconditioning and Evidence for Different Phases of
the Adaptive Response (Fig. 3)
In direct IPC there is evidence for different phases of
ischemic adaptation and protection [70]. These phases
were ﬁrst identiﬁed in the heart and subsequently in
other organs. In the heart the early phase protects
against infarction but not against myocardial dyskine-
sia [70], whereas the late phase protects against both.
The early phase begins soon after reperfusion and lasts
f o ru pt o3hi nischemic preconditioning, whereas the
late phase starts 12–24 h later [71]. The early phase is
independent of protein synthesis and is due to release
of endogenous substances, which stimulate posttrans-
lational modiﬁcations in proteins, whereas the late
phase is stimulated by release of endogenous sub-
stances, which lead to synthesis of new proteins and
altered gene expression. This is referred to as the sec-
ond window of protection [72]. The effects of the acute
phase are short lived, lasting for 3–4 h, whereas the
effects of the delayed phase are longer, lasting for
48–96 h or sometimes for weeks [25, 27, 28].
The protective effect of the delayed phase of precon-
ditioning is less compared to the early phase and mech-
anistically different [70].
Does RIPC Confer Early and Late Protection?
Eight studies have shown two phases of protection
(ischemic adaptation) in RIPC [27, 29, 30, 36, 38].
These studies showed the existence of both phases in
all organ systems in animal models and in recent hu-
man studies. (1) Two studies [25, 27, 28] showed brief
MAO-induced early and delayed preconditioning in the
heart. (2) Li et al. showed a pronounced reduction in
myocardial infarct size 24 h after hindlimb RIPC [44].
(3) Four studies demonstrated late RIPC in remote
skeletal muscle following skeletal muscle precondition-
ing [51–53]. (4) One study showed ischemic adaptation
of the brain to hindlimb ischemia after 24 h of precon-
ditioning [56]. (5) One study showed late phase of RIPC
in the heart and liver due to heat shock protein (HSP)
expression. (6) The ﬁrst clinical application of RIPC in
children undergoing cardiac surgery on bypass showed
that RIPC was most effective in myocardial protection
if applied 24 h prior to the coronary ischemic insult
[73].
Evidence for the Pathway of Transduction of
Remote Protection
Four studies [25–28] in renal preconditioning and
four studies [30, 32, 33, 55] in mesenteric precondition-
FIG. 3. Phases of preconditioning.
TABLE 9
Studies on Remote Microvascular Preconditioning
Author/reference
Site of preconditioning
stimulus Site of response Model Endpoint Organ protection
Proposed
mechanism
Remote microvascular
preconditioning
Mabanta et al. [129] Proximal microvascular
network
Distal microvascular
network
Microvascular
network
Local
response
Microvascular KATP channels
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ated with brief periods of reperfusion of the remote
organ; however, persistent ischemia without reperfu-
sion did not protect remote organs. Liem et al. [32]
showed that brief MAO and reperfusion conferred myo-
cardial protection demonstrating that reperfusion of
virgin intestine was necessary for activation of the
neurogenic pathway. Subsequent permanent MAO re-
duced infarct size signiﬁcantly more than brief MAO
alone, suggesting that brief periods of MAO are cardio-
protective but not optimal as their effect was enhanced
by further permanent occlusion. Four studies demon-
strated the role of the neurogenic pathway in transduc-
tion of RIPC from the limb. In an animal model, Ox-
man et al. [38] showed rise in plasma catecholamine
levels on preconditioning, which was abolished by au-
tonomic nerve blockade with reserpine. Loukogeor-
gakis et al. showed the role of the autonomic nervous
system in transduction of the protective signal. How-
ever, they were unable to deﬁne the speciﬁc component
of the autonomic system [74]. Birnbaum et al. demon-
strated RIPC by electrical stimulation of gastroen-
emius muscle in conjunction with brief limb ischemia
in a rabbit model [39] and Kharbanda showed RIPC
from the limb was abolished by sympathetic nerve
blockade with reserpine [20]. In contrast six studies
demonstrated rises in plasma levels of nitrates, opi-
oids, free radicals, and catecholamines [36, 38, 41, 49,
75–77] following RIPC, providing evidence in support
of a humoral pathway. In Weinbrenner’s study [41],
the protective effect was only seen in groups who had a
period of reperfusion after ischemia in comparison to
those who had no reperfusion after ischemia [25, 78]
and simultaneous aortic occlusion along with coronary
occlusion did not confer protection, indicating that pre-
conditioning had to be prior to allow for the substance
released to reach the heart. These ﬁndings demon-
strate the release of protective substances into the
circulation. Autonomic nerve blockade with hexame-
thonium did not abolish RIPC [75]. Two studies
showed cardioprotection in a rat cardiac transplant
model (denervated heart), suggesting the role of blood-
borne factors in preconditioning [45, 46]. Whether the
neurogenic pathway was activated locally in the mes-
enteric, renal, or skeletal beds or by release of media-
tors into the circulation (humoral pathway) and subse-
quent stimulation of sensory afferent ﬁbers is unclear
from these studies. The need for reperfusion to confer
remote protection and rise in plasma levels of cat-
echolamines, adenosine, neuropeptides, cytokines, or
free radicals suggests that these substances may acti-
vate neuronal pathways after release into circulation.
It seems that both the neurogenic pathway and the
humoral pathway have some element of overlap and
are not mutually exclusive. Measurement of intersti-
tial levels of mediators and sensory afferent nerve ac-
tivity prior to and after preconditioning and speciﬁc
blockade of synthesis and release of the mediators
would help clarify their role in activation of neuronal
pathways. Blockade of neuronal pathways and end
receptors would help deﬁne the predominant pathway
for transduction of preconditioning in different organ
systems.
Role of Nitric Oxide
Studies in direct IPC have demonstrated the protec-
tive effect of NO on microcirculation [14, 79–90].N Oi s
a free radical produced from L-arginine by the enzyme
NO synthase, which has three forms: endogenous NOS
(eNOS), neuronal NOS (nNOS), and inducible NOS
(iNOS) [82, 83]. Of these, eNOS and nNOS are consti-
tutively expressed, while iNOS is produced in response
to cytokines and NF-B. eNOS has a protective effect
on microcirculation and always produces NO in small
amounts, which predominates in the circulation, pro-
ducing a protective effect on the microcirculation.
Evidence in Remote Ischemic Preconditioning
(Table 10, Studies 1–10)
Six studies have demonstrated the role of NO [48,
50–53, 56] in remote preconditioning of skeletal mus-
cle, intestine, brain, and heart. These studies showed
hindlimb RIPC induced protection of muscle ﬂaps in
the early and late phase of RIPC [36, 51, 52], induction
of myocardial iNOS following mesenteric RIPC, and
reduction in myocardial infarct size as well as MPO
activity (marker of neutrophilic activation). Blockade
of NO activity abrogated the decrease in myocardial
infarct size and MPO activity, suggesting that NO in-
hibits neutrophil inﬁltration. Tokuno et al. showed
that spontaneous brain ischemic events 24–48 h prior
to cardiac IR injury reduced myocardial infarct size
[23, 49] with loss of RIPC in iNOS knock out mice.
Vlasov et al. [56] showed recovery of brain blood ﬂow at
120 min after reperfusion and reduced cerebral edema
in the late phase of RIPC (hindlimb) due to iNOS-
induced cerebral ischemic adaptation. A recent study
has shown expression of NF-B due to brief limb ische-
mia and NF-B-induced iNOS 24 h later, which re-
duced myocardial infarct size [44] with loss of protec-
tion in iNOS knockout mice. This observation is sup-
ported from studies of direct IPC that have demon-
strated that cytokines induce iNOS production. Con-
versely Petrischev showed that NO is not involved in
RIPC [43] since the nonspeciﬁc NO blocker L-NNA did
not abolish increase in nicotinamide adenine dinucle-
otide phosphate activity in intact cardiomyocytes fol-
lowing limb/mesenteric remote ischemia [43] or block
attenuation of decrease in nicotinamide adenine dinu-
cleotide phosphate activity in ischemic tissue by pre-
conditioning. These studies demonstrate the role of NO
in acute RIPC of the heart and muscle but its role in
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Studies on Mechanisms in RIPC
Proposed mechanism
Site of index
ischemia
Site of
preconditioning
stimulus Author/reference Model Endpoint Organ protection
1 iNOS expression
(humoral
mechanism)
Hindlimb (right)
cremaster ﬂap
Hindlimb (femoral
artery)
Wang et al. [55] Rat Flap necrosis Flap protection
2 iNOS and NO Cardiac ischemia Cerebral ischemia Tokuno et al. [23] Mouse
isolated
heart
Infarct size Reduced infarct size
3 NFkB and iNOS Cardiac ischemia Hindlimb Li et al. [44] Mice Infarct size Reduced infarct size
Delayed
protection
4 NO Adipocutaneous
ﬂaps
Hindlimb Kuntscher et al. [48] Rat Flap necrosis Protection
5 NO Adipocutaneous
ﬂaps
Hindlimb Kuntscher et al. [50] Rat Flap necrosis Flap protection
6 NO Cardiac ischemia Hindlimb Chen et al. [75] Rat Infarct size Reduced infarct size
7 NO Rat cremasteric
muscle ﬂaps
Hindlimb Kuntscher et al. [52] Rat Flap necrosis Protection
8 NO in direct
preconditioning
but not in RIPC
Heart and intestine Intestinal ischemia Vlasov et al. [56] Rat Infarct size No myocardial
protection
Intestinal
adaptation
9 Role for iNOS Cardiac ischemia Mesenteric Wang et al. [36] Rat Infarct size Reduced infarct size
10 NO unlikely
pathway
Cardiac ischemia Direct cardiac and
remote
mesenteric
ischemia
Petrishcev et al. [43] Rats Infarct size Reduced infarct size
11 Increased interstitial
adenosine levels;
afferent autonomic
nerve stimulation,
activation of
myocardial
adenosine
receptors
Cardiac ischemia Mesenteric
ischemia
Liem et al. [32] Rat Infarct size Reduced infarct size
12 Adenosine receptors
and sarcolemmal
KATP channels
Cardiac ischemia Renal Pell et al. [27] Rabbit Infarct size Reduced infarct size
13 Adenosine Cardiac ischemia Renal Takaoka et al. [25] Rabbit Infarct size Reduced infarct size
14 Adenosine Cardiac ischemia RPCT Ren et al. [63] Mouse Infarct size Reduced infarct size
15 Angiotensin
receptors
Cardiac ischemia Renal Singh et al. [28] Rat Infarct size Reduced infarct size
16 Autonomic nervous
system
Endothelial limb
injury
Hindlimb Loukogeorgakis et al.
[74]
Humans Flow-mediated
dilatation
Endothelial function
protected
17 Neurogenic, humoral Cardiac ischemia Mesenteric and
renal
Gho et al. [26] Rat Infarct size Reduced infarct size
18 Bradykinin-mediated
and neuronal
pathway
Cardiac ischemia Mesenteric
ischemia
Schoemaker et al. [29] Rat Infarct size Reduced infarct size
19 Brain gut axis,
sensory and vagal
activation, CGRP
release
Gastric ischemia Hepatic/cardiac Brzozowski et al. [54] Rat Gastric lesions Protection
20 Calcitonin gene-
related peptide
Cardiac ischemia Mesenteric Wolfrum et al. [31] Rat Infarct size Reduced infarct size
21 Capsaicin sensitive
sensory nerve and
NOS
Cardiac ischemia Mesenteric Xiao et al. [34] Rat Infarct size Reduced infarct size
22 Capsaicin-sensitive
sensory nerves
Cardiac ischemia Mesenteric Tang et al. [35] Rat Infarct size Reduced infarct size
23 Cyclo-oxygenase 1
and cyclo-
oxygenase-2,
sensory nerve
activation and
release of CGRP,
NO, inhibition of
IL-1 and TNF-
Gastric ischemia
reperfusion
injury
Hepatic/cardiac Brzozowski et al. [53] Rat Gastric lesions and
blood ﬂow
Protection of the
stomach
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mains unproven. IR injury impairs endothelial func-
tion in the initial phase primarily by impairment of
formation and bioavailability of NO, which may explain
the lack of effect of the early phase of RIPC in the brain
and intestine. This may also be explained by different
TABLE 10
Continued
Proposed mechanism
Site of index
ischemia
Site of
preconditioning
stimulus Author/reference Model Endpoint Organ protection
24 Cytokine IL-6 Lung IRI Hindlimb Waldow et al. [59] Pigs Lung functions Protection of lung
functions
25 Inhibition of TnF-
induced selectin
up regulation
Kidneys, lungs, and
other organs
Hepatic ischemia Peralta et al. (2003) Rat Organ failure Protection of remote
organs
26 Enhanced anaerobic
glycolysis
Cardiopulmonary
bypass
Upper limb Gunaydin et al. [42] Human LDH, CK release Not conclusive
27 Free radicals Cardiac ischemia Hindlimb Chen et al. [76] Rat Infarct size Reduced infarct size
28 Heat shock proteins Remote myocardial
preconditioning
Cardiac ischemia Tanaka et al. [131] Rabbit Infarct size Reduced infarct size
29 Inﬂammatory gene
suppression
Cardiac ischemia Hindlimb Konstantinov [40] Mouse Infarct size Reduced infarct size
30 Inﬂammatory gene
suppression
Cardiac ischemia Mesenteric
ischemia
Huda et al. [140] Rat Infarct size Reduced infarct size
31 K ATP channels Cardiac ischemia in
explanted heart
Hindlimb Kristiansen et al. [45] Rat Infarct size Reduced infarct size
32 K ATP, Late phase Skeletal muscle Hindlimb Moses (2005) Rat Infarction Reduced
33 KATP channel–
pulmonary
vascular
dilatation and
myocardial
protection
Cardiac ischemia Iliac artery Xia et al. [57] Sheep Pulmonary function
and pulmonary
vascular
resistance
Lung protection and
decreased pulmonary
vascular resistance
34 KATP channels
modulation in
recipient
Cardiac ischemia in
transplanted
heart
Hindlimb Konstantinov [46] Rat Infarct size Reduced infarct size
35 KATP channels
(early phase)
Hindlimb Moses et al. [47] Rat Flap necrosis Skeletal muscle
protection
36 Ventricular pacing
by activation of
KATP channels
Cardiac ischemia Mesenteric
ischemia, renal
ischemia, and
ventricular
pacing
Verdouw et al. [139] Pig Infarct size Reduced infarct size
37 Myocardial PKC
activation
Cardiac ischemia Mesenteric Wolfrum et al. [30] Rat Infarct size Reduced infarct size
38 PKC and
mitochondrial
KATP channels
Cardiac ischemia Mesenteric
ischemia
Wang et al. (2002) Rat Infarct size Reduced infarct size
39 Norepinephrine Cardiac ischemia Hindlimb Oxman et al. [38] Rat Reperfusion,
arrythmias
Decreased arrythmias
40 Norepinephrine Cardiac ischemia Cerebral ischemia de Zeeuw et al. [119] Pig Infarct size No change in infarct
size
41 Suggested
adrenergic
Pathway and
blockade by
reserpine.
Cardiac ischemia Hindlimb Kharbanda et al. [20] Pig Infarct size Reduced infarct size
42 Opioid delta 1
receptors
Global skeletal
protection
Hindlimb Addison et al. [47] Pig Ischemic necrosis Skeletal protection
43 Opioid receptors Cardiac ischemia Coronary efﬂuent
of donor
following cardiac
ischemia
Dickson et al. [67] Rabbit Infarct size Reduced infarct size
44 Opioid receptors and
PKC; humoral
pathway
Cardiac ischemia Infrarenal Weinbrenner et al. [78] Rat Infarct size Reduced infarct size
45 Metenkephalins Cardiac ischemia Coronary efﬂuent
following cardiac
ischemia
Dickson et al. [68] Rabbit Infarct size Reduced infarct
46 Endogenous opioids Cardiac ischemia Mesenteric Patel et al. [33] Rat Infarct size Reduced infarct size
47 Hemoxygenase Liver ischemia Hindlimb ischemia Lai et al. [136] Rat Liver function Improved liver function
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ing in different organs and different criteria for assess-
ment of preconditioning in the heart and muscle (cyto-
protective effects) as against endothelial function in the
intestine and brain. Therefore similar outcome measures
are needed to investigate the role of NO.
What Induces NO?
In a mouse model increased NF-B expression in the
limb following RIPC induced NF-B and iNOS in the
heart, suggesting the role of cytokines in the signaling
pathway for induction of NO [44]. In a rat model, brief
hepatic ischemia increased gastric CGRP, increased
mucosal ﬂow [34], and reduced gastric mucosal ero-
sions and this effect was abolished by L-NAME (NO
blocker), suggesting that CGRP induces NO release
and subsequent vasodilatory effects and increased
ﬂow. Evidence suggests release of ROS, cytokines, and
NO into the venous efﬂuent following intestinal ische-
mia reperfusion [91] activates NF-B and PKC [92].
These signaling pathways induce iNOS [93] in the
target organ. Peralta has shown adenosine increases
NO formation and this effect is blocked by adenosine
antagonists [94].
Pathway
The data from the studies discussed show that brief
periods of ischemia reperfusion in RIPC induce NO
pathways. Li et al. showed that RIPC by hindlimb
ischemia increased NF-B in skeletal muscle and heart
and induced ischemic adaptation in the heart by iNOS
formation [44]. In view of the short half-life of NO (5 s),
it is unlikely for NO to be produced in the remote
organ and reach the target organ to confer protection
by the blood stream. Chen et al. [75] showed that
RIPC of the limb reduced myocardial infarct size
through NO production. Since hexamethonium (auto-
nomic ganglion blocker) did not abrogate reduction in
myocardial infarct size, it seems that NO pathways act
through the bloodstream. In an animal model of warm
hepatic IRI, Kanoria’s group showed increased hepatic
venous plasma nitrates/nitrites [77] and amelioration of
hepatic IR following hindlimb RIPC. This provides fur-
ther support for the argument in favor of the bloodstream
being the NO pathway. Clearly, further clariﬁcation of
this is needed by measuring systemic venous plasma
nitrate/nitrite levels and plasma arginine levels (NO pre-
cursors) after RIPC. Also, knockout models of NOS would
be speciﬁc for investigating the role of NO pathways in
preconditioning.
Is NO a Trigger or Mediator?
Tokuno et al. demonstrated reduced myocardial in-
farct size following induced brief brain ischemia with-
out an increase in cardiac iNOS; however; the protec-
tion was abolished in NOS knockouts, suggesting the
role of NO as a trigger [23]. Blockade of NO prior to
RIPC by L-NAME abolished myocardial protection,
supporting the role of NO as a trigger [75]. Increased
iNOS production 24 h after RIPC would suggest its role
as a mediator and future studies by blocking NO after
RIPC are needed to demonstrate its role as a mediator.
Effector Mechanism
IPC studies have demonstrated that NO modulates
microvascular perfusion through its vasodilatory effect
[95] and through its anti-inﬂammatory actions, includ-
ing inhibition of stellate cell activation [96], neutrophil
adhesion [88, 90, 97], and platelet aggregation. NO
plays a key role in initiating and maintaining precon-
ditioning. The early phase of preconditioning mediated
by eNOS is through generation of cGMP [98], as shown
by Lochner et al. in the myocardium [99] and subse-
quently inhibition of cAMP levels as well as reduction
in energy demands. The late phase is protein synthesis
dependent and is through activation of PKC, NF-B,
and transcription of iNOS [100]. In the liver NO medi-
ates preconditioning by inhibitory actions on endothe-
lin [14], activation of adenosine A2 receptors, and sub-
sequent NO formation [94]. NO also has been shown to
confer protection against cold ischemia [15] of liver. NO
inhibits apoptosis of cells by inhibition of caspase ac-
tivity, TNF-, and up-regulation of Bcl-2 [101–103].
NO has a protective effect on intestinal microcircula-
tion such as scavenging of oxygen free radicals, main-
tenance of normal vascular permeability, inhibition of
smooth muscle proliferation, reduction of leukocyte ad-
herence to the mesenteric endothelium, prevention of
mast cell activation, and platelet aggregation [84, 86,
88, 104]. Kubes et al. [83] have demonstrated in the
intestine that eNOS has a protective effect on intesti-
nal mucosa, while increased iNOS has been shown to
increase mucosal apoptosis by generation of free radi-
cals such as peroxynitrate [105, 106]. However recent
studies have shown that the production of peroxyni-
trate may be associated with loss of eNOS rather than
increased iNOS production [107]. This observation
suggests a dichotomous role for NO in IR injury with
small quantities of NO produced by eNOS, reducing
IRI, while excessive NO due to iNOS, causing delete-
rious effects.
Adenosine (Table 10, Studies 11–14)
Evidence
Adenosine is an extracellular molecule that is both a
trigger and a mediator of IPC as demonstrated from
past studies [108]. Adenosine is a hormone widely dis-
tributed in human tissues. Adenosine production oc-
curs in myocytes, endothelial cells, and vascular cells.
During ischemia of the heart, brain, and the kidney,
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results in net breakdown of adenosine triphosphate
(ATP) and release of adenosine, which can increase up
to 50 fold.
Three studies have shown the role of adenosine in
RIPC of the heart by RAO and MAO. Two studies in a
rabbit model [25, 27] showed RIPC by RAO (10 min);
reperfusion (10 min) prior to CAO reduced myocardial
infarct size, and 8-SPT (adenosine blocker) abolished
the protective effects, while RIPC by single cycle of
MAO (15 min) and reperfusion prior to CAO in a rat
model increased plasma adenosine levels and reduced
myocardial infarct size.
The following two studies demonstrated the role of
adenosine in RIPC of skeletal muscle. Adenosine release
has been shown to be an effector molecule in skeletal
muscle IPC [109]. (1) RIPC increased adenosine plasma
levels and the protective effect was partially blocked with
reserpine. (2) Prior adenosine blockade [49] did not com-
pletely abolish latissmus dorsi ﬂap protection by RIPC
(limb ischemia, 3  10 min cycles); however, adenosine
blockade (8-SPT) and free radical scavenger mercapto-
propionyl glycine (MPG) completely abolished the RIPC
effect, suggesting that adenosine plays a partial role in
RIPC.
Trigger or Mediator
In a rabbit model adenosine blockade prior to RIPC
abolished cardioprotection, demonstrating its role as a
trigger of RIPC [27]. Adenosine blockade after RIPC
before reperfusion abolished cardioprotection, suggest-
ing its role as a mediator of RIPC also.
Pathway
Following ischemia-induced ATP breakdown, adeno-
sine crosses the cell membrane and enters into the
interstitial space by simple diffusion. From the inter-
stitial space it escapes into the intravascular space by
paracellular washout (slow, 10% under physiological
conditions). It would seem that in RIPC adenosine
produced in the remote organ would reach its target
organ by the bloodstream; however, it has a half-life of
0.6–1.5 s as it is rapidly taken up by endothelial cells,
RBCs, and pericytes, which contain nucleoside trans-
porters and are responsible for rapid degradation of
adenosine [110], making it unlikely for adenosine to
reach its target by the circulation. There are no studies
in RIPC that demonstrate modulation of adenosine
degradation or activation of nucleoside transport in-
hibitors. Two studies showed a rise in plasma adeno-
sine levels following preconditioning, suggesting that
reperfusion and release into circulation is required for
adenosine-induced RIPC [25, 27]. One study [32] sup-
ported a neurogenic pathway for adenosine in RIPC.
They demonstrated abrogation of preconditioning of
the heart by brief cycles of MAO and reperfusion due to
prior ganglion blockade. To further clarify the path-
way, they demonstrated that intramesenteric infusion
with adenosine mimicked the effects of brief MAO and
prior ganglion blockade abolished the protective effects
of RIPC. Ganglion blockade after reperfusion did not
abrogate the protective effects but adenosine receptor
blockade abolished myocardial protection. These obser-
vations suggest that adenosine acts locally to stimulate
afferent nerves in the mesenteric bed, which in turn
activate adenosine receptors in the heart. This argu-
ment is supported by data demonstrating lack of pre-
conditioning following intraportal or intracaval infu-
sion of adenosine and effectively excludes effects of
adenosine spillover during mesenteric infusion, which
could potentially stimulate adenosine receptors in the
liver and contribute to myocardial protection.
Effector Mechanism
8-SPT (adenosine receptor blocker) abolished RIPC
by MAO. 8-SPT was given after reocclusion of mesen-
teric artery [32], preventing adenosine access to the
mesenteric bed. This suggested the presence of adeno-
sine receptors on the heart, the effect of which was
blocked by 8-SPT.
Does Adenosine Modulate End Effectors KATP Channels?
In RIPC two studies (RAO reduced myocardial in-
farct size, rabbit model) [25, 27, 28] demonstrated that
selective mitochondrial KATP channels blockers (5-HD)
abolish the protective effect. The action potential of
sarcolemmal KATP channels was unaffected. Modula-
tion of KATP channels reduced ATP depletion, preserved
intracellular pH, and enhanced recovery of ATP and
phosphocreatinine levels during reperfusion [25]. De-
creased acidosis reduced intracellular Ca accumulation
and myocardial infarct size. These observations are
supported by IPC studies [109] and suggest that KATP
channels serve as end effectors in adenosine pathways.
IPC studies have shown that adenosine mediates
both the early and the late phases of preconditioning
via different end-organ receptors. In the heart aden-
osine acts via the A1 receptor. Adenosine receptors
mediate anti-adrenergic effects indirectly by reduc-
ing C-AMP levels. The A1 receptor-mediated effects
involve activation of PKC, tyrosine kinases [111],
heat shock protein, and MAPK. Kinases modulate
end effector mitochondrial KATP channels. A2 recep-
tors act in the hepatic microcirculation as shown by
Peralta et al. [94]. A2 receptors are linked to vasodila-
tation and antiplugging effects of adenosine. Activa-
tion of these receptors and their effects are due to
endothelium dependent and independent mechanisms,
indirectly through release of NO and through direct
relaxation of vascular smooth muscles. A3 receptors
are found in myocytes.
The effects of adenosine include vasodilatation [110],
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let function [112], and free radical production. These
have to be clearly demonstrated in future studies in
RIPC.
Cytokines (Table 10, Studies 3, 24, 25)
NF-B
Li et al. in a mouse model showed RIPC (six cycles
brief hind limb ischemia) prior to myocardial IR re-
duced infarct size. IRI activated NF-B in hearts but
prior RIPC attenuated activation of NF-Bi nI R[44].
However RIPC in sham animals demonstrated NF-B
activation in both the limb and hearts. This study
demonstrates a dual role for NF-B. While excessive
NF-B activation in IR injury has deleterious effects
and increases infarct size, activation of NF-B follow-
ing limb preconditioning led to an adaptive response in
the heart, increased i (inhibitory KB) expression,
which attenuated NF-B activation following sus-
tained IR injury and reduced myocardial infarct size,
attenuated decrease in left ventricular developed pres-
sures (LVDF) and increases in left ventricular end-
diastolic pressures (LVEDP) on reperfusion. In NF-B
and iNOS knockout models, the decrease in LVDF
was attenuated but preconditioning did not confer
any additional beneﬁt. NF-B and iNOS knockouts
had less severe increase in LVEDP but no addi-
tional attenuation was conferred by preconditioning.
NF-B is induced by ROS and subsequently acts
through activation of kinases in the preconditioning
response. Preconditioning may down-regulate the in-
ﬂammatory response during reperfusion as NF-B
activation increases its own inhibitor I (Tahepold)
or it may act through a mediator such as iNOS, as
suggested by data from this study.
TNF-
Increases in TNF- levels following hepatic IR injury
led to remote organ injury (lung and kidney) and IPC of
the liver reduced both TNF- levels and remote organ
injury as demonstrated by Peralta et al.[113]. This
study suggested that TNF- may have a role in remote
preconditioning. In RIPC two studies have investi-
gated the role of TNF-. Ates et al. showed raised
TNF- levels following renal IR, which were reduced
by preconditioning with brief hepatic ischemia and as-
sociated with improved renal function as compared to
IR groups [24]. RIPC by brief hepatic ischemia prior to
gastric IR (30 min) attenuated plasma TNF- levels in
a rat model [60]. Ren et al. showed in a rat model of
cardiac IR reduced myocardial infarct size following IPC
and in TNF- knockout mice. The protective effect of the
early phase of IPC was not abolished in TNF- knockouts
but that of the late phase of IPC was abolished in knock-
outs, suggesting that late IPC is TNF- dependent. Both
the early and the late phase of RPCT (abdominal incision
prior to cardiac IR) in TNF- knockouts further reduced
myocardial infarct size, suggesting that remote precondi-
tioning of trauma was mechanistically different from
TNF- ablation [63]. Clinical efﬁcacy of cardioprotective
strategies maybe maximized by using a combination of
RPCT and TNF- ablation. This study also showed that
blockade of NF-B and TNF- was additive, suggesting
NF-B to be involved in the signaling pathway of TNF-.
The mechanism of TNF--induced RIPC and IR is un-
clear and future studies are needed to study the mecha-
nism and signaling pathways involved.
IL-6
In lung IR injury secondary to remote limb ischemia
reperfusion, blockade of interorgan inﬂammatory media-
tors such as cytokine IL-6 and levels of primed neutro-
phils by prior limb preconditioning confers protection
with no signiﬁcant difference in levels of TNF-. Con-
versely lung protection against local IRI by remote brief
limb ischemia is mechanistically different and entails
incomplete blockade of systemic inﬂammatory response
syndrome mediators such as IL-6 and circulating primed
neutrophils and complete suppression of IL-1, which is
an early mediator of reperfusion injury. Therefore, de-
spite incomplete blockade, it is likely that remote precon-
ditioning reduces expression of adhesion molecules and
neutrophilic inﬁltration in the lung.
IL-1
RIPC has been shown to confer protection on the
remote organ in lung dysfunction due to limb IR and
local IR by blockade of IL-1. The role of IL-1 was
demonstrated by Harkin et al., who clearly showed an
increase in IL-1 in limb IR, which led to lung injury
and deterioration of lung function [58]. In sustained
limb IR, limb IPC protected lung function from remote
IR injury by blocking the cytokine IL-1. A similar rise
in IL-1 was shown by Waldow in IRI of the lung. RIPC
of the limb ameliorated the rise in IL-1 and conferred
protection on the lung. Thus IL-1 has been shown to
have a role as an interorgan mediator of IR injury and
as a mediator of local IRI [59].
PKC (Table 10, Studies 37, 38)
Evidence
Wolfrum et al. showed that PKC was responsible for
reduction in myocardial infarct size after mesenteric
ischemia reperfusion and blockade of PKC by a highly
selective inhibitor chelerythrine prevented reduction
in infarct size [30]. They showed an increase in myo-
cardial PKC following RIPC and blockade of PKC abol-
ished the protective effect. Weinbrenner et al. showed
RIPC by infrarenal aortic occlusion for 15 min followed
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was abolished by chelerythrine [78].
Pathway of Transduction
There is evidence that myocardial PKC undergoes
activation following ischemic stimuli in IPC [114–116].
This leads to conversion of the cytosolic PKC to partic-
ulate PKC fraction, thereby increasing the ratio of the
particulate to cytosolic fraction. Subsequent activation
of mitochondrial PKC receptors results in activation of
tyrosine kinases and MAP kinases, which lead to opening
up of mitochondrial potassium receptor KATP channels.
Mitochondrial KATP channels serve as end effectors in
modulation of mitochondrial energy ﬂow and preserva-
tion of mitochondrial membrane integrity. Both humoral
and neuronal pathways have an important role in PKC-
mediated RIPC. Wolfrum et al. demonstrated increased
plasma bradykinin levels following mesenteric ischemic
preconditioning, which activated myocardial PKC and
blockade of bradykinin receptors with bradykinin an-
tagonist HOE 140 abolished myocardial protection
[30]. Ganglion blockade with hexamethonium did not
alter the cytosolic to particulate ratio of PKC but pre-
vented activation of PKC. These observations suggest
that bradykinin-induced PKC activation is a prerequi-
site for the cardioprotective effect of RIPC, that activa-
tion of PKC is a decisive step in conferring cardioprotec-
tion, and that both the bradykinin-dependent humoral
pathway as well as the neuronal pathway are essential
for PKC activation.
Bradykinin (Table 10, Studies 18, 37)
Evidence
Shoemaker et al. [29] were the ﬁrst to demonstrate
that mesenteric preconditioning induced increased en-
dogenous bradykinin levels, which had a remote pre-
conditioning effect on the heart and reduced infarct
size following coronary infarction. Blockade of brady-
kinin receptors was associated with increased myocar-
dial infarct size. However, bradykinin blockade in non-
preconditioned animals did not inﬂuence infarct size
and in the absence of preconditioning there was no
change in basal bradykinin levels [117].
What Is the Pathway?
A combined sensory neurogenic and humoral path-
way is strongly suggested in the bradykinin-mediated
RIPC [29]. Following mesenteric ischemia reperfusion,
there is local release of bradykinins, which stimulates
the sensory afferent nerves projecting on efferent
nerves to the heart, which in turn precondition the
heart. Bradykinin receptors B2 are involved in sensory
nerve stimulation and bradykinin receptor antagonists
HOE-140 (Hoechst-140) abolish the protective effect.
This study also showed that bradykinin receptor block-
ade led to loss of protection in both direct and remote
IPC but ganglion blockade abolished protection only in
remote preconditioning. Thus direct preconditioning is
associated with blood-borne kininogens in contrast to
the complementary effect of humoral and neurogenic
pathways in RIPC. Bradykinins activate intracellular
transduction of PKC as demonstrated by Wolfrum et
al. [117]. However, the pathway downstream of ki-
nases remains unclear. Although modulation of KATP
channels is suggested, this needs to be clariﬁed in
future studies.
Catecholamines (Table 10, Studies 39, 40, 41)
Toombs et al. showed IPC by 5 min of CAO, 10 min
reperfusion in rabbits prior to 30 min CAO, and 120
min reperfusion reduced infarct size [118]. In reserpin-
ized rabbits subsequent IPC failed to reduce infarct
size, suggesting the role of noradrenaline release in
IPC. In RIPC two studies provided evidence to support
the role of catecholamines. Oxman et al. [38] showed an
increase in cardiac norepinephrine release and in-
creased baseline plasma levels after limb precondition-
ing due to a systemic stress response that was partially
abolished by reserpine due to depletion of catechol-
amine stores. In reserpinized animals the antiarrhyth-
mic effect of RIPC was blocked. Kharbanda et al.
showed that sympathetic blockade abolished RIPC re-
sulting in increased myocardial infarct size [20].d e
Zeeuw et al. demonstrated that increase in cardiac
interstitial norepinephrine levels following ischemia
was cardioprotective but RIPC by cerebral ischemia
was ineffective due to inadequate increase in norepi-
nephrine levels [119]. The role of catecholamines in
RPCT is only speculative and future studies are needed
to clarify this.
Pathway and Effector Mechanism
In direct IPC endogenous catecholamines are known
to act upon cardiac adenoreceptors, stimulating myo-
cardial protein kinase eventually leading to precondi-
tioning of the heart [120]. In RIPC the likely pathway
seems to be the sympathetic nerve pathway as reser-
pine abolished protection. It is also possible that cat-
echolamines released into the circulation may act on
sympathetic nerve endings in target organs; however,
this needs to be further clariﬁed by measurement of
plasma catecholamine levels and use of adrenergic re-
ceptor blockers. The postreceptor mechanisms are un-
clear and the role of catecholamines in activation of
kinases as well as modulation of KATP channels as end
effectors needs to be clearly demonstrated in future
experiments.
Opioids (Table 10, Studies 42, 43, 44, 45, 46)
Evidence
IPC of the intestine (three cycles of 8 min ischemia,
10 min reperfusion) prior to intestinal IRI (30 min
321 TAPURIA ET AL: REMOTE ISCHEMIC PRECONDITIONINGMAO, 2 h reperfusion) reduced intestinal injury,
edema, LDH, and malionaldehyde levels (markers of
oxidative stress) [121]. Pretreatment with morphine
mimicked the effects of IPC and naloxone abolished the
protective effects of both IPC and morphine [121]. The
intestine and colon are rich in opioid receptors and
contain opioid peptides [121]. This study demonstrated
an increase in endogenous opioid peptides in the efﬂu-
ent collected after IPC and suggested that opioids are
released in response to oxidative stress to confer a
protective effect against stress.
Opioid release from the stress of brief IR could result
in a remote protective mechanism. Five studies have
demonstrated the role of opioids in RIPC in intestinal,
skeletal muscle, and heart tissue. (1) On the basis of
the theory that opioids are released as a natural re-
sponse to stress, are released irrespective of whichever
organ is stressed, and act widely and ubiquitously on
remote organs, Patel et al. [33] demonstrated in a rat
model that RIPC (MAO, 15 min) prior to CAO reduced
myocardial infarct size, which was abolished by nalox-
one. (2) Hindlimb RIPC (3  10 min IR cycles) prior to
4 h of muscle ﬂap ischemia and 48 h reperfusion re-
duced latissmus dorsi, rectus abdominis, and gracilis
ﬂap infarct size. This study demonstrated the remote
protection of all skeletal tissue by RIPC. RIPC (3  5
min IR cycles) prior to 30 min CAO and 120 min reper-
fusion in a rat model reduced myocardial infarct size
and plasma LDH levels [122] and naloxone abolished
these effects. Brief infrarenal aortic occlusion (IOA) 15
min prior to prolonged infrarenal aortic occlusion (30
min) protected myocardium [78]. Dickson et al. demon-
strated a role for opioids in transferred precondition-
ing. Met and leu-enkephalins were liberated from the
preconditioned donor rabbit heart into the coronary
efﬂuent, which subsequently elicited protection when
given to virgin acceptor hearts. Addition of naloxone to
the coronary efﬂuent abolished opioid-induced protec-
tion. Based on evidence that opioids induce ischemic
tolerance in the intestine in direct IPC and the pres-
ence of abundant opioid receptors in the intestine,
Dickson et al. treated ischemic gut with coronary efﬂu-
ent from preconditioned hearts and showed that the
recovery of maximal contractile force of gut after ische-
mia was enhanced by opioids [66–69].
Pathway
Opioid receptors are known to be present in neuro-
muscular regions, especially delta receptors [123], and
previous studies have described the humoral action of
opioid receptors in skeletal muscle by demonstrating
[124] that B-endorphins released in the circulation
stimulate glucose uptake in muscle. In RIPC (hind-
limb) autonomic ganglion blockade by hexamethonium
did not abolish the effects of opioids [49], suggesting
the blood circulation to be the likely pathway of trans-
mission of protection in opioid-induced RIPC. The need
for reperfusion following IOA for cardioprotection and
lack of protection in occlusion without reperfusion [78]
and the evidence for transferred preconditioning in
virgin acceptor hearts by opioids in coronary efﬂuent
from preconditioned hearts are observations that sup-
port a humoral pathway.
Effector Mechanism
Opioids act on receptors in the target organ. This has
been shown in heart, skeletal muscle, and intestinal tis-
sue [33, 49, 122]. Skeletal muscle ﬂap protection by RIPC
was abolished by selective 1 opioid receptor antagonists
and myocardial protection was abolished by selective 1
receptor antagonists. 1 receptors have been shown in all
species and human cardiomyocytes [78]. Activated 1
opioid receptors induce effects which mimic RIPC. In
transferred preconditioning leu-enkephalins activate 1
opioid receptors to induce ischemic tolerance in myocar-
dium or gut [66].
Opioid-induced RIPC prior to skeletal muscle IRI
reduced ATP depletion, lactate accumulation, neutro-
phil inﬁltration, and myeloperoxidase activity in pre-
conditioned skeletal muscle [49], which was abolished
by opioid receptor antagonists. These observations sug-
gest that the energy-sparing effect coupled with atten-
uation of lactate accumulation during early reperfu-
sion is triggered by activation of opioid receptors. This
is supported by IPC studies ([125].
Do Opioid Receptors Modulate KATP Channels?
One study has shown the role of KATP channels in the
end effector energy sparing effect [66, 122]. Coadmin-
istration of Glibenclamide to coronary efﬂuent from
preconditioned hearts abolished transferred precondi-
tioning in ischemic gut [66]. RIPC by  opioid receptors
in the heart modulates mitochondrial pore mobility in
the post receptor mechanism [122]. IPC studies have
shown opioid receptors to act via inhibitory G-protein,
activation of multiple kinases with modulation of mi-
tochondrial and sarcolemmal KATP channels serving as
ﬁnal end effectors [122]. Future studies are needed to
clarify postreceptor mechanisms in RIPC and resolve
receptor subtypes.
Free Radicals (Table, Studies 10–27)
IPC studies have shown that free radicals can di-
rectly activate kinases leading to transcription of pro-
tective proteins [92, 126], and free radical scavenger
MPG abrogates the protective effects of direct precon-
ditioning. Weinbrenner et al. were the ﬁrst to show
that free radicals are key candidate molecules in RIPC
[41]. A single cycle of 15 min of infrarenal aortic occlu-
sion followed by 10 min reperfusion reduced myocar-
dial infarct size signiﬁcantly. MPG blocked the effects
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ing but failed to block multiple cycles of direct precon-
ditioning. This suggested that preconditioning is a
graded phenomenon with multiple cycles producing a
more robust preconditioning stimulus with free radi-
cals being only partially involved in the mechanism of
protection. This study did not demonstrate the source
of free radicals. Recently, Patwell et al. demonstrated
the appearance of hydroxyl free radicals in the circu-
lation following IR of the limb [127], and the argument
that free radicals may be produced from the ischemic
limb in RIPC was supported by Chen et al. [128], who
showed that myocardial infarction was reduced by four
cycles of 10 min femoral artery occlusion-reperfusion
associated with an elevation in whole blood free radical
counts up to 2 h following RIPC. Since ROS levels were
signiﬁcantly low compared to the IRI group, this data
suggest the role of low-dose ROS in inducing precon-
ditioning. In addition, a period of reperfusion for
generation and action of free radicals is needed.
These ﬁndings collectively suggest that free radicals
reach the remote organ via the bloodstream to induce
a preconditioning effect. Conversely, in an animal
model, occlusion of the coronary artery before pre-
conditioning supported a nerve pathway of transmis-
sion of the preconditioning effect [128].
Effector Mechanism
Direct IPC studies have shown that ROS led to the
release of triggers such as NO, catecholamines, aden-
osine, and bradykinin. ROS activates intracellular ki-
nases directly [126] and induces synthesis of protective
proteins. Also ROS activates cytokine NF-B, which
induces iNOS mRNA transcription 24 h later to confer
delayed protection in the target organ. None of these
pathways have been clearly demonstrated in RIPC.
Chen et al. [76] showed that ROS induced elevation of
heat shock protein and mitochondrial antioxidant en-
zymatic activity, which helped maintain mitochondrial
function and reduce apoptosis. However, pretreatment
with MPG abrogated HSP and antioxidant activity.
Further clariﬁcation of the end effector mechanism of
ROS in RIPC, the source of ROS, pathway, and the role
of low-dose ROS in maintenance of mitochondrial
membrane permeability as well as prevention of apo-
ptosis is needed. Also quantiﬁcation of the levels of
ROS, which induce protective mechanisms need to be
determined since high levels of ROS are the key ele-
ments in the initial cascade of IR injury.
KATP Channels (Table 10, Studies 31–36, 38)
Evidence
Moses et al. [47] showed that RIPC (three cycles
hindlimb occlusion) reduced latissmus dorsi infarct
size, which was abolished by nonselective blockers
(glibenclamide) and selective mitochondrial channel
blockers (5-HD). Kristiansen et al. showed RIPC of the
donor heart by hindlimb IR (4  5 min cycles) was
abolished by blockade of nonselective and mitochon-
drial KATP channels and increased infarct size in donor
heart on implantation. Administration of diazoxide (se-
lective mitochondrial k channel activator) prior to ex-
plant conferred protective effects similar to RIPC, sug-
gesting that the effects of RIPC are memorized in the
explanted hearts and are critically dependent on mod-
ulation of mitochondrial KATP channels [45]. Kon-
stantinov et al. showed that blockade of KATP channels
following RIPC in the recipient increased myocardial
infarct size in the implanted heart [46]. Dickson et al.
showed blockade of KATP channels abolished transferred
preconditioning in virgin hearts conferred by coronary
efﬂuent from preconditioned hearts [66]. Mabanta et al.
showed that remote microvascular preconditioning is me-
diated by KATP channels and blockade of KATP channels
abolished preconditioning [129]. Pell et al. showed renal
IR (10 min cycles) reduced myocardial infarct size and
cardioprotection was abolished by KATP blockers (5-HD)
[27]. Moses et al. showed remote skeletal protection by
limb RIPC (3  10 min ischemia) was abolished by 5-HD
(selective mitochondrial channel blocker) [47].
Pathway and Effector Mechanism
Two studies have demonstrated the modulation of
IRI in denervated hearts in a transplant model; this
suggests that the humoral pathway is involved in con-
ferring protection. The role of opioids in transferred
preconditioning supports the humoral pathway.
Are These KATP Channels Triggers of RIPC,
Mediators, or End Effectors?
Moses showed blockade of KATP channels prior to
RIPC abolished protection, suggesting their role in the
trigger mechanism of RIPC [47]. Blockade of KATP
channels after RIPC abolished protection; however,
blockade 10 min prior to ischemia did not inﬂuence
infarct size, indicating a role of KATP channels in the
mediation of signal transduction. This study demon-
strated that the critical time period for KATP channels
to remain open after triggering was 10 min further,
supporting a role in mediation of signal transduction.
One study has shown the opening of mitochondrial
KATP channels and ionic ﬂuxes across mitochondrial
KATP channels in the opioid pathway of RIPC [122] and
one study showed ionic ﬂuxes across KATP channels in
RIPC by the adenosine pathway [27]. These observa-
tions suggest that KATP channels serve as end effectors
in the pathway of RIPC and their role needs to be
further clariﬁed as end effectors for other candidate
molecules.
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All studies discussed above clearly demonstrate the
role of mitochondrial KATP channels in RIPC as blockade
with 5-HD (selective mitochondrial channel blocker) abol-
ished RIPC. Pell et al. [27] showed that RIPC was abol-
ished by 5-HD without affecting the action potential of
sarcolemmal ﬁbers or vasodilator effects of sarcolemmal
KATP channels. The muscle used in the Moses model was
surgically denervated, not associated with changes in
action potential and muscle contractility, suggesting
the unlikely role of sarcolemmal KATP channels in the
energy-sparing effect. Two studies showed K ﬂux
across mitochondrial KATP channels after RIPC [27,
122].
Pell et al. [27] showed that KATP channels reduce ATP
depletion and maintain intracellular pH and phospho-
creatinine levels in heart muscle after RIPC. Moses et
al. showed decreased neutrophilic inﬁltration, myelo-
peroxidase activity, and ATP-sparing effect in precon-
ditioned skeletal muscle [47]. These data suggest that
KATP channel opening reduces the rate of ATP hydro-
lysis or mitochondrial ATPase activity, thereby de-
creasing the rate of ATP depletion. Also, opening of
mitochondrial KATP channels decreases mitochondrial
calcium load, which preserves mitochondrial integrity.
Mitochondrial volume is regulated by KATP channels
and volume changes modify energy ﬂow through the
electron system, thereby inﬂuencing energy transfer
between mitochondria and cellular ATPases. These
studies showed that RIPC applied in vivo exerts pro-
tection upon skeletal muscle and heart after explanta-
tion from the body and has potential beneﬁcial effects
in relation to heart transplantation, cardiopulmonary
bypass, and autologous skeletal muscle transplanta-
tion.
CGRP and Brain Gut Axis (Table 10, Studies 19, 20, 21, 22)
Evidence
CGRP is a neuropeptide and principal neurotrans-
mitter found in capsaicin-sensitive sensory nerves.
CGRP receptor antagonists abolished reduction in in-
farct size by IPC [130] in a rat model, suggesting the
role of CGRP in mediation of IPC of the heart.
Five studies demonstrated the role of CGRP in RIPC
by brief MAO. Tang, Xiao, Wolfrum et al. showed that
brief MAO increased plasma levels of CGRP following
RIPC and reduced myocardial infarct size and blockade
of CGRP receptors, and ganglion blockade abolished
RIPC [31, 34, 35]. Ganglion blockade did not affect
CGRP release. Brzozowski et al. showed decreased mu-
cosal CGRP and blood ﬂow in gastric IR and RIPC by
hepatic/coronary ischemia (2 cycles  5 min IR) re-
stored mucosal CGRP levels in gastric IR and gastric
ﬂow and prior treatment with CGRP receptor antago-
nist and capsaicin-induced sensory nerve deactivation
abolished RIPC by MAO [61]. Administration of exog-
enous CGRP in denervated animals restored RIPC ef-
fects.
What Is the Pathway?
An increase in plasma levels of CGRP as shown in
three studies [31, 34, 35] supports a humoral pathway.
However, ganglion blockade abolished myocardial pro-
tection from brief MAO, demonstrating a neuronal
pathway for CGRP in RIPC by MAO.
Capsaicin selectively depletes neurotransmitters in
sensory nerves and is known to cause deactivation of
sensory afferent neurons. Two studies in RIPC by MAO
have shown that treatment with capsaicin prior to
RIPC by MAO abolished both reduction in myocardial
infarct size and increase in CGRP levels [34, 35]. Two
studies in RIPC by brief hepatic artery occlusion and
CAO [60, 61] showed that prior treatment with capsa-
icin abolished the increase in gastric mucosal CGRP,
increase in gastric blood ﬂow, and reduction in gastric
erosions following RIPC. These observations strongly
support the role of sensory neurons in RIPC. In addi-
tion Brzozowski et al. showed that vagotomy abolished
RIPC from brief hepatic ischemia or CAO and reduced
plasma levels of CGRP. This observation suggests that
vagal efferents form a part of the effector pathway in
CGRP-mediated RIPC and demonstrates the role of the
brain gut axis in RIPC. Finally, L-name (NO blocker)
abolished reduction of myocardial infarct size by CGRP-
mediated RIPC, suggesting that CGRP acts via the NO
pathway [34].
End Effector Mechanism
One study showed that in RIPC by MAO, CGRP
activated myocardial PKC and reduced infarct size
[31]. PKC activation and myocardial protection was
abolished by both ganglion blockade and CGRP recep-
tor antagonists. These data suggest that in RIPC,
CGRP acts at the cellular level by activation of kinases.
Another study showed the NO pathway as discussed
above and NO may be the end effector responsible for
CGRP effects. This argument is supported by past
studies providing evidence for CGRP-related NO re-
lease [34]. One study showed the inhibition of cyto-
kines (TNF- and IL-1) release in the target organ
[60]. Further clariﬁcation of the pathway downstream
is needed in future studies.
Prostaglandins (PGEs) (Table 10, Study 23)
Evidence
Brzozowski et al. showed that indomethacin (nonse-
lective cyclooxygenase blockers), SC-560 (selective cox-
1), and rofecoxib (selective cox-2) blockers abolished
the gastric protective effects of IPC by two cycles of 5
min celiac artery occlusion, RIPC by 2 cycles of 5 min
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with exogenous PGE2 counteracted the effects of Cox
blockers and restored the hyperemic mucosal effects of
RIPC. Brzozowksi et al. also showed increased gastric
mucosal generation of PGE2 in IPC and RIPC. These
observations suggest that increased endogenous activ-
ity of prostaglandins particularly of the COX-2 variety
could be involved in preconditioning and it is known
from past studies that they have a protective effect in
gastric ulcers.
Pathway and Effector Mechanism
Brozozowski et al. showed that functional ablation of
sensory nerves by pretreatment with capsaicin abol-
ished the protective effects in all preconditioned
groups. This observation suggests the involvement of
sensory afferent neurons in the pathway. Vagotomy
abolished RIPC from brief hepatic/CAO, suggesting the
role of vagal efferents and the brain gut axis in medi-
ation of RIPC. RIPC was associated with increased
CGRP and decreased TNF- and IL-1 expression and
release, suggesting amelioration of gastric IRI by pros-
taglandins through modulation of cytokine release and
increased mucosal ﬂow by vasodilatory effects of CGRP
through NO release. These effects were attenuated by
pretreatment with capsaicin and ablation of sensory
nerves known to release NO and CGRP.
HSPs and Hemoxygenase (HO-1) (Table 10, Studies 28, 47)
HSP28, 40, 60, 70, 90, 104 have an important phys-
iological and pathological role. One of the most impor-
tant HSPs is HSP70, which has a cytoprotective role.
The constitutive form of HSP is HSP73, which all cells
express to some extent. The inducible form is HSP72.
HSP expression is more in myocytes compared to
microvascular cells. Enhanced HSP expression may
serve to protect the heart against ischemia reperfusion,
hypoxia, and chemicals in addition to hyperthermia.
HSP express themselves as early as 3 h post reperfu-
sion in the myocardium, begin to decay from 42 h post
reperfusion, and persist up to 72 h as detected by
immunohistochemistry.
In three studies in RIPC, Tanaka et al. showed in a
rabbit model RIPC by four cycles of 5 min CAO and 5
min reperfusion [21, 131] increased cardiac tolerance
due to increased HSP expression in the ischemic and
remote myocardium; Konstantinov showed RIPC by six
cycles of 4 min femoral artery occlusion and 4 min
reperfusion increased expression of HSP73 genes (anti-
inﬂammatory) in the heart of preconditioned mice as
compared to sham [40] and Chen et al. in a rat model
showed increased myocardial HSP expression (HSP70)
following hindlimb RIPC [76].
What Induces HSP?
HSP is induced by ischemia [131] and ROS [76].
Tanaka showed myocytes with immunoreactivity for
HSP as early as 3 h and persistence of this immunoreac-
tivity up to 72 h. This suggests that HSP expression may
be associated with a delayed phase of protection. Mech-
anisms by which ischemia may induce HSP expression
include enhanced tissue levels of catecholamines and an-
giotensins, which induce HSP expression, myocardial
dyskinesia, which induces compensatory hypercontrac-
tion of non-preconditioned myocardium, increased work-
load and a modest increase in HSP in the nonischemic
myocardium, and elevated end-diastolic pressure, which
leads to increased workload and HSP expression. How-
ever these need to be clearly demonstrated in experimen-
tal settings.
What Is the Pathway and Effector Mechanism?
One study [40] showed that reperfusion stimulates
HSP gene expression in myocardium following limb
RIPC in a rat model. Chen et al. demonstrated that
reperfusion induced myocardial HSP expression fol-
lowing limb RIPC and this was abrogated by free rad-
ical scavengers (MPG) [76]. These studies suggest that
circulatory mediators stimulate HSP expression in re-
mote tissue and free radicals are one of these media-
tors. The effector mechanism may involve scavenging
of ROS and modulation of K-channels but this needs to
be clearly demonstrated.
HO-1 (Table 10, Study 47)
HO-1 is a form of inducible HSP. It is an enzyme that
mediates the rate-limiting step of breakdown of haem
to biliverdin, CO, and iron. In this process it scavenges
ROS and mitigates IRI. Previous studies have shown
hemoxygenase to reduce hepatic IR and lung IR [132–
135].
One study showed RIPC by limb ischemia [136] (four
cycles of 10 min ischemia) reduced hepatic IRI and
improved liver function. Hemoxygenase expression at
3 h of reperfusion suggested its role in amelioration of
IR. Zinc protoporphyrin (HO-1 inhibitor) 1 h prior to IR
abolished RIPC effects.
What Is the Pathway?
Thus far no studies have demonstrated HO-1 activ-
ity in serum following RIPC. It is likely that following
RIPC peripheral breakdown of haem may lead to in-
creased CO levels in the blood and CO has both vaso-
dilatory and antiplugging effects in hepatic sinusoids.
However no study has measured post RIPC serum
carboxyhemoglobin levels to demonstrate this. Lai et
al. [136] demonstrated no increase in HO-1 in periph-
eral macrophages following RIPC and therefore the
role of peripheral macrophages as a pathway for HO-1
induction in the liver is unlikely. RIPC induces a low-
grade oxidative stress in the limb that may lead to
release of ROS and cytokines into the circulation, low-
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patic HO-1 expression. This is hypothetical and needs
to be proved by using ROS scavengers. HO-1 pathways
scavenge ROS following IR, stabilize mitochondrial
membrane permeability, and reduce apoptosis by de-
creased cytochrome C release as shown by previous
studies. HO-1 also down-regulates iNOS and inhibits
NF-B expression. Future studies are needed to deﬁne
the pathway and effector mechanism of HO-1.
Effect of RIPC on Inﬂammatory Gene Expression (Table 10,
Studies 29, 30)
The ﬁrst study to look at the effect of remote precondi-
tioning on inﬂammatory gene expression modiﬁcation in
a human model showed that brief forearm ischemia led to
suppression of proinﬂammatory genes [137] encoding
proteins in circulating leukocytes, reduction in neutro-
phil chemotaxis, adhesion, and exocytosis. Studies by
Huda et al. (RIPC MAO model) [140] showed expression
of genes associated with organ protection following RIPC.
Clinical Trials
Kharbanda et al. conducted the ﬁrst clinical trial in
humans [20] and showed that forearm ischemic pre-
conditioning is associated with diminished ischemia
reperfusion injury in the contralateral arm as well as
diminished endothelial injury. The mechanism was not
clearly identiﬁed, although it was thought to be due to
a substance released in the circulation. In a recent trial
in children undergoing cardiac surgery for congenital
heart defects on cardiopulmonary bypass, Cheung et
al. demonstrated that four cycles of right hindlimb
ischemia (5 min) followed by reperfusion (5 min) prior
to cardiopulmonary bypass preconditioned the heart
and reduced infarct size [73]. Thereafter Kristiansen et
al. studied the effect of forearm ischemia on cardiac
ischemia in cardiopulmonary bypass procedures and
found it to be protective. This protective effect was
attributed to KATP channels [45].
In humans, Konstaninov et al. [137] showed dimin-
ished expression of inﬂammatory genes in neutrophils
following limb RIPC. Since neutrophils are one of the
key mediators of the late phase of IRI responsible for
oxidative stress and injury to organs, modulation of
neutrophil activation would be of prime importance in
reducing IRI.
CONCLUSIONS AND FUTURE WORK
Remote preconditioning is a novel method of precon-
ditioning. Limb, mesentery, and kidney are organs
that can effectively be used to induce remote protection
and reduce IRI. Brief periods of cardiac ischemia confer
protection on the lungs and vice versa. This may be of
beneﬁt in cardiovascular surgery and coronary bypass
procedures.
Similar protection in musculoskeletal ﬂaps and pro-
tection of the brain function needs to be evaluated in
clinical trials. Adenosine, NO, PKC, bradykinins, cat-
echolamines, opioids, HO-1 (HSP), free radicals, and
cytokines are the candidate mechanisms that form
part of a complex cascade involved in transduction of
the preconditioning effect with overlap between neuro-
genic and humoral pathways. The RIPC stimulus re-
quires reperfusion, providing unequivocal evidence of a
humoral mediator. However, there are many circulat-
ing mediators such as NO, opioids, and adenosine
which have undergone selective blockade to abrogate
RIPC. The end effect of the remote stimulus is to re-
duce the mitochondrial permeability in the target or-
gan, conserving cellular ATP levels and reducing apo-
ptosis. Microarray analysis has shown transcription of
anti-inﬂammatory genes and modulation of oxidative
stress to be of prime importance in preconditioning.
Application of remote preconditioning in clinical set-
tings has thus far been limited and its use particularly
in organ transplantation is of interest. Future studies
are necessary to study the beneﬁt of this method in a
clinical setting. Modulation of gene expression to pre-
vent IRI is a key area to be studied.
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Effect of remote ischemic preconditioning on hepatic
microcirculation and function in a rat model of hepatic ischemia
reperfusion injury
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Abstract
Background: Liver transplantation involves a period of ischemia and reperfusion to the graft which leads
to primary non-function and dysfunction of the liver in 5–10% of cases. Remote ischemic preconditioning
(RIPC) has been shown to reduce ischemia reperfusion injury (IRI) injury to the liver and increase hepatic
blood flow. We hypothesized that RIPC may directly modulate hepatic microcirculation and have inves-
tigated this using intravital microscopy.
Methods: A rat model of liver IRI was used with 45 min of partial hepatic ischemia (70%) followed by 3 h
of reperfusion. Four groups of animals (Sham, IRI, RIPC+IRI, RIPC+Sham) were studied (n = 6, each
group). Intravital microscopy was used to measure red blood cell (RBC) velocity, sinusoidal perfusion,
sinusoidal flow and sinusoidal diameter. Neutrophil adhesion was assessed by rhodamine labeling of
neutrophils and cell death using propidium iodide.
Results: RIPC reduced the effects of IRI by significantly increasing red blood cell velocity, sinusoidal flow
and sinusoidal perfusion along with decreased neutrophil adhesion and cell death.
Conclusions: Using intravital microscopy, this study demonstrates that RIPC modulates hepatic micro-
circulation to reduce the effects of IRI. HO-1 may have a key role in the modulation of hepatic micro-
circulation and endothelial function.
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Introduction
Livertransplantationinvolvesaperiodof coldandwarmischemia
followed by reperfusion which initiates an inﬂammatory cascade
resulting in organ non-function and dysfunction.
1–3 This is
referred to as ischemia reperfusion injury (IRI).
IRI remains a major concern in liver surgery and transplanta-
tion as the incidence of primary non-function is 5–10% in liver
transplantation and the problem is aggravated in fatty livers. The
success and expansion of liver transplantation has resulted in a
shortage of organ donors and the use of marginal grafts including
steatotic livers. Preconditioning is an adaptive response which
helps reduce the severity of IRI in an experimental setting and has
the potential of increasing the donor pool by increasing tolerance
of marginally fatty livers to IRI. Ischemic preconditioning (IPC)
involves the interruption of blood ﬂow to the liver for brief
periods followed by reperfusion. Nitric oxide (NO)/adenosine
release has been shown to regulate endothelial function and
increase blood ﬂow to the liver.
4–8 However, direct IPC produces
trauma to major vessels and direct stress to the target organ.
Remote ischemic preconditioning (RIPC) is a novel method
which entails brief periods of ischemia followed by reperfusion of
one organ and results in protection of remote organs from
ischemia without direct stress or trauma to blood vessels. It is
DOI:10.1111/j.1477-2574.2009.00006.x HPB
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chemical messengers into the circulation or by activation of nerve
pathways which confer protection on the remote organ. Studies
have been carried out to show the beneﬁt to the heart, lung and
kidney after brief ischemia in the mesentery,
9–12 limb
13–20 and
kidney.
Previous studies (Menger et al.)
21using intravital microscopy
have shown that the hepatic microcirculation is a major
target of hepatic IRI. Microvascular injury precedes parenchymal
injury and is as a result of hypoxia secondary to lack of
microvascular perfusion (no-reﬂow) and reperfusion-associated
inﬂammatory response which includes activation of kupffer cells
and neutrophils (reﬂow – paradox). No reﬂow in sinusoids is
because of endothelial swelling and intravascular hemoconcen-
tration. Reperfusion is associated with release of proinﬂamma-
tory cytokines, oxygen radicals, up-regulation of endothelial and
leukocyte adhesion molecules and interaction of leukocytes with
endothelial lining of the hepatic microvasculature. Hepatic IR
induces neutrophil adhesion in sinusoids and post-sinusoidal
venules.
22,23
Kanoria et al. demonstrated improved liver function using
RIPC in hepatic IRI and increased hepatic blood ﬂow by ICG
and laser Doppler ﬂow measurements.
13 Lai et al. demonstrated
improved liver function and the role of hemoxygenase in hepatic
protection.
24 Gustaffson demonstrated protection of hepatic
function by remote preconditioning.
25 None of these studies
addressed the in vivo microcirculatory changes seen in hepatic
IR and the effect of RIPC on hepatic IR. We focused our study
on the hepatic microcirculatory changes in hepatic IR and the
modulation of the hepatic microcirculation by RIPC. We
hypothesized that RIPC directly modulates hepatic microcircu-
lation in IR injury and applied intravital microscopy to investi-
gate the effects of RIPC.
Material and methods
Animals and surgical procedures
All experiments were conducted under a project license from the
UK home ofﬁce in accordance with the Animals’ Scientiﬁc proce-
dures act 1986. Male Sprague–Dawley rats, weighing 250–300 g,
were used. Animals were kept in a temperature-controlled envi-
ronment with a 12 h light/dark cycle and allowed tap water as well
as standard rat chew pellets ad libitium. Animals were anesthe-
tized with 4 l/min of isoﬂurane (Baxter, Norfolk, UK) and main-
tained with 1–1.5 l/min of O
2 and 0.5–1.0% isoﬂurane.They were
allowed to breathe spontaneously through a concentric mask con-
nected to an oxygen regulator and monitored with a pulse oxime-
ter (Ohmeda biox 3740 pulse oximeter; Ohmeda, Louisville, KY,
USA).
Polyethylene catheters (0.76-mm inner diameter; Portex, Kent,
UK) were inserted into the right carotid artery for monitoring of
mean arterial blood pressure and the left jugular vein (0.40-mm
inner diameter; Portex) for administering normal saline (1 ml/
100 g/h body weight to compensate for intra-operative ﬂuid
loss). The animals were placed in a supine position on a heating
mat (Harvard apparatus Ltd., Kent, UK) to maintain their
temperature.
Animal model
Hepatic I/R
A standard model of lobar hepatic ischemia of the left lateral and
median lobes (70% of liver) was used.
26 Laparotomy was carried
out through a midline incision. The ligamentous attachments of
the liver were cut and the liver was exposed.Ischemia was induced
by clamping the corresponding vascular pedicle with an atrau-
matic microvascular clamp.This model avoids splanchnic conges-
tion. Hepatic ischemia was for a period of 45 min followed by 3 h
of reperfusion.Allanimalsweregivenabolusof heparin[20 U/kg,
intravenously (i.v.)] prior to clamping to prevent hepatic artery
thrombosis.
Limb preconditioning
The technique of remote ischemic preconditioning involved a
hind limb tourniquet, which was applied around the thigh. Limb
perfusion was monitored by a laser Doppler (Moor instruments,
Surrey, UK); the tourniquet around the limb was tightened
until no ﬂow was detected. The procedure involved 5 min of
ischemia followed by 5 min of reperfusion. This was repeated
four times.
27
Tissue and blood collection
After3 hof reperfusion,theanimalswerekilledbyexsanguination
and blood was collected in a BD vacutainer tube SST
mII advance
5.0 ml tubes for Serum, BD vacutainer tube LH 102 I.U> (6 ml)
for citrated plasma and BD vacutainer K 2E 7.2 mg (4 ml) for
ethylenediaminetetraacetic acid (EDTA) plasma and centrifuged
at 1500 g for 10 min to sediment the red blood cells (RBC).Serum
and plasma samples were snap frozen in liquid nitrogen and sub-
sequently stored at -80°C. Liver tissue was also snap frozen and
stored at -80°C. Tissues were also ﬁxed in 10% formalin and
stored for histology.
Experimental groups (n = 6 in each group)
Four groups of animals were studied. Group one (Sham) in
which animals were subjected to laparotomy only and under-
went an identical experimental protocol without clamping. In
group two (IRI) the animals were subjected to 45 min of liver
ischemia followed by 3 hours of reperfusion. Ischemia was
induced by a microvascular clamp applied across the vascular
pedicle supplying the left and median lobes of the liver (70%
ischemia). Group three were preconditioned immediately prior
to the IRI (RIPC+IRI) group as shown in Fig. 1. In group four
(RIPC+Sham) preconditioning was done in the Sham group.
Standard protocols for preconditioning and inducing ischemia
as described above were used.
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The animals were maintained under anesthesia with isoﬂurane
and oxygen .Their temperature was maintained by a warming mat
(which was regulated by a thermostat).
The liver was exposed, placed upon a glass mount and covered
withacoverslip.Theliverwascontinuouslyirrigatedwithnormal
saline.A drop of saline was placed on the cover slip and the tip of
the microscope lens was immersed in the saline drop.
A Nikon (Tokyo, Japan) microscope (Nikon epi-illumination
system with ﬁlter block set suitable for Texas Red,FITC and DAPI
dyes) coupled to a CCD camera [JVC TK-C1360b (Osaka, Japan)
colour video camera] was used. The power of magniﬁcation was
10¥ and 40¥. The microscopy images were recorded for ofﬂine
analysis. Quantitative assessment of microcirculatory parameters
was performed both during the experiment and ofﬂine using
frame-by-frame analysis of the recorded images.
Microcirculation was assessed by evaluating acinar perfusion
in 10 randomly chosen acini and leukocyte endothelial interac-
tion in 10 post-sinusoidal venules.
21,22,23,28 LUCIA (lab universal
computer image analysis; Nikon) software was used to analyze
the images.
RBC velocity (V)
FITC (Fluoroisothyocyanate; Sigma-Aldrich, Dorset, UK) labeled
red cells were prepared from rat blood suspended in glucose
saline buffer solution (20 mg FITC/ml of RBC).
29 Labeled RBCs
(0.5 ml) were administered i.v. to assess the velocity of RBC ﬂow.
Ten randomly chosen non-overlapping rappaport acini were
assessed at each time point and the mean value was calculated.
The RBC velocity was calculated by assessing the distance of
RBC movement (microns) in each sinusoid in subsequent
frames. Twenty-ﬁve frames were captured per second. The veloc-
ity was calculated using the formula = D ¥ 25/number of frames
moved.
Sinusoidal perfusion and perfusion index (PI)
The sinusoidal perfusion index was calculated as the ratio of per-
fused hepatic sinusoids.Continuous perfusion has been described
as continuous ﬂow of red cells through hepatic sinusoids for at
least 1 min. Intermittent perfusion has been described as occa-
sional ﬂow of RBCs in sinusoids. Perfusion index = (Scp + Sip/
Scp+Sip+Snp). [Continuous perfusion (Scp) + intermittent
perfusion (Sip) to the total visible sinusoids which includes non
perfused sinusoids (Snp)].
22
Sinusoidal diameter (D)
Sinusoidal diameter was assessed by measuring the length across
10 randomly chosen hepatic sinusoids at 30, 60, 120 and 180 min
of reperfusion and the mean value was expressed in microns.
Sinusoidal blood flow
The sinusoidal blood ﬂow was calculated using the formula: (V)
¥22/7¥ (D/2)2.
V = Velocity, D = diameter.
Neutrophil adhesion
Rhodamine 6 G (0.3 mg/kg; Sigma)
30 was given i.v. after 180 min
of reperfusion to assess neutrophil adhesion. The numbers of
leukocytes adherent to the sinusoidal endothelium and venular
endothelium were counted as those stationary for a period of 30 s
under green ﬁlter light and expressed as leukocytes/mm
2.The area
Figure 1 Changes in blood pressure
seen in hepatic ischemia reperfusion (IR)
and effect of preconditioning. Both IR
and (RIPC)+IR show a similar fall in blood
pressure; however, RIPC prior to IR
rapidly restores blood pressure to base-
line compared with IR only. Values
expressed as mean + SEM. P < 0.05
Blood pressure changes in hepatic IR and RIPC
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length assuming cylindrical geometry (3.14 ¥ D ¥ L).
Cell death
Hepatocellular death was assessed by i.v. injection of Propidium
iodide (0.05 mg/kg i.v.)
31 at 180 min of reperfusion prior to
terminationof theanimal.Thenumbersof nucleistainedwiththe
dye per high power ﬁeld were counted.Ten randomly chosen high
power ﬁelds were assessed.
Histology
At the end of the experiment,liver tissue was ﬁxed in 10% forma-
lin and embedded in parafﬁn in preparation for light microscopy
analysis.Sectionswerecutat5mandstainedwithhematoxylinand
eosin (H&E) for histological analysis. The histologic changes in
the routine (H&E) stained sections were graded using the modi-
ﬁed Suzuki’s criteria.
32 In this classiﬁcation system, sinusoidal
congestion, hepatocyte necrosis and hepatocyte vacuolation were
graded on a score of 0–4. No changes were scored as 0 whereas
severe congestion, extensive vacuolation and greater than 60% of
lobular necrosis was awarded a score of 4.
Numerical
assessment
01 2 3 4
Sinusoidal
congestion
None Minimal Mild Moderate Severe
Vacuolation None Minimal Mild Moderate Severe
Necrosis None Single cell 30% 60% >60%
Statistical analysis
All data are presented as mean and standard error of the mean
(SEM).Differences were considered signiﬁcant for P < 0.05.Com-
parisons between groups were performed using one-way analysis
(anova). Bonferroni’s correction was applied for anova.
Results
Hemodynamic parameters
Blood pressure (MAP)
There was no signiﬁcant difference in the sham group between
baseline and 180 min demonstrating a hemodynamically stable
model. The blood pressure reduced transiently in the IR and
RIPC+IR groups but this was insigniﬁcant.However,the recovery
to baseline was more rapid in the RIPC group (Fig. 1).
Pulse rate
No signiﬁcant difference was seen between the groups.
Oxygen saturations
The fall in saturations in both the IR group and RIPC+IR group
was not statistically signiﬁcant.
Hepatocellular injury (liver function tests)
After 180 min of reperfusion, the difference between the Sham
and IRI groups was statistically signiﬁcant (P < 0.05). Precondi-
tioning prior to IRI reduced serum transaminase levels although
the difference was not statistically signiﬁcant. Preconditioning
in Sham animals did not show any signiﬁcant elevation in
transaminases.
IR RIPC+IR Sham RIPC+
Sham
ALT (IU/ml) 2079  322.3 1398  460.8 118  22.37 132  25.49
Histologic investigation
Histology of the liver tissue revealed that IR injury produced
signiﬁcant periportal congestion in association with severe necro-
sis in zones 2 and 3 and also sub capsular necrosis. The changes
were diffuse. RIPC+IR showed less necrosis and damage com-
paredwiththeIRgroup.Shamanimalsrevealedminimalchanges.
Congestion was present in both portal vein and central veins.
Hepatocytes showed vacuolation. RIPC+Sham animals showed
minimal changes, some vacuolation, but no necrosis, similar to
the Sham group (Fig. 2)
Histological scoring table
IR RIPC+IR Sham RIPC+Sham
Suzuki score 8.83  0.7 6.2  0.58 4  0.31 1.5  0.34
Sham
(a) (b)
RIPC+Sham
IR Injury. RIPC+IR
(c) (d)
Figure 2 Histology (a) remote ischemic preconditioning+ischemia
reperfusion (RIPC+IR): the hematoxylin and eosin (H&E) section
shows sinusoidal congestion, some hepatocyte vacuolation but no
significant necrosis. (b) IR: the H&E section shows large areas of
necrosis and sinusoidal congestion, normal residual hepatocytes
noted at bottom of the frame. (c) Sham: the H&E section reveals no
significant damage. (d) RIPC+Sham: the H&E section reveals a con-
gested central vein but no other significant change
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group compared with the IR group (P < 0.001).
Intravital microscopy results
Intravital microscopy demonstrated signiﬁcant changes
to the hepatic microcirculation after IR and modiﬁcation by
RIPC.
Velocity of RBC flow
The mean RBC velocity in the Sham group was constant through-
out the time of observation. IRI led to decreased RBC velocity
whereas preconditioning signiﬁcantly increased RBC velocity
(Fig. 3a).
Sinusoidal blood flow
ThesinusoidalbloodﬂowwassigniﬁcantlybetterintheRIPC+IRI
group compared with the IRI group (Fig. 3b).
Diameter of sinusoids
The mean diameter showed no signiﬁcant difference between the
RIPC+IR group and the IR group. The difference between the
Sham and RIPC+IR and between the Sham and IRI groups was
not statistically signiﬁcant.
Perfusion of sinusoids
Preconditioning signiﬁcantly improved sinusoidal perfusion
being signiﬁcantly high compared with the IRI group. These data
show no signiﬁcant difference between RIPC+ IRI and Sham
groups at all time points (Fig. 4).
Neutrophil adhesion
Thenumberof adherentneutrophilswassigniﬁcantlylowerinthe
RIPC+IRIgroupascomparedwiththeIRgroupandsimilartothe
Sham group. In the sinusoidal bed, neutrophil adhesion was sig-
niﬁcantly reduced in the preconditioned group as compared with
the IR group (Figs 5a,b,6).
Hepatocellular death
No signiﬁcant difference was found between the Sham and RIPC
groups but both had a signiﬁcantly lower number of apoptotic
cells compared with IRI (Fig. 7).
Discussion
New findings
This study demonstrates that RIPC modulates microcirculatory
disturbances in hepatic IR leading to increased RBC velocity,
sinusoidal perfusion, decreased sinusoidal and venular neutro-
phil adhesion, improved hepatic microcirculation and de-
creased hepatocyte cell death. This is the ﬁrst in vivo study to
Figure 3 (a) Velocity of red blood cell
(RBC) flow in Sham animals remained
unchanged throughout 180 min of obser-
vation, although there was a significant
increase in velocity in preconditioned
animals prior to ischemia reperfusion
injury (RIPC+IRI) as compared with IRI at
30, 60 and 120 min of reperfusion.
Values expressed as mean  SEM. *P <
0.05 (RIPC+IR/IR). **P < 0.05 (RIPC+IR/
Sham). , P < 0.05 (Sham/IR). +, P < 0.05
(Sham/RIPC+Sham). (b) Sinusoidal flow:
V ¥ (D/2)2 ¥p=V is velocity of RBC, D is
sinusoidal diameter. There was a signifi-
cantly better flow in preconditioned
animals (RIPC+IRI) as compared with
non-preconditioned (IR). Values
expressed as mean  SEM. *P < 0.05
(RIPC+IR/IR). **P < 0.05 (RIPC+IR/
Sham). , P < 0.05 (Sham/IR)
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intravital microscopy and suggest that improvement of
hepatic microcirculation is a key mechanism responsible for
hepatic protection by RIPC in IRI. Recently RIPC has been
shown to modulate pancreatic microcirculation and reduce pan-
creatic IRI.
33
Adequacy of model
The experimental model used is a previously well-described
hepatic lobar ischemia model of warm IR.In the model 45 min of
partial ischemia (70% of the liver) was induced followed by 3 h of
reperfusion.
26 Intravital microscopy has shown that IRI signiﬁ-
cantly reduced velocity of ﬂow and perfusion as compared with
Sham animals. Therefore the model was considered suitable to
studytheeffectsof RIPC.Asthisstudywaslimitedtoinvestigating
theeffectsof warmIRandtheeffectsof RIPCinwarmIR,apartial
hepatic IR model was chosen as against a transplant model. RIPC
was produced using a tourniquet around the hind limb for four
cycles of 5-min ischemia followed by reperfusion. This technique
of RIPChaspreviouslybeenusedinthemodulationof cardiacIRI
after transplantation.
25 Three or more cycles of preconditioning
have been shown to be more effective than a single cycle in pre-
vious experimental studies
27,34,35 and this formed the basis for four
cycles of RIPC used in the current study.
Figure 4 Sinusoidal perfusion index (PI):
the PI remains unchanged in Sham
animals throughout 180 min of observa-
tion. The PI in remote preconditioned
animals (RIPC+IRI) is significantly higher
than non-preconditioned animals (IRI).
The PI in RIPC+IR is not different from
Sham. Values expressed as mean 
SEM. *P < 0.05
Modulation of sinusodial perfusion by RIPC 
0
20
40
60
80
100
30 60 120 180
Reperfusion (min)
P
e
r
f
u
s
i
o
n
 
i
n
d
e
x
 
%
IRI
RIPC+IRI
Sham
RIPC+Sham
**      *  *
Figure 5 (a) Neutrophils stained using
rhodamine are seen adherent to post-
sinusoidal venular endothelium. The
number of adherent neutrophils divided
by the area of endothelial surface (p¥D
¥ L) gives the number of neutrophils/
mm
2. D, sinusoidal diameter, L, length of
segment along adherent neutrophils. (b)
Significantly reduced venular neutrophil
adhesion in the preconditioned
(RIPC+IRI) group compared with the
non-preconditioned group (IRI). Values
expressed as mean  SEM. *P < 0.05
(IR/RIPC+IR), **P < 0.05 (IR/Sham), , P
< 0.05 (IR/RIPC+Sham)
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Shams were hemodynamically stable throughout the course of the
experiments. Limb preconditioning in Sham animals caused a
transient insigniﬁcant fall in blood pressure during precondition-
ing with rapid recovery to baseline levels suggesting no major
effects of Sham laparotomy,anesthesia or RIPC alone.A transient
fall in blood pressure and oxygen saturations associated with
onset of reperfusion was seen in both the IR and RIPC+IR groups.
However,recovery of blood pressure to normal levels was rapid in
the RIPC+IR group as compared with the IR group only. These
observations have been observed in preconditioning models of
lung IRI.
36,37 Kanoria et al. have demonstrated a fall in blood pres-
sureafterhepaticIRinarabbitmodelandrapidrecoveryof blood
pressure in the group which was preconditioned.
13
Histologic findings and limitations of the scoring
system
The RIPC+IR group showed less necrosis, vacuolation and con-
gestion compared with the IR group and objective scoring showed
a signiﬁcantly lower score. However, it was difﬁcult to arrive at an
objective score if the changes noted were focal/patchy. There were
several sections with only sub capsular infarction/necrosis.
Scoring these sections were difﬁcult using the criteria.
Hepatic microcirculatory changes
Sham
The Sham group showed constant velocity, ﬂow and perfusion
over the 180 min of observation. This suggests a stable model for
the study.
Figure 6 Significantly reduced sinusoidal
neutrophil adhesion in the precondi-
tioned group (RIPC+IRI) compared with
non-preconditioned group (IRI). Values
expressed as mean  SEM. *P < 0.05
(IR/RIPC+IR), **P < 0.05 (IR/Sham), , P
< 0.05 (IR/RIPC+Sham)
Sinusoidal neutrophil adhesion in IR and effect of
RIPC
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Figure 7 (a) Hepatocellular cell death in
ischemia reperfusion injury (IRI) using
propidium iodide staining (IVM). The
dead cells appear pink stained by pro-
pidium iodide. The number of cells
divided by the surface area of the field
above gives the number of cells/mm
2.
(b) Hepatocellular cell death seen in
remote ischemic preconditioning (RIPC)+
IR using IVM. (c) Hepatocellular cell
death in the preconditioned group
(RIPC+IRI) was significantly less com-
pared with the non-preconditioned (IRI)
group. Values expressed as mean 
SEM. *P < 0.05 (IR/RIPC+IR), **P < 0.05
(IR/Sham), , P < 0.05 (IR/RIPC+Sham)
Hepatocellular death  as seen using propidium
iodide staining.
0
20
40
60
80
100
(c)
(a) (b)
Animal groups
N
u
m
b
e
r
 
o
f
 
a
p
o
p
t
o
t
i
c
 
c
e
l
l
s
/
H
P
F IRI
RIPC+IR
Sham
RIPC+sham * ** 
114 HPB
HPB 2009, 11, 108–117 © 2009 International Hepato-Pancreato-Biliary AssociationEffects of IRI on hepatic microcirculation
Our study shows a signiﬁcant fall in sinusoidal perfusion and
velocity of ﬂow in the IRI group which was observed at all time
points. Increased venular neutrophil adhesion, hepatocyte cell
death, sinusoidal neutrophil stasis in the IR group with
signiﬁcantly increased serum transaminase levels in IRI and a
signiﬁcantly lower perfusion index compared with Sham animals
wereobserved.Leukocyteadhesioncausesendothelialinjury,RBC
stasis, modulation of sinusoidal tone and perfusion in hepatic
IR.
22,23 Mechanisms which contribute to failure of perfusion
include endothelial swelling and injury, leukocyte endothelial
interaction, leukostasis, alteration in RBC ﬂow and increased vis-
cosity of blood.
22,23,38–40 Both Perfusion failure and venular adhe-
sion have been shown to correlate with hepatic dysfunction,
reduced bile ﬂow and increased transaminases.
39 These studies
support our observations in the hepatic IR model in this study.
Reduced RBC velocity seen in hepatic IR in our study is explained
by previous studies which suggest that free radical release during
IRI leads to erythrocyte damage, increased deformity and
sluggishness of RBC causing reduced RBC velocity, erythrocyte
ﬂux and increased viscosity of blood.
39
Effects of RIPC on hepatic microcirculation in IRI
This study demonstrates that RIPC increases RBC velocity and
erythrocyte ﬂux across sinusoids, signiﬁcantly reduced hepato-
cyte cell death, increased sinusoidal perfusion and sinusoidal
ﬂow as compared with the IR group. The serum transaminase
levels in the RIPC+IR group were lower than IRI. These obser-
vations suggest an improvement in liver function in the
RIPC+IR group as compared with IR group. Interestingly there
is a signiﬁcant initial rise in RBC velocity and ﬂow in the
RIPC+IR group as compared with Sham and IR although the
initial velocities in Sham and IR are not signiﬁcantly different.
However, at 120-min reperfusion a signiﬁcant drop in velocity is
seen in the IR group as compared with Sham whereas the veloc-
ity in RIPC+IR is similar to the Sham group. These observations
suggest that the initial rise in baseline velocity in the RIPC+IR
group acts as a protective mechanism against the deleterious
effects of IR and prevents a fall in velocity and sinusoidal per-
fusion below Sham values as reperfusion injury progresses over a
period of time. The initial molecular pathway responsible for the
increased baseline velocity is unclear but it is likely to be induced
by RIPC in the hepatic ischemia period itself as the velocity of
ﬂow is seen to be high at 30 min of reperfusion.
A signiﬁcant reduction in both venular neutrophil adhesion
and sinusoidal adhesion implies modulation of neutrophil acti-
vation by RIPC leading to decreased oxidative stress, IRI and
perfusion failure. Previous studies
41 have shown ischemic pre-
conditioning to reduce hepatic IR-induced perfusion failure and
preservation of mitochondrial redox state but none have dem-
onstrated the role of RIPC in hepatic IR. Studies have shown
that reduction in RBC velocity occurs because of leukocyte
adhesion, endothelial injury and perfusion impairment (no
reﬂow phenomenon) and increased RBC damage as a result of
free radical release during IR. The observations in our study
suggest that RIPC modulates hepatic microcirculation and may
induce protective mechanisms which protect RBC against free
radical induced damage; however, this needs to be investigated
further.
Effects of RIPC on sham
Remote ischemic preconditioning in the normal Sham group
showed a reduced RBC velocity and sinusoidal ﬂow at 120 min as
compared with 30 min and recovery to baseline at 180 min. This
change in velocity was not statistically signiﬁcant.This maybe as a
result of initial preconditioning induced oxidative stress followed
by development of a tolerance to the low-grade oxidative stress.
This observation is supported by Chen et al.
20 who demonstrated
that limb RIPC produced an increase in free radical levels in the
blood of preconditioned animals which served as a trigger to
induce heat shock protein expression in remote skeletal tissues
and confer protection against skeletal IR. In comparison with the
Sham group, the velocity of ﬂow and sinusoidal ﬂow in RIPC+
Sham was less at 120 min and 180 min as a result of low-grade
oxidative stress induced in a normal liver.
Potential pathway and mechanisms in remote
ischemic preconditioning of the liver
Studies have shown RIPC-induced NO in the heart to reduce
myocardialIRIwhichwasnotabolishedbyneurogenicblockade,
19
increase in plasma free radicals after brief limb RIPC which
induced heat shock proteins in remote skeletal muscle
20 and
increased hemoxygenase (HO-1) in hepatic macrophages after
limb preconditioning the source of which was notperipheral lym-
phocytes.
24 These data suggest that brief limb ischemia leads to
release of biochemical messengers such as free radicals in the
blood which may induce oxidative stress in the remote organ and
HO-1 expression. HO-1 is known to promote degradation of
hem, increase CO production and scavenge free radicals resulting
in improved hepatic function. In vivo studies of the liver have
shown cells, which are hepatic sinusoid-associated pericytes pri-
marily responsible for CO-mediated blood ﬂow regulation in
sinusoids.
42,43 The role of free radicals as messengers in inducing
HO-1 in the liver, the pathway for HO-1 induction in the liver
after brief limb ischemia and the role of HO-1 in modulation of
hepatic microcirculation and endothelial function needs to be
investigated further. The ﬁndings in this study suggest decreased
neutrophil activation, decreased endothelial adhesion and injury
resulting in improved perfusion and ﬂow in the hepatic microcir-
culation. These data suggest that RIPC may induce a decrease
in endothelial adhesion molecule expression through HO-1.
HO-1 is known to reduce endothelial ICAM expression
30,42,44 and
this needs further investigation in animal models of remote
ischemic preconditioning.
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RIPC protects the liver from IRI by modulation of the hepatic
microcirculation. Our study using intravital microscopy demon-
stratesthatincreasedhepaticbloodﬂowafterRIPCisasaresultof
increased RBC velocity, sinusoidal perfusion and decreased neu-
trophil adhesion and cell death. Future animal studies need to
focus on the role of RIPC in animal transplant models and the use
of HO-1 knockout models to clarify the role of HO-1 pathways in
the regulation of endothelial function. Clinical trials need to
investigate the role of RIPC in reducing morbidity and mortality
in patients undergoing liver transplant and resection surgery.
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